17,20-lyase deficiency, isolated, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	CYP17A1
17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	CYP17A1
2-aminoadipic 2-oxoadipic aciduria, 204750 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	DHTKD1
2-methylbutyrylglycinuria, 610006 (3)	ACADSB, SBCAD	600301	10q26.13	ACADSB
3-M syndrome 1, 273750 (3)	CUL7, 3M1	609577	6p21.1	CUL7
3-M syndrome 2, 612921 (3)	OBSL1, KIAA0657, 3M2	610991	2q35	OBSL1
3-M syndrome 3, 614205 (3)	CCDC8, 3M3	614145	19q13.32	CCDC8
3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	MCCC1, MCCA	609010	3q27.1	MCCC1
3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	MCCC2, MCCB	609014	5q13.2	MCCC2
3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)	HADHSC, SCHAD, HHF4	601609	4q25	HADHSC
3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	HIBCH	610690	2q32.2	HIBCH
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	SERAC1, MEGDEL	614725	6q25.3	SERAC1
3-methylglutaconic aciduria, type I, 250950 (3)	AUH	600529	9q22.31	AUH
3-methylglutaconic aciduria, type III, 258501 (3)	OPA3, MGA3	606580	19q13.32	OPA3
3-methylglutaconic aciduria, type IX, 617698 (3)	TIMM50, TIM50, MGCA9	607381	19q13.2	TIMM50
3-methylglutaconic aciduria, type V, 610198 (3)	DNAJC19, TIM14	608977	3q26.33	DNAJC19
3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	CLPB, SKD3, MEGCANN, MGCA7	616254	11q13.4	CLPB
3-methylglutaconic aciduria, type VIII, 617248 (3)	HTRA2, OMI, PARK13, PRSS25, MGCA8	606441	2p13.1	HTRA2
3MC syndrome 1, 257920 (3)	MASP1, CRARF, 3MC1	600521	3q27.3	MASP1
3MC syndrome 2, 265050 (3)	COLEC11, CLK1, 3MC2	612502	2p25.3	COLEC11
3MC syndrome 3, 248340 (3)	COLEC10, CLL1, 3MC3	607620	8q24.12	COLEC10
3p- syndrome (4)	DEL3pterp25, C3DELpterp25	613792	3pter-p25	DEL3pterp25
46, XX sex reversal 4, 617480 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	184757	9q33.3	NR5A1
46XX sex reversal 1, 400045 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRY
46XX sex reversal 2 (4)	SRXX2, DUP17q24.3	278850	17q24.3-q25.1	SRXX2
46XX sex reversal 3 (4)	SRXX3	300833	Xq26.3	SRXX3
46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	DHH
46XY sex reversal 1, 400044 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRY
46XY sex reversal 10 (4)	SRXY10	616425	17q24	SRXY10
46XY sex reversal 2, dosage-sensitive, 300018 (3)	NR0B1, DAX1, AHC, AHX, SRXY2	300473	Xp21.2	NR0B1
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	184757	9q33.3	NR5A1
46XY sex reversal 4 (4)	DEL9p24.3, C9DELp24.3, SRXY4	154230	9p24.3	DEL9p24.3
46XY sex reversal 6, 613762 (3)	MAP3K1, MEKK1, MEKK, SRXY6	600982	5q11.2	MAP3K1
46XY sex reversal 7, 233420 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	DHH
46XY sex reversal 8, 614279 (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	AKR1C2
46XY sex reversal 9, 616067 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	ZFPM2
5-fluorouracil toxicity, 274270 (3)	DPYD, DPD	612779	1p21.3	DPYD
5-oxoprolinase deficiency, 260005 (3)	OPLAH, OPLAHD	614243	8q24.3	OPLAH
?2,4-dienoyl-CoA reductase deficiency, 616034 (3)	NADK2, C5orf33, DECRD	615787	5p13.2	NADK2
?46XY sex reversal 5, 613080 (3)	CBX2, M33, SRXY5	602770	17q25.3	CBX2
?ACAT2 deficiency, 614055 (1)	ACAT2	100678	6q25.3	ACAT2
?Abruzzo-Erickson syndrome, 302905 (3)	TBX22, CPX, ABERS	300307	Xq21.1	TBX22
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
?Advanced sleep phase syndrome, familial, 3, 616882 (3)	PER3, FASPS3	603427	1p36.23	PER3
?Agammaglobulinemia 5, 613506 (3)	LRRC8A, KIAA1437, AGM5	608360	9q34.11	LRRC8A
?Agammaglobulinemia 7, autosomal recessive, 615214 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	PIK3R1
?Al-Gazali-Bakalinova syndrome, 607131 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	RBM28, ANES	612074	7q32.1	RBM28
?Amelogenesis imperfecta, type IE, X-linked 2 (2)	AI1E2, AIH3	301201	Xq22-q28	AI1E2
?Amelogenesis imperfecta, type IIIB, 617607 (3)	AMTN, AI3B	610912	4q13.3	AMTN
?Amyloidosis, familial visceral, 105200 (3)	B2M, IMD43	109700	15q21.1	B2M
?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	SIGMAR1
?Anal canal carcinoma (2)	ANC	105580	11q22-qter	ANC
?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	STEAP3, TSAP6, AHMIO2	609671	2q14.2	STEAP3
?Anencephaly, 206500 (3)	TRIM36, RBCC728, ANPH	609317	5q22.3	TRIM36
?Anhidrosis, isolated, with normal sweat glands, 106190 (3)	ITPR2, ANHD	600144	12p11.23	ITPR2
?Aniridia 2, 617141 (3)	ELP4, PAX6NEB, AN2	606985	11p13	ELP4
?Aniridia 3, 617142 (3)	TRIM44, AN3	612298	11p13	TRIM44
?Antiphospholipid syndrome, familial (2)	ATPLS	107320	6p21.3	ATPLS
?Aplasia cutis congenita, nonsyndromic, 107600 (3)	BMS1, BMS1L, KIAA0187, ACC	611448	10q11.21	BMS1
?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NEK9
?Arthrogryposis, mental retardation, and seizures, 615553 (3)	SLC35A3, AMRS	605632	1p21.2	SLC35A3
?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	DNAJC3, PRKRI, P58, ACPHD	601184	13q32.1	DNAJC3
?Ataxia-telangiectasia-like disorder 2, 615919 (3)	PCNA, ATLD2	176740	20p12.3	PCNA
?Atrial fibrillation 15, 615770 (3)	NUP155, KIAA0791, ATFB15	606694	5p13.2	NUP155
?Atrial fibrillation, familial, 18, 617280 (3)	MYL4	160770	17q21.32	MYL4
?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
?Avascular necrosis of femoral head, primary, 2, 617383 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
?Bardet-Biedl syndrome 11, 615988 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	TRIM32
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
?Bardet-Biedl syndrome 15, 615992 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	WDPCP
?Bardet-Biedl syndrome 18, 615995 (3)	BBIP1, NCRNA00081, BBIP10, BBS18	613605	10q25.2	BBIP1
?Bardet-Biedl syndrome 19, 615996 (3)	IFT27, RABL4, BBS19	615870	22q12.3	IFT27
?Bardet-Biedl syndrome 20, 617119 (3)	IFT74, CCDC2, CMG1, BBS20	608040	9p21.2	IFT74
?Bile acid synthesis defect, congenital, 5, 616278 (3)	ABCD3, PXMP1, PMP70, CBAS5	170995	1p21.3	ABCD3
?Birk-Landau-Perez syndrome, 617595 (3)	SLC30A9, C4orf1, HUEL, BILAPES	604604	4p13	SLC30A9
?Bleeding disorder, platelet-type, 18, 615888 (3)	RASGRP2, CDC25L	605577	11q13.1	RASGRP2
?Bleeding disorder, platelet-type, 19, 616176 (3)	PRKACG, BDPLT19	176893	9q21.11	PRKACG
?Brachydactyly-syndactyly syndrome, 610713 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	PTPRF, LAR, BNAH2	179590	1p34.2	PTPRF
?CHARGE syndrome, 214800 (3)	SEMA3E, SEMAH, KIAA0331	608166	7q21.11	SEMA3E
?Camptosynpolydactyly, complex, 607539 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	BHLHA9
?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	IL17F, ML1, CANDF6	606496	6p12.2	IL17F
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	TRAF3IP2
?Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	TNNI3K, CCDD	613932	1p31.1	TNNI3K
?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	COA5, C2orf64, PET191, CEMCOX3	613920	2q11.2	COA5
?Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CSRP3
?Cardiomyopathy, dilated, 2A, 611880 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
?Cardiomyopathy, dilated, 2B, 614672 (3)	GATAD1, ODAG, CMD2B	614518	7q21.2	GATAD1
?Cardiomyopathy, hypertrophic, 19, 613875 (3)	CALR3, CRT2, CMH19	611414	19p13.11	CALR3
?Carnitine acetyltransferase deficiency (1)	CRAT, CAT1	600184	9q34.11	CRAT
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
?Cataract 42, 115900 (3)	CRYBA2, CTRCT42	600836	2q35	CRYBA2
?Cataract 43, 616279 (3)	UNC45B, SMUNC45, CTRCT43	611220	17q12	UNC45B
?Cataract 45, 616851 (3)	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	616655	19q13.1-q13.2	SIPA1L3
?Cataract, congenital (2)	SORD, SORD1	182500	15q21.1	SORD
?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	IARS2, CAGSSS	612801	1q41	IARS2
?Caudal duplication anomaly, 607864 (3)	AXIN1, AXIN	603816	16p13.3	AXIN1
?Central areolar choroidal dystrophy 1, 215500 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1	600179	17p13.1	GUCY2D
?Centronuclear myopathy 4, 614807 (3)	CCDC78, C16orf25, CNM4	614666	16p13.3	CCDC78
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	ATP8A2, ATPIB, CAMRQ4	605870	13q12.13	ATP8A2
?Cerebellar atrophy, developmental delay, and seizures, 617643 (3)	KCNMA1, SLO, PNKD3, CADEDS	600150	10q22.3	KCNMA1
?Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	GAD1, SCP, CPSQ1	605363	2q31.1	GAD1
?Cerebrooculofacioskeletal syndrome 2, 610756 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	ERCC2
?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3)	PDK3, CMTX6	300906	Xp22.11	PDK3
?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	JPH1, JP1, CMT2K	605266	8q21.11	JPH1
?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	DHTKD1
?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	NAGLU
?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	KARS
?Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	KIF1B
?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	MED25
?Chilblain lupus 2, 614415 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	SAMHD1
?Choanal atresia and lymphedema, 613611 (3)	PTPN14, PEZ, CATLPH	603155	1q32-q41	PTPN14
?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3)	HDAC6, CPBHM	300272	Xp11.23	HDAC6
?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	GPR88, STRG, COCPMR	607468	1p21.2	GPR88
?Ciliary dyskinesia, primary, 37, 617577 (3)	DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37	603332	3p21.1	DNAH1
?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	COQ7, CLK1, COQ10D8	601683	16p12.3	COQ7
?Cognitive impairment with or without cerebellar ataxia, 614306 (3)	SCN8A, CIAT, EIEE13, BFIS5	600702	12q13.13	SCN8A
?Coloboma of optic nerve, 120430 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
?Coloboma, ocular, 120200 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
?Coloboma, ocular, autosomal recessive, 216820 (3)	SALL2, HSAL2, COLB	602219	14q11.2	SALL2
?Combined oxidative phosphorylation deficiency 16, 615395 (3)	MRPL44, COXPD16	611849	2q36.1	MRPL44
?Combined oxidative phosphorylation deficiency 19, 615595 (3)	LYRM4, ISD11, C6orf149, COXPD19	613311	6p25.1	LYRM4
?Combined oxidative phosphorylation deficiency 21, 615918 (3)	TARS2, COXPD21	612805	1q21.2	TARS2
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATP5A1
?Combined oxidative phosphorylation deficiency 25, 616430 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	MARS2
?Combined oxidative phosphorylation deficiency 29, 616811 (3)	TXN2, TRX2, MTRX, COXPD29	609063	22q12.3	TXN2
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFB
?Cone-rod dystrophy (3)	UNC119, HRG4, IMD13	604011	17q11.2	UNC119
?Congenital disorder of glycosylation, type 1aa, 617082 (3)	NUS1, NGBR, C6orf68, CDG1AA	610463	6q22.1	NUS1
?Congenital disorder of glycosylation, type IIq, 617395 (3)	COG2, LDLC, CDG2Q	606974	1q42.2	COG2
?Congenital disorder of glycosylation, type Ii, 607906 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	ALG2
?Congenital disorder of glycosylation, type Ir, 614507 (3)	DDOST, OST, OST48, CDG1R	602202	1p36.12	DDOST
?Congenital disorder of glycosylation, type Is, 300884 (3)	ALG13, GLT28D1, CDG1S, EIEE36	300776	Xq23	ALG13
?Congenital disorder of glycosylation, type Iw, 615596 (3)	STT3A, ITM1, TMC	601134	11q24.2	STT3A
?Congenital disorder of glycosylation, type Ix, 615597 (3)	STT3B, SIMP, CDG1X	608605	3p23	STT3B
?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	WDPCP
?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	FRMD4A, KIAA1294, CCAFCA	616305	10p13	FRMD4A
?Cranioectodermal dysplasia 4, 614378 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	VSX1
?Craniofacioskeletal syndrome (2)	CFSS	300712	Xq26-q27	CFSS
?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	ATR
?Deafness, X-linked 6, 300914 (3)	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	303631	Xq22.3	COL4A6
?Deafness, autosomal dominant 44, 607453 (3)	CCDC50, C3orf6, DFNA44	611051	3q28	CCDC50
?Deafness, autosomal dominant 66, 616969 (3)	CD164, DFNA66	603356	6q21	CD164
?Deafness, autosomal dominant 68, 616707 (3)	HOMER2, HOMER2B, HOMER2A, DFNA68	604799	15q25.2	HOMER2
?Deafness, autosomal dominant 70, 616968 (3)	MCM2, CDCL1, DFNA70	116945	3q21.3	MCM2
?Deafness, autosomal dominant 71, 617605 (3)	DMXL2, RC3, KIAA0856, PEPNS, DFNA71	612186	15q21.2	DMXL2
?Deafness, autosomal dominant 72, 617606 (3)	SLC44A4, CTL4, C6orf29, DFNA72	606107	6p21.33	SLC44A4
?Deafness, autosomal recessive 101, 615837 (3)	GRXCR2, DFNB101	615762	5q32	GRXCR2
?Deafness, autosomal recessive 102, 615974 (3)	EPS8, DFNB102	600206	12p12.3	EPS8
?Deafness, autosomal recessive 103, 616042 (3)	CLIC5, DFNB103	607293	6p21.1	CLIC5
?Deafness, autosomal recessive 104, 616515 (3)	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	611410	6p22.3	FAM65B
?Deafness, autosomal recessive 108, 617654 (3)	ROR1, NTRKR1	602336	1p31.3	ROR1
?Deafness, autosomal recessive 44, 610154 (3)	ADCY1, DFNB44	103072	7p12.3	ADCY1
?Deafness, autosomal recessive 61, 613865 (3)	SLC26A5, PRES, DFNB61	604943	7q22.1	SLC26A5
?Deafness, autosomal recessive 66, 610212 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	605755	6p22.3	DCDC2
?Deafness, autosomal recessive 88, 615429 (3)	ELMOD3, RBED1, DFNB88	615427	2p11.2	ELMOD3
?Deafness, autosomal recessive 91, 613453 (3)	SERPINB6, PI6, PTI, SPI3, DFNB91	173321	6p25.2	SERPINB6
?Deafness, autosomal recessive 97, 616705 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
?Deafness, congenital heart defects, and posterior embryotoxon (3)	JAG1, AGS1, AHD	601920	20p12.2	JAG1
?Diabetes mellitus, insulin-dependent, neonatal (2)	PBCA	600089	6p21.3	PBCA
?Diamond-Blackfan anemia 11, 614900 (3)	RPL26, DBA11	603704	17p13.1	RPL26
?Diamond-Blackfan anemia 12, 615550 (3)	RPL15, DBA12	604174	3p24.2	RPL15
?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	TSR2, WGG1, DBA14	300945	Xp11.22	TSR2
?Diamond-Blackfan anemia 16, 617408 (3)	RPL27, DBA16	607526	17q21.31	RPL27
?Diamond-Blackfan anemia 17, 617409 (3)	RPS27, MPS1, DBA17	603702	1q21.3	RPS27
?Diarrhea 7, 615863 (3)	DGAT1, ARGP1, DIAR7	604900	8q24.3	DGAT1
?Dyskeratosis congenita, autosomal dominant 6, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	ACD
?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	ACD
?Dyskinesia, seizures, and intellectual developmental disorder, 617171 (3)	DEAF1, SPN, ZMYND5, MRD24	602635	11p15.5	DEAF1
?Dystonia 23, 614860 (3)	CACNA1B, CACNL1A5, DYT23	601012	9q34.3	CACNA1B
?Dystonia, juvenile-onset, 607371 (3)	ACTB, BRWS1	102630	7p22.1	ACTB
?EEC syndrome-1 (2)	EEC1	129900	7q11.2-q21.3	EEC1
?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3)	KDF1, C1orf172, ECTD12	616758	1p36.11	KDF1
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT74
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
?Epilepsy, familial temporal lobe, 8, 616461 (3)	GAL, GALN, GLNN, ETL8	137035	11q13.2	GAL
?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	CNTN2, TAX, TAX1, FAME5	190197	1q32.1	CNTN2
?Epilepsy, progressive myoclonic, 10, 616640 (3)	PRDM8, EPM10	616639	4q21.21	PRDM8
?Epilepsy, progressive myoclonic, 8, 616230 (3)	CERS1, LASS1, UOG1, EPM8	606919	19p13.11	CERS1
?Epilepsy, progressive myoclonic, 9, 616540 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	LMNB2
?Epileptic encephalopathy, early infantile, 15, 615006 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	ST3GAL3
?Epileptic encephalopathy, early infantile, 21, 615833 (3)	NECAP1, EIEE21	611623	12p13.31	NECAP1
?Epileptic encephalopathy, early infantile, 40, 617065 (3)	GUF1, EF4, EIEE40	617064	4p12	GUF1
?Epileptic encephalopathy, early infantile, 55, 617599 (3)	PIGP, DSCR5, EIEE55	605938	21q22.13	PIGP
?Epileptic encephalopathy, early infantile, 57, 617771 (3)	KCNT2, SLICK, EIEE57	610044	1q31.3	KCNT2
?Epiphyseal dysplasia, multiple, 6, 614135 (3)	COL9A1, EDM6, STL4	120210	6q13	COL9A1
?Episodic pain syndrome, familial, 1, 615040 (3)	TRPA1, ANKTM1, FEPS1	604775	8q21.11	TRPA1
?Exercise intolerance, riboflavin-responsive, 616839 (3)	SLC25A32, MFT, RREI	610815	8q22.3	SLC25A32
?Exudative vitreoretinopathy 6, 616468 (3)	ZNF408, EVR6, RP72	616454	11p11.2	ZNF408
?Facial clefting, oblique, 1, 600251 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	SPECC1L
?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction, 617732 (3)	TUBB6, FPVEPD	615103	18p11.21	TUBB6
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	NLRC4
?Fanconi anemia, complementation group R, 617244 (3)	RAD51A, RECA, MRMV2, FANCR	179617	15q15.1	RAD51A
?Fanconi anemia, complementation group U, 617247 (3)	XRCC2, FANCU	600375	7q36.1	XRCC2
?Fanconi anemia, complementation group V, 617243 (3)	MAD2L2, MAD2B, FANCV	604094	1p36.22	MAD2L2
?Fanconi anemia, complementation group W, 617784 (3)	RFWD3, FANCW	614151	16q23.1	RFWD3
?Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC34A1
?Fanconi renotubular syndrome 3, 615605 (3)	EHHADH, PBFE, LBFP, FRTS3	607037	3q27.2	EHHADH
?Fazio-Londe disease, 211500 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	SLC52A3
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	ADGRV1
?Fetal akinesia deformation sequence, 208150 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	DOK7
?Fibromatosis, gingival, 1, 135300 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	SOS1
?Focal cortical dysplasia, type II, somatic, 607341 (3)	TSC2, LAM	191092	16p13.3	TSC2
?Frontonasal dysplasia 3, 613456 (3)	ALX1, CART1, FND3	601527	12q21.31	ALX1
?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	DCAF8, WDR42A, GAN2	615820	1q23.2	DCAF8
?Glucocorticoid deficiency 5, 617825 (3)	TXNRD2, TRXR2, SELZ, GCCD5	606448	22q11.21	TXNRD2
?Glycogen storage disease XIII, 612932 (3)	ENO3, GSD13	131370	17p13.2	ENO3
?Glycogen storage disease XV, 613507 (3)	GYG1, GSD15	603942	3q24	GYG1
?Glycoprotein Ia deficiency, 614200 (1)	ITGA2, CD49B, BR, BDPLT9	192974	5q11.2	ITGA2
?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	NCF4, P40PHOX, CGD3	601488	22q12.3	NCF4
?Growth restriction, severe, with distinctive facies, 616489 (3)	IGF2, GRDF	147470	11p15.5	IGF2
?Hairy ears, Y-linked (2)	HEY	425500	Yq	HEY
?Hemochromatosis, type 5, 615517 (3)	FTH1, FTHL6, HFE5	134770	11q12.3	FTH1
?Hepatocellular carcinoma (1)	LCO	165320	2q14-q21	LCO
?Hermansky-Pudlak syndrome 10, 617050 (3)	AP3D1, HPS10	607246	19p13.3	AP3D1
?Hermansky-pudlak syndrome 9, 614171 (3)	BLOC1S6, BLOS6, PLDN, PA, HPS9	604310	15q21.1	BLOC1S6
?Heterotaxy, visceral, 3, autosomal (2)	HTX3	606325	6q21	HTX3
?Hip dysplasia, Beukes type, 142669 (3)	UFSP2, C4orf20, BHD	611482	4q35.1	UFSP2
?Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3)	ECE1	600423	1p36.12	ECE1
?Huntington disease-like 2, 606438 (3)	JPH3, JP3, HDL2	605268	16q24.2	JPH3
?Hydrocephalus, autosomal dominant (2)	HDCPH1	123155	8q12.2-q21.2	HDCPH1
?Hydrolethalus syndrome 2, 614120 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	LARS2
?Hydroxykynureninuria, 236800 (3)	KYNU, KYNUU, VCRL2	605197	2q22.2	KYNU
?Hyperimmunoglobulin G1 syndrome (2)	IGHR	144120	14q32.33	IGHR
?Hyperleucinemia-isoleucinemia or hypervalinemia (1)	BCAT1, BCT1	113520	12p12.1	BCAT1
?Hyperphosphatasia with mental retardation syndrome 5, 616025 (3)	PIGW, HPMRS5	610275	17q12	PIGW
?Hyperprolactinemia, 615555 (3)	PRLR, MFAB, HPRL	176761	5p13.2	PRLR
?Hypertension, salt-resistant (1)	NPR3, ANPRC	108962	5p13.3	NPR3
?Hypertrichosis universalis congenita, Ambras type (2)	HTC1	145701	8q22	HTC1
?Hypervalinemia or hyperleucine-isoleucinemia (1)	BCAT2, BCT2	113530	19q13.33	BCAT2
?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	GNRH1, LNRH, HH12	152760	8p21.2	GNRH1
?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3)	KISS1, HH13	603286	1q32.1	KISS1
?Hypotrichosis 13, 615896 (3)	KRT71, K6IRS1, KRT6IRS1, HYPT13	608245	12q13.13	KRT71
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT74
?Hypotrichosis and recurrent skin vesicles, 613102 (3)	DSC3, DSC4	600271	18q12.1	DSC3
?Immunodeficiency 13, 615518 (3)	UNC119, HRG4, IMD13	604011	17q11.2	UNC119
?Immunodeficiency 16, 615593 (3)	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	600315	1p36.33	TNFRSF4
?Immunodeficiency 22, 615758 (3)	LCK, IMD22	153390	1p35.2	LCK
?Immunodeficiency 25, 610163 (3)	CD247, CD3Z, TCRZ, IMD25	186780	1q24.2	CD247
?Immunodeficiency 37, 616098 (3)	BCL10, IMD37	603517	1p22.3	BCL10
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IRF7
?Immunodeficiency 45, 616669 (3)	IFNAR2, IMD45	602376	21q22.11	IFNAR2
?Immunodeficiency 49, 617237 (3)	BCL11B, CTIP2, IMD49	606558	14q32.2	BCL11B
?Immunodeficiency 53, 617585 (3)	RELB, IREL, IMD53	604758	19q13.32	RELB
?Immunodeficiency, common variable, 11, 615767 (3)	IL21, CVID11	605384	4q27	IL21
?Immunodeficiency, common variable, 14, 617765 (3)	IRF2BP2, CVID14	615332	1q42.3	IRF2BP2
?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)	HNRPA2B1, IBMPFD2	600124	7p15.2	HNRPA2B1
?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	HNRNPA1
?Infantile liver failure syndrome 1, 615438 (3)	LARS, LFIS, ILFS1	151350	5q32	LARS
?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	ADAM17, TACE, NISBD1	603639	2p25.1	ADAM17
?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
?Isolated growth hormone deficiency due to defect in GHRF (1)	GHRH, GHRF	139190	20q11.23	GHRH
?Joubert syndrome 22, 615665 (3)	PDE6D, JBTS22	602676	2q37.1	PDE6D
?Joubert syndrome 26, 616784 (3)	KATNIP, KIAA0556	616650	16p12.1	KATNIP
?Joubert syndrome 29, 617562 (3)	TMEM107, MKS13, JBTS29	616183	17p13.1	TMEM107
?Juvenile myelomonocytic leukemia, 607785 (3)	CBL, CBL2, NSLL	165360	11q23.3	CBL
?Keratoderma, palmoplantar, punctate type 3 (2)	PPKP3	101850	2p25-p12	PPKP3
?Keratosis pilaris atrophicans, 604093 (3)	LRP1, A2MR, KPA	107770	12q13.3	LRP1
?Lacrimal duct defect, 149700 (3)	IGSF3, LCDD	603491	1p13.1	IGSF3
?Laryngeal adductor paralysis (2)	LAP	150270	6p21.3-p21.2	LAP
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
?Lethal congenital contracture syndrome 6, 616248 (3)	ZBTB42, ZNF925, LCCS6	613915	14q32.33	ZBTB42
?Lethal congenital contracture syndrome 8, 616287 (3)	ADCY6, LCCS8	600294	12q13.12	ADCY6
?Leukemia, acute myeloid, 601626 (3)	CEBPA, CEBP	116897	19q13.11	CEBPA
?Leukodystrophy, progressive, early childhood-onset, 617762 (3)	ACER3, APHC, PHCA, PLDECO	617036	11q13.5	ACER3
?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)	SCP2	184755	1p32.3	SCP2
?Lichtenstein-Knorr syndrome, 616291 (3)	SLC9A1, NHE1, APNH, LIKNS	107310	1p36.11	SLC9A1
?Lipodystrophy, congenital generalized, type 3, 612526 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CAV1
?Lipodystrophy, familial partial, type 5, 615238 (3)	CIDEC, FSP27, CIDE3, FPLD5	612120	3p25.3	CIDEC
?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3)	CDK5, LIS7	123831	7q36.1	CDK5
?Long QT syndrome-11, 611820 (3)	AKAP9, YOTIAO, AKAP450	604001	7q21.2	AKAP9
?Lysosomal acid phosphatase deficiency, 200950 (1)	ACP2	171650	11p11.2	ACP2
?Macular degeneration, age-related, 6, 613757 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	RAX2
?Macular dystrophy, patterned, 3, 617111 (3)	MAPKAP3, 3PK, MDPT3	602130	3p21.2	MAPKAP3
?Male infertility (1)	UBE2B, RAD6B	179095	5q31.1	UBE2B
?Male infertility due to acrosin deficiency (2)	ACR	102480	22q13.33	ACR
?Maple syrup urine disease, mild variant, 615135 (3)	PPM1K, PP2CM, PTMP, MSUDMV	611065	4q22.1	PPM1K
?Marden-Walker syndrome, 248700 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	613629	18p11.22-p11.21	PIEZO2
?Meckel syndrome 10, 614175 (3)	B9D2, MKS10, JBTS34	611951	19q13.2	B9D2
?Meckel syndrome 12, 616258 (3)	KIF14, KIAA0042, MKS12	611279	1q32.1	KIF14
?Meckel syndrome 8, 613885 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	TCTN2
?Meckel syndrome 9, 614209 (3)	B9D1, MKSR1, MKS9, JBTS27	614144	17p11.2	B9D1
?Meier-Gorlin syndrome 5, 613805 (3)	CDC6, CDC18L, MGORS5	602627	17q21.2	CDC6
?Meier-Gorlin syndrome 8, 617564 (3)	MCM5, CDC46, MGORS8	602696	22q12.3	MCM5
?Melkersson-Rosenthal syndrome (2)	MROS	155900	9p11	MROS
?Mental retardation, X-linked 100, 300923 (3)	KIF4A, KIF4, MRX100	300521	Xq13.1	KIF4A
?Mental retardation, X-linked 101, 300928 (3)	MID2, MRX101	300204	Xq22.3	MID2
?Mental retardation, X-linked 91, 300577 (3)	ZDHHC15, MRX91	300576	Xq13.3	ZDHHC15
?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3)	RBMX, MRXS11	300199	Xq26.3	RBMX
?Mental retardation, X-linked, syndromic 12 (2)	MRXS12	309545	Xp11	MRXS12
?Mental retardation, X-linked, syndromic 32, 300886 (3)	CLIC2, XAP121, MRXS32	300138	Xq28	CLIC2
?Mental retardation, autosomal dominant 10, 614256 (3)	CACNG2, MRD10	602911	22q12.3	CACNG2
?Mental retardation, autosomal dominant 11, 614257 (3)	EPB41L1, MRD11	602879	20q11.23	EPB41L1
?Mental retardation, autosomal recessive 43, 615817 (3)	WASHC4, KIAA1033, SWIP, MRT43	615748	12q23.3	WASHC4
?Mental retardation, autosomal recessive 45, 615979 (3)	FBXO31, FBX31, FBXO14, FBX14, MRT45	609102	16q24.2	FBXO31
?Mental retardation, autosomal recessive 50, 616460 (3)	EDC3, YJDC, MRT50	609842	15q24.1	EDC3
?Mental retardation, autosomal recessive 55, 617051 (3)	PUS3, MRT55	616283	11q24.2	PUS3
?Mental retardation, autosomal recessive, 37, 615493 (3)	ANK3, MRT37	600465	10q21.2	ANK3
?Mental retardation, autosomal recessive, 52, 616887 (3)	LMAN2L, VIPL, MRT52	609552	2q11.2	LMAN2L
?Methemoglobinemia, type IV, 250790 (3)	CYB5A, MCB5	613218	18q22.3	CYB5A
?Microcephaly 10, primary, autosomal recessive, 615095 (3)	ZNF335, NIF1, NIF2, MCPH10	610827	20q13.12	ZNF335
?Microcephaly 11, primary, autosomal recessive, 615414 (3)	PHC1, EDR1, HPH1, RAE28, MCPH11	602978	12p13.31	PHC1
?Microcephaly 12, primary, autosomal recessive, 616080 (3)	CDK6, PLSTIRE, MCPH12	603368	7q21.2	CDK6
?Microcephaly 13, primary, autosomal recessive, 616051 (3)	CENPE, MCPH13	117143	4q24	CENPE
?Microcephaly 14, primary, autosomal recessive, 616402 (3)	SASS6, SAS6, MCPH14	609321	1p21.2	SASS6
?Microcephaly 16, primary, autosomal recessive, 616681 (3)	ANKLE2, LEM4, KIAA0692, MCPH16	616062	12q24.33	ANKLE2
?Microcephaly 18, primary, autosomal dominant, 617520 (3)	WDFY3, ALFY, BCHS, MCPH18	617485	4q21.23	WDFY3
?Microcephaly 19, primary, autosomal recessive, 617800 (3)	COPB2, MCPH19	606990	3q23	COPB2
?Microhydranencephaly, 605013 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	NDE1
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	NAA10
?Microphthalmia, syndromic 11, 614402 (3)	VAX1, MCOPS11	604294	10q25.3	VAX1
?Microphthalmia, syndromic 13, 300915 (3)	HMGB3, HMG4, HMG2A, MCOPS13	300193	Xq28	HMGB3
?Microphthalmia, syndromic 4 (2)	MCOPS4, ANOP1	301590	Xq27-q28	MCOPS4
?Microtia with or without hearing impairment (AD), 612290 (3)	HOXA2, MCOHI	604685	7p15.2	HOXA2
?Microtia, hearing impairment, and cleft palate (AR), 612290 (3)	HOXA2, MCOHI	604685	7p15.2	HOXA2
?Mirror movements 3, 616059 (3)	DNAL4, MRMV3	610565	22q13.1	DNAL4
?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3)	TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15	600438	10q21.1	TFAM
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATP5A1
?Mitochondrial complex I deficiency, 252010 (3)	NDUFB11, LSDMCA3	300403	Xp11.3	NDUFB11
?Mitochondrial complex I deficiency, 252010 (3)	NDUFB9, UQOR22	601445	8q24.13	NDUFB9
?Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	UQCC2, C6orf126, M19	614461	6p21.31	UQCC2
?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	UQCC3, C11orf83, MC3DN9	616097	11q12.3	UQCC3
?Mitochondrial complex IV deficiency, 220110 (3)	COA7, RESA1, SELRC1, C1orf163	615623	1p32.3	COA7
?Mitochondrial complex IV deficiency, 220110 (3)	COX14, C12orf62	614478	12q13.12	COX14
?Mitochondrial complex IV deficiency, 220110 (3)	COX8A	123870	11q13.1	COX8A
?Mitochondrial complex IV deficiency, 220110 (3)	FASTKD2, KIAA0971	612322	2q33.3	FASTKD2
?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	ATPAF2, ATP12, MC5DN1	608918	17p11.2	ATPAF2
?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	ATP5E, MC5DN3	606153	20q13.32	ATP5E
?Mitochondrial myopathy with lactic acidosis, 251950 (3)	PNPLA8, MMLA	612123	7q31.1	PNPLA8
?Moebius syndrome (2)	MBS, MBS1	157900	13q12.2-q13	MBS
?Morning glory disc anomaly, 120430 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
?Mucopolysaccharidosis type IX, 601492 (3)	HYAL1, MPS9	607071	3p21.31	HYAL1
?Multiple mitochondrial dysfunctions syndrome 3, 615330 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	IBA57
?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	TRIP4
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
?Muscular dystrophy, limb-girdle, type 2X, 616812 (3)	BVES, HBVES, POPDC1, LGMD2X	604577	6q21	BVES
?Muscular dystrophy, limb-girdle, type 2Y, 617072 (3)	TOR1AIP1, LAP1, LAP1B, LGMD2Y	614512	1q25.2	TOR1AIP1
?Muscular dystrophy, limb-girdle, type 2Z, 617232 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMD2Z	615618	3q13.33	POGLUT1
?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	POMK
?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3)	ALG14, CMS15	612866	1p21.3	ALG14
?Myasthenic syndrome, congenital, 17, 616304 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	LRP4
?Myasthenic syndrome, congenital, 18, 616330 (3)	SNAP25, CMS18	600322	20p12.2	SNAP25
?Myasthenic syndrome, congenital, 22, 616224 (3)	PREPL, KIAA0436, CMS22	609557	2p21	PREPL
?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CHRNB1
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
?Myofibromatosis, infantile 2, 615293 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	NOTCH3
?Myopathy, congenital, Compton-North, 612540 (3)	CNTN1, MYPCN	600016	12q12	CNTN1
?Myopathy, congenital, with neuropathy and deafness, 617519 (3)	SPTBN4, QV, CMND	606214	19q13.2	SPTBN4
?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	CHCHD10
?Myopathy, scapulohumeroperoneal, 616852 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
?Myosclerosis, congenital, 255600 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	COL6A2
?N-acetylaspartate deficiency, 614063 (3)	NAT8L, CML3, NACED	610647	4p16.3	NAT8L
?Narcolepsy 1, 161400 (3)	HCRT, OX, NRCLP1	602358	17q21.2	HCRT
?Narcolepsy 7, 614250 (3)	MOG, NRCLP7	159465	6p22.1	MOG
?Nephrolithiasis, calcium oxalate, 167030 (3)	SLC26A1, SAT1, CAON	610130	4p16.3	SLC26A1
?Nephronophthisis 9, 613824 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	NEK8
?Nephrotic syndrome, type 13, 616893 (3)	NUP205, C7orf14, KIAA0225, NPHS13	614352	7q33	NUP205
?Neuroblastoma (1)	TP73	601990	1p36.32	TP73
?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3)	SARS, SERS, NEDMAS	607529	1p13.3	SARS
?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3)	ARHGEF2, GEFH1, KIAA0651, NEDMHM	607560	1q22	ARHGEF2
?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	HSPB3, HSPL27, HMN2C, DHMN2C	604624	5q11.2	HSPB3
?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	REEP1, C2orf23, SPG31, HMN5B	609139	2p11.2	REEP1
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	DST
?Neuropathy, inflammatory demyelinating, 139393 (3)	PMP22, CMT1A, CMT1E, DSS, CIDP	601097	17p12	PMP22
?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	GFI1
?Neutropenia, severe congenital 2, autosomal dominant, 613107 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	GFI1
?Neutrophil chemotactic response, abnormal (2)	NM, NCR	162820	7q22-qter	NM
?Night blindness, congenital stationary, type 1G, 616389 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	GNAT1
?Olmsted syndrome, X-linked, 300918 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	MBTPS2
?Optic atrophy 11, 617302 (3)	YME1L1, YME1L, PAMP, OPA11	607472	10p12.1	YME1L1
?Optic atrophy 9, 616289 (3)	ACO2, ICRD, OPA9	100850	22q13.2	ACO2
?Orofacial cleft 15, 616788 (3)	DLX4, DLX7, DLX8, OFC15	601911	17q21.33	DLX4
?Orofaciodigital syndrome XIV, 615948 (3)	C2CD3, OFD14	615944	11q13.4	C2CD3
?Orofaciodigital syndrome XV, 617127 (3)	KIAA0753, OFIP, OFD15	617112	17p13.1	KIAA0753
?Osteogenesis imperfecta, type XII, 613849 (3)	SP7, OSX, OI12	606633	12q13.13	SP7
?Osteoporosis, involutional, 166710 (1)	VDR	601769	12q13.11	VDR
?Otofaciocervical syndrome 2, 615560 (3)	PAX1, OFC2	167411	20p11.22	PAX1
?Otofaciocervical syndrome, 166780 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
?PEHO syndrome-like, 617507 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL	609736	2p16.1	CCDC88A
?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	TRPV3
?Pancreatic endocrine tumors (1)	ST11, PETS1	602011	3p25	ST11
?Pancreatic lipase deficiency, 614338 (3)	PNLIP, PNLIPD	246600	10q25.3	PNLIP
?Parkinsonism with spasticity, X-linked, 300911 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	ATP6AP2
?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	PIGT
?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CAV1
?Peeling skin syndrome 3, 616265 (3)	CHST8, GALNAC4ST1, PSS3	610190	19q13.11	CHST8
?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	MYH14
?Periventricular nodular heterotopia 6, 615544 (3)	ERMARD, C6orf70, PVNH6	615532	6q27	ERMARD
?Peroxisome biogenesis disorder 10B, 617370 (3)	PEX3, PBD10A, PBD10B	603164	6q24.2	PEX3
?Peroxisome biogenesis disorder 14B, 614920 (3)	PEX11B, PEX14B	603867	1q21.1	PEX11B
?Perrault syndrome 2, 614926 (3)	HARS2, HARSL, HARSR, HO3, PRLTS2	600783	5q31.3	HARS2
?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3)	PCK1, PCKDC	614168	20q13.31	PCK1
?Phosphoserine aminotransferase deficiency, 610992 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSAT1
?Polydactyly, postaxial, type A6, 615226 (3)	ZNF141, D4S90, PAPA6	194648	4p16.3	ZNF141
?Polydactyly, postaxial, type A7, 617642 (3)	IQCE, KIAA1023, PAPA7	617631	7p22.3	IQCE
?Polyendocrine-polyneuropathy syndrome, 616113 (3)	DMXL2, RC3, KIAA0856, PEPNS, DFNA71	612186	15q21.2	DMXL2
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
?Pontocerebellar hypoplasia type 2C, 612390 (3)	TSEN34, PCH2C, LENG5, SEN34	608754	19q13.42	TSEN34
?Pontocerebellar hypoplasia type 5, 610204 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	TSEN54
?Pontocerebellar hypoplasia, type 3, 608027 (3)	PCLO, PCH3	604918	7q21.11	PCLO
?Preauricular fistulae, congenital (2)	PAFC	128700	8q11.1-q13.3	PAFC
?Precocious puberty, central, 1, 176400 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	KISS1R
?Premature ovarian failure 10, 612885 (3)	MCM8, POF10	608187	20p12.3	MCM8
?Premature ovarian failure 12, 616947 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	SYCE1
?Premature ovarian failure 13, 617442 (3)	MSH5, POF13	603382	6p21.33	MSH5
?Premature ovarian failure 2A, 300511 (3)	DIAPH2, DIA, POF2A	300108	Xq21.33	DIAPH2
?Premature ovarian failure 2B, 300604 (3)	FLJ22792, POF1B, POF2B	300603	Xq21.1	FLJ22792
?Progesterone resistance, 264080 (2)	PGR	607311	11q22.1	PGR
?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3, 617069 (3)	TK2, MTDPS2, PEOB3	188250	16q21	TK2
?Prune belly syndrome, 100100 (3)	CHRM3, PBS, EGBRS	118494	1q43	CHRM3
?Ptosis, congenital, 178300 (2)	ZFHX4, ZFH4	606940	8q21.13	ZFHX4
?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
?Ragweed sensitivity (2)	RWS	179450	6p21.3	RWS
?Renal hypodysplasia/aplasia 2, 615721 (3)	FGF20, RHDA2	605558	8p22	FGF20
?Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	NEK8
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
?Retinal cone dystrophy-1 (2)	RCD1	180020	6q25-q26	RCD1
?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	MIR204, MIRN204, RDICC	610942	9q21.12	MIR204
?Retinal dystrophy and obesity, 616188 (3)	TUB, RDOB	601197	11p15.4	TUB
?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ITM2B
?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	RDH11, PSDR1, RALR1, RDJCSS	607849	14q24.1	RDH11
?Retinitis pigmentosa 23, 300424 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
?Retinitis pigmentosa 51, 613464 (3)	TTC8, BBS8, RP51	608132	14q31.3	TTC8
?Retinitis pigmentosa 55, 613575 (3)	ARL6, BBS3, RP55	608845	3q11.2	ARL6
?Retinitis pigmentosa 58, 613617 (3)	ZNF513, RP58	613598	2p23.3	ZNF513
?Retinitis pigmentosa 66, 615233 (3)	RBP3, RP66	180290	10q11.22	RBP3
?Retinitis pigmentosa 67, 615565 (3)	NEK2, RP67	604043	1q32.3	NEK2
?Retinitis pigmentosa 9, 180104 (3)	RP9, PAP1	607331	7p14.3	RP9
?Retinitis pigmentosa, X-linked recessive, 6 (2)	RP6	312612	Xp21.3-p21.2	RP6
?Reynolds syndrome, 613471 (3)	LBR, PHA	600024	1q42.12	LBR
?Ribose 5-phosphate isomerase deficiency, 608611 (3)	RPIA, RPI, RPIAD	180430	2p11.2	RPIA
?Roifman-Chitayat syndrome (2)	RCHTS	613328	15q11-q21.1	RCHTS
?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	SRPX2, SRPUL, RESDX	300642	Xq22.1	SRPX2
?SERKAL syndrome, 611812 (3)	WNT4, SERKAL	603490	1p36.12	WNT4
?Sarcoma, synovial, 300813 (3)	SSX1, SSRC	312820	Xp11.23	SSX1
?Sarcoma, synovial, 300813 (3)	SSX2	300192	Xp11.22	SSX2
?Seckel syndrome 4, 613676 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	CENPJ
?Seckel syndrome 6, 614728 (3)	CEP63, SCKL6	614724	3q22.2	CEP63
?Seckel syndrome 7, 614851 (3)	NIN, KIAA1565, SCKL7	608684	14q22.1	NIN
?Seckel syndrome 8, 615807 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	DNA2
?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	EXT2, SSMS	608210	11p11.2	EXT2
?Sertoli-cell-only syndrome (1)	DAZ	400003	Yq11.223	DAZ
?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
?Slowed nerve conduction velocity, AD, 608236 (3)	ARHGEF10, KIAA0294, SNCV	608136	8p23.3	ARHGEF10
?Sneddon syndrome, 182410 (3)	CECR1, PAN, SNEDS	607575	22q11.1	CECR1
?Sotos syndrome 3, 617169 (3)	APC2, APCL, SOTOS3	612034	19p13.3	APC2
?Spastic ataxia 4, autosomal recessive, 613672 (3)	MTPAP, PAPD1, SPAX4	613669	10p11.23	MTPAP
?Spastic paraplegia 41, autosomal dominant (2)	SPG41	613364	11p14.1-p11.2	SPG41
?Spastic paraplegia 43, autosomal recessive, 615043 (3)	C19orf12, NBIA4, SPG43	614297	19q12	C19orf12
?Spastic paraplegia 57, autosomal recessive, 615658 (3)	TFG, HMSNP, SPG57	602498	3q12.2	TFG
?Spastic paraplegia 61, autosomal recessive, 615685 (3)	ARL6IP1, KIAA0069, SPG61	607669	16p12.3	ARL6IP1
?Spastic paraplegia 63, 615686 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	AMPD2
?Spastic paraplegia 72, autosomal dominant, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	REEP2
?Spastic paraplegia 72, autosomal recessive, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	REEP2
?Spastic paraplegia 73, autosomal dominant, 616282 (3)	CPT1C, SPG73	608846	19q13.33	CPT1C
?Spastic paraplegia 74, autosomal recessive, 616451 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	IBA57
?Spastic paraplegia 77, autosomal recessive, 617046 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	FARS2
?Spermatogenic failure 13, 615841 (3)	TAF4B, TAF2C2, TAFII105, SPGF13	601689	18q11.2	TAF4B
?Spermatogenic failure 14, 615842 (3)	ZMYND15, SPGF14	614312	17p13.2	ZMYND15
?Spermatogenic failure 15, 616950 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	SYCE1
?Spermatogenic failure 17, 617214 (3)	PLCZ1, SPGF17	608075	12p12.3	PLCZ1
?Spermatogenic failure 20, 617593 (3)	CFAP44, WDR52, SPGF20	617559	3q13.2	CFAP44
?Spermatogenic failure 21, 617644 (3)	BRDT, SPGF21	602144	1p22.1	BRDT
?Spermatogenic failure 22, 617706 (3)	MEIOB, SPGF22	617670	16p13.3	MEIOB
?Spermatogenic failure 23, 617707 (3)	TEX14, SPGF23	605792	17q22	TEX14
?Spermatogenic failure 6, 102530 (3)	SPATA16, SPGF6	609856	3q26.31	SPATA16
?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	ASCC1, p50, SMABF2	614215	10q22.1	ASCC1
?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	SIGMAR1
?Spinocerebellar ataxia 26, 609306 (3)	EEF2, EF2, SCA26	130610	19p13.3	EEF2
?Spinocerebellar ataxia 30 (2)	SCA30	613371	4q34.3-q35.1	SCA30
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	CCDC88C
?Spinocerebellar ataxia 41, 616410 (3)	TRPC3, TRP3, SCA41	602345	4q27	TRPC3
?Spinocerebellar ataxia 43, 617018 (3)	MME, CD10, CALLA, NEP, CMT2T, SCA43	120520	3q25.2	MME
?Spinocerebellar ataxia 46, 617770 (3)	PLD3, HUK4, SCA46	615698	19q13.2	PLD3
?Spinocerebellar ataxia, X-linked 1, 302500 (3)	ATP2B3, PMCA3, SCAX1	300014	Xq28	ATP2B3
?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	RUBCN, RUBICON, KIAA0226, SCAR15	613516	3q29	RUBCN
?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3)	VWA3B, SCAR22	614884	2q11.2	VWA3B
?Spinocerebellar ataxia, autosomal recessive 24, 617133 (3)	UBA5, UBE1DC1, EIEE44, SCAR24	610552	3q22.1	UBA5
?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3)	ATG5, APG5, APG5L, ASP, SCAR25	604261	6q21	ATG5
?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3)	XRCC1, SCAR26	194360	19q13.31	XRCC1
?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)	DLX5, SHFM1D	600028	7q21.3	DLX5
?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	LFNG, SCDO3	602576	7p22.3	LFNG
?Spondylocostal dysostosis 6, 616566 (3)	RIPPLY2, C6orf59, SCDO6	609891	6q14.2	RIPPLY2
?Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	155760	15q26.1	ACAN
?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	155760	15q26.1	ACAN
?Steel syndrome, 615155 (3)	COL27A1, KIAA1870, STLS	608461	9q32	COL27A1
?Stickler syndrome, type V, 614284 (3)	COL9A2, EDM2, STL5	120260	1p34.2	COL9A2
?Sudden cardiac failure, alcohol-induced, 617223 (3)	PPA2, SCFI, SCFAI	609988	4q24	PPA2
?Testicular anomalies with or without congenital heart disease, 615542 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
?Tetra-amelia syndrome, 273395 (3)	WNT3, INT4, TETAMS	165330	17q21.31-q21.32	WNT3
?Thrombocytopenia 6, 616937 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	SRC
?Thrombocytopenia, Paris-Trousseau type (4)	TCPT	188025	11q23	TCPT
?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3)	G6B, C6orf25, THAMY	606520	6p21.33	G6B
?Thrombophilia due to decreased release of tissue plasminogen (1)	THPH9	612348	8p12	THPH9
?Thromboxane synthase deficiency, 614158 (1)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	TBXAS1
?Tibial hemimelia (2)	THM	275220	8q24.1	THM
?Townes-Brocks syndrome 2, 617466 (3)	DACT1, DPR1, DAPPER1, FRODO, TBS2	607861	14q23.1	DACT1
?Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	RNF113A, ZNF183, TTD5	300951	Xq24	RNF113A
?Trichotillomania, 613229 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	SLITRK1
?Ullrich congenital muscular dystrophy 2, 616470 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	COL12A1
?Uncombable hair syndrome 2, 617251 (3)	TGM3, UHS2	600238	20p13	TGM3
?Uncombable hair syndrome 3, 617252 (3)	TCHH, THH, THL, TRHY, UHS3	190370	1q21.3	TCHH
?Urocanase deficiency, 276880 (3)	UROC1, UROCD	613012	3q21.3	UROC1
?Uruguay faciocardiomusculoskeletal syndrome, 300280 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	300163	Xq26.3	FHL1
?Waisman syndrome, 311510 (3)	RAB39B, MRX72, WSMN	300774	Xq28	RAB39B
?Webb-Dattani syndrome, 615926 (3)	ARNT2, WEDAS	606036	15q25.1	ARNT2
?Weill-Marchesani syndrome 3, recessive, 614819 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP2
?Weyers acrofacial dysostosis, 193530 (3)	EVC	604831	4p16.2	EVC
?Winchester syndrome, 277950 (3)	MMP14, WNCHRS	600754	14q11.2	MMP14
?Wiskott-Aldrich syndrome 2, 614493 (3)	WIPF1, WASPIP, WIP, WAS2	602357	2q31.1	WIPF1
?XFE progeroid syndrome, 610965 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	NEFH, CMT2CC	162230	22q12.2	NEFH
ABCD syndrome, 600501 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	EDNRB
ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3)	ARMC5, AIMAH2	615549	16p11.2	ARMC5
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
AICA-ribosiduria due to ATIC deficiency, 608688 (3)	ATIC, PURH, AICAR	601731	2q35	ATIC
Aarskog-Scott syndrome, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	FGD1
Abdominal obesity-metabolic syndrome (2)	AOMS2	605572	17p12	AOMS2
Abdominal obesity-metabolic syndrome 1 (2)	AOMS1, SYNX	605552	3q27	AOMS1
Abdominal obesity-metabolic syndrome 3, 615812 (3)	DYRK1B, MIRK, AOMS3	604556	19q13.2	DYRK1B
Abetalipoproteinemia, 200100 (3)	MTP	157147	4q23	MTP
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	TWIST2
Acampomelic campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SOX9
Acatalasemia, 614097 (3)	CAT	115500	11p13	CAT
Acetyl-CoA carboxylase deficiency, 613933 (1)	ACACA, ACAC, ACC1, ACACAD	200350	17q12	ACACA
Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	AAAS, AAA	605378	12q13.13	AAAS
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Achondrogenesis Ib, 600972 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Achondrogenesis, type IA, 200600 (3)	TRIP11, TRIP230, CEV14, ACG1A	604505	14q32.12	TRIP11
Achondrogenesis, type II or hypochondrogenesis, 200610 (3)	COL2A1	120140	12q13.11	COL2A1
Achondroplasia, 100800 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Achromatopsia 2, 216900 (3)	CNGA3, CNG3, ACHM2	600053	2q11.2	CNGA3
Achromatopsia 3, 262300 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	CNGB3
Achromatopsia 4, 613856 (3)	GNAT2, ACHM4	139340	1p13.3	GNAT2
Achromatopsia 6, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	PDE6H
Achromatopsia 7, 616517 (3)	ATF6, ACHM7	605537	1q23.3	ATF6
Acid-labile subunit, deficiency of, 615961 (3)	IGFALS, ALS, ACLSD	601489	16p13.3	IGFALS
Acne inversa, familial, 1, 142690 (3)	NCSTN	605254	1q23.2	NCSTN
Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3)	PSENEN, PEN2, ACNINV2	607632	19q13.12	PSENEN
Acne inversa, familial, 3, 613737 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Acrocallosal syndrome, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
Acrocapitofemoral dysplasia, 607778 (3)	IHH, BDA1	600726	2q35	IHH
Acrodermatitis enteropathica, 201100 (3)	SLC39A4, ZIP4	607059	8q24.3	SLC39A4
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Acrodysostosis 2, with or without hormone resistance, 614613 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	PDE4D
Acrofacial dysostosis 1, Nager type, 154400 (3)	SF3B4, SF3B49, SAP49, AFD1	605593	1q21.2	SF3B4
Acrofacial dysostosis, Cincinnati type, 616462 (3)	POLR1A, RPA194, AFDCIN	616404	2p11.2	POLR1A
Acrokeratosis verruciformis, 101900 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	ATP2A2
Acromegaloid features, overgrowth, cleft palate, and hernia (2)	AOCH	606049	Chr.11	AOCH
Acromelic frontonasal dysostosis, 603671 (3)	ZSWIM6, KIAA1577, AFND	615951	5q12.1	ZSWIM6
Acromesomelic dysplasia, Demirhan type, 609441 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BMPR1B
Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	NPR2
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Acropectoral syndrome (2)	ACRPS	605967	7q36	ACRPS
Acropectorovertebral dysplasia (2)	ACRPV	102510	2q36	ACRPV
Acute insulin response (2)	AIR	601676	1p31	AIR
Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	ACADM, MCAD	607008	1p31.1	ACADM
Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	ACADS, SCAD	606885	12q24.31	ACADS
Adams-Oliver syndrome 1, 100300 (3)	ARHGAP31, CDGAP, KIAA1204, AOS1	610911	3q13.32-q13.33	ARHGAP31
Adams-Oliver syndrome 2, 614219 (3)	DOCK6, KIAA1395, AOS2	614194	19p13.2	DOCK6
Adams-Oliver syndrome 3, 614814 (3)	RBPJ, RBPSUH, IGKJRB1, AOS3	147183	4p15.2	RBPJ
Adams-Oliver syndrome 4, 615297 (3)	EOGT, EOGT1, C3orf64, AOS4	614789	3p14.1	EOGT
Adams-Oliver syndrome 5, 616028 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	NOTCH1
Adams-Oliver syndrome 6, 616589 (3)	DLL4, AOS6	605185	15q15.1	DLL4
Adenine phosphoribosyltransferase deficiency, 614723 (3)	APRT, APRTD	102600	16q24.3	APRT
Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
Adenocarcinoma of lung, somatic, 211980 (3)	BRAF, NS7	164757	7q34	BRAF
Adenocarcinoma of lung, somatic, 211980 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Adenocarcinoma of lung, somatic, 211980 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
Adenocarcinoma, colonic, somatic (3)	RAD54L, HR54, HRAD54	603615	1p34.1	RAD54L
Adenocarcinoma, ovarian, somatic, 167000 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
Adenoma, periampullary, somatic (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Adenomas, multiple colorectal, 608456 (3)	MUTYH, MYH	604933	1p34.1	MUTYH
Adenomas, salivary gland pleomorphic, somatic, 181030 (3)	PLAG1, SGPA, PSA	603026	8q12.1	PLAG1
Adenomatous polyposis coli, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Adenosine deaminase deficiency, partial, 102700 (3)	ADA	608958	20q13.12	ADA
Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	PKLR, PK1	609712	1q22	PKLR
Adenylosuccinase deficiency, 103050 (3)	ADSL	608222	22q13.1	ADSL
Adermatoglyphia, 136000 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS	612761	4q22.3	SMARCAD1
Adiponectin deficiency, 612556 (3)	ADIPOQ, APM1, GBP28, ADIPQTL1	605441	3q27.3	ADIPOQ
Adrenal adenoma, somatic (3)	MEN1	613733	11q13.1	MEN1
Adrenal cortical carcinoma, 202300 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	CYP11B1
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CYP21A2
Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3)	HSD3B2	613890	1p12	HSD3B2
Adrenal hypoplasia, congenital, 300200 (3)	NR0B1, DAX1, AHC, AHX, SRXY2	300473	Xp21.2	NR0B1
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	CYP11A1, P450SCC	118485	15q24.1	CYP11A1
Adrenocortical insufficiency, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	184757	9q33.3	NR5A1
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Adrenocorticotropic hormone deficiency, 201400 (3)	TBX19	604614	1q24.2	TBX19
Adrenoleukodystrophy, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	ABCD1
Adrenomyeloneuropathy, adult, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	ABCD1
Adult i phenotype without cataract, 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	GCNT2
Advanced sleep phase syndrome, familial, 1, 604348 (3)	PER2, FASPS1, KIAA0347	603426	2q37.3	PER2
Advanced sleep-phase syndrome, familial, 2, 615224 (3)	CSNK1D, ASPS, FASPS2	600864	17q25.3	CSNK1D
Afibrinogenemia, congenital, 202400 (3)	FGA	134820	4q31.3	FGA
Afibrinogenemia, congenital, 202400 (3)	FGB	134830	4q31.3	FGB
Afibrinogenemia, congenital, 202400 (3)	FGG	134850	4q32.1	FGG
Agammaglobulinemia 1, 601495 (3)	IGHM, MU, AGM1	147020	14q32.33	IGHM
Agammaglobulinemia 2, 613500 (3)	IGLL1, IGO, IGL5, VPREB2, AGM2	146770	22q11.23	IGLL1
Agammaglobulinemia 3, 613501 (3)	CD79A, IGA	112205	19q13.2	CD79A
Agammaglobulinemia 4, 613502 (3)	BLNK, SLP65, AGM4	604515	10q24.1	BLNK
Agammaglobulinemia 6, 612692 (3)	CD79B, IGB, B29, AGM6	147245	17q23.3	CD79B
Agammaglobulinemia 8, autosomal dominant, 616941 (3)	TCF3, E2A, AGM8	147141	19p13.3	TCF3
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	BTK
Agammaglobulinemia, X-linked 1, 300755 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	BTK
Agammaglobulinemia, X-linked 2 (2)	AGMX2, XLA2, IMD6	300310	Xp22	AGMX2
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q14	SLC12A6
Agnathia-otocephaly complex, 202650 (3)	PRRX1, PMX1, PHOX1, AGOTC	167420	1q24.2	PRRX1
Aicardi syndrome (2)	AIC	304050	Xp22	AIC
Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
Aicardi-Goutieres syndrome 2, 610181 (3)	RNASEH2B, DLEU8, FLJ11712, AGS2	610326	13q14.3	RNASEH2B
Aicardi-Goutieres syndrome 3, 610329 (3)	RNASEH2C, AYP1, FLJ20974, AGS3	610330	11q13.1	RNASEH2C
Aicardi-Goutieres syndrome 4, 610333 (3)	RNASEH2A, RNHIA, AGS4	606034	19p13.13	RNASEH2A
Aicardi-Goutieres syndrome 5, 612952 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	SAMHD1
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	ADAR
Aicardi-Goutieres syndrome 7, 615846 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	IFIH1
Al Kaissi syndrome, 617694 (3)	CDK10, PISSLRE, ALSAS	603464	16q24.3	CDK10
Al-Raqad syndrome, 616459 (3)	DCPS, HINT5, DCS1, ARS	610534	11q24.2	DCPS
Alacrima, achalasia, and mental retardation syndrome, 615510 (3)	GMPPA, AAMR	615495	2q35	GMPPA
Alagille syndrome 1, 118450 (3)	JAG1, AGS1, AHD	601920	20p12.2	JAG1
Alagille syndrome 2, 610205 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	NOTCH2
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CACNA1F
Alazami syndrome, 615071 (3)	LARP7, PIP7S, ALAZS	612026	4q25	LARP7
Alazami-Yuan syndrome, 617126 (3)	TAF6, TAF2E, TAFII80, ALYUS	602955	7q22.1	TAF6
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
Albinism, oculocutaneous, type IA, 203100 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
Albinism, oculocutaneous, type IB, 606952 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
Albinism, oculocutaneous, type III, 203290 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	TYRP1
Albinism, oculocutaneous, type IV, 606574 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
Albinism, oculocutaneous, type V (2)	OCA5	615312	4q24	OCA5
Albinism, oculocutaneous, type VI, 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	SLC24A5
Albinism, oculocutaneous, type VII, 615179 (3)	C10orf11, OCA7	614537	10q22.2-q22.3	C10orf11
Albinism-deafness syndrome (2)	ADFN, ALDS	300700	Xq24-q26	ADFN
Alcohol sensitivity, acute, 610251 (3)	ALDH2	100650	12q24.12	ALDH2
Aldosterone to renin ratio raised (3)	CYP11B2	124080	8q24.3	CYP11B2
Aldosteronism, glucocorticoid-remediable, 103900 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	CYP11B1
Alexander disease, 203450 (3)	GFAP, ALXDRD	137780	17q21.31	GFAP
Alkaptonuria, 203500 (3)	HGD, AKU	607474	3q13.33	HGD
Allan-Herndon-Dudley syndrome, 300523 (3)	SLC16A2, DXS128, XPCT	300095	Xq13.2	SLC16A2
Alopecia areata 1 (2)	AA1	104000	18p11.3-p11.2	AA1
Alopecia areata 2 (2)	AA2	610753	16q11-q22	AA2
Alopecia universalis, 203655 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HR
Alopecia, androgenetic, 1 (2)	AGA1, MPB	109200	3q26	AGA1
Alopecia, androgenetic, 2 (2)	AGA2	300710	Xq11-q12	AGA2
Alopecia, androgenetic, 3 (2)	AGA3	612421	20p11.22	AGA3
Alopecia-mental retardation syndrome 1 (2)	APMR1	203650	3q26.3-q27.3	APMR1
Alopecia-mental retardation syndrome 2 (2)	APMR2	610422	3q26.2-q26.31	APMR2
Alopecia-mental retardation syndrome 3 (2)	APMR3	613930	18q11.2-q12.2	APMR3
Alpha-1-antichymotrypsin deficiency (3)	SERPINA3, AACT, ACT	107280	14q32.13	SERPINA3
Alpha-2-macroglobulin deficiency, 614036 (1)	A2M , A2MD	103950	12p13.31	A2M 
Alpha-2-plasmin inhibitor deficiency, 262850 (3)	PLI, SERPINF2	613168	17p13.3	PLI
Alpha-fetoprotein deficiency, 615969 (3)	AFP, HPAFP, AFPD	104150	4q13.3	AFP
Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)	OGDH	613022	7p13	OGDH
Alpha-methylacetoacetic aciduria, 203750 (3)	ACAT1	607809	11q22.3	ACAT1
Alpha-methylacyl-CoA racemase deficiency, 614307 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	AMACR
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	ATRX
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	ATRX
Alpha-thalassemia/mental retardation syndrome, type 1 (4)	HBHR, ATR1	141750	16pter-p13.3	HBHR
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)	RAG1	179615	11p12	RAG1
Alport syndrome, 301050 (3)	COL4A5, ATS, ASLN	303630	Xq22.3	COL4A5
Alport syndrome, autosomal dominant, 104200 (3)	COL4A3	120070	2q36.3	COL4A3
Alport syndrome, autosomal recessive, 203780 (3)	COL4A3	120070	2q36.3	COL4A3
Alport syndrome, autosomal recessive, 203780 (3)	COL4A4	120131	2q36.3	COL4A4
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	AMMEC, DELXq22.3, CXDELq22.3	300194	Xq22.3	AMMEC
Alstrom syndrome, 203800 (3)	ALMS1, ALSS, KIAA0328	606844	2p13.1	ALMS1
Alternating hemiplegia of childhood 2, 614820 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	ATP1A3
Alternating hemiplegia of childhood, 104290 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	ATP1A2
Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	FOXF1, FKHL5, ACDMPV	601089	16q24.1	FOXF1
Alveolar soft-part sarcoma, 606243 (3)	ASPSCR1, RCC17, ASPL, ASPS	606236	17q25.3	ASPSCR1
Alzheimer disease 1, familial, 104300 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	APP
Alzheimer disease 17 (2)	AD17	615080	6p21.2	AD17
Alzheimer disease 6 (2)	AD6	605526	10q24	AD6
Alzheimer disease 8 (2)	AD8	607116	20p	AD8
Alzheimer disease, type 3, 607822 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Alzheimer disease-10 (2)	AD10	609636	7q36	AD10
Alzheimer disease-11 (2)	AD11	609790	9p22.1	AD11
Alzheimer disease-2, 104310 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Alzheimer disease-4, 606889 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	PSEN2
Alzheimer disease-5 (2)	AD5	602096	12p11.23-q13.12	AD5
Alzheimer disease-7 (2)	AD7	606187	10p13	AD7
Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3)	GPR68, OGR1, AI2A6	601404	14q32.11	GPR68
Amelogenesis imperfecta, type 1E, 301200 (3)	AMELX, AMG, AIH1, AMGX, AI1E	300391	Xp22.2	AMELX
Amelogenesis imperfecta, type IA, 104530 (3)	LAMB3, AI1A	150310	1q32.2	LAMB3
Amelogenesis imperfecta, type IB, 104500 (3)	ENAM, AIH2, AI1C	606585	4q13.3	ENAM
Amelogenesis imperfecta, type IC, 204650 (3)	ENAM, AIH2, AI1C	606585	4q13.3	ENAM
Amelogenesis imperfecta, type IF, 616270 (3)	AMBN, AI1F	601259	4q13.3	AMBN
Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	FAM20A, AIGFS, AI1G	611062	17q24.2	FAM20A
Amelogenesis imperfecta, type IH, 616221 (3)	ITGB6, AI1H	147558	2q24.2	ITGB6
Amelogenesis imperfecta, type IIA1, 204700 (3)	KLK4, EMSP1, PRSS17, AI2A1	603767	19q13.41	KLK4
Amelogenesis imperfecta, type IIA2, 612529 (3)	MMP20, AI2A2	604629	11q22.2	MMP20
Amelogenesis imperfecta, type IIA3, 613211 (3)	WDR72, AI2A3	613214	15q21.3	WDR72
Amelogenesis imperfecta, type IIA4, 614832 (3)	ODAPH, C4orf26	614829	4q21.1	ODAPH
Amelogenesis imperfecta, type IIA5, 615887 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SLC24A4
Amelogenesis imperfecta, type IIIA, 130900 (3)	FAM83H, AI3A	611927	8q24.3	FAM83H
Amelogenesis imperfecta, type IJ, 617297 (3)	ACPT, AI1J	606362	19q13.33	ACPT
Amelogenesis imperfecta, type IV, 104510 (3)	DLX3, TDO, AI4	600525	17q21.33	DLX3
Aminoacylase 1 deficiency, 609924 (3)	ACY1, ACY1D	104620	3p21.2	ACY1
Amyloidosis, 3 or more types, 105200 (3)	APOA1	107680	11q23.3	APOA1
Amyloidosis, Finnish type, 105120 (3)	GSN	137350	9q33.2	GSN
Amyloidosis, familial visceral, 105200 (3)	FGA	134820	4q31.3	FGA
Amyloidosis, hereditary, transthyretin-related, 105210 (3)	TTR, PALB	176300	18q12.1	TTR
Amyloidosis, primary localized cutaneous, 1, 105250 (3)	OSMR, OSMRB, PLCA1	601743	5p13.1	OSMR
Amyloidosis, primary localized cutaneous, 2, 613955 (3)	IL31RA, GLMR, GPL, PLCA2	609510	5q11.2	IL31RA
Amyloidosis, renal, 105200 (3)	LYZ	153450	12q15	LYZ
Amyotrophic lateral sclerosis 1, 105400 (3)	SOD1, ALS1	147450	21q22.11	SOD1
Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	TARDBP
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	OPTN
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	VCP
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	UBQLN2, PLIC2, CHAP1, ALS15	300264	Xp11.21	UBQLN2
Amyotrophic lateral sclerosis 17, 614696 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	CHMP2B
Amyotrophic lateral sclerosis 18, 614808 (3)	PFN1, ALS18	176610	17p13.2	PFN1
Amyotrophic lateral sclerosis 19, 615515 (3)	ERBB4, HER4, ALS19	600543	2q34	ERBB4
Amyotrophic lateral sclerosis 2, juvenile, 205100 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALS2
Amyotrophic lateral sclerosis 20, 615426 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	HNRNPA1
Amyotrophic lateral sclerosis 21, 606070 (3)	MATR3, MPD2, ALS21	164015	5q31.2	MATR3
Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3)	TUBA4A, TUBA1, ALS22	191110	2q35	TUBA4A
Amyotrophic lateral sclerosis 3 (2)	ALS3	606640	18q21	ALS3
Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	SETX
Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	SPG11
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	FUS
Amyotrophic lateral sclerosis 7 (2)	ALS7	608031	20p13	ALS7
Amyotrophic lateral sclerosis 8, 608627 (3)	VAPB, VAPC, ALS8	605704	20q13.32	VAPB
Amyotrophic lateral sclerosis 9, 611895 (3)	ANG, RNASE5, ALS9	105850	14q11.2	ANG
Amyotrophy, hereditary neuralgic, 162100 (3)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	SEPT9
Analbuminemia, 616000 (3)	ALB, ANALBA, FDAH	103600	4q13.3	ALB
Anauxetic dysplasia 1, 607095 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRP
Anauxetic dysplasia 2, 617396 (3)	POP1, ANXD2	602486	8q22.2	POP1
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KCNJ2
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Anemia, hemolytic, Rh-null, regulator type, 268150 (3)	RHAG, RH50A, OHST	180297	6p12.3	RHAG
Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	NT5C3A, NT5C3, UMPH1, PSN1	606224	7p14.3	NT5C3A
Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	600523	12q13.12	SLC11A2
Anemia, neonatal hemolytic, fatal and near-fatal (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPTB
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1	301300	Xp11.21	ALAS2
Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	SLC25A38, SIDBA2	610819	3p22.1	SLC25A38
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	GLRX5
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	HSPA9
Anemia, sideroblastic, with ataxia, 301310 (3)	ABCB7, ABC7, ASAT	300135	Xq13.3	ABCB7
Aneurysm, intracranial berry, 1 (2)	ANIB1	105800	7q11.2	ANIB1
Aneurysm, intracranial berry, 11 (2)	ANIB11	614252	8p22	ANIB11
Aneurysm, intracranial berry, 2 (2)	ANIB2	608542	19q13	ANIB2
Aneurysm, intracranial berry, 3 (2)	ANIB3	609122	1p36.13-p34.3	ANIB3
Aneurysm, intracranial berry, 4 (2)	ANIB4	610213	5p15.2-p14.3	ANIB4
Aneurysm, intracranial berry, 5 (2)	ANIB5	300870	Xp22	ANIB5
Aneurysm, intracranial berry, 7 (2)	ANIB7	612161	11q24-q25	ANIB7
Aneurysm, intracranial berry, 8 (2)	ANIB8	612162	14q23	ANIB8
Aneurysmal bone cysts (2)	ANBC	606179	16q22	ANBC
Angelman syndrome, 105830 (3)	UBE3A, ANCR	601623	15q11.2	UBE3A
Angio serpiginosum (2)	AGSPX	300652	Xp11.3-q12	AGSPX
Angioedema, hereditary, type III, 610618 (3)	F12, HAF, HAE3	610619	5q35.3	F12
Angioedema, hereditary, types I and II, 106100 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	C1NH
Angiofibroma, somatic (3)	MEN1	613733	11q13.1	MEN1
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Aniridia, 106210 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
Anisomastia (2)	ANMA	605746	16q13-q21	ANMA
Anonychia congenita, 206800 (3)	RSPO4, CRISTIN4	610573	20p13	RSPO4
Anosmia, isolated congenital (2)	ANIC	107200	18p11.23-q12.2	ANIC
Anterior segment anomalies with or without cataract, 602588 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
Anterior segment dysgenesis 1, multiple subtypes, 107250 (3)	PITX3, CTPP4, CTRCT11, ASGD1	602669	10q24.32	PITX3
Anterior segment dysgenesis 2, multiple subtypes, 610256 (3)	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	601094	1p33	FOXE3
Anterior segment dysgenesis 3, multiple subtypes, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3	601090	6p25.3	FOXC1
Anterior segment dysgenesis 4, 137600 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	601542	4q25	PITX2
Anterior segment dysgenesis 5, multiple subtypes, 604229 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
Anterior segment dysgenesis 6, multiple subtypes, 617315 (3)	CYP1B1, GLC3A, ASGD6	601771	2p22.2	CYP1B1
Anterior segment dysgenesis 7, with sclerocornea, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7	605158	2p25.3	PXDN
Anterior segment dysgenesis 8, 617319 (3)	CPAMD8, KIAA1283, ASGD8	608841	19p13.11	CPAMD8
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3)	POR	124015	7q11.23	POR
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Aortic aneurysm, familial abdominal 1 (2)	AAA1, AAA	100070	19q13	AAA1
Aortic aneurysm, familial abdominal 2 (2)	AAA2	609782	4q31	AAA2
Aortic aneurysm, familial abdominal, 4 (2)	AAA4	614375	12q13.3	AAA4
Aortic aneurysm, familial thoracic 1 (2)	AAT1, FAA1	607086	11q23.3-q24	AAT1
Aortic aneurysm, familial thoracic 10, 617168 (3)	LOX, AAT10	153455	5q23.1	LOX
Aortic aneurysm, familial thoracic 2 (2)	AAT2, FAA2	607087	5q13-q14	AAT2
Aortic aneurysm, familial thoracic 4, 132900 (3)	MYH11, AAT4, FAA4	160745	16p13.11	MYH11
Aortic aneurysm, familial thoracic 6, 611788 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTA2
Aortic aneurysm, familial thoracic 7, 613780 (3)	MYLK, MLCK, AAT7	600922	3q21.1	MYLK
Aortic aneurysm, familial thoracic 8, 615436 (3)	PRKG1, PRKG1B, PRKGR1B, AAT8	176894	10q11.2-q21.1	PRKG1
Aortic aneurysm, familial thoracic 9, 616166 (3)	MFAP5, MAGP2, AAT9	601103	12p13.31	MFAP5
Aortic valve disease 1, 109730 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	NOTCH1
Aortic valve disease 2, 614823 (3)	SMAD6, MADH6, AOVD2	602931	15q22.31	SMAD6
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Aphasia, primary progressive, 607485 (3)	GRN, CLN11	138945	17q21.31	GRN
Aplasia of lacrimal and salivary glands, 180920 (3)	FGF10	602115	5p12	FGF10
Aplastic anemia, 609135 (3)	NBN, NBS1	602667	8q21.3	NBN
Aplastic anemia, 609135 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	PRF1
Apnea, postanesthetic (3)	BCHE, CHE1	177400	3q26.1	BCHE
ApoA-I and apoC-III deficiency, combined (3)	APOA1	107680	11q23.3	APOA1
Apolipoprotein A-II deficiency (3)	APOA2	107670	1q23.3	APOA2
Apolipoprotein C-III deficiency, 614028 (3)	APOC3, HALP2	107720	11q23.3	APOC3
Apparent mineralocorticoid excess, 218030 (3)	HSD11B2, HSD11K, AME	614232	16q22.1	HSD11B2
Argininemia, 207800 (3)	ARG1	608313	6q23.2	ARG1
Argininosuccinic aciduria, 207900 (3)	ASL	608310	7q11.21	ASL
Aromatase deficiency, 613546 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	CYP19A1
Aromatase excess syndrome, 139300 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	CYP19A1
Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	DDC	107930	7p12.2-p12.1	DDC
Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	TGFB3
Arrhythmogenic right ventricular dysplasia 10, 610193 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	DSG2
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	DSC2
Arrhythmogenic right ventricular dysplasia 11, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	DSC2
Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	JUP
Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	RYR2
Arrhythmogenic right ventricular dysplasia 3 (2)	ARVD3	602086	14q12-q22	ARVD3
Arrhythmogenic right ventricular dysplasia 4 (2)	ARVD4	602087	2q32.1-q32.3	ARVD4
Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	TMEM43
Arrhythmogenic right ventricular dysplasia 6 (2)	ARVD6	604401	10p14-p12	ARVD6
Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	PKP2, ARVD9	602861	12p11.21	PKP2
Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3)	CTNNA3, ARVD13	607667	10q21.3	CTNNA3
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABCC6
Arterial tortuosity syndrome, 208050 (3)	SLC2A10, GLUT10, ATS	606145	20q13.12	SLC2A10
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNI2, AMCD2B, DA2B, FSSV	191043	11p15.5	TNNI2
Arthrogryposis multiplex congenita, neurogenic (2)	AMCN, AMCN1	208100	5q35	AMCN
Arthrogryposis multiplex congenita, neurogenic, with myelin defect, 617468 (3)	LGI4, AMCNMY	608303	19q13.12	LGI4
Arthrogryposis, distal, type 10 (2)	DA10	187370	2q31.3-q32.1	DA10
Arthrogryposis, distal, type 1B, 614335 (3)	MYBPC1, LCCS4	160794	12q23.2	MYBPC1
Arthrogryposis, distal, type 2A, 193700 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	MYH3
Arthrogryposis, distal, type 2B, 601680 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	MYH3
Arthrogryposis, distal, type 2B, 601680 (3)	TNNT3, AMCD2B, DA2B, FSSV	600692	11p15.5	TNNT3
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
Arthrogryposis, distal, type 3, 114300 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	613629	18p11.22-p11.21	PIEZO2
Arthrogryposis, distal, type 5, 108145 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	613629	18p11.22-p11.21	PIEZO2
Arthrogryposis, distal, type 5D, 615065 (3)	ECEL1, XCE, DA5D	605896	2q37.1	ECEL1
Arthrogryposis, distal, type 8, 178110 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	MYH3
Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT	613629	18p11.22-p11.21	PIEZO2
Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	GLE1
Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	VPS33B	608552	15q26.1	VPS33B
Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	VIPAS39, VIPAR, SPE39, C14orf133	613401	14q24.3	VIPAS39
Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	WISP3
Arts syndrome, 301835 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Asparagine synthetase deficiency, 615574 (3)	ASNS, ASNSD	108370	7q21.3	ASNS
Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	GOT1, ASTQTL1	138180	10q24.2	GOT1
Aspartylglucosaminuria, 208400 (3)	AGA	613228	4q34.3	AGA
Asplenia, isolated congenital, 271400 (3)	RPSA, LAMR1, LAMBR, ICAS	150370	3p22.1	RPSA
Asthma and nasal polyps, 208550 (3)	TBX21, TBET	604895	17q21.32	TBX21
Ataxia with isolated vitamin E deficiency, 277460 (3)	TTPA, TTP1, AVED	600415	8q12.3	TTPA
Ataxia, cerebellar, Cayman type, 601238 (3)	ATCAY, CLAC, KIAA1872	608179	19p13.3	ATCAY
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	APTX, AOA, AOA1	606350	9p21.1	APTX
Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	FLVCR1, AXPC1, PCARP	609144	1q32.3	FLVCR1
Ataxia, sensory, 1, autosomal dominant, 608984 (3)	RNF170, SNAX1	614649	8p11.21	RNF170
Ataxia-oculomotor apraxia 3, 615217 (3)	PIK3R5, p101	611317	17p13.1	PIK3R5
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, AOA4	605610	19q13.33	PNKP
Ataxia-pancytopenia syndrome, 159550 (3)	SAMD9L, ATXPC	611170	7q21.2	SAMD9L
Ataxia-telangiectasia, 208900 (3)	ATM, ATA, AT1	607585	11q22.3	ATM
Ataxia-telangiectasia-like disorder 1, 604391 (3)	MRE11A, MRE11, ATLD	600814	11q21	MRE11A
Atelosteogenesis II, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Atelosteogenesis, type I, 108720 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Atelosteogenesis, type III, 108721 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Athabaskan brainstem dysgenesis syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	HOXA1
Atransferrinemia, 209300 (3)	TF, TFQTL1	190000	3q22.1	TF
Atrial fibrillation, familial, 1 (2)	ATFB1	608583	10q22-q24	ATFB1
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Atrial fibrillation, familial, 11, 614049 (3)	GJA5, CX40, ATFB11	121013	1q21.2	GJA5
Atrial fibrillation, familial, 12, 614050 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ABCC9
Atrial fibrillation, familial, 13, 615377 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52	600235	19q13.11	SCN1B
Atrial fibrillation, familial, 14, 615378 (3)	SCN2B, ATFB14	601327	11q23.3	SCN2B
Atrial fibrillation, familial, 16, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	SCN3B
Atrial fibrillation, familial, 17, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	SCN4B
Atrial fibrillation, familial, 2 (2)	ATFB2	608988	6q14-q16	ATFB2
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Atrial fibrillation, familial, 4, 611493 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	KCNE2
Atrial fibrillation, familial, 6, 612201 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	NPPA
Atrial fibrillation, familial, 7, 612240 (3)	KCNA5, ATFB7	176267	12p13.32	KCNA5
Atrial fibrillation, familial, 8 (2)	ATFB8	613055	16q22	ATFB8
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KCNJ2
Atrial septal defect 1 (2)	ASD1	108800	5p	ASD1
Atrial septal defect 2, 607941 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
Atrial septal defect 4, 611363 (3)	TBX20, ASD4	606061	7p14.2	TBX20
Atrial septal defect 5, 612794 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Atrial septal defect 6, 613087 (3)	TLL1, TLL, ASD6	606742	4q32.3	TLL1
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Atrial septal defect 8, 614433 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	CITED2
Atrial septal defect 9, 614475 (3)	GATA6, AVSD5, ASD9, PACHD	601656	18q11.2	GATA6
Atrial standstill 2, 615745 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	NPPA
Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	GJA5, CX40, ATFB11	121013	1q21.2	GJA5
Atrichia with papular lesions, 209500 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HR
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Atrioventricular septal defect 4, 614430 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Atrioventricular septal defect 5, 614474 (3)	GATA6, AVSD5, ASD9, PACHD	601656	18q11.2	GATA6
Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	CRELD1, AVSD2	607170	3p25.3	CRELD1
Au-Kline syndrome, 616580 (3)	HNRNPK, HNRPK, AUKS	600712	9q21.32	HNRNPK
Auditory neuropathy and optic atrophy, 617717 (3)	FDXR, ADXR, ANOA	103270	17q25.1	FDXR
Auditory neuropathy, autosomal dominant, 1, 609129 (3)	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	614567	13q21.2	DIAPH3
Auditory neuropathy, autosomal recessive, 1, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	OTOF
Aural atresia, congenital, 607842 (3)	TSHZ1, TSH1, CAA	614427	18q22.3	TSHZ1
Auriculocondylar syndrome 1, 602483 (3)	GNAI3, ARCND1	139370	1p13.3	GNAI3
Auriculocondylar syndrome 2, 614669 (3)	PLCB4, ARCND2	600810	20p12.3-p12.2	PLCB4
Auriculocondylar syndrome 3, 615706 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	EDN1
Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	STAT3
Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	ZAP70
Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	ITCH, AIP4, NAPP1, ADMFD	606409	20q11.22	ITCH
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	FAS
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	FASLG
Autoimmune lymphoproliferative syndrome, type II, 603909 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	CASP10
Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	PRKCD, CVID9, ALPS3	176977	3p21.1	PRKCD
Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	AIRE, APECED, APS1	607358	21q22.3	AIRE
Autoinflammation with arthritis and dyskeratosis, 617388 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK	606636	17p13.2	NLRP1
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	NLRC4
Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	PLCG2
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	PSMB8
Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3)	OTULIN, FAM105B, GUM, AIPDS	615712	5p15.2	OTULIN
Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	TNFAIP3, A20, OTUD7C, AISBL	191163	6q23.3	TNFAIP3
Autonomic nervous system dysfunction (3)	DRD4	126452	11p15.5	DRD4
Avascular necrosis of the femoral head, 608805 (3)	COL2A1	120140	12q13.11	COL2A1
Axenfeld-Rieger syndrome, type 1, 180500 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	601542	4q25	PITX2
Axenfeld-Rieger syndrome, type 3, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3	601090	6p25.3	FOXC1
Ayme-Gripp syndrome, 601088 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	MAF
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	607210	7p22.2	CARD11
B-cell non-Hodgkin lymphoma, high-grade (3)	BCL7A, BCL7	601406	12q24.31	BCL7A
Bainbridge-Ropers syndrome, 615485 (3)	ASXL3, KIAA1713, BRPS	615115	18q12.1	ASXL3
Baller-Gerold syndrome, 218600 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQL4
Bamforth-Lazarus syndrome, 241850 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	FOXE1
Band heterotopia, 600348 (3)	EML1, EMAPL, EMAP, BH	602033	14q32.2	EML1
Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Baraitser-Winter syndrome 1, 243310 (3)	ACTB, BRWS1	102630	7p22.1	ACTB
Baraitser-Winter syndrome 2, 614583 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	ACTG1
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	TWIST2
Bardet-Biedl syndrome 1, 209900 (3)	BBS1	209901	11q13.2	BBS1
Bardet-Biedl syndrome 10, 615987 (3)	BBS10, C12orf58, FLJ23560	610148	12q21.2	BBS10
Bardet-Biedl syndrome 12, 615989 (3)	BBS12, FLJ35630, C4orf24	610683	4q27	BBS12
Bardet-Biedl syndrome 13, 615990 (3)	MKS1, MKS, BBS13, JBTS28	609883	17q22	MKS1
Bardet-Biedl syndrome 16, 615993 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	SDCCAG8
Bardet-Biedl syndrome 17, 615994 (3)	LZTFL1, BBS17	606568	3p21.31	LZTFL1
Bardet-Biedl syndrome 2, 615981 (3)	BBS2, RP74	606151	16q13	BBS2
Bardet-Biedl syndrome 21, 617406 (3)	C8orf37, CORD16, RP64, BBS21	614477	8q22.1	C8orf37
Bardet-Biedl syndrome 3, 600151 (3)	ARL6, BBS3, RP55	608845	3q11.2	ARL6
Bardet-Biedl syndrome 4, 615982 (3)	BBS4	600374	15q24.1	BBS4
Bardet-Biedl syndrome 5, 615983 (3)	BBS5	603650	2q31.1	BBS5
Bardet-Biedl syndrome 6, 605231 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	MKKS
Bardet-Biedl syndrome 7, 615984 (3)	BBS7	607590	4q27	BBS7
Bardet-Biedl syndrome 8, 615985 (3)	TTC8, BBS8, RP51	608132	14q31.3	TTC8
Bardet-Biedl syndrome 9, 615986 (3)	PTHB1, BBS9	607968	7p14.3	PTHB1
Bare lymphocyte syndrome, type I, 604571 (3)	TAP1, ABCB2, RING4, PSF1	170260	6p21.32	TAP1
Bare lymphocyte syndrome, type I, 604571 (3)	TAPBP, TPSN	601962	6p21.32	TAPBP
Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	TAP2
Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)	CIITA, MHC2TA, C2TA	600005	16p13.13	CIITA
Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)	RFX5	601863	1q21.3	RFX5
Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	RFXAP	601861	13q13.3	RFXAP
Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	RFX5	601863	1q21.3	RFX5
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	ASCC1, p50, SMABF2	614215	10q22.1	ASCC1
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	CTHRC1	610635	8q22.3	CTHRC1
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	MSR1, SCARA1, SRA	153622	8p22	MSR1
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Barth syndrome, 302060 (3)	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	TAZ
Bartter syndrome, type 1, 601678 (3)	SLC12A1, NKCC2	600839	15q21.1	SLC12A1
Bartter syndrome, type 2, 241200 (3)	KCNJ1, ROMK1	600359	11q24.3	KCNJ1
Bartter syndrome, type 3, 607364 (3)	CLCNKB	602023	1p36.13	CLCNKB
Bartter syndrome, type 4a, 602522 (3)	BSND	606412	1p32.3	BSND
Bartter syndrome, type 4b, digenic, 613090 (3)	CLCNKA	602024	1p36.13	CLCNKA
Bartter syndrome, type 4b, digenic, 613090 (3)	CLCNKB	602023	1p36.13	CLCNKB
Bartter syndrome, type 5, antenatal, transient, 300971 (3)	MAGED2, MAGED, BARTS5	300470	Xp11.21	MAGED2
Basal cell carcinoma, somatic, 605462 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	PTCH1
Basal cell carcinoma, somatic, 605462 (3)	PTCH2	603673	1p34.1	PTCH2
Basal cell carcinoma, somatic, 605462 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	RASA1
Basal cell carcinoma, somatic, 605462 (3)	SMOH, SMO, CRJS	601500	7q32.1	SMOH
Basal cell nevus syndrome, 109400 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	PTCH1
Basal cell nevus syndrome, 109400 (3)	PTCH2	603673	1p34.1	PTCH2
Basal cell nevus syndrome, 109400 (3)	SUFU, SUFUXL, SUFUH, JBTS32	607035	10q24.32	SUFU
Basal ganglia calcification, idiopathic, 1, 213600 (3)	SLC20A2, MLVAR, GLVR2, IBGC1	158378	8p11.21	SLC20A2
Basal ganglia calcification, idiopathic, 2 (2)	IBGC2	606656	2q37	IBGC2
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Basal ganglia calcification, idiopathic, 5, 615483 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	PDGFB
Basal ganglia calcification, idiopathic, 6, 616413 (3)	XPR1, SYG1, IBGC6	605237	1q25.3	XPR1
Basal laminar drusen, 126700 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
Basan syndrome, 129200 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS	612761	4q22.3	SMARCAD1
Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	MED25
Bazex syndrome (2)	BZX	301845	Xq24-q27	BZX
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Beaulieu-Boycott-Innes syndrome, 613680 (3)	THOC6, FSAP35, BBIS	615403	16p13.3	THOC6
Becker muscular dystrophy, 300376 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	DMD
Beckwith-Wiedemann syndrome, 130650 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	CDKN1C
Beckwith-Wiedemann syndrome, 130650 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	H19
Beckwith-Wiedemann syndrome, 130650 (3)	ICR1	616186	11p15.5	ICR1
Beckwith-Wiedemann syndrome, 130650 (3)	KCNQ1OT1, LIT1	604115	11p15.5	KCNQ1OT1
Behr syndrome, 210000 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
Bernard-Soulier syndrome, type B, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	GP1BB
Bernard-Soulier syndrome, type C, 231200 (3)	GP9	173515	3q21.3	GP9
Bestrophinopathy, autosomal recessive, 611809 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Beta-2-adrenoreceptor agonist, reduced response to (3)	ADRB2	109690	5q32	ADRB2
Beta-ureidopropionase deficiency, 613161 (3)	UPB1, BUP1	606673	22q11.23	UPB1
Bethlem myopathy 1, 158810 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	COL6A1
Bethlem myopathy 1, 158810 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	COL6A2
Bethlem myopathy 1, 158810 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	COL6A3
Bethlem myopathy 2, 616471 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	COL12A1
Bietti crystalline corneoretinal dystrophy, 210370 (3)	CYP4V2, BCD	608614	4q35.1-q35.2	CYP4V2
Bifid nose with or without anorectal and renal anomalies, 608980 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	FREM1
Bile acid malabsorption, primary, 613291 (3)	SLC10A2, NTCP2, PBAM	601295	13q33.1	SLC10A2
Bile acid synthesis defect, congenital, 1, 607765 (3)	HSD3B7, CBAS1	607764	16p11.2	HSD3B7
Bile acid synthesis defect, congenital, 2, 235555 (3)	AKR1D1, SRD5B1, CBAS2	604741	7q33	AKR1D1
Bile acid synthesis defect, congenital, 3, 613812 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	CYP7B1
Bile acid synthesis defect, congenital, 4, 214950 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	AMACR
Bile acid synthesis defect, congenital, 6, 617308 (3)	ACOX2, BRCACOX, CBAS6	601641	3p14.3	ACOX2
Biliary cirrhosis, primary, 1 (2)	PBC1	109720	3p12-q13.2	PBC1
Biliary cirrhosis, primary, 4 (2)	PBC4	614220	7q32	PBC4
Biliary cirrhosis, primary, 5 (2)	PBC5	614221	17q12	PBC5
Biotinidase deficiency, 253260 (3)	BTD	609019	3p25.1	BTD
Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)	KCNK9, TASK3	605874	8q24.3	KCNK9
Birt-Hogg-Dube syndrome, 135150 (3)	FLCN, BHD	607273	17p11.2	FLCN
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Bladder cancer, somatic, 109800 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Bladder cancer, somatic, 109800 (3)	RB1	614041	13q14.2	RB1
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	605956	16q12.1	NOD2
Bleeding disorder, east Texas type (2)	BDET	605913	1q23	BDET
Bleeding disorder, platelet-type, 11, 614201 (3)	GP6, GPIV, BDPLT11	605546	19q13.42	GP6
Bleeding disorder, platelet-type, 15, 615193 (3)	ACTN1, BDPLT15	102575	14q24.1	ACTN1
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	ITGA2B
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Bleeding disorder, platelet-type, 17, 187900 (3)	GFI1B, BDPLT17	604383	9q34.13	GFI1B
Bleeding disorder, platelet-type, 20, 616913 (3)	SLFN14, BDPLT20	614958	17q12	SLFN14
Bleeding disorder, platelet-type, 21, 617443 (3)	FLI1, BDPLT21	193067	11q24.3	FLI1
Bleeding disorder, platelet-type, 8, 609821 (3)	P2RY12, P2Y12, BDPLT8	600515	3q25.1	P2RY12
Blepharocheilodontic syndrome 1, 119580 (3)	CDH1, UVO, LCAM, ECAD, BCDS1	192090	16q22.1	CDH1
Blepharocheilodontic syndrome 2, 617681 (3)	CTNND1, CTNND, BCDS2	601045	11q12.1	CTNND1
Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	FOXL2
Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	FOXL2
Blood group--Lutheran inhibitor, 111150 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	KLF1
Bloom syndrome, 210900 (3)	RECQL3, RECQ2, BLM, BS	604610	15q26.1	RECQL3
Blue cone monochromacy, 303700 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	OPN1LW
Blue cone monochromacy, 303700 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	OPN1MW
Bohring-Opitz syndrome, 605039 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	ASXL1
Bone marrow failure syndrome 1, 614675 (3)	SRP72, BMFS1	602122	4q12	SRP72
Bone marrow failure syndrome 2, 615715 (3)	ERCC6L2, RAD26L, BMFS2	615667	9q22.32	ERCC6L2
Bone marrow failure syndrome 3, 617052 (3)	DNAJC21, DNAJA5, BMFS3	617048	5p13.2	DNAJC21
Bone mineral density QTL18, osteoporosis, 300910 (3)	PLS3, BMND18	300131	Xq23	PLS3
Boomerang dysplasia, 112310 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Bor-Duane hydrocephalus contiguous gene syndrome (4)	DEL8q12q21, C8DELq12q21	600257	8q12.2-q21.2	DEL8q12q21
Borjeson-Forssman-Lehmann syndrome, 301900 (3)	PHF6, BFLS	300414	Xq26.2	PHF6
Bornholm eye disease (2)	BED	300843	Xq28	BED
Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	132890	5q15	NR2F1
Bosley-Salih-Alorainy syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	HOXA1
Bosma arhinia microphthalmia syndrome, 603457 (3)	SMCHD1, KIAA0650, BAMS	614982	18p11.32	SMCHD1
Bothnia retinal dystrophy, 607475 (3)	RLBP1	180090	15q26.1	RLBP1
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
Bowen-Conradi syndrome, 211180 (3)	EMG1, NEP1, C2F, BWCNS	611531	12p13.31	EMG1
Brachycephaly, trichomegaly, and developmental delay, 617412 (3)	RPS23, BTDD, MCINS	603683	5q14.2	RPS23
Brachydactyly, type A1, 112500 (3)	IHH, BDA1	600726	2q35	IHH
Brachydactyly, type A1, B (2)	BDA1B	607004	5p13.3-p13.2	BDA1B
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Brachydactyly, type A1, D, 616849 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BMPR1B
Brachydactyly, type A2, 112600 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BMP2
Brachydactyly, type A2, 112600 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BMPR1B
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Brachydactyly, type B1, 113000 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	ROR2
Brachydactyly, type B2, 611377 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Brachydactyly, type D, 113200 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Brachydactyly, type E, 113300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Brachydactyly, type E2, 613382 (3)	PTHLH, BDE2	168470	12p11.22	PTHLH
Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	PAPSS2, ATPSK2, BCYM4	603005	10q23.2-q23.3	PAPSS2
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Bradyopsia, 608415 (3)	RGS9, PERRS	604067	17q24.1	RGS9
Bradyopsia, 608415 (3)	RGS9BP, R9AP, RGS9, PERRS	607814	19q13.11	RGS9BP
Brain malformations with or without urinary tract defects, 613735 (3)	NFIA, BRMUTD	600727	1p31.3	NFIA
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Brain tumor-polyposis syndrome 2, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	BCKDK, BDK, BCKDKD	614901	16p11.2	BCKDK
Branchiooculofacial syndrome, 113620 (3)	TFAP2A, AP2TF, BOFS	107580	6p24.3	TFAP2A
Branchiootic syndrome 1, 602588 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
Branchiootic syndrome 2 (2)	BOS2	120502	1q31	BOS2
Branchiootic syndrome 3, 608389 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	SIX1
Branchiootorenal syndrome 1, with or without cataracts, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
Branchiootorenal syndrome 2, 610896 (3)	SIX5, DMAHP, BOR2	600963	19q13.32	SIX5
Breast cancer (1)	BCPR	113721	17p13.3	BCPR
Breast cancer, 114480 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Breast cancer, early-onset, 114480 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	BRIP1
Breast cancer, somatic, 114480 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Breast cancer, somatic, 114480 (3)	PPM1D, WIP1, IDDGIP	605100	17q23.2	PPM1D
Breast cancer, somatic, 114480 (3)	RB1CC1, CC1, KIAA0203	606837	8q11.23	RB1CC1
Breast cancer, somatic, 114480 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	SLC22A1L
Breast cancer, somatic, 114480 (3)	TSG101	601387	11p15.1	TSG101
Brittle cornea syndrome 1, 229200 (3)	ZNF469, KIAA1858, BCS1	612078	16q24.2	ZNF469
Brittle cornea syndrome 2, 614170 (3)	PRDM5, BCS2	614161	4q27	PRDM5
Brody myopathy, 601003 (3)	ATP2A1, SERCA1	108730	16p11.2	ATP2A1
Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	SCNN1B, BESC1	600760	16p12.2	SCNN1B
Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)	SCNN1A, BESC2	600228	12p13.31	SCNN1A
Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	SCNN1G
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CYLD
Brooks-Wisniewski-Brown syndrome (2)	MRXSBWB	300612	Chr.X	MRXSBWB
Brown-Vialetto-Van Laere syndrome 1, 211530 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	SLC52A3
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	SLC52A2
Bruck syndrome 1, 259450 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	FKBP10
Bruck syndrome 2, 609220 (3)	PLOD2, LH2, TLH, BRKS2	601865	3q24	PLOD2
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Brugada syndrome 2, 611777 (3)	GPD1L, KIAA0089	611778	3p22.3	GPD1L
Brugada syndrome 3, 611875 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CACNA1C
Brugada syndrome 4, 611876 (3)	CACNB2	600003	10p12.33-p12.31	CACNB2
Brugada syndrome 5, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52	600235	19q13.11	SCN1B
Brugada syndrome 6, 613119 (3)	KCNE3, HOKPP, HYPP	604433	11q13.4	KCNE3
Brugada syndrome 7, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	SCN3B
Brugada syndrome 8, 613123 (3)	HCN4, SSS2	605206	15q24.1	HCN4
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3
Brunner syndrome, 300615 (3)	MAOA, BRNRS	309850	Xp11.3	MAOA
Burkitt lymphoma, 113970 (3)	MYC	190080	8q24.21	MYC
Burn-McKeown syndrome, 608572 (3)	TXNL4A, DIM1, BMKS	611595	18q23	TXNL4A
Buschke-Ollendorff syndrome, 166700 (3)	LEMD3, MAN1	607844	12q14.3	LEMD3
C syndrome, 211750 (3)	CD96, TACTILE	606037	3q13.1-q13.2	CD96
C1q deficiency, 613652 (3)	C1QA	120550	1p36.12	C1QA
C1q deficiency, 613652 (3)	C1QB	120570	1p36.12	C1QB
C1q deficiency, 613652 (3)	C1QC, C1QG	120575	1p36.12	C1QC
C1s deficiency, 613783 (3)	C1S, EDSPD2	120580	12p13.31	C1S
C2 deficiency, 217000 (3)	C2, ARMD14	613927	6p21.33	C2
C3 deficiency, 613779 (3)	C3, ARMD9, AHUS5	120700	19p13.3	C3
C4B deficiency, 614379 (3)	C4B, C4F, C4BD	120820	6p21.33	C4B
C4a deficiency, 614380 (3)	C4A, C4S, C4AD	120810	6p21.33	C4A
C5 deficiency, 609536 (3)	C5, C5D, ECLZB	120900	9q33.2	C5
C6 deficiency, 612446 (3)	C6	217050	5p13.1	C6
C7 deficiency, 610102 (3)	C7	217070	5p13.1	C7
C8 deficiency, type I, 613790 (3)	C8A	120950	1p32.2	C8A
C8 deficiency, type II, 613789 (3)	C8B	120960	1p32.2	C8B
C9 deficiency, 613825 (3)	C9, C9D, ARMD15	120940	5p13.1	C9
CAP myopathy 1, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	TPM3
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
CAPOS syndrome, 601338 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	ATP1A3
CARASIL syndrome, 600142 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
CATSHL syndrome, 610474 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
CD8 deficiency, familial, 608957 (3)	CD8A	186910	2p11.2	CD8A
CDAGS syndrome (2)	CDAGS	603116	22q12-q13	CDAGS
CHARGE syndrome, 214800 (3)	CHD7, HH5	608892	8q12.2	CHD7
CHILD syndrome, 308050 (3)	NSDHL	300275	Xq28	NSDHL
CHIME syndrome, 280000 (3)	PIGL, CHIME	605947	17p11.2	PIGL
CHOPS syndrome, 616368 (3)	AFF4, AF5Q31, CHOPS	604417	5q31.1	AFF4
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34	606416	1q44	NLRP3
CK syndrome, 300831 (3)	NSDHL	300275	Xq28	NSDHL
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
COACH syndrome, 216360 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	CC2D2A
COACH syndrome, 216360 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	RPGRIP1L
COACH syndrome, 216360 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
CODAS syndrome, 600373 (3)	LONP1, PRSS15, LON, CODASS	605490	19p13.3	LONP1
COMMAD syndrome, 617306 (3)	MITF, WS2A, CMM8, COMMAD	156845	3p13	MITF
COPD, rate of decline of lung function in, 606963 (3)	MMP1, CLG	120353	11q22.2	MMP1
CPT II deficiency, infantile, 600649 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
CPT II deficiency, lethal neonatal, 608836 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
CPT II deficiency, myopathic, stress-induced, 255110 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
CPT deficiency, hepatic, type IA, 255120 (3)	CPT1A	600528	11q13.3	CPT1A
CR1 deficiency (1)	CR1, C3BR	120620	1q32.2	CR1
CRASH syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
Calcification of joints and arteries, 211800 (3)	NT5E, NT5	129190	6q14.3	NT5E
Campomelic dysplasia with autosomal sex reversal, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SOX9
Campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SOX9
Camptodactyly 1 (2)	CAMPD1	114200	3q11.2-q13.12	CAMPD1
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4, CACP, MSF, SZP, HAPO	604283	1q31.1	PRG4
Camurati-Engelmann disease, 131300 (3)	TGFB1, DPD1, CED	190180	19q13.2	TGFB1
Canavan disease, 271900 (3)	ASPA	608034	17p13.2	ASPA
Candidiasis, familial, 1, autosomal dominant (2)	CANDF1, CMCT	114580	2p22.3-p21	CANDF1
Candidiasis, familial, 2, autosomal recessive, 212050 (3)	CARD9, CANDF2	607212	9q34.3	CARD9
Candidiasis, familial, 3 (2)	CANDF3, CANDN1, FCNC	607644	11p13-q12	CANDF3
Candidiasis, familial, 4, autosomal recessive, 613108 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CLEC7A
Candidiasis, familial, 9, 616445 (3)	IL17RC, IL17RL, CANDF9	610925	3p25.3	IL17RC
Capillary malformation-arteriovenous malformation, 608354 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	RASA1
Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	GNAQ, SWS, CMC1	600998	9q21.2	GNAQ
Carbamoylphosphate synthetase I deficiency, 237300 (3)	CPS1, PHN	608307	2q34	CPS1
Carboxylesterase 1 deficiency (3)	CES1, SES1	114835	16q12.2	CES1
Carboxypeptidase N deficiency, 212070 (3)	CPN1, SCPN, CPN	603103	10q24.2	CPN1
Carcinoid tumor of lung (3)	MEN1	613733	11q13.1	MEN1
Carcinoid tumors, intestinal, 114900 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	ANK2, LQT4	106410	4q25-q26	ANK2
Cardiac conduction defect, nonspecific, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52	600235	19q13.11	SCN1B
Cardiac valvular defect, developmental, 212093 (3)	PLD1, CVDD	602382	3q26.31	PLD1
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	SCO2
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3)	COX15, CEMCOX2	603646	10q24.2	COX15
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3)	COA6, C1orf31, CEMCOX4	614772	1q42.2	COA6
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Cardiofaciocutaneous syndrome 3, 615279 (3)	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	176872	15q22.31	MAP2K1
Cardiofaciocutaneous syndrome 4, 615280 (3)	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	601263	19p13.3	MAP2K2
Cardiofaciocutaneous syndrome, 115150 (3)	BRAF, NS7	164757	7q34	BRAF
Cardiomyopathy, dilated 1B (2)	CMD1B, CMPD1, FDC	600884	9q13	CMD1B
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	ACTN2
Cardiomyopathy, dilated, 1BB, 612877 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	DSG2
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Cardiomyopathy, dilated, 1CC, 613122 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	NEXN
Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Cardiomyopathy, dilated, 1DD, 613172 (3)	RBM20	613171	10q25.2	RBM20
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	CMD1F, CDCD3, LGMD1D	602067	6q23	CMD1F
Cardiomyopathy, dilated, 1FF, 613286 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY	188840	2q31.2	TTN
Cardiomyopathy, dilated, 1GG, 613642 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Cardiomyopathy, dilated, 1H (2)	CMD1H	604288	2q14-q22	CMD1H
Cardiomyopathy, dilated, 1HH, 613881 (3)	BAG3, MFM6	603883	10q26.11	BAG3
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Cardiomyopathy, dilated, 1J, 605362 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	EYA4
Cardiomyopathy, dilated, 1JJ, 615235 (3)	LAMA4, LAMA3, CMD1JJ	600133	6q21	LAMA4
Cardiomyopathy, dilated, 1K (2)	CMD1K	605582	6q12-q16	CMD1K
Cardiomyopathy, dilated, 1KK, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4, NEM11	608517	10q21.3	MYPN
Cardiomyopathy, dilated, 1L, 606685 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	SGCD
Cardiomyopathy, dilated, 1LL, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	PRDM16
Cardiomyopathy, dilated, 1MM, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	MYBPC3
Cardiomyopathy, dilated, 1NN, 615916 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	RAF1
Cardiomyopathy, dilated, 1O, 608569 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ABCC9
Cardiomyopathy, dilated, 1P, 609909 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	PLN
Cardiomyopathy, dilated, 1Q (2)	CMD1Q	609915	7q22.3-q31.1	CMD1Q
Cardiomyopathy, dilated, 1R, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Cardiomyopathy, dilated, 1U, 613694 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Cardiomyopathy, dilated, 1V, 613697 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	PSEN2
Cardiomyopathy, dilated, 1W, 611407 (3)	VCL, CMD1W, CMH15	193065	10q22.2	VCL
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Cardiomyopathy, dilated, 1Y, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	TPM1
Cardiomyopathy, dilated, 1Z, 611879 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	TNNC1
Cardiomyopathy, dilated, 3B, 302045 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	DMD
Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Cardiomyopathy, familial hypertrophic, 192600 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY	188840	2q31.2	TTN
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Cardiomyopathy, familial restrictive, 1, 115210 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
Cardiomyopathy, familial restrictive, 2 (2)	RCM2	609578	10q23.3	RCM2
Cardiomyopathy, familial restrictive, 3, 612422 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Cardiomyopathy, familial restrictive, 4, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4, NEM11	608517	10q21.3	MYPN
Cardiomyopathy, hypertrophic 6, 600858 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	PRKAG2
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3)	MYLK2, MLCK	606566	20q11.21	MYLK2
Cardiomyopathy, hypertrophic, 10, 608758 (3)	MYL2, CMH10	160781	12q24.11	MYL2
Cardiomyopathy, hypertrophic, 11, 612098 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Cardiomyopathy, hypertrophic, 12, 612124 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CSRP3
Cardiomyopathy, hypertrophic, 13, 613243 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	TNNC1
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
Cardiomyopathy, hypertrophic, 15, 613255 (3)	VCL, CMD1W, CMH15	193065	10q22.2	VCL
Cardiomyopathy, hypertrophic, 16, 613838 (3)	MYOZ2, CMH16	605602	4q26	MYOZ2
Cardiomyopathy, hypertrophic, 17, 613873 (3)	JPH2, JP2, CMH17	605267	20q13.12	JPH2
Cardiomyopathy, hypertrophic, 18, 613874 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	PLN
Cardiomyopathy, hypertrophic, 2, 115195 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Cardiomyopathy, hypertrophic, 20, 613876 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	NEXN
Cardiomyopathy, hypertrophic, 21 (2)	CMH21	614676	7p12.1-q21	CMH21
Cardiomyopathy, hypertrophic, 22, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4, NEM11	608517	10q21.3	MYPN
Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	ACTN2
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Cardiomyopathy, hypertrophic, 25, 607487 (3)	TCAP, LGMD2G, CMH25	604488	17q12	TCAP
Cardiomyopathy, hypertrophic, 3, 115196 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	TPM1
Cardiomyopathy, hypertrophic, 4, 115197 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	MYBPC3
Cardiomyopathy, hypertrophic, 7, 613690 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
Cardiomyopathy, hypertrophic, 8, 608751 (3)	MYL3, CMH8	160790	3p21.31	MYL3
Cardiospondylocarpofacial syndrome, 157800 (3)	MAP3K7, TAK1, CSCF, FMD2	602614	6q15	MAP3K7
Carey-Fineman-Ziter syndrome, 254940 (3)	MYMK, TMEM8C	615345	9q34.2	MYMK
Carney complex variant, 608837 (3)	MYH8, DA7	160741	17p13.1	MYH8
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Carney complex, type II (2)	CNC2	605244	2p16	CNC2
Carnitine deficiency, systemic primary, 212140 (3)	SLC22A5, OCTN2, CDSP, SCD	603377	5q31.1	SLC22A5
Carnitine-acylcarnitine translocase deficiency, 212138 (3)	SLC25A20, CACT, CAC	613698	3p21.31	SLC25A20
Carnosinemia (2)	CNSN	212200	18q21.3	CNSN
Carotid intimal medial thickness (2)	CIMT	608447	12q24	CIMT
Carotid intimal medial thickness 1, 609338 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Carpal tunnel syndrome, familial, 115430 (3)	TTR, PALB	176300	18q12.1	TTR
Carpenter syndrome 2, 614976 (3)	MEGF8, EGFL4, CRPT2	604267	19q13.2	MEGF8
Carpenter syndrome, 201000 (3)	RAB23	606144	6p12.1-p11.2	RAB23
Cartilage-hair hypoplasia, 250250 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRP
Cat eye syndrome (4)	CECR, CES	115470	22q11	CECR
Cataract 1, multiple types, 116200 (3)	GJA8, CX50, CTRCT1, CZP1, CAE1	600897	1q21.2	GJA8
Cataract 10, multiple types, 600881 (3)	CRYBA1, CRYB1, CTRCT10	123610	17q11.2	CRYBA1
Cataract 11, multiple types, 610623 (3)	PITX3, CTPP4, CTRCT11, ASGD1	602669	10q24.32	PITX3
Cataract 11, syndromic, 610623 (3)	PITX3, CTPP4, CTRCT11, ASGD1	602669	10q24.32	PITX3
Cataract 12, multiple types, 611597 (3)	BFSP2, CP49, CP47, CTRCT12	603212	3q22.1	BFSP2
Cataract 13 with adult i phenotype, 116700 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	GCNT2
Cataract 14, multiple types, 601885 (3)	GJA3, CX46, CZP3, CAE3, CTRCT14	121015	13q12.11	GJA3
Cataract 15, multiple types, 615274 (3)	MIP, AQP0, CTRCT15	154050	12q13.3	MIP
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Cataract 17, multiple types, 611544 (3)	CRYBB1, CATCN3, CTRCT17	600929	22q12.1	CRYBB1
Cataract 18, autosomal recessive, 610019 (3)	FYCO1, CATC2, CTRCT18	607182	3p21.31	FYCO1
Cataract 19, multiple types, 615277 (3)	LIM2, MP19, CTRCT19	154045	19q13.41	LIM2
Cataract 2, multiple types, 604307 (3)	CRYGC, CRYG3, CTRCT2, CCL	123680	2q33.3	CRYGC
Cataract 20, multiple types, 116100 (3)	CRYGS, CRYG8, CTRCT20	123730	3q27.3	CRYGS
Cataract 21, multiple types, 610202 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	MAF
Cataract 22, 609741 (3)	CRYBB3, CRYB3, CATCN2, CTRCT22	123630	22q11.23	CRYBB3
Cataract 23, 610425 (3)	CRYBA4, CTRCT23	123631	22q12.1	CRYBA4
Cataract 24, anterior polar (2)	CTRCT24, CTAA2	601202	17p13	CTRCT24
Cataract 25 (2)	CTRCT25, CCSSO	605728	15q21-q22	CTRCT25
Cataract 26, multiple types (2)	CTRCT26, CAAR	605749	9q13-q22	CTRCT26
Cataract 27, nuclear progressive (2)	CTRCT27, CCNP	607304	2p12	CTRCT27
Cataract 29, coralliform (2)	CTRCT29	115800	2pter-p24	CTRCT29
Cataract 3, multiple types, 601547 (3)	CRYBB2, CRYB2, CTRCT3, CCA2	123620	22q11.23	CRYBB2
Cataract 30, pulverulent, 116300 (3)	VIM, CTRCT30	193060	10p13	VIM
Cataract 31, multiple types, 605387 (3)	CHMP4B, SNF7, CTPP3, CTRCT31	610897	20q11.22	CHMP4B
Cataract 32, multiple types (2)	CTRCT32, CTAA1, CAP, CTPP5	115650	14q22-q23	CTRCT32
Cataract 33, multiple types, 611391 (3)	BFSP1, CP115, CTRCT33	603307	20p12.1	BFSP1
Cataract 34, multiple types, 612968 (3)	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	601094	1p33	FOXE3
Cataract 35, congenital nuclear (2)	CTRCT35, CATCN1	609376	19q13	CTRCT35
Cataract 36, 613887 (3)	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	611258	9q22.33	TDRD7
Cataract 37, autosomal dominant (2)	CTRCT37, CCA5	614422	12q24.2-q24.3	CTRCT37
Cataract 38, autosomal recessive, 614691 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	AGK
Cataract 39, multiple types, autosomal dominant, 615188 (3)	CRYGB, CRYG2, CTRCT39	123670	2q33.3	CRYGB
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	CRYGD
Cataract 40, X-linked, 302200 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	NHS
Cataract 44, 616509 (3)	LSS, OSC, CTRCT44	600909	21q22.3	LSS
Cataract 46, juvenile-onset, 212500 (3)	LEMD2, NET25, CTRCT42	616312	6p21.31	LEMD2
Cataract 47, juvenile, with microcornea, 612018 (3)	SLC16A12, MCT12, CTRCT47	611910	10q23.31	SLC16A12
Cataract 5, multiple types, 116800 (3)	HSF4, CTM, CTRCT5	602438	16q22.1	HSF4
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	EPHA2
Cataract 7 (2)	CTRCT7, CCA1	115660	17q24	CTRCT7
Cataract 8, multiple types (2)	CTRCT8, CCV	115665	1pter-p36.13	CTRCT8
Cataract 9, multiple types, 604219 (3)	CRYAA, CRYA1, CTRCT9	123580	21q22.3	CRYAA
Cataract with late-onset corneal dystrophy, 106210 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
Catel-Manzke syndrome, 616145 (3)	TGDS, SDR2E1, CATMANS	616146	13q32.1	TGDS
Caudal regression syndrome, 600145 (3)	VANGL1, STBM2	610132	1p13.1	VANGL1
Cavernous malformations of CNS and retina, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CCM1
Cavitary optic disc anomalies, 611543 (3)	MMP19, MMP18, CODA	601807	12q13.2	MMP19
Cayler cardiofacial syndrome (2)	ACF	125520	22q11	ACF
Cenani-Lenz syndactyly syndrome, 212780 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	LRP4
Central core disease, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Central hypoventilation syndrome, 209880 (3)	GDNF, HSCR3	600837	5p13.2	GDNF
Central hypoventilation syndrome, congenital, 209880 (3)	ASCL1, ASH1	100790	12q23.2	ASCL1
Central hypoventilation syndrome, congenital, 209880 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
Central hypoventilation syndrome, congenital, 209880 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	EDN3
Central hypoventilation syndrome, congenital, 209880 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PMX2B
Centronuclear myopathy 1, 160150 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Centronuclear myopathy 2, 255200 (3)	BIN1, AMPHL, CNM2	601248	2q14.3	BIN1
Centronuclear myopathy 3, 614408 (3)	MYF6, CNM3	159991	12q21.31	MYF6
Centronuclear myopathy 5, 615959 (3)	SPEG, APEG1, CNM5	615950	2q35	SPEG
Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3)	ZAK, MLTK, MRK, SFMMP, CNM6	609479	2q31.1	ZAK
Centrotemporal epilepsy (2)	ECT, BECTS	117100	11p13	ECT
Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	RNF216, TRIAD3, ZIN, CAHH	609948	7p22.1	RNF216
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	CA8, CALS, CARP, CAMRQ3	114815	8q12.1	CA8
Cerebellar ataxia, 604290 (3)	CP	117700	3q24-q25	CP
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	DNMT1
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3)	WDR81, CAMRQ2	614218	17p13.3	WDR81
Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	CAMTA1, KIAA0833, CANPMR	611501	1p36.31-p36.23	CAMTA1
Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	EMC1, KIAA0090, CAVIPMR	616846	1p36.13	EMC1
Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	VLDLR, CAMRQ1	192977	9p24.2	VLDLR
Cerebellofaciodental syndrome, 616202 (3)	BRF1, TAF3C, GTF3B, TF3B90, CFDS	604902	14q32.33	BRF1
Cerebral amyloid angiopathy, 105150 (3)	CST3, ARMD11	604312	20p11.21	CST3
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	APP
Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	NOTCH3
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
Cerebral cavernous malformations 3, 603285 (3)	PDCD10, TFAR15, CCM3	609118	3q26.1	PDCD10
Cerebral cavernous malformations-1, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CCM1
Cerebral cavernous malformations-2, 603284 (3)	C7orf22, CCM2, MGC4067	607929	7p13	C7orf22
Cerebral creatine deficiency syndrome 1, 300352 (3)	SLC6A8, CRTR, CCDS1	300036	Xq28	SLC6A8
Cerebral creatine deficiency syndrome 2, 612736 (3)	GAMT, CCDS2	601240	19p13.3	GAMT
Cerebral creatine deficiency syndrome 3, 612718 (3)	GATM, AGAT, CCDS3	602360	15q21.1	GATM
Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	SNAP29, CEDNIK	604202	22q11.21	SNAP29
Cerebral palsy, ataxic, autosomal recessive (2)	ACP	605388	9p12-q12	ACP
Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	607704	9p24.3	KANK1
Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	ADD3, ADDL, CPSQ3	601568	10q25.1-q25.2	ADD3
Cerebral-cerebellar-coloboma syndrome, X-linked (2)	CCCSX	300864	Chr.X	CCCSX
Cerebrocostomandibular syndrome, 117650 (3)	SNRPB, CCMS	182282	20p13	SNRPB
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
Cerebrooculofacioskeletal syndrome 3, 616570 (3)	ERCC5, XPG, COFS3	133530	13q33.1	ERCC5
Cerebrooculofacioskeletal syndrome 4, 610758 (3)	ERCC1, UV20, COFS4	126380	19q13.32	ERCC1
Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3)	STN1, OBFC1, AAF44	613128	10q24.33	STN1
Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	CTC1, CRMCC, C17orf68, AAF132	613129	17p13.1	CTC1
Cerebrotendinous xanthomatosis, 213700 (3)	CYP27A1, CYP27, CTX	606530	2q35	CYP27A1
Cerebrovascular disease, occlusive (3)	SERPINA3, AACT, ACT	107280	14q32.13	SERPINA3
Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	PPT1, CLN1	600722	1p34.2	PPT1
Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	CTSD, CPSD, CLN10	116840	11p15.5	CTSD
Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	GRN, CLN11	138945	17q21.31	GRN
Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3)	CTSF, CLN13	603539	11q13.2	CTSF
Ceroid lipofuscinosis, neuronal, 2, 204500 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	TPP1
Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	CLN3, BTS	607042	16p12.1	CLN3
Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	DNAJC5, DNAJC5A, CSP, CLN4B	611203	20q13.33	DNAJC5
Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	CLN5	608102	13q22.3	CLN5
Ceroid lipofuscinosis, neuronal, 6, 601780 (3)	CLN6, CLN4A	606725	15q23	CLN6
Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	MFSD8
Ceroid lipofuscinosis, neuronal, 8, 600143 (3)	CLN8, EPMR	607837	8p23.3	CLN8
Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	CLN8, EPMR	607837	8p23.3	CLN8
Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	CLN6, CLN4A	606725	15q23	CLN6
Cervical cancer, somatic, 603956 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Cervical carcinoma (2)	ST3	191181	11q13	ST3
Chanarin-Dorfman syndrome, 275630 (3)	ABHD5, CGI58, IECN2, NCIE2	604780	3p21.33	ABHD5
Char syndrome, 169100 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	TFAP2B
Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DYNC1H1
Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3)	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B	608507	1p36.22	MFN2
Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3)	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B	608507	1p36.22	MFN2
Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	NEFH, CMT2CC	162230	22q12.2	NEFH
Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HSPB1
Charcot-Marie-Tooth disease, axonal, type 2H (2)	CMT2H	607731	8q13-q23	CMT2H
Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	HSPB8
Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	AARS
Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3)	LRSAM1, TAL, RIFLE, CMT2P	610933	9q33.3-q34.1	LRSAM1
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	IGHMBP2
Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	MME, CD10, CALLA, NEP, CMT2T, SCA43	120520	3q25.2	MME
Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	MARS
Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	HARS, USH3B, CMT2W	142810	5q31.3	HARS
Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	SPG11
Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	616661	22q12.2	MORC2
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, dominant intermediate A (2)	CMTDIA	606483	10q24.1-q25.1	CMTDIA
Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	YARS, CMTDIC, TYRRS, YTS, YRS	603623	1p35.1	YARS
Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	INF2
Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	GNB4, CMTD1F	610863	3q26.33	GNB4
Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	HOXD10, HOX4D	142984	2q31.1	HOXD10
Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	PLEKHG5
Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	COX6A1, CMTRID	602072	12q24.31	COX6A1
Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, type 1A, 118220 (3)	PMP22, CMT1A, CMT1E, DSS, CIDP	601097	17p12	PMP22
Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, type 1C, 601098 (3)	LITAF, CMT1C	603795	16p13.13	LITAF
Charcot-Marie-Tooth disease, type 1D, 607678 (3)	EGR2, KROX20	129010	10q21.3	EGR2
Charcot-Marie-Tooth disease, type 1E, 118300 (3)	PMP22, CMT1A, CMT1E, DSS, CIDP	601097	17p12	PMP22
Charcot-Marie-Tooth disease, type 1F, 607734 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	NEFL
Charcot-Marie-Tooth disease, type 2B, 600882 (3)	RAB7, CMT2B, PSN	602298	3q21.3	RAB7
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Charcot-Marie-Tooth disease, type 2D, 601472 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	GARS
Charcot-Marie-Tooth disease, type 2E, 607684 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	NEFL
Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, type 2R, 615490 (3)	TRIM2, KIAA0517, CMT2R	614141	4q31.3	TRIM2
Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	VCP
Charcot-Marie-Tooth disease, type 4A, 214400 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	MTMR2, CMT4B1	603557	11q21	MTMR2
Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	SBF2, MTMR13, CMT4B2	607697	11p15.4	SBF2
Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	SBF1, MTMR5, CMT4B3	603560	22q13.33	SBF1
Charcot-Marie-Tooth disease, type 4C, 601596 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	SH3TC2
Charcot-Marie-Tooth disease, type 4D, 601455 (3)	NDRG1, HMSNL, CMT4D	605262	8q24.22	NDRG1
Charcot-Marie-Tooth disease, type 4F, 614895 (3)	PRX, CMT4F	605725	19q13.2	PRX
Charcot-Marie-Tooth disease, type 4H, 609311 (3)	FGD4, FRABIN, CMT4H	611104	12p11.21	FGD4
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
Charcot-Marie-Tooth disease, type 4K, 616684 (3)	SURF1, CMT4K	185620	9q34.2	SURF1
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	GJB1, CX32, CMTX1	304040	Xq13.1	GJB1
Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)	CMTX2	302801	Xp22.2	CMTX2
Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)	CMTX3	302802	Xq26	CMTX3
Chediak-Higashi syndrome, 214500 (3)	LYST, CHS1	606897	1q42.3	LYST
Cherubism, 118400 (3)	SH3BP2, CRPM	602104	4p16.3	SH3BP2
Chilblain lupus, 610448 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
Chitayat syndrome, 617180 (3)	ERF, PE2, CRS4, CHYTS	611888	19q13.2	ERF
Cholangitis, primary sclerosing (2)	PSC	613806	3p21	PSC
Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	ABCB11
Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ATP8B1
Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ATP8B1
Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ABCB4
Cholestasis, progressive canalicular (1)	VIL1	193040	2q35	VIL1
Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ATP8B1
Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	ABCB11
Cholestasis, progressive familial intrahepatic 3, 602347 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ABCB4
Cholestasis, progressive familial intrahepatic 4, 615878 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	TJP2
Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	NR1H4, FXR, RIP14, PFIC5	603826	12q23.1	NR1H4
Cholestasis-lymphedema syndrome (2)	LCS1, CHLS	214900	15q	LCS1
Cholesteryl ester storage disease, 278000 (3)	LIPA, CESD	613497	10q23.31	LIPA
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	ANKH
Chondrocalcinosis with early-onset osteoarthritis (2)	CCAL1	600668	8q	CCAL1
Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	EBP
Chondrodysplasia punctata, X-linked recessive, 302950 (3)	ARSE, CDPX1, CDPXR	300180	Xp22.33	ARSE
Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	IMPAD1, GPAPP, IMPA3	614010	8q12.1	IMPAD1
Chondrodysplasia, Blomstrand type, 215045 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Chondrosarcoma, 215300 (3)	EXT1	608177	8q24.11	EXT1
Chondrosarcoma, extraskeletal myxoid, 612237 (1)	TAF15, TAF2N, RBP56	601574	17q12	TAF15
Chondrosarcoma, extraskeletal myxoid, 612237 (3)	CSMF	600542	9q31.1	CSMF
Chorea, hereditary benign, 118700 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2-1
Choreoacanthocytosis, 200150 (3)	VPS13A, CHAC	605978	9q21.2	VPS13A
Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2-1
Chorioretinal atrophy, progressive bifocal (2)	PBCRA, CRAPB	600790	6q14-q16.2	PBCRA
Choroid plexus papilloma, 260500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Choroidal dystrophy, central areolar 1 (2)	CACD1	215500	17p	CACD1
Choroidal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Choroideremia, 303100 (3)	CHM, TCD	300390	Xq21.2	CHM
Choroideremia, deafness, and mental retardation (4)	DELXq21, CXDELq21	303110	Xq21	DELXq21
Chromosome 10q22.3-q23.2 deletion syndrome (4)	DEL10q23, C10DELq23	612242	10q23	DEL10q23
Chromosome 10q26 deletion syndrome (4)	DEL10q26, C10q26DEL	609625	10q26	DEL10q26
Chromosome 11p13 deletion syndrome, distal, 616902 (4)	DEL11p13, C11DELp13	616902	11p13	DEL11p13
Chromosome 11p15-p14 deletion syndrome (4)	DEL11p15p14, C11DELp15p14	606528	11p15-p14	DEL11p15p14
Chromosome 13q14 deletion syndrome (4)	DEL13q14, C13DELq14	613884	13q14	DEL13q14
Chromosome 14q11-q22 deletion syndrome (4)	DEL14q11q22, C14DELq11q22	613457	14q11-q22	DEL14q11q22
Chromosome 15q11.2 deletion syndrome (4)	DEL15q11.2, C15DELq11.2	615656	15q11.2	DEL15q11.2
Chromosome 15q13.3 microdeletion syndrome (4)	DEL15q13.3, MICRODEL15q13.3	612001	15q13.3	DEL15q13.3
Chromosome 15q14 deletion syndrome (4)	DEL15q14, C15DELq14	616898	15q14	DEL15q14
Chromosome 15q25 deletion syndrome (4)	DEL15q25, C15DELq25	614294	15q25	DEL15q25
Chromosome 15q26-qter deletion syndrome (4)	DEL15q26qter, C15DELq26qter	612626	15q26-qter	DEL15q26qter
Chromosome 16p11.2 deletion syndrome, 220kb (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	BMIQ16
Chromosome 16p11.2 deletion syndrome, 593kb (4)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	DEL16p11.2
Chromosome 16p11.2 duplication syndrome (4)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	DUP16p11.2
Chromosome 16p12.1 deletion syndrome, 520kb (4)	DEL16p12.1, C16DELp12.1	136570	16p12	DEL16p12.1
Chromosome 16p12.2-p11.2 deletion syndrome (4)	DEL16p12.1p11.2, C16DELp12.1p11.2	613604	16p12.2-p11.2	DEL16p12.1p11.2
Chromosome 16p13.2 deletion syndrome (4)	DEL16p13.2, C16DELp13.2	616863	16p13.2	DEL16p13.2
Chromosome 16p13.3 deletion syndrome (4)	DEL16p13.3, RSTSS	610543	16p13.3	DEL16p13.3
Chromosome 16p13.3 duplication syndrome (4)	DUP16p13.3, C16DUPq13.3	613458	16p13.3	DUP16p13.3
Chromosome 16q22 deletion syndrome (4)	C16DELq22, DEL16q22	614541	16q22	C16DELq22
Chromosome 17p13.1 deletion syndrome (4)	DEL17p13.1, C17DELp13.1	613776	17p13.1	DEL17p13.1
Chromosome 17p13.3 duplication syndrome (4)	DUP17p13.3, C17DUPp13.3	613215	17p13.3	DUP17p13.3
Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)	DEL17q11.2, C17DELq11.2	613675	17q11.2	DEL17q11.2
Chromosome 17q12 deletion syndrome (4)	DEL17q12, C17DELq12	614527	17q12	DEL17q12
Chromosome 17q12 duplication syndrome (4)	DUP17q12, C17DUPq12	614526	17q12	DUP17q12
Chromosome 17q21.31 duplication syndrome (4)	DUP17q21.31, C17DUPq21.31	613533	17q21.31	DUP17q21.31
Chromosome 17q23.1-q23.2 deletion syndrome (4)	DEL17q23.1q23.2, C17DELq23.1q23.2	613355	17q23.1-q23.2	DEL17q23.1q23.2
Chromosome 17q23.1-q23.2 duplication syndrome (4)	DUP17q23.1q23.2, C17DUPq23.1q23.2	613618	17q23.1-q23.2	DUP17q23.1q23.2
Chromosome 18 pericentric inversion (4)	DUP18pDEL18q, DUP18qDEL18p	609334	18q22	DUP18pDEL18q
Chromosome 18p deletion syndrome (4)	DEL18p, C18DELp	146390	18p	DEL18p
Chromosome 18q deletion syndrome (4)	DEL18q	601808	18q	DEL18q
Chromosome 19p13.13 deletion syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	DEL19p13.13
Chromosome 19p13.13 duplication syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	DEL19p13.13
Chromosome 19q13.11 deletion syndrome, distal (4)	DEL19q13.11d, C19DELq13.11d	613026	19q13.11	DEL19q13.11d
Chromosome 19q13.11 deletion syndrome, proximal (4)	DEL19q13.11p, C19DELq13.11p	617219	19q13.11	DEL19q13.11p
Chromosome 1p36 deletion syndrome (4)	DEL1p36, C1DELp36	607872	1p36	DEL1p36
Chromosome 1q21.1 deletion syndrome (4)	DEL1q21, C1DELq21	612474	1q21.1	DEL1q21
Chromosome 1q21.1 duplication syndrome (4)	DUP1q21, C1DUPq21	612475	1q21.1	DUP1q21
Chromosome 1q41-q42 deletion syndrome (4)	DEL1q41q42, C1DELq41q42	612530	1q41-q42	DEL1q41q42
Chromosome 22q11.2 deletion syndrome, distal (4)	DEL22q11.2, C22DELq11.2	611867	22q11.2	DEL22q11.2
Chromosome 22q11.2 microduplication syndrome (4)	DUP22q11.2	608363	22q11.2	DUP22q11.2
Chromosome 22q13 duplication syndrome, 615538 (4)	DUP22q13, C22DUPq13	615538	22q13	DUP22q13
Chromosome 2p12-p11.2 deletion syndrome (4)	DEL2p12p11.2, C2DELp12p11.2	613564	2p12-p11.2	DEL2p12p11.2
Chromosome 2p16.1-p15 deletion syndrome (4)	DEL2p16.1-p15, C2DELp161-p15	612513	2p16.1-p15	DEL2p16.1-p15
Chromosome 2q31.1 duplication syndrome (4)	DUP2q31.1, C2DUPq31.1	613681	2q31.1	DUP2q31.1
Chromosome 2q31.2 deletion syndrome (4)	DEL2q31	612345	2q31.2	DEL2q31
Chromosome 2q37 deletion syndrome (4)	BDMR, C2DELq37, DEL2q37	600430	2q37	BDMR
Chromosome 3q13.31 deletion syndrome (4)	DEL3q13.31, C13DELq13.31	615433	3q13.31	DEL3q13.31
Chromosome 3q29 microdeletion syndrome (4)	DEL3q29, MICRODEL3q29	609425	3q29	DEL3q29
Chromosome 3q29 microduplication syndrome (4)	DUP3q29, MICRODUP3q29	611936	3q29	DUP3q29
Chromosome 4q21 deletion syndrome (4)	DEL4q21, C4DELq21	613509	4q21	DEL4q21
Chromosome 4q32.1-q32.2 triplication syndrome (4)	TRIP4q32.1q32.2, C4TRIPq32.1q32.2	613603	4q32.1-q32.2	TRIP4q32.1q32.2
Chromosome 5p13 duplication syndrome (4)	DUP5p13, C5DUPp13	613174	5p13	DUP5p13
Chromosome 5q12 deletion syndrome (4)	DEL5q12, C5DELq12	615668	5q12	DEL5q12
Chromosome 5q14.3 deletion syndrome, 613443 (4)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	MEF2C
Chromosome 6pter-p24 deletion syndrome (4)	DEL6pter, C6DELpter	612582	6pter-p24	DEL6pter
Chromosome 6q11-q14 deletion syndrome (4)	DEL6q11q14, C6DELq11q14	613544	6q11-q14	DEL6q11q14
Chromosome 6q25-q25 deletion syndrome (4)	DEL6q24q25, C6DELq25q25	612863	6q24-q25	DEL6q24q25
Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)	DEL7q11.23, C7DELq11.23	613729	7q11.23	DEL7q11.23
Chromosome 7q11.23 duplication syndrome (4)	DUP7q11.23, C7DUPq11.23	609757	7q11.23	DUP7q11.23
Chromosome 8p11 myeloproliferative syndrome (4)	SCLL	613523	8p11	SCLL
Chromosome 8q21.11 deletion syndrome (4)	DEL8q21.11, C8DELq21.11	614230	8q21.11	DEL8q21.11
Chromosome 9p deletion syndrome (4)	DEL9p, C9DELp	158170	9p	DEL9p
Chromosome Xp11.23-p11.22 duplication syndrome (4)	DUPXp11.23p11.22, CXDUPp11.23p11.22	300801	Xp11.23-p11.22	DUPXp11.23p11.22
Chromosome Xp11.3 deletion syndrome (4)	DELXp11.3, CXDELp11.3	300578	Xp11.3	DELXp11.3
Chromosome Xp21 deletion syndrome (4)	DELXp21, CXDELp21	300679	Xp21	DELXp21
Chromosome Xq26.3 duplication syndrome (4)	CXDUPq26.3, DUPXq26.3, XLAG	300942	Xq26.3	CXDUPq26.3
Chromosome Xq27.3-q28 duplication syndrome (4)	DUPXq27.3q28, CXDUPq27.3q28	300869	Xq27.3-q28	DUPXq27.3q28
Chromosome Xq28 duplication syndrome (4)	DUPXq28, CXq28	300815	Xq28	DUPXq28
Chronic atrial and intestinal dysrhythmia, 616201 (3)	SGOL1, SGO, SGO1, CAID	609168	3p24.3	SGOL1
Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)	NCF1	608512	7q11.23	NCF1
Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)	NCF2	608515	1q25.3	NCF2
Chronic granulomatous disease, X-linked, 306400 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	CYBB
Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)	CYBA	608508	16q24.2	CYBA
Chudley-McCullough syndrome, 604213 (3)	GPSM2, LGN, PINS, DFNB82, CMCS	609245	1p13.3	GPSM2
Chylomicron retention disease, 246700 (3)	SAR1B, CMRD, SARA2, ANDD	607690	5q31.1	SAR1B
Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	DNAI1, CILD1, ICS, PCD	604366	9p13.3	DNAI1
Ciliary dyskinesia, primary, 10, 612518 (3)	KTU, C14orf104, CILD10	612517	14q21.3	KTU
Ciliary dyskinesia, primary, 11, 612649 (3)	RSPH4A, CILD11	612647	6q22.1	RSPH4A
Ciliary dyskinesia, primary, 12, 612650 (3)	RSPH9, CILD12	612648	6p21.1	RSPH9
Ciliary dyskinesia, primary, 13, 613193 (3)	DNAAF1, LRRC50, ODA7, CILD13	613190	16q24.1	DNAAF1
Ciliary dyskinesia, primary, 14, 613807 (3)	CCDC39	613798	3q26.33	CCDC39
Ciliary dyskinesia, primary, 15, 613808 (3)	CCDC40, KIAA1640	613799	17q25.3	CCDC40
Ciliary dyskinesia, primary, 16, 614017 (3)	DNAL1, C14orf168, CILD16	610062	14q24.3	DNAL1
Ciliary dyskinesia, primary, 17, 614679 (3)	CCDC103, SMH, PR46B, CILD17	614677	17q21.31	CCDC103
Ciliary dyskinesia, primary, 18, 614874 (3)	DNAAF5, HEATR2, CILD18	614864	7p22.3	DNAAF5
Ciliary dyskinesia, primary, 19, 614935 (3)	LRRC6, LRTP, CILD19	614930	8q24.22	LRRC6
Ciliary dyskinesia, primary, 2, 606763 (3)	DNAAF3, PF22, DAB1, CILD2	614566	19q13.42	DNAAF3
Ciliary dyskinesia, primary, 20, 615067 (3)	CCDC114, CILD20	615038	19q13.33	CCDC114
Ciliary dyskinesia, primary, 21, 615294 (3)	DRC1, CCDC164, C2orf39, CILD21	615288	2p23.3	DRC1
Ciliary dyskinesia, primary, 22, 615444 (3)	ZMYND10, BLU	607070	3p21.31	ZMYND10
Ciliary dyskinesia, primary, 23, 615451 (3)	ARMC4, CILD23	615408	10p12.1	ARMC4
Ciliary dyskinesia, primary, 24, 615481 (3)	RSPH1, TSGA2, TSA2, CILD24	609314	21q22.3	RSPH1
Ciliary dyskinesia, primary, 25, 615482 (3)	DNAAF4, DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DNAAF4
Ciliary dyskinesia, primary, 26, 615500 (3)	C21orf59, CILD26	615494	21q22.11	C21orf59
Ciliary dyskinesia, primary, 27, 615504 (3)	CCDC65, CILD27	611088	12q13.12	CCDC65
Ciliary dyskinesia, primary, 28, 615505 (3)	SPAG1, CILD28	603395	8q22.2	SPAG1
Ciliary dyskinesia, primary, 29, 615872 (3)	CCNO, UNG2, CILD29	607752	5q11.2	CCNO
Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	DNAH5, HL1, PCD, CILD3	603335	5p15.2	DNAH5
Ciliary dyskinesia, primary, 30, 616037 (3)	CCDC151, CILD30	615956	19p13.2	CCDC151
Ciliary dyskinesia, primary, 32, 616481 (3)	RSPH3, RSHL2, RSP3, CILD32	615876	6q25.3	RSPH3
Ciliary dyskinesia, primary, 33, 616726 (3)	GAS8, GAS11, CILD33	605178	16q24.3	GAS8
Ciliary dyskinesia, primary, 34, 617091 (3)	DNAJB13, TSARG6, CILD34	610263	11q13.4	DNAJB13
Ciliary dyskinesia, primary, 35, 617092 (3)	TTC25, CILD35	617095	17q21.2	TTC25
Ciliary dyskinesia, primary, 36, X-linked, 300991 (3)	PIH1D3, CILD36	300933	Xq22.3	PIH1D3
Ciliary dyskinesia, primary, 4 (2)	CILD4	608646	15q13.1-q15.1	CILD4
Ciliary dyskinesia, primary, 5, 608647 (3)	HYDIN, HYDIN1, CILD5	610812	16q22.2	HYDIN
Ciliary dyskinesia, primary, 6, 610852 (3)	NME8, TXNDC3, SPTRX2, CILD6	607421	7p14.1	NME8
Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	DNAH11, DNAHC11, CILD7, DNAHBL	603339	7p15.3	DNAH11
Ciliary dyskinesia, primary, 8 (2)	CILD8	612274	15q24-q25	CILD8
Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	DNAI2, CILD9	605483	17q25.1	DNAI2
Cirrhosis due to liver phosphorylase kinase deficiency (3)	PHKG2, GSD9C	172471	16p11.2	PHKG2
Cirrhosis, cryptogenic, 215600 (3)	KRT18	148070	12q13.13	KRT18
Cirrhosis, cryptogenic, 215600 (3)	KRT8	148060	12q13.13	KRT8
Citrullinemia, 215700 (3)	ASS1, ASS	603470	9q34.11	ASS1
Citrullinemia, adult-onset type II, 603471 (3)	SLC25A13, CTLN2	603859	7q21.3	SLC25A13
Citrullinemia, type II, neonatal-onset, 605814 (3)	SLC25A13, CTLN2	603859	7q21.3	SLC25A13
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	NECTIN1
Cleft palate with ankyloglossia, 303400 (3)	TBX22, CPX, ABERS	300307	Xq21.1	TBX22
Cleft palate, cardiac defects, and mental retardation, 600987 (3)	MEIS2, MRG1, CPCMR	601740	15q14	MEIS2
Cleft palate, isolated, 119540 (2)	UBB	191339	17p11.2	UBB
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	KDM1A
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Clopidogrel, impaired responsiveness to, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	PITX1
Cockayne syndrome, type A, 216400 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	ERCC8
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
Cocoon syndrome, 613630 (3)	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	600664	10q24.31	CHUK
Coenzyme Q10 deficiency, primary, 1, 607426 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	COQ2
Coenzyme Q10 deficiency, primary, 2, 614651 (3)	PDSS1, TPT, COQ1, COQ10D2	607429	10p12.1	PDSS1
Coenzyme Q10 deficiency, primary, 3, 614652 (3)	PDSS2, DLP1, C6orf210, COQ10D3	610564	6q21	PDSS2
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	ADCK3
Coenzyme Q10 deficiency, primary, 5, 614654 (3)	COQ9, C16orf49, COQ10D5	612837	16q21	COQ9
Coenzyme Q10 deficiency, primary, 6, 614650 (3)	COQ6, CGI10, COQ10D6	614647	14q24.3	COQ6
Coenzyme Q10 deficiency, primary, 7, 616276 (3)	COQ4, COQ10D7	612898	9q34.11	COQ4
Coffin-Lowry syndrome, 303600 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	RPS6KA3
Coffin-Siris syndrome 1, 135900 (3)	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	614556	6q25.3	ARID1B
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	ARID1A
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
Coffin-Siris syndrome 4, 614609 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	SMARCA4
Coffin-Siris syndrome 5, 616938 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	SMARCE1
Coffis-Siris syndrome 6, 617808 (3)	ARID2, BAF200, KIAA1557, CSS6	609539	12q12	ARID2
Cohen syndrome, 216550 (3)	VPS13B, KIAA0532, COH1	607817	8q22.2	VPS13B
Cohen-Gibson syndrome, 617561 (3)	EED, WAIT1, COGIS	605984	11q14.2	EED
Cold-induced sweating syndrome 1, 272430 (3)	CRLF1, CISS1	604237	19p13.11	CRLF1
Cold-induced sweating syndrome 2, 610313 (3)	CLCF1, BSF3, CLC, CISS2	607672	11q13.2	CLCF1
Cold-induced sweating syndrome 3, 617055 (3)	KLHL7, RP42, CISS3	611119	7p15.3	KLHL7
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
Cole-Carpenter syndrome 1, 112240 (3)	P4HB, PROHB, CLCRP1	176790	17q25.3	P4HB
Cole-Carpenter syndrome 2, 616294 (3)	SEC24D, KIAA0755, CLCRP2	607186	4q26	SEC24D
Coloboma, ocular, 120433 (3)	YAP1, COB1	606608	11q22.1	YAP1
Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3)	YAP1, COB1	606608	11q22.1	YAP1
Colon cancer, advanced, somatic, 114500 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	SRC
Colon cancer, somatic, 114500 (3)	PTPN12, PTPG1	600079	7q11.23	PTPN12
Colon cancer, somatic, 114500 (3)	PTPRJ, DEP1	600925	11p11.2	PTPRJ
Colon cancer, somatic, 114500 (3)	RAD54B	604289	8q22.1	RAD54B
Colorblindness, deutan, 303800 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	OPN1MW
Colorblindness, protan, 303900 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	OPN1LW
Colorblindness, tritan, 190900 (3)	OPN1SW, BCP, CBT	613522	7q32.1	OPN1SW
Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	MUTYH, MYH	604933	1p34.1	MUTYH
Colorectal cancer with chromosomal instability, somatic (3)	BUB1	602452	2q13	BUB1
Colorectal cancer, 114500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	MSH2
Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	MLH1
Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	PMS2
Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	MSH6
Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	TGFBR2
Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3)	MLH3, HNPCC7	604395	14q24.3	MLH3
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	EPCAM
Colorectal cancer, somatic (3)	BRAF, NS7	164757	7q34	BRAF
Colorectal cancer, somatic, 114500 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Colorectal cancer, somatic, 114500 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Colorectal cancer, somatic, 114500 (3)	AXIN2, ODCRCS	604025	17q24.1	AXIN2
Colorectal cancer, somatic, 114500 (3)	BAX	600040	19q13.33	BAX
Colorectal cancer, somatic, 114500 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUB1B
Colorectal cancer, somatic, 114500 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
Colorectal cancer, somatic, 114500 (3)	DCC, MRMV1, HGPPS2	120470	18q21.2	DCC
Colorectal cancer, somatic, 114500 (3)	DLC1	604258	8p22	DLC1
Colorectal cancer, somatic, 114500 (3)	EP300, RSTS2	602700	22q13.2	EP300
Colorectal cancer, somatic, 114500 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Colorectal cancer, somatic, 114500 (3)	FLCN, BHD	607273	17p11.2	FLCN
Colorectal cancer, somatic, 114500 (3)	MCC	159350	5q22.2	MCC
Colorectal cancer, somatic, 114500 (3)	MLH3, HNPCC7	604395	14q24.3	MLH3
Colorectal cancer, somatic, 114500 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Colorectal cancer, somatic, 114500 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PDGFRL
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Combined C6/C7 deficiency (3)	C6	217050	5p13.1	C6
Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	SLC25A1, SLC20A3, CTP, D2L2AD	190315	22q11.21	SLC25A1
Combined SAP deficiency, 611721 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Combined cellular and humoral immune defects with granulomas, 233650 (3)	RAG1	179615	11p12	RAG1
Combined cellular and humoral immune defects with granulomas, 233650 (3)	RAG2	179616	11p12	RAG2
Combined factor V and VIII deficiency, 227300 (3)	LMAN1, ERGIC53, F5F8D, MCFD1	601567	18q21.32	LMAN1
Combined hyperlipidemia, familial, 144250 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LPL
Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3)	MTHFD1, MTHFC, CIMAH	172460	14q23.3	MTHFD1
Combined immunodeficiency, X-linked, moderate, 312863 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	IL2RG
Combined malonic and methylmalonic aciduria, 614265 (3)	ACSF3	614245	16q24.3	ACSF3
Combined oxidative phosphorylation deficiency 1, 609060 (3)	GFM1, EFG1, GFM, COXPD1	606639	3q25.32	GFM1
Combined oxidative phosphorylation deficiency 10, 614702 (3)	MTO1, COXPD10	614667	6q13	MTO1
Combined oxidative phosphorylation deficiency 11, 614922 (3)	RMND1, COXPD11	614917	6q25.1	RMND1
Combined oxidative phosphorylation deficiency 12, 614924 (3)	EARS2, KIAA1970, COXPD12	612799	16p12.2	EARS2
Combined oxidative phosphorylation deficiency 13, 614932 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	PNPT1
Combined oxidative phosphorylation deficiency 14, 614946 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	FARS2
Combined oxidative phosphorylation deficiency 15, 614947 (3)	MTFMT, COXPD15	611766	15q22.31	MTFMT
Combined oxidative phosphorylation deficiency 17, 615440 (3)	ELAC2, HPC2, COXPD17	605367	17p12	ELAC2
Combined oxidative phosphorylation deficiency 18, 615578 (3)	SFXN4, COXPD18	615564	10q26.11	SFXN4
Combined oxidative phosphorylation deficiency 2, 610498 (3)	MRPS16, COXPD2	609204	10q22.2	MRPS16
Combined oxidative phosphorylation deficiency 20, 615917 (3)	VARS2, KIAA1885, COXPD20	612802	6p21.33	VARS2
Combined oxidative phosphorylation deficiency 23, 616198 (3)	GTPBP3, MSS1, COXPD23	608536	19p13.11	GTPBP3
Combined oxidative phosphorylation deficiency 24, 616239 (3)	NARS2, COXPD24	612803	11q14.1	NARS2
Combined oxidative phosphorylation deficiency 26, 616539 (3)	TRMT5, TRM5, KIAA1393, COXPD26	611023	14q23.1	TRMT5
Combined oxidative phosphorylation deficiency 27, 616672 (3)	CARS2, COXPD27	612800	13q34	CARS2
Combined oxidative phosphorylation deficiency 28, 616794 (3)	SLC25A26, SAMC, COXPD28	611037	3p14.1	SLC25A26
Combined oxidative phosphorylation deficiency 3, 610505 (3)	TSFM, COXPD3	604723	12q14.1	TSFM
Combined oxidative phosphorylation deficiency 30, 616974 (3)	TRMT10C, RG9MTD1, MRPP1, COXPD30	615423	3q12.3	TRMT10C
Combined oxidative phosphorylation deficiency 31, 617228 (3)	MIPEP, COXPD31	602241	13q12.12	MIPEP
Combined oxidative phosphorylation deficiency 32, 617664 (3)	MRPS34, MRPS12, COXPD32	611994	16p13.3	MRPS34
Combined oxidative phosphorylation deficiency 33, 617713 (3)	C1QBP, HABP1, COXPD33	601269	17p13.2	C1QBP
Combined oxidative phosphorylation deficiency 4, 610678 (3)	TUFM, EFTU, COXPD4	602389	16p11.2	TUFM
Combined oxidative phosphorylation deficiency 5, 611719 (3)	MRPS22, C3orf5, COXPD5	605810	3q23	MRPS22
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIFM1
Combined oxidative phosphorylation deficiency 7, 613559 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	C12orf65
Combined oxidative phosphorylation deficiency 8, 614096 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	AARS2
Combined oxidative phosphorylation deficiency 9, 614582 (3)	MRPL3, MRL3, COXPD9	607118	3q22.1	MRPL3
Complement component 4, partial deficiency of, 120790 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	C1NH
Complement factor D deficiency, 613912 (3)	CFD, ADN	134350	19p13.3	CFD
Complement factor H deficiency, 609814 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
Complement factor I deficiency, 610984 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	CFI
Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3)	CD55, DAF, CROM, CHAPLE	125240	1q32.2	CD55
Cone dystrophy 4, 613093 (3)	PDE6C, PDEA2, COD4	600827	10q23.33	PDE6C
Cone dystrophy, progressive X-linked, 2 (2)	COD2	300085	Xq27	COD2
Cone dystrophy-3, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	GUCA1A
Cone-rod dystrophy 10, 610283 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	SEMA4A
Cone-rod dystrophy 11, 610381 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	RAX2
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Cone-rod dystrophy 13, 608194 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	RPGRIP1
Cone-rod dystrophy 14, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	GUCA1A
Cone-rod dystrophy 15, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	CDHR1
Cone-rod dystrophy 16, 614500 (3)	C8orf37, CORD16, RP64, BBS21	614477	8q22.1	C8orf37
Cone-rod dystrophy 17 (2)	CORD17	615163	10q26	CORD17
Cone-rod dystrophy 18, 615374 (3)	RAB28, CORD18	612994	4p15.33	RAB28
Cone-rod dystrophy 19, 615860 (3)	TTLL5, STAMP, KIAA0998, CORD19	612268	14q24.3	TTLL5
Cone-rod dystrophy 20, 615973 (3)	POC1B, PIX1, CORD20	614784	12q21.33	POC1B
Cone-rod dystrophy 21, 616502 (3)	DRAM2, TMEM77, CORD21	613360	1p13.3	DRAM2
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Cone-rod dystrophy 5, 600977 (3)	PITPNM3, NIR1, CORD5	608921	17p13.2-p13.1	PITPNM3
Cone-rod dystrophy 6, 601777 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1	600179	17p13.1	GUCY2D
Cone-rod dystrophy 7, 603649 (3)	RIMS1, RIM1, RIM, KIAA0340, CORD7	606629	6q13	RIMS1
Cone-rod dystrophy 8 (2)	CORD8	605549	1q12-q24	CORD8
Cone-rod dystrophy 9, 612775 (3)	ADAM9, MDC9, MCMP, CORD9	602713	8p11.22	ADAM9
Cone-rod dystrophy and hearing loss, 617236 (3)	CEP78, CRDHL	617110	9q21.2	CEP78
Cone-rod dystrophy, 604393 (3)	AIPL1, LCA4	604392	17p13.2	AIPL1
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CACNA1F
Cone-rod retinal dystrophy-1 (2)	CORD1, CRD1	600624	18q21.1-q21.3	CORD1
Cone-rod retinal dystrophy-2, 120970 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CRX
Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	CABP4, CRSD, CSNB2B	608965	11q13.2	CABP4
Congenital anomalies of kidney and urinary tract 2, 143400 (3)	TBX18, CAKUT2	604613	6q14.3	TBX18
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3)	PBX1, CAKUHED	176310	1q23.3	PBX1
Congenital bilateral absence of vas deferens, 277180 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	CTDP1, FCP1, CCFDN	604927	18q23	CTDP1
Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	SLC33A1
Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	NALCN
Congenital disorder of deglycosylation, 615273 (3)	NGLY1, PNG1, CDDG, CDG1V	610661	3p24.2	NGLY1
Congenital disorder of glycosylation, type IIa, 212066 (3)	MGAT2, CDGS2, CDG2A	602616	14q21.3	MGAT2
Congenital disorder of glycosylation, type IIb, 606056 (3)	MOGS, GCS1, CDG2B	601336	2p13.1	MOGS
Congenital disorder of glycosylation, type IIc, 266265 (3)	SLC35C1, FUCT1, CDG2C	605881	11p11.2	SLC35C1
Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1, GGTB2, GT1, GTB, CDG2D	137060	9p21.1	B4GALT1
Congenital disorder of glycosylation, type IIe, 608779 (3)	COG7, CDG2E	606978	16p12.2	COG7
Congenital disorder of glycosylation, type IIf, 603585 (3)	SLC35A1, CST, CDG2F	605634	6q15	SLC35A1
Congenital disorder of glycosylation, type IIg, 611209 (3)	COG1, LDLB, KIAA1381, CDG2G	606973	17q25.1	COG1
Congenital disorder of glycosylation, type IIh, 611182 (3)	COG8, DOR1, CDG2H	606979	16q22.1	COG8
Congenital disorder of glycosylation, type IIi, 613612 (3)	COG5, GOLTC1, GTC90, CDG2I	606821	7q22.3	COG5
Congenital disorder of glycosylation, type IIj, 613489 (3)	COG4, COD1, CDG2J	606976	16q22.1	COG4
Congenital disorder of glycosylation, type IIk, 614727 (3)	TMEM165, FT27, CDG2K	614726	4q12	TMEM165
Congenital disorder of glycosylation, type IIl, 614576 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	COG6
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	SLC35A2
Congenital disorder of glycosylation, type IIn, 616721 (3)	SLC39A8, BIGM103, CDG2N	608732	4q24	SLC39A8
Congenital disorder of glycosylation, type IIo, 616828 (3)	CCDC115, CCP1, CDG2O	613734	2q21.1	CCDC115
Congenital disorder of glycosylation, type IIp, 616829 (3)	TMEM199, VMA12, VPH2, C17orf32, CDG2P	616815	17q11.2	TMEM199
Congenital disorder of glycosylation, type Ia, 212065 (3)	PMM2, CDG1A	601785	16p13.2	PMM2
Congenital disorder of glycosylation, type Ib, 602579 (3)	MPI, PMI1, CDG1B	154550	15q24.1	MPI
Congenital disorder of glycosylation, type Ic, 603147 (3)	ALG6, CDG1C	604566	1p31.3	ALG6
Congenital disorder of glycosylation, type Id, 601110 (3)	ALG3, NOT56L, CDGS4, CDG1D	608750	3q27.1	ALG3
Congenital disorder of glycosylation, type Ie, 608799 (3)	DPM1, MPDS, CDGIE	603503	20q13.13	DPM1
Congenital disorder of glycosylation, type If, 609180 (3)	MPDU1, SL15, CDGIF	604041	17p13.1	MPDU1
Congenital disorder of glycosylation, type Ig, 607143 (3)	ALG12, CDG1G	607144	22q13.33	ALG12
Congenital disorder of glycosylation, type Ih, 608104 (3)	ALG8, CDG1H	608103	11q14.1	ALG8
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DPAGT1
Congenital disorder of glycosylation, type Ik, 608540 (3)	ALG1, HMAT1, HMT1, CDG1K	605907	16p13.3	ALG1
Congenital disorder of glycosylation, type Il, 608776 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	ALG9
Congenital disorder of glycosylation, type Im, 610768 (3)	DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M	610746	9q34.11	DOLK
Congenital disorder of glycosylation, type In, 612015 (3)	RFT1, CDG1N	611908	3p21.1	RFT1
Congenital disorder of glycosylation, type Io, 612937 (3)	DPM3, CDG1O	605951	1q22	DPM3
Congenital disorder of glycosylation, type Ip, 613661 (3)	ALG11, KIAA1266, CDG1P	613666	13q14.3	ALG11
Congenital disorder of glycosylation, type Iq, 612379 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	SRD5A3
Congenital disorder of glycosylation, type It, 614921 (3)	PGM1, GSD14, CDG1T	171900	1p31.3	PGM1
Congenital disorder of glycosylation, type Iu, 615042 (3)	DPM2, CDG1U	603564	9q34.11	DPM2
Congenital disorder of glycosylation, type Iy, 300934 (3)	SSR4, TRAPD, CDG1Y	300090	Xq28	SSR4
Congenital heart defects and ectodermal dysplasia, 617364 (3)	PRKD1, PRKCM, PKD, CHDED	605435	14q12	PRKD1
Congenital heart defects and skeletal malformations syndrome, 617602 (3)	ABL1, CHDSKM	189980	9q34.12	ABL1
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3)	CDK13, CDC2L5, CHED, CHDFIDD	603309	7p14.1	CDK13
Congenital heart defects, multiple types, 3 (2)	CHDT3	614954	9q31.1	CHDT3
Congenital heart defects, multiple types, 4, 615779 (3)	NR2F2, TFCOUP2, ARP1, CHTD4	107773	15q26.2	NR2F2
Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	ZIC3
Congenital heart defects, nonsyndromic, 2, 614980 (3)	TAB2, MAP3K7IP2, KIAA0733, CHTD2	605101	6q25.1	TAB2
Congenital myopathy with excess of muscle spindles, 218040 (3)	HRAS	190020	11p15.5	HRAS
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Congenital short bowel syndrome, 615237 (3)	CLMP, ASAM, ACAM, CSBS	611693	11q24.1	CLMP
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
Conotruncal heart malformations, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	NKX2-6
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Contractural arachnodactyly, congenital, 121050 (3)	FBN2, CCA, EOMD	612570	5q23.3	FBN2
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PRRT2
Coproporphyria, 121300 (3)	CPOX	612732	3q11.2	CPOX
Cornea plana 1, autosomal dominant (2)	CNA1	121400	12q21.33	CNA1
Cornea plana 2, autosomal recessive, 217300 (3)	KERA, CNA2	603288	12q21.33	KERA
Corneal clouding, autosomal recessive (3)	APOA1	107680	11q23.3	APOA1
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Fuchs endothelial, 1, 136800 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	COL8A2
Corneal dystrophy, Fuchs endothelial, 2 (2)	FECD2, FCD1	610158	13pter-q12.13	FECD2
Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	TCF4
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	SLC4A11
Corneal dystrophy, Fuchs endothelial, 5 (2)	FECD5, FCD3	613269	5q33.1-q35.2	FECD5
Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	ZEB1
Corneal dystrophy, Fuchs endothelial, 7 (2)	FECD7, FCD4	613271	9p24.1-p22.1	FECD7
Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	AGBL1, CCP4, FECD8	615496	15q25.3	AGBL1
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Lisch epithelial (2)	LECD	300778	Xp22.3	LECD
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Schnyder type, 121800 (3)	UBIAD1, TERE1, SCCD	611632	1p36.22	UBIAD1
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, congenital stromal, 610048 (3)	DCN, CSCD	125255	12q21.33	DCN
Corneal dystrophy, endothelial, X-linked (2)	XECD	300779	Xq25	XECD
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, gelatinous drop-like, 204870 (3)	TACSTD2, TROP2, M1S1	137290	1p32.1	TACSTD2
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, posterior amorphous (4)	PACD	612868	12q21.33	PACD
Corneal dystrophy, posterior polymorphous 2, 609140 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	COL8A2
Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	OVOL2, ZNF339, PPCD1	616441	20p11.23	OVOL2
Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	ZEB1
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	SLC4A11
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	SLC4A11
Corneal fleck dystrophy, 121850 (3)	PIKFYVE, PIP5K3	609414	2q34	PIKFYVE
Cornelia de Lange syndrome 1, 122470 (3)	NIPBL, CDLS1	608667	5p13.2	NIPBL
Cornelia de Lange syndrome 2, 300590 (3)	SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2	300040	Xp11.22	SMC1A
Cornelia de Lange syndrome 3, 610759 (3)	SMC3, CSPG6, HCAP, BAM, CDLS3	606062	10q25.2	SMC3
Cornelia de Lange syndrome 4, 614701 (3)	RAD21, SCC1, NXP1, KIAA0078, CDLS4	606462	8q24.11	RAD21
Cornelia de Lange syndrome 5, 300882 (3)	HDAC8, MRXS6, CDLS5	300269	Xq13.1	HDAC8
Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	IGBP1	300139	Xq13.1	IGBP1
Corpus callosum, partial agenesis of, 304100 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	TUBB3
Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	KIF5C, NKHC2, CDCBM2	604593	2q23.1-q23.2	KIF5C
Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	KIF2A, CDCBM3	602591	5q12.1	KIF2A
Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	TUBG1, CDCBM4	191135	17q21.2	TUBG1
Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	TUBB2A, CDCBM5	615101	6p25.2	TUBB2A
Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	TUBB
Cortical dysplasia, complex, with other brain malformations 7, 610031 (3)	TUBB2B, CDCBM7	612850	6p25.2	TUBB2B
Cortical dysplasia, complex, with other brain malformations 8, 613180 (3)	TUBA8, TUBAL2, CDCBM8	605742	22q11.21	TUBA8
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CNTNAP2
Cortical malformations, occipital, 614115 (3)	LAMC3, OCCM	604349	9q34.12	LAMC3
Corticosteroid-binding globulin deficiency, 611489 (3)	CBG, SERPINA6	122500	14q32.13	CBG
Cortisone reductase deficiency 1, 604931 (3)	H6PD, GDH, G6PDH, CORTRD1	138090	1p36.22	H6PD
Cortisone reductase deficiency 2, 614662 (3)	HSD11B1, HSD11, HSD11L, CORTRD2	600713	1q32.2	HSD11B1
Costello syndrome, 218040 (3)	HRAS	190020	11p15.5	HRAS
Coumarin resistance, 122700 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A6
Cousin syndrome, 260660 (3)	TBX15	604127	1p12	TBX15
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIFM1
Cowden syndrome 1, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Cowden syndrome 2, 612359 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Cowden syndrome 3, 615106 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Cowden syndrome 4, 615107 (3)	KLLN, CWS4	612105	10q23.31	KLLN
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Cowden syndrome 6, 615109 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Cowden syndrome 7, 616858 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	SEC23B
Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST
Cranioectodermal dysplasia 1, 218330 (3)	IFT122, WDR10, CED1	606045	3q21.3-q22.1	IFT122
Cranioectodermal dysplasia 2, 613610 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	WDR35
Cranioectodermal dysplasia 3, 614099 (3)	IFT43, C14orf179, CED3	614068	14q24.3	IFT43
Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3)	TMCO1, CFSMR	614123	1q24.1	TMCO1
Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Craniofrontonasal dysplasia, 304110 (3)	EFNB1, EPLG2, CFNS, CFND	300035	Xq13.1	EFNB1
Craniolenticulosutural dysplasia, 607812 (3)	SEC23A, CLSD	610511	14q21.1	SEC23A
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	ANKH
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Cranioosteoarthropathy, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	HPGD
Craniosynostosis 1, 123100 (3)	TWIST1, ACS3, SCS, CRS1, SWCOS	601622	7p21.1	TWIST1
Craniosynostosis 2, 604757 (3)	MSX2, CRS2, HOX8	123101	5q35.2	MSX2
Craniosynostosis 3, 615314 (3)	TCF12, HTF4, CRS3	600480	15q21.3	TCF12
Craniosynostosis 4, 600775 (3)	ERF, PE2, CRS4, CHYTS	611888	19q13.2	ERF
Craniosynostosis 6, 616602 (3)	ZIC1, CRS6	600470	3q24	ZIC1
Craniosynostosis and dental anomalies, 614188 (3)	IL11RA, CRSDA	600939	9p13.3	IL11RA
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	CYP26B1, CYP26A2, P450RAI2, RHFCA	605207	2p13.2	CYP26B1
Craniosynostosis, Adelaide type (2)	CRSA, CRS3	600593	4p16	CRSA
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Creatine phosphokinase, elevated serum, 123320 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Creatinine clearance QTL (2)	CRCL	607135	3p	CRCL
Creutzfeldt-Jakob disease, 123400 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Crigler-Najjar syndrome, type I, 218800 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
Crigler-Najjar syndrome, type II, 606785 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
Crouzon syndrome with acanthosis nigricans, 612247 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Cryptorchidism, 219050 (3)	INSL3	146738	19p13.11	INSL3
Cubitus valgus with mental retardation and unusual facies (2)	CVMRF	300471	Chr.X	CVMRF
Culler-Jones syndrome, 615849 (3)	GLI2, HPE9, CJS	165230	2q14.2	GLI2
Currarino syndrome, 176450 (3)	MNX1, HLXB9, HOXHB9, SCRA1	142994	7q36.3	MNX1
Curry-Jones syndrome, somatic mosaic, 601707 (3)	SMOH, SMO, CRJS	601500	7q32.1	SMOH
Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)	PRKACA	601639	19p13.12	PRKACA
Cutis laxa, autosomal dominant 2, 614434 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Cutis laxa, autosomal dominant, 123700 (3)	ELN, SVAS, ADCL1	130160	7q11.23	ELN
Cutis laxa, autosomal recessive, type IA, 219100 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Cutis laxa, autosomal recessive, type IB, 614437 (3)	EFEMP2, FBLN4, UPH1, ARCL1B	604633	11q13.1	EFEMP2
Cutis laxa, autosomal recessive, type IC, 613177 (3)	LTBP4, LTBP4S, LTBP4L, ARCL1C	604710	19q13.2	LTBP4
Cutis laxa, autosomal recessive, type IIA, 219200 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	ATP6V0A2
Cutis laxa, autosomal recessive, type IIB, 612940 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	PYCR1
Cutis laxa, autosomal recessive, type IIC, 617402 (3)	ATP6V1E1, ATP6E, ARCL2C	108746	22q11.21	ATP6V1E1
Cutis laxa, autosomal recessive, type IID, 617403 (3)	ATP6V1A1, HO68, ARCL2D	607027	3q13.31	ATP6V1A1
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	PYCR1
Cyanosis, transient neonatal, 613977 (3)	HBG2, TNCY	142250	11p15.4	HBG2
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CYLD
Cystathioninuria, 219500 (3)	CTH	607657	1p31.1	CTH
Cystic fibrosis, 219700 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
Cystinosis, atypical nephropathic, 219800 (3)	CTNS	606272	17p13.2	CTNS
Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)	CTNS	606272	17p13.2	CTNS
Cystinosis, nephropathic, 219800 (3)	CTNS	606272	17p13.2	CTNS
Cystinosis, ocular nonnephropathic, 219750 (3)	CTNS	606272	17p13.2	CTNS
Cystinuria, 220100 (3)	SLC3A1, ATR1, D2H, NBAT	104614	2p21	SLC3A1
Cystinuria, 220100 (3)	SLC7A9, CSNU3	604144	19q13.11	SLC7A9
Czech dysplasia, 609162 (3)	COL2A1	120140	12q13.11	COL2A1
D-2-hydroxyglutaric aciduria 2, 613657 (3)	IDH2, IDPM, D2HGA2	147650	15q26.1	IDH2
D-2-hydroxyglutaric aciduria, 600721 (3)	D2HGDH, D2HGD	609186	2q37.3	D2HGDH
D-bifunctional protein deficiency, 261515 (3)	HSD17B4, PRLTS1	601860	5q23.1	HSD17B4
D-glyceric aciduria, 220120 (3)	GLYCTK, GLYCTK1	610516	3p21.2	GLYCTK
DNA ligase I deficiency (3)	LIG1	126391	19q13.33	LIG1
DNA topoisomerase I, camptothecin-resistant (3)	TOP1	126420	20q12	TOP1
DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	TOP2A, TOP2	126430	17q21.2	TOP2A
DOORS syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Dandy-Walker syndrome (4)	DWS, C3DELq22q24, DEL3q22q24	220200	3q22-q24	DWS
Danon disease, 300257 (3)	LAMP2, LAMPB, LGP110	309060	Xq24	LAMP2
Darier disease, 124200 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	ATP2A2
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
De la Chapelle dysplasia, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Deafness and male infertility (4)	DEL15q15.3, C15DELq15.3	611102	15q15.3	DEL15q15.3
Deafness and myopia, 221200 (3)	SLITRK6, DFNMYP	609681	13q31.1	SLITRK6
Deafness autosomal recessive 106, 617637 (3)	EPS8L2, EPS8R2, DFNB106	614988	11p15.5	EPS8L2
Deafness, X-linked 1, 304500 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Deafness, X-linked 2, 304400 (3)	POU3F4, DFN3, DFNX2	300039	Xq21.1	POU3F4
Deafness, X-linked 3 (2)	DFNX3, DFN4	300030	Xp21.2	DFNX3
Deafness, X-linked 4, 300066 (3)	SMPX, DFNX4	300226	Xp22.12	SMPX
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIFM1
Deafness, Y-linked 1 (1)	DFNY1	400043	Chr.Y	DFNY1
Deafness, autosomal dominant 1, 124900 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	DIAPH1
Deafness, autosomal dominant 10, 601316 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	EYA4
Deafness, autosomal dominant 11, 601317 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	MYO7A
Deafness, autosomal dominant 13, 601868 (3)	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	120290	6p21.32	COL11A2
Deafness, autosomal dominant 15, 602459 (3)	POU4F3, BRN3C	602460	5q32	POU4F3
Deafness, autosomal dominant 16 (2)	DFNA16	603964	2q23-q24.3	DFNA16
Deafness, autosomal dominant 17, 603622 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Deafness, autosomal dominant 18 (2)	DFNA18	606012	3q22	DFNA18
Deafness, autosomal dominant 20/26, 604717 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	ACTG1
Deafness, autosomal dominant 21 (2)	DFNA21	607017	6p24.1-p22.3	DFNA21
Deafness, autosomal dominant 22, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	MYO6
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	MYO6
Deafness, autosomal dominant 23, 605192 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	SIX1
Deafness, autosomal dominant 24 (2)	DFNA24	606282	4q35-qter	DFNA24
Deafness, autosomal dominant 25, 605583 (3)	SLC17A8, VGLUT3, DFNA25	607557	12q23.1	SLC17A8
Deafness, autosomal dominant 27 (2)	DFNA27	612431	4q12-q13.1	DFNA27
Deafness, autosomal dominant 28, 608641 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	GRHL2
Deafness, autosomal dominant 2A, 600101 (3)	KCNQ4, DFNA2A	603537	1p34.2	KCNQ4
Deafness, autosomal dominant 2B, 612644 (3)	GJB3, CX31, DFNA2B, EKVP1	603324	1p34.3	GJB3
Deafness, autosomal dominant 30 (2)	DFNA30	606451	15q25-q26	DFNA30
Deafness, autosomal dominant 31 (2)	DFNA31	608645	6p21.3	DFNA31
Deafness, autosomal dominant 33 (2)	DFNA33	614211	13q34	DFNA33
Deafness, autosomal dominant 34, with or without inflammation, 617772 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34	606416	1q44	NLRP3
Deafness, autosomal dominant 36, 606705 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	TMC1
Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Deafness, autosomal dominant 40, 616357 (3)	CRYM, DFNA40	123740	16p12.2	CRYM
Deafness, autosomal dominant 41, 608224 (3)	P2RX2, P2X2, DFNA41	600844	12q24.33	P2RX2
Deafness, autosomal dominant 43 (2)	DFNA43	608394	2p12	DFNA43
Deafness, autosomal dominant 47 (2)	DFNA47, DFNB83	608652	9p22-p21	DFNA47
Deafness, autosomal dominant 48 (2)	DFNA48	607841	12q13-q14	DFNA48
Deafness, autosomal dominant 49 (2)	DFNA49	608372	1q21-q23	DFNA49
Deafness, autosomal dominant 4A, 600652 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	MYH14
Deafness, autosomal dominant 4B, 614614 (3)	CEACAM16, CEAL2, DFNA4B	614591	19q13.31-q13.32	CEACAM16
Deafness, autosomal dominant 5, 600994 (3)	GSDME, DFNA5	608798	7p15.3	GSDME
Deafness, autosomal dominant 50, 613074 (3)	MIR96, MIRN96, DFNA50	611606	7q32.2	MIR96
Deafness, autosomal dominant 51 (4)	DFNA51, C9DUPq21.11, DUP9q21.11	613558	9q21.11	DFNA51
Deafness, autosomal dominant 52 (2)	DFNA52, DFNA42	607683	5q31.1-q32	DFNA52
Deafness, autosomal dominant 53 (2)	DFNA53	609965	14q11.2-q12	DFNA53
Deafness, autosomal dominant 54 (2)	DFNA54	615649	5q31	DFNA54
Deafness, autosomal dominant 56, 615629 (3)	TNC, HXB, DFNA56	187380	9q33.1	TNC
Deafness, autosomal dominant 58 (2)	DFNA58	615654	2p21-p12	DFNA58
Deafness, autosomal dominant 59 (2)	DFNA59	612642	11p14.2-q12.3	DFNA59
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
Deafness, autosomal dominant 64, 614152 (3)	SMAC, DIABLO, DFNA64	605219	12q24.31	SMAC
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Deafness, autosomal dominant 67, 616340 (3)	OSBPL2, ORP2, KIAA0772, DNFA67	606731	20q13.33	OSBPL2
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	KITLG
Deafness, autosomal dominant 7 (2)	DFNA7	601412	1q21-q23	DFNA7
Deafness, autosomal dominant 73, 617663 (3)	PTPRQ, PTPGMC1, DFNB84A, DFNA73	603317	12q21.31	PTPRQ
Deafness, autosomal dominant 8/12, 601543 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	TECTA
Deafness, autosomal dominant 9, 601369 (3)	COCH, DFNA9	603196	14q12	COCH
Deafness, autosomal dominant, with peripheral neuropathy (3)	GJB3, CX31, DFNA2B, EKVP1	603324	1p34.3	GJB3
Deafness, autosomal recessive (3)	GJB3, CX31, DFNA2B, EKVP1	603324	1p34.3	GJB3
Deafness, autosomal recessive 105, 616958 (3)	CDC14A, DFNB105	603504	1p21.2	CDC14A
Deafness, autosomal recessive 107, 617639 (3)	WBP2, DFNB107	606962	17q25.1	WBP2
Deafness, autosomal recessive 12, 601386 (3)	CDH23, USH1D, DFNB12, PITA5	605516	10q22.1	CDH23
Deafness, autosomal recessive 13 (2)	DFNB13	603098	7q34-q36	DFNB13
Deafness, autosomal recessive 14 (2)	DFNB14	603678	7q31	DFNB14
Deafness, autosomal recessive 15, 601869 (3)	GIPC3, DFNB15, DFNB72, DFNB95	608792	19p13.3	GIPC3
Deafness, autosomal recessive 16, 603720 (3)	STRC, DFNB16	606440	15q15.3	STRC
Deafness, autosomal recessive 17 (2)	DFNB17	603010	7q31	DFNB17
Deafness, autosomal recessive 18A, 602092 (3)	USH1C, DFNB18A	605242	11p15.1	USH1C
Deafness, autosomal recessive 18B, 614945 (3)	OTOG, OTGN, DFNB18B	604487	11p15.1	OTOG
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Deafness, autosomal recessive 2, 600060 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	MYO7A
Deafness, autosomal recessive 20 (2)	DFNB20	604060	11q25-qter	DFNB20
Deafness, autosomal recessive 21, 603629 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	TECTA
Deafness, autosomal recessive 22, 607039 (3)	OTOA, DFNB22	607038	16p12.2	OTOA
Deafness, autosomal recessive 23, 609533 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	PCDH15
Deafness, autosomal recessive 24, 611022 (3)	RDX, DFNB24	179410	11q22.3	RDX
Deafness, autosomal recessive 25, 613285 (3)	GRXCR1	613283	4p13	GRXCR1
Deafness, autosomal recessive 26 (2)	DFNB26	605428	4q31	DFNB26
Deafness, autosomal recessive 27 (2)	DFNB27	605818	2q23-q31	DFNB27
Deafness, autosomal recessive 28, 609823 (3)	TRIOBP, KIAA1662	609761	22q13.1	TRIOBP
Deafness, autosomal recessive 29, 614035 (3)	CLDN14, DFNB29	605608	21q22.13	CLDN14
Deafness, autosomal recessive 3, 600316 (3)	MYO15A, DFNB3	602666	17p11.2	MYO15A
Deafness, autosomal recessive 30, 607101 (3)	MYO3A, DFNB30	606808	10p12.1	MYO3A
Deafness, autosomal recessive 31, 607084 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	WHRN
Deafness, autosomal recessive 32 (2)	DFNB32	608653	1p22.1-p13.3	DFNB32
Deafness, autosomal recessive 33 (2)	DFNB33	607239	10p11.23-q21.1	DFNB33
Deafness, autosomal recessive 35, 608565 (3)	ESRRB, ESRL2, DFNB35	602167	14q24.3	ESRRB
Deafness, autosomal recessive 36, 609006 (3)	ESPN	606351	1p36.31	ESPN
Deafness, autosomal recessive 37, 607821 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	MYO6
Deafness, autosomal recessive 38 (2)	DFNB38	608219	6q26-q27	DFNB38
Deafness, autosomal recessive 39, 608265 (3)	HGF, DFNB39	142409	7q21.11	HGF
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	SLC26A4
Deafness, autosomal recessive 40 (2)	DFNB40	608264	22q11.21-q12.1	DFNB40
Deafness, autosomal recessive 42, 609646 (3)	ILDR1, DFNB42	609739	3q13.33	ILDR1
Deafness, autosomal recessive 45 (2)	DFNB45	612433	1q43-q44	DFNB45
Deafness, autosomal recessive 46 (2)	DFNB46	609647	18p11.32-p11.31	DFNB46
Deafness, autosomal recessive 48, 609439 (3)	CIB2, KIP2	605564	15q25.1	CIB2
Deafness, autosomal recessive 49, 610153 (3)	MARVELD2, MARVD2, TRIC, DFNB49	610572	5q13.2	MARVELD2
Deafness, autosomal recessive 5 (2)	DFNB5	600792	14q12	DFNB5
Deafness, autosomal recessive 51 (2)	DFNB51	609941	11p13-p12	DFNB51
Deafness, autosomal recessive 53, 609706 (3)	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	120290	6p21.32	COL11A2
Deafness, autosomal recessive 55 (2)	DFNB55	609952	4q12-q13.2	DFNB55
Deafness, autosomal recessive 59, 610220 (3)	PJVK, DFNB59	610219	2q31.2	PJVK
Deafness, autosomal recessive 6, 600971 (3)	TMIE, DFNB6	607237	3p21.31	TMIE
Deafness, autosomal recessive 62 (2)	DFNB62	610143	12p13.2-p11.23	DFNB62
Deafness, autosomal recessive 63, 611451 (3)	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	612414	11q13.4	LRTOMT
Deafness, autosomal recessive 65 (2)	DFNB65	610248	20q13.2-q13.3	DFNB65
Deafness, autosomal recessive 67, 610265 (3)	LHFPL5, TMHS, DFNB67	609427	6p21.31	LHFPL5
Deafness, autosomal recessive 68, 610419 (3)	S1PR2, EDG5, DFNB68	605111	19p13.2	S1PR2
Deafness, autosomal recessive 7, 600974 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	TMC1
Deafness, autosomal recessive 70, 614934 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	PNPT1
Deafness, autosomal recessive 71 (2)	DFNB71	612789	8p22-p21.3	DFNB71
Deafness, autosomal recessive 74, 613718 (3)	MSRB3, DFNB74	613719	12q14.3	MSRB3
Deafness, autosomal recessive 76, 615540 (3)	SYNE4, NESP4, C19orf46, DFNB76	615535	19q13.12	SYNE4
Deafness, autosomal recessive 77, 613079 (3)	LOXHD1, DFNB77	613072	18q21.1	LOXHD1
Deafness, autosomal recessive 79, 613307 (3)	TPRN, C9orf75, DFNB79	613354	9q34.3	TPRN
Deafness, autosomal recessive 8/10, 601072 (3)	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	TMPRSS3
Deafness, autosomal recessive 83 (2)	DFNB83	613685	9p23-p21.2	DFNB83
Deafness, autosomal recessive 84A, 613391 (3)	PTPRQ, PTPGMC1, DFNB84A, DFNA73	603317	12q21.31	PTPRQ
Deafness, autosomal recessive 84B, 614944 (3)	OTOGL, C12orf64, DFNB84B	614925	12q21.31	OTOGL
Deafness, autosomal recessive 85 (2)	DFNB85	613392	17p12-q11.2	DFNB85
Deafness, autosomal recessive 89, 613916 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	KARS
Deafness, autosomal recessive 9, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	OTOF
Deafness, autosomal recessive 93, 614899 (3)	CABP2, DFNB93	607314	11q13.2	CABP2
Deafness, autosomal recessive 96 (2)	DFNB96	614414	1p36.31-p36.13	DFNB96
Deafness, autosomal recessive 98, 614861 (3)	TSPEAR, C21orf29, DFNB98	612920	21q22.3	TSPEAR
Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)	DFCTRPS	300719	Chr.X	DFCTRPS
Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	FGF3, INT2	164950	11q13.3	FGF3
Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ATP6V1B2
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Deafness, digenic, GJB2/GJB3, 220290 (3)	GJB3, CX31, DFNA2B, EKVP1	603324	1p34.3	GJB3
Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	BCAP31, BAP31, DXS1357E, DDCH	300398	Xq28	BCAP31
Deafness, neurosensory, autosomal recessive 47 (2)	DFNB47	609946	2p25.1-p24.3	DFNB47
Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)	ESPN	606351	1p36.31	ESPN
Dehydrated hereditary stomatocytosis 2, 616689 (3)	KCNN4, KCA4, SK4, DHS2	602754	19q13.31	KCNN4
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	PIEZO1
Dejerine-Sottas disease, 145900 (3)	EGR2, KROX20	129010	10q21.3	EGR2
Dejerine-Sottas disease, 145900 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Dejerine-Sottas disease, 145900 (3)	PMP22, CMT1A, CMT1E, DSS, CIDP	601097	17p12	PMP22
Dejerine-Sottas disease, 145900 (3)	PRX, CMT4F	605725	19q13.2	PRX
Delta-beta thalassemia, 141749 (3)	HBB	141900	11p15.4	HBB
Dementia, Lewy body, 127750 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	SNCA
Dementia, Lewy body, 127750 (3)	SNCB	602569	5q35.2	SNCB
Dementia, familial British, 176500 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ITM2B
Dementia, familial Danish, 117300 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ITM2B
Dementia, familial, nonspecific, 600795 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	CHMP2B
Dementia, frontotemporal, 600274 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Dementia, frontotemporal, with or without parkinsonism, 600274 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Dent disease 2, 300555 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	OCRL
Dent disease, 300009 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Dental anomalies and short stature, 601216 (3)	LTBP3, LTBP2, DASS, GPHYSD3	602090	11q13.1	LTBP3
Dentatorubro-pallidoluysian atrophy, 125370 (3)	ATN1, DRPLA, HRS, NOD	607462	12p13.31	ATN1
Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	SMOC2, SMAP2, DTDP1	607223	6q27	SMOC2
Dentin dysplasia, type II, 125420 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Denys-Drash syndrome, 194080 (3)	WT1, NPHS4	607102	11p13	WT1
Dermatofibrosarcoma protuberans, 607907 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	PDGFB
Dermatopathia pigmentosa reticularis, 125595 (3)	KRT14	148066	17q21.2	KRT14
Dermoids of cornea (2)	CND	304730	Xq24-qter	CND
Desanto-Shinawi syndrome, 616708 (3)	WAC, KIAA1844, DESSH	615049	10p12.1	WAC
Desbuquois dysplasia 1, 251450 (3)	CANT1, SCAN1, DBQD1, EDM7	613165	17q25.3	CANT1
Desbuquois dysplasia 2, 615777 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	XYLT1
Desmoid disease, hereditary, 135290 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Desmosterolosis, 602398 (3)	DHCR24, KIAA0018	606418	1p32.3	DHCR24
Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	DPH1, DPH2L1, OVCA1, DEDSSH	603527	17p13.3	DPH1
Developmental dysplasia of the hip 1 (2)	DDH1	142700	13q22	DDH1
Developmental dysplasia of the hip 2 (2)	DDH2	615612	3p22.2	DDH2
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)	DGCR2, DGS2	601362	10p14-p13	DGCR2
Diabetes insipidus, nephrogenic, 125800 (3)	AQP2	107777	12q13.12	AQP2
Diabetes insipidus, nephrogenic, 304800 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	AVPR2
Diabetes insipidus, neurohypophyseal, 125700 (3)	AVP, AVRP, VP	192340	20p13	AVP
Diabetes mellitus, insulin-dependent, 2, 125852 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Diabetes mellitus, insulin-dependent, 20, 612520 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)	INSR, HHF5	147670	19p13.2	INSR
Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	GLIS3, ZNF515, NDH	610192	9p24.2	GLIS3
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF1B
Diabetes mellitus, noninsulin-dependent, 2 (2)	NIDDM2	601407	12q24.2	NIDDM2
Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)	GCK, HHF3	138079	7p13	GCK
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Diabetes mellitus, permanent neonatal, 606176 (3)	GCK, HHF3	138079	7p13	GCK
Diabetes mellitus, permanent neonatal, 606176 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Diabetes mellitus, transient neonatal, 1, 601410 (3)	ZFP57, TNDM1	612192	6p22.1	ZFP57
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Diabetes mellitus, type 2, 125853 (3)	PAX4, MODY9, KPD	167413	7q32.1	PAX4
Diabetes mellitus, type II, 125853 (3)	AKT2, HIHGHH	164731	19q13.2	AKT2
Diabetes, permanent neonatal, with or without neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	RPS28, DBA15	603685	19p13.2	RPS28
Diamond-Blackfan anemia 1, 105650 (3)	RPS19, DBA, DBA1	603474	19q13.2	RPS19
Diamond-Blackfan anemia 10, 613309 (3)	RPS26, DBA10	603701	12q13.2	RPS26
Diamond-Blackfan anemia 13, 615909 (3)	RPS29, DBA13	603633	14q21.3	RPS29
Diamond-Blackfan anemia 2 (2)	DBA2	606129	8p23.3-p22	DBA2
Diamond-Blackfan anemia 4, 612527 (3)	RPS17, RPS17L1, RPS17L2, DBA4	180472	15q25.2	RPS17
Diamond-Blackfan anemia 5, 612528 (3)	RPL35A, DBA5	180468	3q29	RPL35A
Diamond-Blackfan anemia 6, 612561 (3)	RPL5, DBA6	603634	1p22.1	RPL5
Diamond-Blackfan anemia 7, 612562 (3)	RPL11, DBA7	604175	1p36.11	RPL11
Diamond-Blackfan anemia 8, 612563 (3)	RPS7, DBA8	603658	2p25.3	RPS7
Diamond-Blackfan anemia 9, 613308 (3)	RPS10, DBA9	603632	6p21.31	RPS10
Diamond-blackfan anemia 3, 610629 (3)	RPS24, DBA3	602412	10q22.3	RPS24
Diaphanospondylodysostosis, 608022 (3)	BMPER, CV2	608699	7p14.3	BMPER
Diaphragmatic hernia 3, 610187 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	ZFPM2
Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	MTAP, DMSMFH	156540	9p21.3	MTAP
Diarrhea 1, secretory chloride, congenital, 214700 (3)	SLC26A3, DRA, CLD	126650	7q22.3-q31.1	SLC26A3
Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	SPINT2, HAI2, DIAR3	605124	19q13.2	SPINT2
Diarrhea 4, malabsorptive, congenital, 610370 (3)	NEUROG3, NGN3, ATOH5	604882	10q22.1	NEUROG3
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	EPCAM
Diarrhea 6, 614616 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	GUCY2C
Diarrhea 8, secretory sodium, congenital, 616868 (3)	SLC9A3, NHE3, DIAR8	182307	5p15.33	SLC9A3
Dias-Logan syndrome, 617101 (3)	BCL11A, CTIP1, EVI9, KIAA1809, DILOS	606557	2p16.1	BCL11A
Diastrophic dysplasia, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Dicarboxylic aminoaciduria, 222730 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	SLC1A1
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Digital clubbing, isolated congenital, 119900 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	HPGD
Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	DLD, LAD, PHE3, DLDD	238331	7q31.1	DLD
Dihydropyrimidine dehydrogenase deficiency, 274270 (3)	DPYD, DPD	612779	1p21.3	DPYD
Dihydropyrimidinuria, 222748 (3)	DPYS, DHP	613326	8q22.3	DPYS
Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Dimethylglycine dehydrogenase deficiency, 605850 (3)	DMGDH, DMGDHD	605849	5q14.1	DMGDH
Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	POR	124015	7q11.23	POR
Donnai-Barrow syndrome, 222448 (3)	LRP2, DBS	600073	2q31.1	LRP2
Dopamine beta-hydroxylase deficiency, 223360 (3)	DBH	609312	9q34.2	DBH
Dopamine receptor D2, reduced brain density of (3)	ANKK1	608774	11q23.2	ANKK1
Double-outlet right ventricle, 217095 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Dowling-Degos disease 1, 179850 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Dowling-Degos disease 2, 615327 (3)	POFUT1, OFUCT1, KIAA0180, DDD2	607491	20q11.21	POFUT1
Dowling-Degos disease 3 (2)	DDD3	615674	17q21.3-q22	DDD3
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMD2Z	615618	3q13.33	POGLUT1
Down syndrome (4)	DCR, DSCR	190685	21q22.3	DCR
Doyne honeycomb degeneration of retina, 126600 (3)	EFEMP1, FBNL, DHRD	601548	2p16.1	EFEMP1
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Duane retraction syndrome 1 (2)	DURS1, DUS	126800	8q13	DURS1
Duane retraction syndrome 2, 604356 (3)	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	118423	2q31.1	CHN1
Duane retraction syndrome 3, 617041 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	MAFB
Duane-radial ray syndrome, 607323 (3)	SALL4, HSAL4	607343	20q13.2	SALL4
Dubin-Johnson syndrome, 237500 (3)	ABCC2, CMOAT	601107	10q24.2	ABCC2
Duchenne muscular dystrophy, 310200 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	DMD
Dupuytren contracture 1 (2)	DUPC1	126900	16q11.1-q22	DUPC1
Dursun syndrome, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	G6PC3
Dyggve-Melchior-Clausen disease, 223800 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	DYM
Dysautonomia, familial, 223900 (3)	IKBKAP, IKAP	603722	9q31.3	IKBKAP
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	ADAR
Dyschromatosis universalis hereditaria 1 (2)	DUH1, DUH	127500	6q24.2-q25.2	DUH1
Dyschromatosis universalis hereditaria 2 (2)	DUH2	612715	12q21-q23	DUH2
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
Dyserythropoietic anemia, congenital, type II, 224100 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	SEC23B
Dyserythropoietic anemia, congenital, type III (2)	CDAN3, CDA3	105600	15q21	CDAN3
Dyserythropoietic anemia, congenital, type IV, 613673 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	KLF1
Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	CDAN1, CDA1, CDAN1A	607465	15q15.2	CDAN1
Dyserythropoietic anemia, congenital, type Ib, 615631 (3)	C15orf41	615626	15q14	C15orf41
Dysfibrinogenemia, congenital, 616004 (3)	FGA	134820	4q31.3	FGA
Dysfibrinogenemia, congenital, 616004 (3)	FGB	134830	4q31.3	FGB
Dysfibrinogenemia, congenital, 616004 (3)	FGG	134850	4q32.1	FGG
Dyskeratosis congenita, X-linked, 305000 (3)	DKC1, DKCX	300126	Xq28	DKC1
Dyskeratosis congenita, autosomal dominant 1, 127550 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TERC
Dyskeratosis congenita, autosomal dominant 3, 613990 (3)	TINF2, TIN2, DKCA3	604319	14q12	TINF2
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	RTEL1
Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	NOLA3, NOP10, DKCB1	606471	15q14	NOLA3
Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	NOLA2, NHP2, DKCB2	606470	5q35.3	NOLA2
Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	WRAP53, TCAB1, WDR79, DKCB3	612661	17p13.1	WRAP53
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	RTEL1
Dyskeratosis congenita, autosomal recessive 6, 616353 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	PARN
Dyskeratosis, hereditary benign intraepithelial (2)	DKBI	127600	4q35	DKBI
Dyskinesia, familial, with facial myokymia, 606703 (3)	ADCY5, FDFM	600293	3q21.1	ADCY5
Dyskinesia, limb and orofacial, infantile-onset, 616921 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	PDE10A
Dysplasminogenemia, 217090 (3)	PLG	173350	6q26	PLG
Dysprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	HSPG2
Dystonia 13, torsion (2)	DYT13	607671	1p36.32-p36.13	DYT13
Dystonia 16, 612067 (3)	PRKRA, PACT, RAX, DYT16	603424	2q31.2	PRKRA
Dystonia 2, torsion, autosomal recessive, 224500 (3)	HPCA, DYT2	142622	1p35.1	HPCA
Dystonia 21 (2)	DYT21	614588	2q14.3-q21.3	DYT21
Dystonia 24, 615034 (3)	ANO3, TMEM16C, C11orf25, DYT24	610110	11p14.3-p14.2	ANO3
Dystonia 25, 615073 (3)	GNAL, DYT25	139312	18p11.21	GNAL
Dystonia 26, myoclonic, 616398 (3)	KCTD17	616386	22q12.3	KCTD17
Dystonia 27, 616411 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	COL6A3
Dystonia 28, childhood-onset, 617284 (3)	KMT2B, MLL4, KIAA0304, DYT28	606834	19q13.12	KMT2B
Dystonia 4, torsion, autosomal dominant, 128101 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	TUBB4A
Dystonia 6, torsion, 602629 (3)	THAP1, DYT6	609520	8p11.21	THAP1
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	GCH1
Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3)	MECR, NRBF1, DYTOABG	608205	1p35.3	MECR
Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	SPR	182125	2p13.2	SPR
Dystonia, primary cervical (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD5
Dystonia-1, torsion, 128100 (3)	DYT1, TOR1A	605204	9q34.11	DYT1
Dystonia-11, myoclonic, 159900 (3)	SGCE, DYT11	604149	7q21.3	SGCE
Dystonia-12, 128235 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	ATP1A3
Dystonia-15, myoclonic (2)	DYT15	607488	18p11	DYT15
Dystonia-17, primary torsion (2)	DYT17	612406	20p11.2-q13.12	DYT17
Dystonia-7, torsion (2)	DYT7	602124	18p	DYT7
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	TAF1
EBD inversa, 226600 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
EBD, Bart type, 132000 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
EBD, localisata variant (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
EDICT syndrome, 614303 (3)	MIR184, MIRN184, KTCNCT, EDICT	613146	15q25.1	MIR184
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, HED1, STHAGX1	300451	Xq13.1	EDA
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDAR
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDAR
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	EDARADD
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	EDARADD
Ectodermal dysplasia 13, hair/tooth type, 617392 (3)	KREMEN1, KRM1, ECTD13	609898	22q12.1	KREMEN1
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	MSX1
Ectodermal dysplasia 4, hair/nail type, 602032 (3)	KRT85, KRTHB5, HB5, ECTD4	602767	12q13.13	KRT85
Ectodermal dysplasia 5, hair/nail type (2)	ECTD5	614927	10q24.32-q25.1	ECTD5
Ectodermal dysplasia 6, hair/nail type (2)	ECTD6	614928	17p12-q21.2	ECTD6
Ectodermal dysplasia 8, hair/tooth/nail type (2)	ECTD8	602401	18q22.1-q22.3	ECTD8
Ectodermal dysplasia 9, hair/nail type, 614931 (3)	HOXC13, HOX3G, ECTD9	142976	12q13.13	HOXC13
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)	NFKBIA, IKBA	164008	14q13.2	NFKBIA
Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	CDH3
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	NECTIN 4, PVRL4, PRR4, EDSS1	609607	1q23.3	NECTIN 4
Ectodermal dysplasia-syndactyly syndrome 2 (2)	EDSS2	613576	7p21.2-p14.3	EDSS2
Ectodermal dysplasia/short stature syndrome, 616029 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	GRHL2
Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	PKP1	601975	1q32.1	PKP1
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Ectopia lentis et pupillae, 225200 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	ADAMTSL4
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Ectopia lentis, isolated, autosomal recessive, 225100 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	ADAMTSL4
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Efavirenz, poor metabolism of, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	CYP2B6
Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3)	COL1A2, EDSCV, EDSARTH2	120160	7q21.3	COL1A2
Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3)	COL1A2, EDSCV, EDSARTH2	120160	7q21.3	COL1A2
Ehlers-Danlos syndrome, classic type, 1, 130000 (3)	COL5A1, EDSCL1	120215	9q34.3	COL5A1
Ehlers-Danlos syndrome, classic type, 2, 130010 (3)	COL5A2, EDSCL2	120190	2q32.2	COL5A2
Ehlers-Danlos syndrome, classic-like, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL, VUR8	600985	6p21.33-p21.32	TNXB
Ehlers-Danlos syndrome, dermatosparaxix type, 225410 (3)	ADAMTS2, NPI, EDSDERMS	604539	5q35.3	ADAMTS2
Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3)	PLOD1, LH1, LLH, EDSKCL1	153454	1p36.22	PLOD1
Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3)	FKBP14, EDSKSCL2	614505	7p14.3	FKBP14
Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	CHST14, D4ST1, ATCS, EDSMC1	608429	15q15.1	CHST14
Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	DSE, SART2, EDSMC2	605942	6q22.1	DSE
Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3)	C1R, EDSPD1	613785	12p13.31	C1R
Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3)	C1S, EDSPD2	120580	12p13.31	C1S
Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3)	B4GALT7, XGALT1, XGPT1, EDSSPD1	604327	5q35.3	B4GALT7
Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3)	B3GALT6, SEMDJL1, EDSSPD2	615291	1p36.33	B3GALT6
Ehlers-Danlos syndrome, type VIII (2)	EDS8	130080	12p13	EDS8
Ehlers-Danlos syndrome, vascular type, 130050 (3)	COL3A1, EDSVASC	120180	2q32.2	COL3A1
Eiken syndrome, 600002 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Elliptocytosis-1, 611804 (3)	EPB41, EL1	130500	1p35.3	EPB41
Elliptocytosis-2, 130600 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPTA1
Elliptocytosis-3 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPTB
Ellis-van Creveld syndrome, 225500 (3)	EVC	604831	4p16.2	EVC
Ellis-van Creveld syndrome, 225500 (3)	EVC2, LBN, WAD	607261	4p16.2	EVC2
Emanuel syndrome (4)	DER22t11-22	609029	22q11.2	DER22t11-22
Emberger syndrome, 614038 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	EMD, EDMD, STA	300384	Xq28	EMD
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	SYNE1
Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	SYNE2, NUANCE, KIAA1011, EDMD5	608442	14q23.2	SYNE2
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	300163	Xq26.3	FHL1
Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	TMEM43
Emphysema due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
Emphysema-cirrhosis, due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3)	MFF, C2orf33, EMPF2	614785	2q36.3	MFF
Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	SERPINI1, PI12	602445	3q26.1	SERPINI1
Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5	603850	12p11.21	DNM1L
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3)	LIPT2	617659	11q13.4	LIPT2
Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3)	TRAPPC12, TTC15, PEBAS	614139	2p25.3	TRAPPC12
Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3)	TBCD, PEBAT	604649	17q25.3	TBCD
Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3)	NAXE, APOA1BP, AIBP, PEBEL	608862	1q22	NAXE
Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3)	TBCE, KCS, KCS1, HRD, PEAMO	604934	1q42.3	TBCE
Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Endocrine-cerebroosteodysplasia, 612651 (3)	ICK, MRK, KIAA0936, ECO	612325	6p12.1	ICK
Endometrial cancer, familial, 608089 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	MSH6
Endometrial carcinoma, somatic, 608089 (3)	CDH1, UVO, LCAM, ECAD, BCDS1	192090	16q22.1	CDH1
Endometrial carcinoma, somatic, 608089 (3)	MSH3, FAP4	600887	5q14.1	MSH3
Endometrial carcinoma, somatic, 608089 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Enhanced S-cone syndrome, 268100 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	NR2E3
Enlarged vestibular aqueduct, 600791 (3)	FOXI1, FKHL10, FREAC6	601093	5q35.1	FOXI1
Enlarged vestibular aqueduct, digenic, 600791 (3)	KCNJ10, SESAME	602208	1q23.2	KCNJ10
Enolase deficiency (1)	ENO1, PPH, MPB1	172430	1p36.23	ENO1
Enterokinase deficiency, 226200 (3)	PRSS7, ENTK	606635	21q21.1	PRSS7
Enuresis, nocturnal, 1 (2)	ENUR1	600631	13q13-q14.3	ENUR1
Enuresis, nocturnal, 2 (2)	ENUR2	600808	12q13-q21	ENUR2
Eosinophilia, familial (2)	EOS	131400	5q31-q33	EOS
Epidermal nevus, somatic, 162900 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Epidermodysplasia verruciformis, 226400 (3)	TMC6, EVER1, EV1	605828	17q25.3	TMC6
Epidermodysplasia verruciformis, 226400 (3)	TMC8, EVER2, EV2	605829	17q25.3	TMC8
Epidermolysis bullosa dystrophica, AD, 131750 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa dystrophica, AR, 226600 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa of hands and feet, 131800 (3)	ITGB4	147557	17q25.1	ITGB4
Epidermolysis bullosa pruriginosa, 604129 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, Koebner type, 131900 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, Koebner type, 131900 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	DST
Epidermolysis bullosa simplex, generalized, with scarring and hair loss, 617294 (3)	KLHL24, KRIP6, EBSSH	611295	3q27.1	KLHL24
Epidermolysis bullosa simplex, recessive 1, 601001 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, recessive 1, 601001 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex-MCR, 609352 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex-MP, 131960 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	LAMA3, LOCS	600805	18q11.2	LAMA3
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMA3, LOCS	600805	18q11.2	LAMA3
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMB3, AI1A	150310	1q32.2	LAMB3
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMC2
Epidermolysis bullosa, junctional, localisata variant, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	COL17A1
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	COL17A1
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	ITGB4	147557	17q25.1	ITGB4
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMB3, AI1A	150310	1q32.2	LAMB3
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMC2
Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)	ITGB4	147557	17q25.1	ITGB4
Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	ITGA6	147556	2q31.1	ITGA6
Epidermolysis bullosa, lethal acantholytic, 609638 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	EXPH5, SLAC2B, KIAA0624	612878	11q22.3	EXPH5
Epidermolysis bullosa, pretibial, 131850 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolytic hyperkeratosis, 113800 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Epidermolytic hyperkeratosis, 113800 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	KRT10
Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	SYN1	313440	Xp11.3-p11.2	SYN1
Epilepsy, childhood absence, 1 (2)	ECA1	600131	8q24	ECA1
Epilepsy, early-onset, vitamin B6-dependent, 617290 (3)	PROSC, EPVB6D	604436	8p11.23	PROSC
Epilepsy, familial focal, with variable foci 1, 604364 (3)	DEPDC5, KIAA0645, FFEVF1	614191	22q12.2-q12.3	DEPDC5
Epilepsy, familial focal, with variable foci 2, 617116 (3)	NPR2L, NPRL2, FFEVF2	607072	3p21.31	NPR2L
Epilepsy, familial focal, with variable foci 3, 617118 (3)	NPRL3, CGTHBA, FFEVF3	600928	16p13.3	NPRL3
Epilepsy, familial temporal lobe, 1, 600512 (3)	LGI1, EPT, ETL1, ADLTE, ADPEAF	604619	10q23.33	LGI1
Epilepsy, familial temporal lobe, 2 (2)	ETL2, FTLE	608096	12q22-q23.3	ETL2
Epilepsy, familial temporal lobe, 3 (2)	ETL3, FMTLE	611630	4q13.2-q21.3	ETL3
Epilepsy, familial temporal lobe, 4 (2)	ETL4, ETOLM	611631	9q21-q22	ETL4
Epilepsy, familial temporal lobe, 5, 614417 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	CPA6
Epilepsy, familial temporal lobe, 6 (2)	ETL6	615697	3q25-q26	ETL6
Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	GRIN2A, NMDAR2A, FESD, LKS	138253	16p13.2	GRIN2A
Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52	600235	19q13.11	SCN1B
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GABRG2
Epilepsy, generalized, with febrile seizures plus, type 4 (2)	GEFSP4	609800	2p24	GEFSP4
Epilepsy, generalized, with febrile seizures plus, type 6 (2)	GEFSP6	612279	8p23-p21	GEFSP6
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Epilepsy, generalized, with febrile seizures plus, type 8 (2)	GEFSP8	613828	6q16.3-q22.31	GEFSP8
Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	SPATA5, SPAF, EHLMRS	613940	4q28.1	SPATA5
Epilepsy, hot water, 1 (2)	HWE1	613339	10q21.3-q22.3	HWE1
Epilepsy, hot water, 2 (2)	HWE2	613340	4q24-q28	HWE2
Epilepsy, juvenile myoclonic (2)	EIG7, EJM2	604827	15q14	EIG7
Epilepsy, juvenile myoclonic 3 (2)	EJM3	608816	6p21	EJM3
Epilepsy, myoclonic, familial adult, 1 (2)	FAME1, BAFME1, MEBA	601068	8q24	FAME1
Epilepsy, myoclonic, familial adult, 2, 607876 (3)	ADRA2B, ADRA2L1, FAME2	104260	2q11.2	ADRA2B
Epilepsy, myoclonic, familial adult, 3 (2)	FAME3, FCMTE3	613608	5p15.31-p15.1	FAME3
Epilepsy, myoclonic, familial adult, 4 (2)	FAME4, FCMTE4	615127	3q26.32-q28	FAME4
Epilepsy, nocturnal frontal lobe, 1, 600513 (3)	CHRNA4, ENFL1	118504	20q13.33	CHRNA4
Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	CHRNB2, EFNL3	118507	1q21.3	CHRNB2
Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	KCNT1
Epilepsy, nocturnal frontal lobe, type 2 (2)	ENFL2	603204	15q24	ENFL2
Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	CHRNA2	118502	8p21.2	CHRNA2
Epilepsy, partial, with pericentral spikes (2)	EPPS	607221	4p15	EPPS
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	CSTB
Epilepsy, progressive myoclonic 1B, 612437 (3)	PRICKLE1, RILP, EPM1B	608500	12q12	PRICKLE1
Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	EPM2A, MELF, EPM2	607566	6q24.3	EPM2A
Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	NHLRC1, EPM2A, EPM2B	608072	6p22.3	NHLRC1
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	KCTD7, EPM3, CLN14	611725	7q11.21	KCTD7
Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	SCARB2, CD36L2, LIMPII, AMRF, EPM4	602257	4q21.1	SCARB2
Epilepsy, progressive myoclonic 6, 614018 (3)	GOSR2, GS27, EPM6	604027	17q21.32	GOSR2
Epilepsy, progressive myoclonic 7, 616187 (3)	KCNC1, EPM7	176258	11p15.1	KCNC1
Epilepsy, pyridoxine-dependent, 266100 (3)	ALDH7A1, ATQ1, EPD, PDE	107323	5q23.2	ALDH7A1
Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp (2)	EPRPDC	608105	16p12-p11.2	EPRPDC
Epileptic encephalopathy, childhood-onset, 615369 (3)	CHD2, EEOC	602119	15q26.1	CHD2
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	SCN2A
Epileptic encephalopathy, early infantile, 12, 613722 (3)	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	607120	20p12.3	PLCB1
Epileptic encephalopathy, early infantile, 13, 614558 (3)	SCN8A, CIAT, EIEE13, BFIS5	600702	12q13.13	SCN8A
Epileptic encephalopathy, early infantile, 14, 614959 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	KCNT1
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Epileptic encephalopathy, early infantile, 17, 615473 (3)	GNAO1, EIEE17, NEDIM	139311	16q13	GNAO1
Epileptic encephalopathy, early infantile, 18, 615476 (3)	SZT2, KIAA0467, EIEE18	615463	1p34.2	SZT2
Epileptic encephalopathy, early infantile, 19, 615744 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	GABRA1
Epileptic encephalopathy, early infantile, 2, 300672 (3)	CDKL5, STK9, ISSX, EIEE2	300203	Xp22.13	CDKL5
Epileptic encephalopathy, early infantile, 23, 615859 (3)	DOCK7, KIAA1771, EIEE23	615730	1p31.3	DOCK7
Epileptic encephalopathy, early infantile, 24, 615871 (3)	HCN1, BCNG1, EIEE24	602780	5p12	HCN1
Epileptic encephalopathy, early infantile, 25, 615905 (3)	SLC13A5, NACT, EIEE25	608305	17p13.1	SLC13A5
Epileptic encephalopathy, early infantile, 26, 616056 (3)	KCNB1, EIEE26	600397	20q13.13	KCNB1
Epileptic encephalopathy, early infantile, 27, 616139 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	GRIN2B
Epileptic encephalopathy, early infantile, 28, 616211 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	WWOX
Epileptic encephalopathy, early infantile, 29, 616339 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	AARS
Epileptic encephalopathy, early infantile, 3, 609304 (3)	SLC25A22, GC1, EIEE3	609302	11p15.5	SLC25A22
Epileptic encephalopathy, early infantile, 30, 616341 (3)	SIK1, SNF1LK, MSK, EIEE30	605705	21q22.3	SIK1
Epileptic encephalopathy, early infantile, 31, 616346 (3)	DNM1, EIEE31	602377	9q34.11	DNM1
Epileptic encephalopathy, early infantile, 32, 616366 (3)	KCNA2, EIEE32	176262	1p13.3	KCNA2
Epileptic encephalopathy, early infantile, 33, 616409 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	EEF1A2
Epileptic encephalopathy, early infantile, 34, 616645 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	SLC12A5
Epileptic encephalopathy, early infantile, 35, 616647 (3)	ITPA, EIEE35	147520	20p13	ITPA
Epileptic encephalopathy, early infantile, 36, 300884 (3)	ALG13, GLT28D1, CDG1S, EIEE36	300776	Xq23	ALG13
Epileptic encephalopathy, early infantile, 37, 616981 (3)	FRRS1L, C9orf4, CG6, EIEE37	604574	9q31.3	FRRS1L
Epileptic encephalopathy, early infantile, 38, 617020 (3)	ARV1, EIEE38	611647	1q42.2	ARV1
Epileptic encephalopathy, early infantile, 39, 612949 (3)	SLC25A12, ARALAR, EIEE39	603667	2q31.1	SLC25A12
Epileptic encephalopathy, early infantile, 4, 612164 (3)	STXBP1, UNC18, EIEE4	602926	9q34.11	STXBP1
Epileptic encephalopathy, early infantile, 41, 617105 (3)	SLC1A2, EAAT2, EIEE41	600300	11p13	SLC1A2
Epileptic encephalopathy, early infantile, 42, 617106 (3)	CACNA1A, CACNL1A4, SCA6, EIEE42	601011	19p13.13	CACNA1A
Epileptic encephalopathy, early infantile, 43, 617113 (3)	GABRB3, ECA5, EIEE43	137192	15q12	GABRB3
Epileptic encephalopathy, early infantile, 44, 617132 (3)	UBA5, UBE1DC1, EIEE44, SCAR24	610552	3q22.1	UBA5
Epileptic encephalopathy, early infantile, 45, 617153 (3)	GABRB1, EIEE45	137190	4p12	GABRB1
Epileptic encephalopathy, early infantile, 46, 617162 (3)	GRIN2D, NMDAR2D, EIEE46	602717	19q13.33	GRIN2D
Epileptic encephalopathy, early infantile, 47, 617166 (3)	FGF12, FHF1, EIEE47	601513	3q28-q29	FGF12
Epileptic encephalopathy, early infantile, 48, 617276 (3)	AP3B2, NAPTB, EIEE48	602166	15q25.2	AP3B2
Epileptic encephalopathy, early infantile, 49, 617281 (3)	DENND5A, RAB6IP1, KIAA1091, EIEE49	617278	11p15.4	DENND5A
Epileptic encephalopathy, early infantile, 5, 613477 (3)	SPTAN1, NEAS, EIEE5	182810	9q34.11	SPTAN1
Epileptic encephalopathy, early infantile, 50, 616457 (3)	CAD, CDG1Z, EIEE50	114010	2p23.3	CAD
Epileptic encephalopathy, early infantile, 51, 617339 (3)	MDH2, EIEE51	154100	7q11.23	MDH2
Epileptic encephalopathy, early infantile, 52, 617350 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52	600235	19q13.11	SCN1B
Epileptic encephalopathy, early infantile, 53, 617389 (3)	SYNJ1, PARK20, EIEE53	604297	21q22.11	SYNJ1
Epileptic encephalopathy, early infantile, 54, 617391 (3)	HNRNPU, HNRPU, SAFA, EIEE54	602869	1q44	HNRNPU
Epileptic encephalopathy, early infantile, 56, 617665 (3)	YWHAG, EIEE56	605356	7q11.23	YWHAG
Epileptic encephalopathy, early infantile, 6 (Dravet syndrome), 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Epileptic encephalopathy, early infantile, 7, 613720 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	KCNQ2
Epileptic encephalopathy, early infantile, 8, 300607 (3)	ARHGEF9, PEM2, KIAA0424, EIEE8	300429	Xq11.1	ARHGEF9
Epileptic encephalopathy, early infantile, 9, 300088 (3)	PCDH19, KIAA1313, EFMR, EIEE9	300460	Xq22.1	PCDH19
Epileptic encephalopathy, infantile or early childhood, 617711 (3)	PPP3CA, PPP2B, CALNA, CNA1, IECEE	114105	4q24	PPP3CA
Epiphyseal chondrodysplasia, Miura type, 615923 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	NPR2
Epiphyseal dysplasia, multiple, 1, 132400 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	COMP
Epiphyseal dysplasia, multiple, 2, 600204 (3)	COL9A2, EDM2, STL5	120260	1p34.2	COL9A2
Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3)	COL9A3, EDM3, IDD	120270	20q13.33	COL9A3
Epiphyseal dysplasia, multiple, 4, 226900 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Epiphyseal dysplasia, multiple, 5, 607078 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	MATN3
Epiphyseal dysplasia, multiple, 7, 617719 (3)	CANT1, SCAN1, DBQD1, EDM7	613165	17q25.3	CANT1
Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3)	COL2A1	120140	12q13.11	COL2A1
Episodic ataxia, type 2, 108500 (3)	CACNA1A, CACNL1A4, SCA6, EIEE42	601011	19p13.13	CACNA1A
Episodic ataxia, type 3 (2)	EA3	606554	1q42	EA3
Episodic ataxia, type 5, 613855 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	CACNB4
Episodic ataxia, type 6, 612656 (3)	SLC1A3, EAAT1, EA6	600111	5p13.2	SLC1A3
Episodic ataxia, type 7 (2)	EA7	611907	19q13	EA7
Episodic ataxia, type 8 (2)	EA8	616055	1p36.13-p34.3	EA8
Episodic ataxia/myokymia syndrome, 160120 (3)	KCNA1, AEMK, EA1	176260	12p13.32	KCNA1
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PRRT2
Episodic kinesigenic dyskinesia 2 (2)	EKD2	611031	16q13-q22.1	EKD2
Episodic muscle weakness, X-linked (2)	EMWX	300211	Xp22.3	EMWX
Episodic pain syndrome, familial, 2, 615551 (3)	SCN10A, FEPS2	604427	3p22.2	SCN10A
Episodic pain syndrome, familial, 3, 615552 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	SCN11A
Epithelial recurrent erosion dystrophy, 122400 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	COL17A1
Epstein syndrome, 153650 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Erythremias, alpha- (3)	HBA1, HBH	141800	16p13.3	HBA1
Erythremias, beta- (3)	HBB	141900	11p15.4	HBB
Erythrocyte lactate transporter defect, 245340 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	SLC16A1
Erythrocytosis (3)	HBA2, HBH	141850	16p13.3	HBA2
Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3)	BPGM	613896	7q33	BPGM
Erythrocytosis, familial, 2, 263400 (3)	VHL	608537	3p25.3	VHL
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	EGLN1
Erythrocytosis, familial, 4, 611783 (3)	EPAS1, MOP2, HIF2A, ECYT4	603349	2p21	EPAS1
Erythrocytosis, somatic, 133100 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Erythrocytosis, somatic, 133100 (3)	SH2B3, LNK	605093	12q24.12	SH2B3
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	DSG1
Erythrokeratodermia variabilis et progressiva 1, 133200 (3)	GJB3, CX31, DFNA2B, EKVP1	603324	1p34.3	GJB3
Erythrokeratodermia variabilis et progressiva 2, 617524 (3)	GJB4, CX30.3, EKVP2	605425	1p34.3	GJB4
Erythrokeratodermia variabilis et progressiva 3, 617525 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Erythrokeratodermia variabilis et progressiva 4, 617526 (3)	KDSR, FVT1, EKVP4	136440	18q21.33	KDSR
Erythrokeratodermia variabilis et progressiva 5, 617756 (3)	KRT83, KRTHB3, HB3, MNLIX, EKVP5	602765	12q13.13	KRT83
Escobar syndrome, 265000 (3)	CHRNG, ACHRG	100730	2q37.1	CHRNG
Esophageal cancer, 133239 (1)	DLEC1, DLC1	604050	3p22.2	DLEC1
Esophageal cancer, somatic, 133239 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	TGFBR2
Esophageal carcinoma, somatic, 133239 (3)	DCC, MRMV1, HGPPS2	120470	18q21.2	DCC
Esophageal carcinoma, somatic, 133239 (3)	RNF6	604242	13q12.13	RNF6
Esophageal squamous cell carcinoma, 133239 (1)	DEC1	604767	9q33.1	DEC1
Esophageal squamous cell carcinoma, 133239 (3)	LZTS1, F37, FEZ1	606551	8p21.3	LZTS1
Esophageal squamous cell carcinoma, somatic, 133239 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	WWOX
Essential tremor, hereditary, 2 (2)	ETM2, ETM	602134	2p25-p22	ETM2
Essential tremor, hereditary, 3 (2)	ETM3	611456	6p23	ETM3
Essential tremor, hereditary, 4, 614782 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	FUS
Essential tremor, hereditary, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	TENM4
Estrogen resistance, 615363 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
Ethylmalonic encephalopathy, 602473 (3)	ETHE1, HSCO, D83198	608451	19q13.31	ETHE1
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	HSPA9
Ewing sarcoma, 612219 (3)	EWSR1, EWS	133450	22q12.2	EWSR1
Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	COX4I2	607976	20q11.21	COX4I2
Exostoses, multiple, type 1, 133700 (3)	EXT1	608177	8q24.11	EXT1
Exostoses, multiple, type 2, 133701 (3)	EXT2, SSMS	608210	11p11.2	EXT2
Exostoses, multiple, type 3 (2)	EXT3	600209	19p	EXT3
Exudative vitreoretinopathy 1, 133780 (3)	FZD4, EVR1	604579	11q14.2	FZD4
Exudative vitreoretinopathy 2, X-linked, 305390 (3)	NDP, ND, EVR2	300658	Xp11.3	NDP
Exudative vitreoretinopathy 3 (2)	EVR3	605750	11p13-p12	EVR3
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Exudative vitreoretinopathy 5, 613310 (3)	TSPAN12, NET2, EVR5	613138	7q31.31	TSPAN12
Exudative vitreoretinopathy 7, 617572 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
FG syndrome 3 (2)	FGS3	300406	Xp22.3	FGS3
FG syndrome 4, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CASK
FG syndrome 5 (2)	FGS5	300581	Xq22.3	FGS5
FILS syndrome, 615139 (3)	POLE1, CRCS12, FILS	174762	12q24.33	POLE1
Fabry disease, 301500 (3)	GLA	300644	Xq22.1	GLA
Fabry disease, cardiac variant, 301500 (3)	GLA	300644	Xq22.1	GLA
Facial paresis, hereditary congenital, 1 (2)	HCFP1, MBS2	601471	3q21-q22	HCFP1
Facial paresis, hereditary congenital, 2 (2)	HCFP2	604185	10q21.3-q22.1	HCFP2
Facial paresis, hereditary congenital, 3, 614744 (3)	HOXB1, HOX2I, HCFP3	142968	17q21.32	HOXB1
Facioscapulohumeral muscular dystrophy 1 (4)	FSHD1, FSHD1A	158900	4q35	FSHD1
Factor V and factor VIII, combined deficiency of, 613625 (3)	MCFD2, F5F8D2	607788	2p21	MCFD2
Factor V deficiency, 227400 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
Factor VII deficiency, 227500 (3)	F7	613878	13q34	F7
Factor X deficiency, 227600 (3)	F10	613872	13q34	F10
Factor XI deficiency, autosomal dominant, 612416 (3)	F11	264900	4q35.2	F11
Factor XI deficiency, autosomal recessive, 612416 (3)	F11	264900	4q35.2	F11
Factor XII deficiency, 234000 (3)	F12, HAF, HAE3	610619	5q35.3	F12
Factor XIIIA deficiency, 613225 (3)	F13A1, F13A	134570	6p25.1	F13A1
Factor XIIIB deficiency, 613235 (3)	F13B	134580	1q31.3	F13B
Failure of tooth eruption, primary, 125350 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Familial Mediterranean fever, AD, 134610 (3)	MEFV, MEF, FMF	608107	16p13.3	MEFV
Familial Mediterranean fever, AR, 249100 (3)	MEFV, MEF, FMF	608107	16p13.3	MEFV
Familial adenomatous polyposis 3, 616415 (3)	NTHL1, OCTS3, FAP3	602656	16p13.3	NTHL1
Familial adenomatous polyposis 4, 617100 (3)	MSH3, FAP4	600887	5q14.1	MSH3
Familial cold autoinflammatory syndrome 2, 611762 (3)	NLRP12, NALP12, PYPAF7, RNO, FCAS2	609648	19q13.42	NLRP12
Familial cold autoinflammatory syndrome 3, 614468 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	PLCG2
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34	606416	1q44	NLRP3
Fanconi anemia, complementation group A, 227650 (3)	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	FANCA
Fanconi anemia, complementation group B, 300514 (3)	FAAP95, FAAP90, FLJ34064, FANCB	300515	Xp22.2	FAAP95
Fanconi anemia, complementation group C, 227645 (3)	FANCC, FACC	613899	9q22.32	FANCC
Fanconi anemia, complementation group D1, 605724 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
Fanconi anemia, complementation group D2, 227646 (3)	FANCD2, FANCD, FACD, FAD	613984	3p25.3	FANCD2
Fanconi anemia, complementation group E, 600901 (3)	FANCE, FACE	613976	6p21.31	FANCE
Fanconi anemia, complementation group F, 603467 (3)	FANCF	613897	11p14.3	FANCF
Fanconi anemia, complementation group G, 614082 (3)	XRCC9, FANCG	602956	9p13.3	XRCC9
Fanconi anemia, complementation group I, 609053 (3)	FANCI, KIAA1794	611360	15q26.1	FANCI
Fanconi anemia, complementation group J, 609054 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	BRIP1
Fanconi anemia, complementation group L, 614083 (3)	PHF9, FANCL	608111	2p16.1	PHF9
Fanconi anemia, complementation group N, 610832 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PALB2
Fanconi anemia, complementation group O, 613390 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	RAD51C
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	SLX4
Fanconi anemia, complementation group Q, 615272 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
Fanconi anemia, complementation group T, 616435 (3)	UBE2T, HSPC150, FANCT	610538	1q32.1	UBE2T
Fanconi renotubular syndrome 1 (2)	FRTS1, FRTS, RFS	134600	15q15.3	FRTS1
Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	HNF4A
Fanconi-Bickel syndrome, 227810 (3)	SLC2A2, GLUT2	138160	3q26.2	SLC2A2
Farber lipogranulomatosis, 228000 (3)	ASAH1, AC, SMAPME	613468	8p22	ASAH1
Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3)	SMCHD1, KIAA0650, BAMS	614982	18p11.32	SMCHD1
Fatty liver, acute, of pregnancy, 609016 (3)	HADHA, MTPA	600890	2p23.3	HADHA
Favism, 134700 (3)	G6PD, G6PD1	305900	Xq28	G6PD
Febrile seizures, familial, 1 (2)	FEB1	121210	8q13-q21	FEB1
Febrile seizures, familial, 10 (2)	FEB10	612637	3q26.2-q26.33	FEB10
Febrile seizures, familial, 11, 614418 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	CPA6
Febrile seizures, familial, 2 (2)	FEB2	602477	19p13.3	FEB2
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Febrile seizures, familial, 5 (2)	FEB5	609255	6q22-q24	FEB5
Febrile seizures, familial, 6 (2)	FEB6	609253	18p11.2	FEB6
Febrile seizures, familial, 7 (2)	FEB7	611515	21q22	FEB7
Febrile seizures, familial, 8, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GABRG2
Febrile seizures, familial, 9 (2)	FEB9	611634	3p24.2-p23	FEB9
Fechtner syndrome, 153640 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Feingold syndrome 1, 164280 (3)	MYCN, NMYC, ODED, MODED	164840	2p24.3	MYCN
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	MIR17HG
Fetal akinesia deformation sequence, 208150 (3)	MUSK, CMS9, FADS	601296	9q31.3	MUSK
Fetal akinesia deformation sequence, 208150 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	RAPSN
Fetal hemoglobin quantitative trait locus 1, 141749 (3)	HBG1	142200	11p15.4	HBG1
Fetal hemoglobin quantitative trait locus 1, 141749 (3)	HBG2, TNCY	142250	11p15.4	HBG2
Fetal hemoglobin quantitative trait locus 2 (2)	HBFQTL2, FCP	142470	6q22.3-q23.1	HBFQTL2
Fetal hemoglobin quantitative trait locus 3 (2)	HBFQTL3, FCP1, FCPX, FCP	305435	Xp22.2	HBFQTL3
Fetal hemoglobin quantitative trait locus 4 (2)	HBFQTL4	606789	8q	HBFQTL4
Fibrochondrogenesis 1, 228520 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
Fibrochondrogenesis 2, 614524 (3)	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	120290	6p21.32	COL11A2
Fibrodysplasia ossificans progressiva, 135100 (3)	ACVR1, ACVRLK2, ALK2, FOP	102576	2q24.1	ACVR1
Fibromatosis, gingival, 2 (2)	GINGF2, GGF2, HGF2	605544	5q13-q22	GINGF2
Fibromatosis, gingival, 3 (2)	GINGF3, HGF3, GGF3	609955	2p23.3-p22.3	GINGF3
Fibromatosis, gingival, 4 (2)	GINGF4, HGF4, GGF4	611010	11p15	GINGF4
Fibromatosis, gingival, 5, 617626 (3)	REST, NRSF, WT6, GINGF5, HGF5	600571	4q12	REST
Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	KIF21A
Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	PHOX2A, ARIX, CFEOM2	602753	11q13.4	PHOX2A
Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	TUBB3
Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	KIF21A
Fibrosis of extraocular muscles, congenital, 3C (2)	CFEOM3C, FEOM4	609384	13q12.11	CFEOM3C
Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	COL25A1, CLAC, CFEOM5	610004	4q25	COL25A1
Filippi syndrome, 272440 (3)	CKAP2L, RADMIS	616174	2q14.1	CKAP2L
Fish-eye disease, 136120 (3)	LCAT	606967	16q22.1	LCAT
Fletcher factor (prekallikrein) deficiency, 612423 (3)	KLKB1, KLK3, PKKD	229000	4q35.2	KLKB1
Floating-Harbor syndrome, 136140 (3)	SRCAP, SWR1, KIAA0309, FLHS	611421	16p11.2	SRCAP
Focal cortical dysplasia, type II, somatic, 607341 (3)	MTOR, FRAP1, SKS	601231	1p36.22	MTOR
Focal cortical dysplasia, type II, somatic, 607341 (3)	TSC1, LAM	605284	9q34.13	TSC1
Focal dermal hypoplasia, 305600 (3)	PORCN, PORC, DHOF, FODH	300651	Xp11.23	PORCN
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	TWIST2
Focal facial dermal dysplasia 4, 614974 (3)	CYP26C1, FFDD4	608428	10q23.33	CYP26C1
Focal segmental glomerulosclerosis 8, 616032 (3)	ANLN, FSFS8	616027	7p14.2	ANLN
Focal segmental glomerulosclerosis 9, 616220 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	CRB2
Folate malabsorption, hereditary, 229050 (3)	SLC46A1, HCP1, PCFT	611672	17q11.2	SLC46A1
Forebrain defects (3)	TDGF1	187395	3p21.31	TDGF1
Forsythe-Wakeling syndrome (2)	FWS	613606	1p33-p31.1	FWS
Foveal hypoplasia 1, 136520 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	SLC38A8, FVH2	615585	16q23.3	SLC38A8
Fragile X syndrome, 300624 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FMR1
Fragile X tremor/ataxia syndrome, 300623 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FMR1
Frank-ter Haar syndrome, 249420 (3)	SH3PXD2B, TKS4, KIAA1295, FTHS	613293	5q35.1	SH3PXD2B
Fraser syndrome 1, 219000 (3)	FRAS1, FRASRS1	607830	4q21.21	FRAS1
Fraser syndrome 2, 617666 (3)	FREM2, FRASRS2	608945	13q13.3	FREM2
Fraser syndrome 3, 617667 (3)	GRIP1, FRASRS3	604597	12q14.3	GRIP1
Frasier syndrome, 136680 (3)	WT1, NPHS4	607102	11p13	WT1
Frias syndrome (4)	FRIASS, DEL14q22, C14DELq22	609640	14q22.1-q22.3	FRIASS
Friedreich ataxia 2 (2)	FRDA2	601992	9p23-p11	FRDA2
Friedreich ataxia with retained reflexes, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FXN
Friedreich ataxia, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FXN
Frontometaphyseal dysplasia 1, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Frontometaphyseal dysplasia 2, 617137 (3)	MAP3K7, TAK1, CSCF, FMD2	602614	6q15	MAP3K7
Frontonasal dysplasia 1, 136760 (3)	ALX3, FND1	606014	1p13.3	ALX3
Frontonasal dysplasia 2, 613451 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	ALX4
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	C9orf72, FTDALS1, FTDALS, ALSFTD	614260	9p21.2	C9orf72
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	CHCHD10
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	601530	5q35.3	SQSTM1
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3)	TBK1, NAK, FTDALS4	604834	12q14.2	TBK1
Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3)	GRN, CLN11	138945	17q21.31	GRN
Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	TARDBP
Fructose intolerance, hereditary, 229600 (3)	ALDOB	612724	9q31.1	ALDOB
Fructose-1,6-bisphosphatase deficiency, 229700 (3)	FBP1	611570	9q22.32	FBP1
Fucosidosis, 230000 (3)	FUCA1	612280	1p36.11	FUCA1
Fucosyltransferase 6 deficiency, 613852 (3)	FUT6	136836	19p13.3	FUT6
Fuhrmann syndrome, 228930 (3)	WNT7A	601570	3p25.1	WNT7A
Fumarase deficiency, 606812 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	FH
Fundus albipunctatus, 136880 (3)	RDH5	601617	12q13.2	RDH5
Fundus albipunctatus, 136880 (3)	RLBP1	180090	15q26.1	RLBP1
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
GABA-transaminase deficiency, 613163 (3)	ABAT, GABAT	137150	16p13.2	ABAT
GAPO syndrome, 230740 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	ANTXR1
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
GM1-gangliosidosis, type I, 230500 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
GM1-gangliosidosis, type II, 230600 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
GM1-gangliosidosis, type III, 230650 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
GM2-gangliosidosis, AB variant, 272750 (3)	GM2A	613109	5q33.1	GM2A
GM2-gangliosidosis, several forms, 272800 (3)	HEXA, TSD	606869	15q23	HEXA
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Gabriele-de Vries syndrome, 617557 (3)	YY1, GADEVS	600013	14q32.2	YY1
Galactokinase deficiency with cataracts, 230200 (3)	GALK1	604313	17q25.1	GALK1
Galactose epimerase deficiency, 230350 (3)	GALE	606953	1p36.11	GALE
Galactosemia, 230400 (3)	GALT	606999	9p13.3	GALT
Galactosialidosis, 256540 (3)	CTSA, PPGB, GSL, NGBE, GLB2	613111	20q13.12	CTSA
Gallbladder disease 1, 600803 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ABCB4
Gallbladder disease 2 (2)	GBD2	609918	1p36.21	GBD2
Gallbladder disease 3 (2)	GBD3	609919	1p34.3	GBD3
Galloway-Mowat syndrome 1, 251300 (3)	WDR73, HSPC264, GAMOS1	616144	15q25.2	WDR73
Galloway-Mowat syndrome 2, X-linked, 301006 (3)	LAGE3, ITBA2, GAMOS2	300060	Xq28	LAGE3
Galloway-Mowat syndrome 3, 617729 (3)	OSGEP, FLJ20411, GAMOS3	610107	14q11.2	OSGEP
Galloway-Mowat syndrome 4, 617730 (3)	TP53RK, PRPK, GAMOS4	608679	20q13.12	TP53RK
Galloway-Mowat syndrome 5, 617731 (3)	TPRKB, GAMOS5	608680	2p13.1	TPRKB
Gardner syndrome, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3)	CDH1, UVO, LCAM, ECAD, BCDS1	192090	16q22.1	CDH1
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Gastric cancer, somatic, 613659 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Gastric cancer, somatic, 613659 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	CASP10
Gastric cancer, somatic, 613659 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Gastric cancer, somatic, 613659 (3)	IRF1, MAR	147575	5q31.1	IRF1
Gastric cancer, somatic, 613659 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	KLF6
Gastric cancer, somatic, 613659 (3)	MUTYH, MYH	604933	1p34.1	MUTYH
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Gastroesophageal reflux (2)	GER	109350	13q14	GER
Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	TTC7A, TTC7, KIAA1140, MINAT, GIDID	609332	2p21	TTC7A
Gastrointestinal stromal tumor, 606764 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Gastrointestinal stromal tumor, 606764 (3)	SDHC, PGL3	602413	1q23.3	SDHC
Gastrointestinal stromal tumor, familial, 606764 (3)	KIT, PBT	164920	4q12	KIT
Gastrointestinal stromal tumor, somatic, 606764 (3)	PDGFRA	173490	4q12	PDGFRA
Gaucher disease, atypical, 610539 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Gaucher disease, perinatal lethal, 608013 (3)	GBA	606463	1q22	GBA
Gaucher disease, type I, 230800 (3)	GBA	606463	1q22	GBA
Gaucher disease, type II, 230900 (3)	GBA	606463	1q22	GBA
Gaucher disease, type III, 231000 (3)	GBA	606463	1q22	GBA
Gaucher disease, type IIIC, 231005 (3)	GBA	606463	1q22	GBA
Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3)	ROBO3, RBIG1, RIG1, HGPPS1	608630	11q24.2	ROBO3
Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3)	DCC, MRMV1, HGPPS2	120470	18q21.2	DCC
Geleophysic dysplasia 1, 231050 (3)	ADAMTSL2, KIAA0605, GPHYSD1	612277	9q34.2	ADAMTSL2
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Geleophysic dysplasia 3, 617809 (3)	LTBP3, LTBP2, DASS, GPHYSD3	602090	11q13.1	LTBP3
Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	STX1B, GEFSP9	601485	16p11.2	STX1B
Geniospasm (2)	GSM1, GSP	190100	9q13-q21	GSM1
Genitopatellar syndrome, 606170 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	KAT6B
Germ cell tumors, somatic, 273300 (3)	KIT, PBT	164920	4q12	KIT
Geroderma osteodysplasticum, 231070 (3)	GORAB, SCYL1BP1, NTKLBP1, GO	607983	1q24.2	GORAB
Gerstmann-Straussler disease, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Ghosal hematodiaphyseal syndrome, 231095 (3)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	TBXAS1
Giant axonal neuropathy-1, 256850 (3)	GAN, GAN1	605379	16q23.2	GAN
Giant platelet disorder, isolated, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	GP1BB
Gigantism due to GHRF hypersecretion (1)	GHRH, GHRF	139190	20q11.23	GHRH
Gillespie syndrome, 206700 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	ITPR1
Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	ALG9
Gitelman syndrome, 263800 (3)	SLC12A3, NCCT, TSC	600968	16q13	SLC12A3
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	ITGA2B
Glanzmann thrombasthenia, 273800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Glass syndrome, 612313 (3)	SATB2, KIAA1034, GLSS	608148	2q33.1	SATB2
Glaucoma 1, open angle, 1O, 613100 (3)	NTF4 , NTF5, NT5, NT4, GLC1O	162662	19q13.33	NTF4 
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	OPTN
Glaucoma 1, open angle, F, 603383 (3)	ASB10, GLC1F	615054	7q36.1	ASB10
Glaucoma 1, open angle, G, 609887 (3)	WDR36, TAWDRP, GLC1G	609669	5q22.1	WDR36
Glaucoma 1, open angle, H (2)	GLC1H	611276	2p16-p15	GLC1H
Glaucoma 1, open angle, I (2)	GLC1I	609745	15q11-q13	GLC1I
Glaucoma 1, open angle, M (2)	GLC1M	610535	5q22.1-q32	GLC1M
Glaucoma 1, open angle, N (2)	GLC1N	611274	15q22-q24	GLC1N
Glaucoma 1, open angle, P (4)	GLC1P	177700	12q14	GLC1P
Glaucoma 1A, primary open angle, 137750 (3)	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3	MYOC
Glaucoma 1B, primary open angle, adult onset, (2)	GLC1B	606689	2cen-q13	GLC1B
Glaucoma 1C, primary open angle (2)	GLC1C	601682	3q21-q24	GLC1C
Glaucoma 1D, primary open angle (2)	GLC1D	602429	8q23	GLC1D
Glaucoma 1K, primary open angle, juvenile-onset (2)	GLC1K, JOAG3	608696	20p12	GLC1K
Glaucoma 3, primary congenital, C (2)	GLC3C	613085	14q24.3	GLC3C
Glaucoma 3, primary congenital, D, 613086 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP2
Glaucoma 3, primary congenital, E, 617272 (3)	TEK, TIE2, VMCM, GLC3E	600221	9p21.2	TEK
Glaucoma 3, primary infantile, B (2)	GLC3B	600975	1p36.2-p36.1	GLC3B
Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3)	CYP1B1, GLC3A, ASGD6	601771	2p22.2	CYP1B1
Glaucoma, primary open angle, juvenile-onset, 2 (2)	JOAG2	608695	9q22	JOAG2
Glioblastoma, somatic, 137800 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3)	ZNF148, ZFP148, GDACCF	601897	3q21.2	ZNF148
Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	UMOD
Glomerulopathy with fibronectin deposits 1 (2)	GFND1	137950	1q32	GFND1
Glomerulopathy with fibronectin deposits 2, 601894 (3)	FN1, FN, LETS, FNZ, GFND2, SMDCF	135600	2q35	FN1
Glomerulosclerosis, focal segmental, 1, 603278 (3)	ACTN4, FSGS1, FSGS	604638	19q13.2	ACTN4
Glomerulosclerosis, focal segmental, 2, 603965 (3)	TRPC6, TRP6, FSGS2	603652	11q22.1	TRPC6
Glomerulosclerosis, focal segmental, 3, 607832 (3)	CD2AP, CMS	604241	6p12.3	CD2AP
Glomerulosclerosis, focal segmental, 5, 613237 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	INF2
Glomerulosclerosis, focal segmental, 6, 614131 (3)	MYO1E, MYO1C, FSGS6	601479	15q22.2	MYO1E
Glomerulosclerosis, focal segmental, 7, 616002 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	PAX2
Glomuvenous malformations, 138000 (3)	GLML, GVM, VMGLOM	601749	1p22.1	GLML
Glucocorticoid deficiency 2, 607398 (3)	MRAP, FALP, C21orf61, GCCD2, FGD2	609196	21q22.11	MRAP
Glucocorticoid deficiency 3 (2)	GCCD3, FGD3, GCCD2	609197	8q11.2-q13.2	GCCD3
Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3)	NNT, GCCD4	607878	5p12	NNT
Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	MC2R	607397	18p11.21	MC2R
Glucocorticoid resistance, 615962 (3)	NR3C1, GCR, GRL, GCRST	138040	5q31.3	NR3C1
Glucose/galactose malabsorption, 606824 (3)	SLC5A1, SGLT1	182380	22q12.3	SLC5A1
Glutamate formiminotransferase deficiency, 229100 (3)	FTCD	606806	21q22.3	FTCD
Glutamine deficiency, congenital, 610015 (3)	GLUL, GLNS	138290	1q25.3	GLUL
Glutaric acidemia IIA, 231680 (3)	ETFA, GA2, MADD	608053	15q24.2-q24.3	ETFA
Glutaric acidemia IIB, 231680 (3)	ETFB, MADD	130410	19q13.41	ETFB
Glutaric acidemia IIC, 231680 (3)	ETFDH, MADD	231675	4q32.1	ETFDH
Glutaric aciduria III, 231690 (3)	C7orf10, GA3	609187	7p14.1	C7orf10
Glutaricaciduria, type I, 231670 (3)	GCDH	608801	19p13.13	GCDH
Glutathione synthetase deficiency, 266130 (3)	GSS, GSHS	601002	20q11.22	GSS
Glutathioninuria, 231950 (1)	GGT1, GGT	612346	22q11.23	GGT1
Glycerol kinase deficiency, 307030 (3)	GK	300474	Xp21.2	GK
Glycine N-methyltransferase deficiency, 606664 (3)	GNMT	606628	6p21.1	GNMT
Glycine encephalopathy with normal serum glycine, 617301 (3)	SLC6A9, GLYT1, GCENSG	601019	1p34.1	SLC6A9
Glycine encephalopathy, 605899 (3)	AMT, NKH, GCE	238310	3p21.31	AMT
Glycine encephalopathy, 605899 (3)	GCSH, NKH	238330	16q23.2	GCSH
Glycine encephalopathy, 605899 (3)	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p24.1	GLDC
Glycogen storage disease 0, liver, 240600 (3)	GYS2	138571	12p12.1	GYS2
Glycogen storage disease 0, muscle, 611556 (3)	GYS1, GYS	138570	19q13.33	GYS1
Glycogen storage disease II, 232300 (3)	GAA	606800	17q25.3	GAA
Glycogen storage disease IIIa, 232400 (3)	AGL, GDE	610860	1p21.2	AGL
Glycogen storage disease IIIb, 232400 (3)	AGL, GDE	610860	1p21.2	AGL
Glycogen storage disease IV, 232500 (3)	GBE1, GSD4, APBD	607839	3p12.2	GBE1
Glycogen storage disease IXc, 613027 (3)	PHKG2, GSD9C	172471	16p11.2	PHKG2
Glycogen storage disease Ia, 232200 (3)	G6PC, G6PT	613742	17q21.31	G6PC
Glycogen storage disease Ib, 232220 (3)	SLC37A4, G6PT1	602671	11q23.3	SLC37A4
Glycogen storage disease Ic, 232240 (3)	SLC37A4, G6PT1	602671	11q23.3	SLC37A4
Glycogen storage disease VI, 232700 (3)	PYGL	613741	14q22.1	PYGL
Glycogen storage disease VII, 232800 (3)	PFKM, GSD7	610681	12q13.11	PFKM
Glycogen storage disease X, 261670 (3)	PGAM2, PGAMM, GSD10	612931	7p13	PGAM2
Glycogen storage disease XI, 612933 (3)	LDHA, LDH1, GSD11	150000	11p15.1	LDHA
Glycogen storage disease XII, 611881 (3)	ALDOA, GSD12	103850	16p11.2	ALDOA
Glycogen storage disease of heart, lethal congenital, 261740 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	PRKAG2
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PYKL, GSD9A	300798	Xp22.13	PHKA2
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PYKL, GSD9A	300798	Xp22.13	PHKA2
Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3)	GPAA1, GAA1, GPIBD15	603048	8q24.3	GPAA1
Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3)	PIGC, GPI2, GPIBD16, MRT62	601730	1q24.3	PIGC
Glycosylphosphatidylinositol deficiency, 610293 (3)	PIGM	610273	1q23.2	PIGM
Gnathodiaphyseal dysplasia, 166260 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	ANO5
Goeminne TKCR syndrome (2)	TKCR, TKC	314300	Xq28	TKCR
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	DICER1
Goiter, multinodular, 2 (2)	MNG2	300273	Xp22	MNG2
Goiter, multinodular, 3 (2)	MNG3	606082	3q26.1-q26.3	MNG3
Goldberg-Shprintzen megacolon syndrome, 609460 (3)	KIAA1279	609367	10q22.1	KIAA1279
Gout, PRPS-related, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Gracile bone dysplasia, 602361 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	FAM111A
Grange syndrome, 602531 (3)	YY1AP1, YAP, HCCA2, GRNG	607860	1q22	YY1AP1
Gray platelet syndrome, 139090 (3)	NBEAL2, KIAA0540, GPS, BDPLT4	614169	3p21.31	NBEAL2
Greenberg skeletal dysplasia, 215140 (3)	LBR, PHA	600024	1q42.12	LBR
Greig cephalopolysyndactyly syndrome, 175700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Griscelli syndrome, type 1, 214450 (3)	MYO5A, MYH12, GS1	160777	15q21.2	MYO5A
Griscelli syndrome, type 2, 607624 (3)	RAB27A, RAM, GS2	603868	15q21.3	RAB27A
Griscelli syndrome, type 3, 609227 (3)	MLPH	606526	2q37.3	MLPH
Growth hormone deficiency with pituitary anomalies, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	HESX1
Growth hormone deficiency, isolated partial, 615925 (3)	GHSR, GHDP	601898	3q26.31	GHSR
Growth hormone deficiency, isolated, type IA, 262400 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Growth hormone deficiency, isolated, type IB, 612781 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Growth hormone deficiency, isolated, type IB, 612781 (3)	GHRHR, GHRFR, IGHD1B	139191	7p14.3	GHRHR
Growth hormone deficiency, isolated, type II, 173100 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Growth hormone insensitivity with immunodeficiency, 245590 (3)	STAT5B	604260	17q21.2	STAT5B
Growth hormone insensitivity, partial, 604271 (3)	GHR, GHIP	600946	5p13-p12	GHR
Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	IGF1	147440	12q23.2	IGF1
Growth retardation, developmental delay, facial dysmorphism, 612938 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	FTO
Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, 617093 (3)	IARS, GRIDHH	600709	9q22.31	IARS
Gustavson syndrome (2)	GUST	309555	Xq26	GUST
Guttmacher syndrome, 176305 (3)	HOXA13, HOX1J	142959	7p15.2	HOXA13
Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	OAT, GACR	613349	10q26.13	OAT
HARP syndrome, 607236 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	PANK2
HDL deficiency, type 2, 604091 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABCA1
HELIX syndrome, 617671 (3)	CLDN10, OSPL, CPETRL3, HELIX	617579	13q32.1	CLDN10
HELLP syndrome, maternal, of pregnancy, 609016 (3)	HADHA, MTPA	600890	2p23.3	HADHA
HMG-CoA lyase deficiency, 246450 (3)	HMGCL	613898	1p36.11	HMGCL
HMG-CoA synthase-2 deficiency, 605911 (3)	HMGCS2	600234	1p12	HMGCS2
HPRT-related gout, 300323 (3)	HPRT1, HPRT	308000	Xq26.2-q26.3	HPRT1
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
HSD10 mitochondrial disease, 300438 (3)	HSD17B10, HADH2, ERAB, MRXS10, HSD10MD	300256	Xp11.22	HSD17B10
Haddad syndrome, 209880 (3)	ASCL1, ASH1	100790	12q23.2	ASCL1
Hailey-Hailey disease, 169600 (3)	ATP2C1, BCPM, HHD	604384	3q22.1	ATP2C1
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CTSC
Hair, curly (2)	HRM2	139450	1q21.3	HRM2
Hajdu-Cheney syndrome, 102500 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	NOTCH2
Hamamy syndrome, 611174 (3)	IRX5, HMMS	606195	16q12.2	IRX5
Hand-foot-uterus syndrome, 140000 (3)	HOXA13, HOX1J	142959	7p15.2	HOXA13
Harderoporphyria, 121300 (3)	CPOX	612732	3q11.2	CPOX
Harel-Yoon syndrome, 617183 (3)	ATAD3A, HAYOS	612316	1p36.33	ATAD3A
Hartnup disorder, 234500 (3)	SLC6A19, HND	608893	5p15.33	SLC6A19
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Hashimoto thyroiditis (2)	HT	140300	8q23-q24	HT
Hawkinsinuria, 140350 (3)	HPD	609695	12q24.31	HPD
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Heart and brain malformation syndrome, 616920 (3)	C19orf61, SMG9, HBMS	613176	19q13.31	C19orf61
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Heimler syndrome 1, 234580 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PEX1
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PEX6
Heinz body anemia, 140700 (3)	HBA2, HBH	141850	16p13.3	HBA2
Heinz body anemias, alpha-, 140700 (3)	HBA1, HBH	141800	16p13.3	HBA1
Heinz body anemias, beta-, 140700 (3)	HBB	141900	11p15.4	HBB
Helsmoortel-van der Aa syndrome, 615873 (3)	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	611386	20q13.13	ADNP
Hemangioblastoma, cerebellar, somatic (3)	VHL	608537	3p25.3	VHL
Hemangioma, capillary infantile, somatic, 602089 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	FLT4
Hemangioma, capillary infantile, somatic, 602089 (3)	KDR	191306	4q12	KDR
Hematuria, benign familial, 141200 (3)	COL4A3	120070	2q36.3	COL4A3
Hematuria, familial benign (3)	COL4A4	120131	2q36.3	COL4A4
Heme oxygenase-1 deficiency, 614034 (3)	HMOX1, HMOX1D	141250	22q12.3	HMOX1
Hemifacial microsomia (2)	HFM	164210	14q32	HFM
Hemihypertrophy (2)	IH, HHP	235000	11p15	IH
Hemochromatosis, 235200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
Hemochromatosis, type 2A, 602390 (3)	HJV, HFE2A	608374	1q21.1	HJV
Hemochromatosis, type 2B, 613313 (3)	HAMP, LEAP1, HEPC, HFE2B	606464	19q13.12	HAMP
Hemochromatosis, type 3, 604250 (3)	TFR2, HFE3	604720	7q22.1	TFR2
Hemochromatosis, type 4, 606069 (3)	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32.2	SLC40A1
Hemoglobin H disease, nondeletional, 613978 (3)	HBA1, HBH	141800	16p13.3	HBA1
Hemoglobin H disease, nondeletional, 613978 (3)	HBA2, HBH	141850	16p13.3	HBA2
Hemolytic anemia due to G6PD deficiency, 300908 (3)	G6PD, G6PD1	305900	Xq28	G6PD
Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	AK1	103000	9q34.11	AK1
Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)	GCLC, GLCLC	606857	6p12.1	GCLC
Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	GPX1, GPXD	138320	3p21.31	GPX1
Hemolytic anemia due to glutathione reductase deficiency (1)	GSR	138300	8p12	GSR
Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)	GSS, GSHS	601002	20q11.22	GSS
Hemolytic anemia due to hexokinase deficiency, 235700 (3)	HK1, HKD, HMSNR, RP79	142600	10q22.1	HK1
Hemolytic anemia due to phosphofructokinase deficiency (1)	PFKL	171860	21q22.3	PFKL
Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	TPI1, TPID	190450	12p13.31	TPI1
Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	CD59, MIC11	107271	11p13	CD59
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	GPI	172400	19q13.11	GPI
Hemophagocytic lymphohistiocytosis, familial, 1 (2)	FHL1, HPLH1, HLH1	267700	9q21.3-q22	FHL1
Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	PRF1
Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	UNC13D
Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	STX11, FHL4, HPLH4, HLH4	605014	6q24.2	STX11
Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	STXBP2, UNC18B, FHL5	601717	19p13.2	STXBP2
Hemophilia A, 306700 (3)	F8, F8C, HEMA	300841	Xq28	F8
Hemophilia B, 306900 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	JAM3	606871	11q25	JAM3
Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	CP	117700	3q24-q25	CP
Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	CCBE1, KIAA1983, HKLLS1	612753	18q21.32	CCBE1
Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	FAT4
Hepatic adenoma, somatic, 142330 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
Hepatic lipase deficiency, 614025 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPC
Hepatic venoocclusive disease with immunodeficiency, 235550 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	SP110
Hepatoblastoma, somatic, 114550 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Hepatocellular cancer, somatic, 114550 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PDGFRL
Hepatocellular carcinoma, 114550 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Hepatocellular carcinoma, childhood type, somatic, 114550 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
Hepatocellular carcinoma, somatic, 114550 (3)	AXIN1, AXIN	603816	16p13.3	AXIN1
Hepatocellular carcinoma, somatic, 114550 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
Hepatocellular carcinoma, somatic, 114550 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
Hepatocellular carcinoma, somatic, 114550 (3)	IGF2R, MPRI	147280	6q25.3	IGF2R
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Hereditary motor and sensory neuropathy V (2)	HMSN5	600361	4q34.3-q35.2	HMSN5
Hereditary motor and sensory neuropathy VIA, 601152 (3)	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B	608507	1p36.22	MFN2
Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3)	TFG, HMSNP, SPG57	602498	3q12.2	TFG
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Hereditary persistence of fetal hemoglobin, 141749 (3)	HBB	141900	11p15.4	HBB
Hermansky-Pudlak syndrome 1, 203300 (3)	HPS1	604982	10q24.2	HPS1
Hermansky-Pudlak syndrome 2, 608233 (3)	AP3B1, ADTB3A, HPS2	603401	5q14.1	AP3B1
Hermansky-Pudlak syndrome 3, 614072 (3)	HPS3	606118	3q24	HPS3
Hermansky-Pudlak syndrome 4, 614073 (3)	HPS4	606682	22q12.1	HPS4
Hermansky-Pudlak syndrome 5, 614074 (3)	HPS5, RU2, KIAA1017	607521	11p15.1	HPS5
Hermansky-Pudlak syndrome 6, 614075 (3)	HPS6, RU	607522	10q24.32	HPS6
Hermansky-Pudlak syndrome 7, 614076 (3)	DTNBP1, HPS7	607145	6p22.3	DTNBP1
Hermansky-Pudlak syndrome 8, 614077 (3)	BLOC1S3, BLOS3, HPS8	609762	19q13.32	BLOC1S3
Hernia, congenital diaphragmatic 1 (2)	DIH1, HCD	142340	15q26.1	DIH1
Hernia, congenital diaphragmatic 2 (2)	DIH2	222400	8p23.1	DIH2
Heterotaxy, visceral, 1, X-linked 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	ZIC3
Heterotaxy, visceral, 2, autosomal, 605376 (3)	CFC1, CRYPTIC, HTX2	605194	2q21.1	CFC1
Heterotaxy, visceral, 4, autosomal, 613751 (3)	ACVR2B, ACTRIIB, HTX4	602730	3p22.2	ACVR2B
Heterotaxy, visceral, 5, 270100 (3)	NODAL, HTX5	601265	10q22.1	NODAL
Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	CCDC11, HTX6	614759	18q21.1	CCDC11
Heterotaxy, visceral, 7, autosomal, 616749 (3)	MMP21, HTX7	608416	10q26.2	MMP21
Heterotaxy, visceral, 8, autosomal, 617205 (3)	PKD1L1, HTX8	609721	7p12.3	PKD1L1
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
High density lipoprotein cholesterol level QTL14 (2)	HDLCQ14, HYLAP	605201	11q23.3	HDLCQ14
Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)	CREB1	123810	2q33.3	CREB1
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	HJCD, HCLAP	602782	11q25	HJCD
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	SLC29A3, ENT3, PHID, HCLAP	612373	10q22.1	SLC29A3
Holocarboxylase synthetase deficiency, 253270 (3)	HLCS, HCS	609018	21q22.13	HLCS
Holoprosencephaly 1 (2)	HPE1	236100	21q22.3	HPE1
Holoprosencephaly 11, 614226 (3)	CDON, CDO, HPE11	608707	11q24.2	CDON
Holoprosencephaly 2, 157170 (3)	SIX3, HPE2	603714	2p21	SIX3
Holoprosencephaly 3, 142945 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Holoprosencephaly 4, 142946 (3)	TGIF1, HPE4	602630	18p11.31	TGIF1
Holoprosencephaly 5, 609637 (3)	ZIC2, HPE5	603073	13q32.3	ZIC2
Holoprosencephaly 6 (2)	HPE6	605934	2q37.1-q37.3	HPE6
Holoprosencephaly 7, 610828 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	PTCH1
Holoprosencephaly 8 (2)	HPE8	609408	14q13	HPE8
Holoprosencephaly 9, 610829 (3)	GLI2, HPE9, CJS	165230	2q14.2	GLI2
Holt-Oram syndrome, 142900 (3)	TBX5	601620	12q24.21	TBX5
Homocysteine plasma level (2)	NNMT	600008	11q23.2	NNMT
Homocysteine, total plasma, elevated (3)	CTH	607657	1p31.1	CTH
Homocystinuria due to MTHFR deficiency, 236250 (3)	MTHFR	607093	1p36.22	MTHFR
Homocystinuria, B6-responsive and nonresponsive types, 236200 (3)	CBS	613381	21q22.3	CBS
Homocystinuria, cblD type, variant 1, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	C2orf25
Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3)	MTRR	602568	5p15.31	MTRR
Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3)	MTR, HMAG	156570	1q43	MTR
Humoral hypercalcemia of malignancy (1)	PTHLH, BDE2	168470	12p11.22	PTHLH
Huntington disease, 143100 (3)	HTT, HD, IT15, LOMARS	613004	4p16.3	HTT
Huntington disease-like 1, 603218 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Huntington disease-like 3 (2)	HDL3, HLN2	604802	4p15.3	HDL3
Huriez syndrome (2)	TYS, HRZ	181600	4q23	TYS
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Hyaline fibromatosis syndrome, 228600 (3)	ANTXR2, CMG2, HFS	608041	4q21.21	ANTXR2
Hydatidiform mole, recurrent, 1, 231090 (3)	NALP7, NOD12, PYPAF3, HYDM	609661	19q13.42	NALP7
Hydatidiform mole, recurrent, 2, 614293 (3)	KHDC3L, C6orf221, ECAT1, HYDM2	611687	6q13	KHDC3L
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Hydrocephalus with Hirschsprung disease, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Hydrocephalus, nonsyndromic, autosomal recessive 2, 615219 (3)	MPDZ, MUPP1, HYC2	603785	9p23	MPDZ
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	CCDC88C
Hydrolethalus syndrome, 236680 (3)	HYLS1, FLJ32915	610693	11q24.2	HYLS1
Hyper-IgD syndrome, 260920 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVK
Hyper-IgE recurrent infection syndrome, 147060 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	STAT3
Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)	DOCK8	611432	9p24.3	DOCK8
Hyperaldosteronism, familial, type II (2)	FHII	605635	7p22	FHII
Hyperaldosteronism, familial, type III, 613677 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	KCNJ5
Hyperaldosteronism, familial, type IV, 617027 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	CACNA1H
Hyperalphalipoproteinemia, 143470 (3)	CETP, HDLCQ10	118470	16q13	CETP
Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	CA5A, CA5AD	114761	16q24.2	CA5A
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CYP21A2
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	SLCO1B1
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	605495	12p12.2	SLCO1B3
Hyperbilirubinemia, familial transient neonatal, 237900 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
Hyperbiliverdinemia, 614156 (3)	BLVRA	109750	7p13	BLVRA
Hypercalcemia, infantile, 1, 143880 (3)	CYP24A1, CYP24, HCINF1	126065	20q13.2	CYP24A1
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC34A1
Hypercalciuria, absorptive (2)	HCA1	607258	4q33-qter	HCA1
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	BCMO1, BCDO, BCO1	605748	16q23.2	BCMO1
Hyperchlorhidrosis, isolated, 143860 (3)	CA12	603263	15q22.2	CA12
Hypercholanemia, familial, 607748 (3)	BAAT	602938	9q31.1	BAAT
Hypercholanemia, familial, 607748 (3)	EPHX1	132810	1q42.12	EPHX1
Hypercholanemia, familial, 607748 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	TJP2
Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	APOB
Hypercholesterolemia, familial, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	LDLR
Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	PCSK9
Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	LDLRAP1, ARH, FHCB2, FHCB1	605747	1p36.11	LDLRAP1
Hyperchylomicronemia, late-onset, 144650 (3)	APOA5	606368	11q23.3	APOA5
Hyperekplexia 2, autosomal recessive, 614619 (3)	GLRB, HKPX2	138492	4q32.1	GLRB
Hyperekplexia 3, 614618 (3)	SLC6A5, GLYT2, HKPX3	604159	11p15.1	SLC6A5
Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 (3)	GLRA1, STHE, HKPX1	138491	5q33.1	GLRA1
Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	PDGFRA	173490	4q12	PDGFRA
Hyperferritinemia-cataract syndrome, 600886 (3)	FTL, NBIA3, LFTD	134790	19q13.33	FTL
Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	PLAT, TPA	173370	8p11.21	PLAT
Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	LIAS, PDHLD, HGCLAS	607031	4p14	LIAS
Hyperglycinuria, 138500 (3)	SLC36A2, PAT2	608331	5q33.1	SLC36A2
Hyperglycinuria, 138500 (3)	SLC6A19, HND	608893	5p15.33	SLC6A19
Hyperglycinuria, 138500 (3)	SLC6A20, XT3	605616	3p21.31	SLC6A20
Hyperhidrosis palmaris et plantaris (2)	HHPP	144110	14q11.2-q13	HHPP
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)	GCK, HHF3	138079	7p13	GCK
Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	HADHSC, SCHAD, HHF4	601609	4q25	HADHSC
Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	INSR, HHF5	147670	19p13.2	INSR
Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	SLC16A1
Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	GLUD1	138130	10q23.2	GLUD1
Hyperkalemic periodic paralysis, type 2, 170500 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CCM1
Hyperlipidemia, combined, 2 (2)	HYPLIP2	604499	11p	HYPLIP2
Hyperlipoproteinemia, type 1D, 615947 (3)	GPIHBP1, HYPL1D	612757	8q24.3	GPIHBP1
Hyperlipoproteinemia, type III, 617347 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Hyperlipoproteinemia, type Ib, 207750 (3)	APOC2	608083	19q13.32	APOC2
Hyperlysinemia, 238700 (3)	AASS	605113	7q31.32	AASS
Hypermanganesemia with dystonia 1, 613280 (3)	SLC30A10, ZNT10, HMNDYT1	611146	1q41	SLC30A10
Hypermanganesemia with dystonia 2, 617013 (3)	SLC39A14, ZIP14, KIAA0062, HMNDYT2	608736	8p21.3	SLC39A14
Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	ADK	102750	10q22.2	ADK
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	AHCY, SAHH	180960	20q11.22	AHCY
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	MAT1A
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	SLC25A15, ORNT1, HHH	603861	13q14.11	SLC25A15
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Hyperoxaluria, primary, type 1, 259900 (3)	AGXT, SPAT	604285	2q37.3	AGXT
Hyperoxaluria, primary, type II, 260000 (3)	GRHPR, GLXR	604296	9p13.2	GRHPR
Hyperoxaluria, primary, type III, 613616 (3)	HOGA1, DHDPSL, HP3	613597	10q24.2	HOGA1
Hyperparathyroidism 3 (2)	HRPT3	610071	2p14-p13.3	HRPT3
Hyperparathyroidism 4, 617343 (3)	GCM2, GCMB, HRPT4	603716	6p24.2	GCM2
Hyperparathyroidism, familial primary, 145000 (3)	CDC73, HRPT2, C1orf28	607393	1q31.2	CDC73
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hyperparathyroidism-jaw tumor syndrome, 145001 (3)	CDC73, HRPT2, C1orf28	607393	1q31.2	CDC73
Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	PTS	612719	11q23.1	PTS
Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	GCH1
Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	QDPR, DHPR	612676	4p15.32	QDPR
Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	PCBD1, DCOH	126090	10q22.1	PCBD1
Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3)	DNAJC12, JDP1, HPANBH4	606060	10q21.3	DNAJC12
Hyperphosphatasia with mental retardation syndrome 1, 239300 (3)	PIGV, HPMRS1	610274	1p36.11	PIGV
Hyperphosphatasia with mental retardation syndrome 2, 614749 (3)	PIGO, HPMRS2	614730	9p13.3	PIGO
Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	615187	11p15.4	PGAP2
Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	611801	17q12	PGAP3
Hyperphosphatasia with mental retardation syndrome 6, 616809 (3)	PIGY, HPMRS6	610662	4q22.1	PIGY
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	KITLG
Hyperpigmentation, familial progressive, 1 (2)	FPH1, MUH, HPP	614233	19pter-p13.1	FPH1
Hyperproinsulinemia, 616214 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Hyperprolinemia, type I, 239500 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	PRODH
Hyperprolinemia, type II, 239510 (3)	ALDH4A1, ALDH4, P5CDH	606811	1p36.13	ALDH4A1
Hypertelorism, preauricular sinus, punctal pits, and deafness (2)	HPPD	614187	14q31	HPPD
Hypertension and brachydactyly syndrome, 112410 (3)	PDE3A, HTNB	123805	12p12.2	PDE3A
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	NR3C2, MLR, MCR	600983	4q31.23	NR3C2
Hypertension, essential, 145500 (3)	PTGIS, CYP8A1, PGIS, CYP8	601699	20q13.13	PTGIS
Hypertensive nephropathy (2)	HNP1	608026	9q31-q32	HNP1
Hyperthyroidism, familial gestational, 603373 (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Hyperthyroidism, nonautoimmune, 609152 (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)	HTGH, DEL17q24	135400	17q24.2-q24.3	HTGH
Hypertrichosis, congenital generalized (4)	HTC2, HCG, CGH, CXINSq27.1	307150	Xq27.1	HTC2
Hypertrichotic osteochondrodysplasia, 239850 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ABCC9
Hypertriglyceridemia, transient infantile, 614480 (3)	GPD1, HTGTI	138420	12q13.12	GPD1
Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	HPGD
Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	601460	3q22.1-q22.2	SLCO2A1
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	SARS2	612804	19q13.2	SARS2
Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	UMOD
Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	REN, HNFJ2	179820	1q32.1	REN
Hyperuricemic nephropathy, familial juvenile, 3 (2)	HNFJ3	614227	2p22.1-p21	HNFJ3
Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3)	SEC61A1, SEC61, HNFJ4	609213	3q21.3	SEC61A1
Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3)	CYP11B2	124080	8q24.3	CYP11B2
Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3)	CYP11B2	124080	8q24.3	CYP11B2
Hypoalphalipoproteinemia, 604091 (3)	APOA1	107680	11q23.3	APOA1
Hypobetalipoproteinemia, 615558 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	APOB
Hypobetalipoproteinemia, familial, 2, 605019 (3)	ANGPTL3, ANGPT5, FHBL2	604774	1p31.3	ANGPTL3
Hypocalcemia, autosomal dominant 2, 615361 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	GNA11
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypocalciuric hypercalcemia, type II, 145981 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	GNA11
Hypocalciuric hypercalcemia, type III, 600740 (3)	AP2S1, CLAPS2, AP17, HHC3	602242	19q13.32	AP2S1
Hypochondroplasia, 146000 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Hypochromic microcytic anemia (3)	HBA2, HBH	141850	16p13.3	HBA2
Hypodysfibrinogenemia, 616004 (3)	FGG	134850	4q32.1	FGG
Hypodysfibrinogenemia, congenital, 616004 (3)	FGA	134820	4q31.3	FGA
Hypofibrinogenemia, congenital, 202400 (3)	FGB	134830	4q31.3	FGB
Hypofibrinogenemia, congenital, 202400 (3)	FGG	134850	4q32.1	FGG
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	KAL1, KMS, ADMLX, HH1	300836	Xp22.31	KAL1
Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	TAC3, NKNB, HH10	162330	12q13.3	TAC3
Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	TACR3, NK3R, HH11	162332	4q24	TACR3
Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	WDR11, DR11, KIAA1351, BRWD2, HH14	606417	10q26.12	WDR11
Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	SPRY4, HH17	607984	5q31.3	SPRY4
Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	IL17RD, SEF, HH18	606807	3p14.3	IL17RD
Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	DUSP6, MKP3, PYST1, HH19	602748	12q21.33	DUSP6
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	FGF17, HH20	603725	8p21.3	FGF17
Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	FLRT3, HH21	604808	20p12.1	FLRT3
Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	FEZF1, FEZ, ZNF312B, HH22	613301	7q31.32	FEZF1
Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	LHB, HH23	152780	19q13.33	LHB
Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	FSHB, HH24	136530	11p14.1	FSHB
Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	PROKR2, PKR2, GPR73L1, HH3	607123	20p12.3	PROKR2
Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	PROK2, PK2, BV8, HH4	607002	3p13	PROK2
Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	CHD7, HH5	608892	8q12.2	CHD7
Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	FGF8, HH6	600483	10q24.32	FGF8
Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	GNRHR, LHRHR, HH7	138850	4q13.2	GNRHR
Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	KISS1R
Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	NSMF, NELF, HH9	608137	9q34.3	NSMF
Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	AKT2, HIHGHH	164731	19q13.2	AKT2
Hypokalemic periodic paralysis, type 1, 170400 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNA1S
Hypokalemic periodic paralysis, type 2, 613345 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Hypomagnesemia 1, intestinal, 602014 (3)	TRPM6, CHAK2, HOMG1	607009	9q21.13	TRPM6
Hypomagnesemia 2, renal, 154020 (3)	FXYD2, ATP1G1, HOMG2	601814	11q23.3	FXYD2
Hypomagnesemia 3, renal, 248250 (3)	CLDN16, PCLN1, HOMG3	603959	3q28	CLDN16
Hypomagnesemia 4, renal, 611718 (3)	EGF, URG, HOMG4	131530	4q25	EGF
Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	CLDN19, HOMG5	610036	1p34.2	CLDN19
Hypomagnesemia 6, renal, 613882 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	CNNM2
Hypomagnesemia, seizures, and mental retardation, 616418 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	CNNM2
Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	DARS, HBSL, HBSL	603084	2q21.3	DARS
Hypoparathyroidism, X-linked (2)	HPT, HPTX, HYPX	307700	Xq26-q27	HPT
Hypoparathyroidism, autosomal dominant, 146200 (3)	PTH	168450	11p15.3	PTH
Hypoparathyroidism, autosomal recessive, 146200 (3)	PTH	168450	11p15.3	PTH
Hypoparathyroidism, familial isolated, 146200 (3)	GCM2, GCMB, HRPT4	603716	6p24.2	GCM2
Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	GATA3, HDR, HDRS	131320	10p14	GATA3
Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	TBCE, KCS, KCS1, HRD, PEAMO	604934	1q42.3	TBCE
Hypophosphatasia, adult, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Hypophosphatasia, childhood, 241510 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Hypophosphatasia, infantile, 241500 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Hypophosphatemic rickets and hyperparathyroidism (2)	HPRHP	612089	13q13.1	HPRHP
Hypophosphatemic rickets with hypercalciuria, 241530 (3)	SLC34A3, NPTIIC, HHRH	609826	9q34.3	SLC34A3
Hypophosphatemic rickets, 300554 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Hypophosphatemic rickets, AR, 241520 (3)	DMP1, ARHR, ARHP	600980	4q22.1	DMP1
Hypophosphatemic rickets, X-linked dominant, 307800 (3)	PHEX, HYP, HPDR1, LXHR	300550	Xp22.11	PHEX
Hypophosphatemic rickets, autosomal dominant, 193100 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	FGF23
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Hypoprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Hypospadias 2, X-linked, 300758 (3)	MAMLD1, CXorf6, F18, HYSP2	300120	Xq28	MAMLD1
Hypospadias 3, autosomal (2)	HYSP3	146450	7q32.2-q36.1	HYSP3
Hypothyroidism, central, and testicular enlargement, 300888 (3)	IGSF1, IGDC1, CHTE	300137	Xq26.1	IGSF1
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	PAX8	167415	2q14.1	PAX8
Hypothyroidism, congenital, nongoitrous 4, 275100 (3)	TSHB, CHNG4	188540	1p13.2	TSHB
Hypothyroidism, congenital, nongoitrous, 1 275200 (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Hypothyroidism, congenital, nongoitrous, 3 (2)	CHNG3, RTSH	609893	15q25.3-q26.1	CHNG3
Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	THRA, ERBA1, THRA1, CHNG6	190120	17q21.1	THRA
Hypotonia, ataxia, and delayed development syndrome, 617330 (3)	EBF3, COE3, HADDS	607407	10q26.3	EBF3
Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	NALCN
Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	UNC80, C2orf21, KIAA1843	612636	2q34	UNC80
Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	TBCK, IHPRF3	616899	4q24	TBCK
Hypotonia, infantile, with psychomotor retardation, 616816 (3)	CCDC174, HSPC212, IHPM	616735	3p25.1	CCDC174
Hypotonia-cystinuria syndrome (4)	DEL2p21, C2DELp21	606407	2p21	DEL2p21
Hypotrichosis 1, 605389 (3)	APCDD1, HHS, HYPT1, HTS	607479	18p11.22	APCDD1
Hypotrichosis 10 (2)	HYPT10	614238	7p22.3-p21.3	HYPT10
Hypotrichosis 11, 615059 (3)	SNRPE, HYPT11	128260	1q32.1	SNRPE
Hypotrichosis 12, 615885 (3)	RPL21, HYPT12	603636	13q12.2	RPL21
Hypotrichosis 2, 146520 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	CDSN
Hypotrichosis 4, 146550 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HR
Hypotrichosis 5 (2)	HYPT5, MUHH2	612841	1p21.1-q21.3	HYPT5
Hypotrichosis 6, 607903 (3)	DSG4, LAH, HYPT6	607892	18q12.1	DSG4
Hypotrichosis 7, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	LIPH
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	LPAR6
Hypotrichosis 9 (2)	HYPT9	614237	10q11.23-q22.3	HYPT9
Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	CDH3
Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	SOX18
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	SOX18
Hypouricemia, renal, 2, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	SLC2A9
Hypouricemia, renal, 220150 (3)	SLC22A12, OAT4L, URAT1	607096	11q13.1	SLC22A12
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	MBTPS2
IMAGE syndrome, 614732 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	CDKN1C
IRAK4 deficiency, 607676 (3)	IRAK4, REN64, IPD1	606883	12q12	IRAK4
IVIC syndrome, 147750 (3)	SALL4, HSAL4	607343	20q13.2	SALL4
Ichthyosis bullosa of Siemens, 146800 (3)	KRT2, KRT2A, KRT2E	600194	12q13.13	KRT2
Ichthyosis histrix, Curth-Macklin type, 146590 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Ichthyosis prematurity syndrome, 608649 (3)	SLC27A4, FATP4, IPS	604194	9q34.11	SLC27A4
Ichthyosis vulgaris, 146700 (3)	FLG, ATOD2	135940	1q21.3	FLG
Ichthyosis with confetti, 609165 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	KRT10
Ichthyosis, X-linked, 308100 (3)	STS, ARSC1, ARSC, SSDD, XLI	300747	Xp22.31	STS
Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	TGM1, ICR2, ARCI1	190195	14q12	TGM1
Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	PNPLA1, ARCI10	612121	6p21.31	PNPLA1
Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	ST14, MTSP1, ARCI11	606797	11q24.3	ST14
Ichthyosis, congenital, autosomal recessive 12, 617320 (3)	CASP14, ARCI12	605848	19p13.12	CASP14
Ichthyosis, congenital, autosomal recessive 13, 617574 (3)	SDR9C7, SDRO, ARCI13	609769	12q13.3	SDR9C7
Ichthyosis, congenital, autosomal recessive 14, 617571 (3)	SULT2B1, ARCI14	604125	19q13.33	SULT2B1
Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	ALOX12B, ARCI2	603741	17p13.1	ALOX12B
Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	ALOXE3, ARCI3	607206	17p13.1	ALOXE3
Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ABCA12
Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ABCA12
Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	CYP4F22, ARCI5, LI3	611495	19p13.12	CYP4F22
Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	NIPAL4, ICHYN, ARCI6	609383	5q33.3	NIPAL4
Ichthyosis, congenital, autosomal recessive 7 (2)	ARCI7	615022	12p11.2-q13.1	ARCI7
Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	LIPN, LIPL4, ARCI8, LI4	613924	10q23.31	LIPN
Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	CERS3, LASS3, ARCI9	615276	15q26.3	CERS3
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	KRT10
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	CLDN1, SEMP1, ILVASC	603718	3q28	CLDN1
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ELOVL4
IgG2 deficiency, selective (3)	IGHG2	147110	14q32.33	IGHG2
Iminoglycinuria, digenic, 242600 (3)	SLC36A2, PAT2	608331	5q33.1	SLC36A2
Iminoglycinuria, digenic, 242600 (3)	SLC6A19, HND	608893	5p15.33	SLC6A19
Iminoglycinuria, digenic, 242600 (3)	SLC6A20, XT3	605616	3p21.31	SLC6A20
Immunodeficiency 10, 612783 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STIM1
Immunodeficiency 11A, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	607210	7p22.2	CARD11
Immunodeficiency 11B with atopic dermatitis, 617638 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A	607210	7p22.2	CARD11
Immunodeficiency 12, 615468 (3)	MALT1, MLT, IMD12	604860	18q21.32	MALT1
Immunodeficiency 14, 615513 (3)	PIK3CD, APDS, IMD14	602839	1p36.22	PIK3CD
Immunodeficiency 15, 615592 (3)	IKBKB, NFKBIKB, IMD15	603258	8p11.21	IKBKB
Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	CD3G, IMD17	186740	11q23.3	CD3G
Immunodeficiency 18, 615615 (3)	CD3E, IMD18	186830	11q23.3	CD3E
Immunodeficiency 18, SCID variant, 615615 (3)	CD3E, IMD18	186830	11q23.3	CD3E
Immunodeficiency 19, 615617 (3)	CD3D, T3D, IMD19	186790	11q23.3	CD3D
Immunodeficiency 20, 615707 (3)	FCGR3A, CD16, IGFR3, IMD20	146740	1q23.3	FCGR3A
Immunodeficiency 21, 614172 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
Immunodeficiency 23, 615816 (3)	PGM3, AGM1, IMD23	172100	6q14.1	PGM3
Immunodeficiency 24, 615897 (3)	CTPS1, CTPS, IMD24	123860	1p34.2	CTPS1
Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	PRKDC, HYRC1, DNPK1, IMD26	600899	8q11.21	PRKDC
Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
Immunodeficiency 28, mycobacteriosis, 614889 (3)	IFNGR2, IFNGT1, IFGR2, IMD28	147569	21q22.11	IFNGR2
Immunodeficiency 29, mycobacteriosis, 614890 (3)	IL12B, NKSF2, IMD29	161561	5q33.3	IL12B
Immunodeficiency 30, 614891 (3)	IL12RB1, IMD30	601604	19p13.11	IL12RB1
Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	STAT1
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	STAT1
Immunodeficiency 31C, autosomal dominant, 614162 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	STAT1
Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IRF8
Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 614894 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IRF8
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	CYBB
Immunodeficiency 35, 611521 (3)	TYK2, IMD35	176941	19p13.2	TYK2
Immunodeficiency 36, 616005 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	PIK3R1
Immunodeficiency 38, 616126 (3)	ISG15, G1P2, IFI15, IMD38	147571	1p36.33	ISG15
Immunodeficiency 40, 616433 (3)	DOCK2, IMD40	603122	5q35.1	DOCK2
Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IL2RA
Immunodeficiency 42, 616622 (3)	RORC, RORG, RZRG, IMD42	602943	1q21.3	RORC
Immunodeficiency 43, 241600 (3)	B2M, IMD43	109700	15q21.1	B2M
Immunodeficiency 44, 616636 (3)	STAT2, IMD44	600556	12q13.3	STAT2
Immunodeficiency 46, 616740 (3)	TFRC, TFR, CD71, IMD46	190010	3q29	TFRC
Immunodeficiency 47, 300972 (3)	ATP6AP1, ATP6IP1, ATP6S1, VATPS1	300197	Xq28	ATP6AP1
Immunodeficiency 48, 269840 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	ZAP70
Immunodeficiency 50, 300988 (3)	MSN, IMD50	309845	Xq12	MSN
Immunodeficiency 51, 613953 (3)	IL17RA, IL17R, IMD51	605461	22q11.1	IL17RA
Immunodeficiency 52, 617514 (3)	LAT, IMD52	602354	16p11.2	LAT
Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	TRAC, TRCA, TRA, IMD7	186880	14q11.2	TRAC
Immunodeficiency 8, 615401 (3)	CORO1A, TACO, CLIPINA, IMD8	605000	16p11.2	CORO1A
Immunodeficiency 9, 612782 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	ORAI1
Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	LAMTOR2, MAPBPIP, p14	610389	1q22	LAMTOR2
Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	FCN3, HAKA1	604973	1p36.11	FCN3
Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	PNP, NP	164050	14q11.2	PNP
Immunodeficiency with hyper IgM, type 5, 608106 (3)	UNG, DGU, HIGM5	191525	12q24.11	UNG
Immunodeficiency with hyper-IgM, type 2, 605258 (3)	AICDA, AID, HIGM2	605257	12p13.31	AICDA
Immunodeficiency with hyper-IgM, type 3, 606843 (3)	CD40, TNFRSF5	109535	20q13.12	CD40
Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	TNFSF5, CD40LG, HIGM1, IGM	300386	Xq26.3	TNFSF5
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	MAGT1, IAP, XMEN	300715	Xq21.1	MAGT1
Immunodeficiency, common variable, 1, 607594 (3)	ICOS, AILIM, CVID1	604558	2q33.2	ICOS
Immunodeficiency, common variable, 10, 615577 (3)	NFKB2, LYT10, CVID10	164012	10q24.32	NFKB2
Immunodeficiency, common variable, 12, 616576 (3)	NFKB1, CVID12	164011	4q24	NFKB1
Immunodeficiency, common variable, 13, 616873 (3)	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	603023	7p12.2	IKZF1
Immunodeficiency, common variable, 2, 240500 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	TNFRSF13B
Immunodeficiency, common variable, 3, 613493 (3)	CD19, CVID3	107265	16p11.2	CD19
Immunodeficiency, common variable, 4, 613494 (3)	TNFRSF13C, BAFFR, CVID4	606269	22q13.2	TNFRSF13C
Immunodeficiency, common variable, 5, 613495 (3)	MS4A1, CD20, CVID5	112210	11q12.2	MS4A1
Immunodeficiency, common variable, 6, 613496 (3)	CD81, TAPA1, CVID6	186845	11p15.5	CD81
Immunodeficiency, common variable, 7, 614699 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	CR2
Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	LRBA, LBA, CDC4L, CVID8	606453	4q31.3	LRBA
Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3)	NFE2L2, NRF2, IMDDHH	600492	2q31.2	NFE2L2
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Immunodeficiency, primary, autosomal recessive, IL21R-related, 615207 (3)	IL21R	605383	16p12.1	IL21R
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	DNMT3B, ICF1	602900	20q11.21	DNMT3B
Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	CDCA7, JPO1, ICF3	609937	2q31.1	CDCA7
Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	HELLS, LSH, ICF4	603946	10q23.33	HELLS
Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	614064	6q21	ZBTB24
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	FOXP3
Immunoglobulin A deficiency (2)	IGAD1	137100	6p21.3	IGAD1
Immunoglobulin A deficiency 2, 609529 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	TNFRSF13B
Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3)	EXTL3, EXTR1, ISDNA	605744	8p21.1	EXTL3
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	VCP
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Increased responsiveness to growth hormone (3)	GHR, GHIP	600946	5p13-p12	GHR
Infantile cerebellar-retinal degeneration, 614559 (3)	ACO2, ICRD, OPA9	100850	22q13.2	ACO2
Infantile liver failure syndrome 2, 616483 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	NBAS
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PLA2G6
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	PTRH2, BIT1, IMNEPD	608625	17q23.1	PTRH2
Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations, 613759 (3)	FADD	602457	11q13.3	FADD
Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	CRFB4, IBD25	123889	21q22.11	CRFB4
Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	IL10RA, IL10R, IBD28	146933	11q23.3	IL10RA
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	NTRK1, TRKA, MTC	191315	1q23.1	NTRK1
Insomnia, fatal familial, 600072 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Insulin resistance, severe, digenic, 125853 (3)	PPP1R3A, PPP1R3	600917	7q31.1	PPP1R3A
Insulin resistance, severe, digenic, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Insulin-like growth factor I, resistance to, 270450 (3)	IGF1R	147370	15q26.3	IGF1R
Insulinoma (1)	ITS	606960	22q12.1-q12.2	ITS
Intellectual developmental disorder with cardiac arrhythmia, 617173 (3)	GNB5, GB5, IDDCA, LADCI	604447	15q21.2	GNB5
Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3)	BRPF1, BR140, IDDDFP	602410	3p25.3	BRPF1
Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3)	OTUD6B, DUBA5, IDDFSDA	612021	8q21.3	OTUD6B
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, 617450 (3)	PPM1D, WIP1, IDDGIP	605100	17q23.2	PPM1D
Intellectual developmental disorder with neuropsychiatric features, 617532 (3)	SLC45A1, DNB5, IDDNPF	605763	1p36.23	SLC45A1
Interferon, alpha, deficiency (1)	IFNA1, IFNA@	147660	9p21.3	IFNA1
Interleukin 1 receptor antagonist deficiency, 612852 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	IL1RN
Interstitial lung and liver disease, 615486 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	MARS
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	ITGA3, CD49C, GAPB3, ILNEB	605025	17q21.33	ITGA3
Interstitial nephritis, karyomegalic, 614817 (3)	FAN1, MTMR15, KIAA1018, KMIN	613534	15q13.3	FAN1
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Intrinsic factor deficiency, 261000 (3)	GIF, IF	609342	11q12.1	GIF
Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	IRAK4, REN64, IPD1	606883	12q12	IRAK4
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Iron-refractory iron deficiency anemia, 206200 (3)	TMPRSS6, IRIDA	609862	22q12.3	TMPRSS6
Ischiocoxopodopatellar syndrome, 147891 (3)	TBX4, ICPPS	601719	17q23.2	TBX4
Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	ACAD8	604773	11q25	ACAD8
Isovaleric acidemia, 243500 (3)	IVD	607036	15q15.1	IVD
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Jacobsen syndrome (4)	JBS	147791	11q23	JBS
Jalili syndrome, 217080 (3)	CNNM4, ACDP4	607805	2q11.2	CNNM4
Jawad syndrome, 251255 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RBBP8
Jervell and Lange-Nielsen syndrome 2, 612347 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	KCNE1
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Johanson-Blizzard syndrome, 243800 (3)	UBR1, JBS	605981	15q15.2	UBR1
Joint laxity, short stature, and myopia, 617662 (3)	GZF1, ZNF336, JLSM	613842	20p11.21	GZF1
Joubert syndrome 1, 213300 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	INPP5E
Joubert syndrome 10, 300804 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
Joubert syndrome 12, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
Joubert syndrome 13, 614173 (3)	TECT1, JBTS13	609863	12q24.11	TECT1
Joubert syndrome 14, 614424 (3)	TMEM237, ALS2CR4, JBTS14	614423	2q33.1	TMEM237
Joubert syndrome 15, 614464 (3)	CEP41, TSGA14, JBTS15	610523	7q32.2	CEP41
Joubert syndrome 16, 614465 (3)	TMEM138, JBTS16	614459	11q12.2	TMEM138
Joubert syndrome 17, 614615 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	C5orf42
Joubert syndrome 18, 614815 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	TCTN3
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	ZNF423
Joubert syndrome 2, 608091 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	TMEM216
Joubert syndrome 20, 614970 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	TMEM231
Joubert syndrome 21, 615636 (3)	CSPP1, CSPP, JBTS21	611654	8q13.1-q13.2	CSPP1
Joubert syndrome 23, 616490 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	KIAA0586
Joubert syndrome 24, 616654 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	TCTN2
Joubert syndrome 25, 616781 (3)	CEP104, GLYBP, KIAA0562, JBTS25	616690	1p36.32	CEP104
Joubert syndrome 27, 617120 (3)	B9D1, MKSR1, MKS9, JBTS27	614144	17p11.2	B9D1
Joubert syndrome 28, 617121 (3)	MKS1, MKS, BBS13, JBTS28	609883	17q22	MKS1
Joubert syndrome 3, 608629 (3)	AHI1	608894	6q23.3	AHI1
Joubert syndrome 30, 617622 (3)	ARMC9, KIAA1868, JBTS30	617612	2q37.1	ARMC9
Joubert syndrome 31, 617761 (3)	CEP120, CCDC100, SRTD13, JBTS31	613446	5q23.2	CEP120
Joubert syndrome 32, 617757 (3)	SUFU, SUFUXL, SUFUH, JBTS32	607035	10q24.32	SUFU
Joubert syndrome 33, 617767 (3)	PIBF1, JBTS33	607532	13q21.3-q22.1	PIBF1
Joubert syndrome 34, 614175 (3)	B9D2, MKS10, JBTS34	611951	19q13.2	B9D2
Joubert syndrome 4, 609583 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPHP1
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Joubert syndrome 6, 610688 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
Joubert syndrome 7, 611560 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	RPGRIP1L
Joubert syndrome 8, 612291 (3)	ARL13B, ARL2L1, JBTS8	608922	3q11.1-q11.2	ARL13B
Joubert syndrome 9, 612285 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	CC2D2A
Juvenile polyposis syndrome, infantile form, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	BMPR1A
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, JIP, MYHRS	600993	18q21.2	SMAD4
KBG syndrome, 148050 (3)	ANKRD11, ANCO1, KBGS	611192	16q24.3	ANKRD11
Kabuki syndrome 1, 147920 (3)	KMT2D, MLL2, ALR, KABUK1	602113	12q13.12	KMT2D
Kabuki syndrome 2, 300867 (3)	KDM6A, UTX, KABUK2	300128	Xp11.3	KDM6A
Kagami-Ogata syndrome (4)	KAOGS	608149	14q32	KAOGS
Kahrizi syndrome, 612713 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	SRD5A3
Kanzaki disease, 609242 (3)	NAGA	104170	22q13.2	NAGA
Kappa light chain deficiency, 614102 (3)	IGKC, IGKCD	147200	2p11.2	IGKC
Kaufman oculocerebrofacial syndrome, 244450 (3)	UBE3B, BPIDS, KOS	608047	12q24.11	UBE3B
Kenny-Caffey syndrome, type 1, 244460 (3)	TBCE, KCS, KCS1, HRD, PEAMO	604934	1q42.3	TBCE
Kenny-Caffey syndrome, type 2, 127000 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	FAM111A
Keppen-Lubinsky syndrome, 614098 (3)	KCNJ6, GIRK2, KCNJ7, KPLBS	600877	21q22.13	KCNJ6
Keratitis, 148190 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Keratoconus 1, 148300 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	VSX1
Keratoconus 2 (2)	KTCN2	608932	16q22.3-q23.1	KTCN2
Keratoconus 3 (2)	KTCN3	608586	3p14-q13	KTCN3
Keratoconus 4 (2)	KTCN4	609271	2p24	KTCN4
Keratoconus 5 (2)	KTCN5	614622	5q14.1-q21.3	KTCN5
Keratoconus 6 (2)	KTCN6	614623	9q34	KTCN6
Keratoconus 7 (2)	KTCN7	614629	13q32	KTCN7
Keratoconus 8 (2)	KTCN8	614628	14q24.3	KTCN8
Keratoderma, palmoplantar, punctate type IA, 148600 (3)	AAGAB, p34, PPKP1A, PPKP1, KPPP1	614888	15q23	AAGAB
Keratoderma, palmoplantar, punctate type IB (2)	PPKP1B	614936	8q24.13-q24.21	PPKP1B
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Keratolytic winter erythema (2)	KWE	148370	8p23-p22	KWE
Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	MBTPS2
Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)	POMP, UMP1	613386	13q12.3	POMP
Keratosis palmoplantaris striata I, AD, 148700 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	DSG1
Keratosis palmoplantaris striata II, 612908 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Keratosis palmoplantaris striata III, 607654 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Keutel syndrome, 245150 (3)	MGP	154870	12p12.3	MGP
Kindler syndrome, 173650 (3)	KIND1, URP1, C20orf42	607900	20p12.3	KIND1
King-Denborough syndrome, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Kleefstra syndrome 1, 610253 (3)	EHMT1, EUHMTASE1, DEL9q34, KLEFS1	607001	9q34.3	EHMT1
Kleefstra syndrome 2, 617768 (3)	KMT2C, MLL3, KIAA1506, KLEFS2	606833	7q36.1	KMT2C
Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Klippel-Feil syndrome 2, 214300 (3)	MEOX1, MOX1, KFS2	600147	17q21.31	MEOX1
Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	GDF3
Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	MYO18B, KFS4	607295	22q12.1	MYO18B
Klippel-Trenaunay-Weber syndrome (2)	KTWS, KTS	149000	8q22.3	KTWS
Kniest dysplasia, 156550 (3)	COL2A1	120140	12q13.11	COL2A1
Knobloch syndrome, type 1, 267750 (3)	COL18A1, KNO1	120328	21q22.3	COL18A1
Kohlschutter-Tonz syndrome, 226750 (3)	ROGDI, KTZS	614574	16p13.3	ROGDI
Kondoh syndrome (2)	KONDS	606242	1p36.32-p35.3	KONDS
Koolen-De Vries syndrome, 610443 (3)	KANSL1, KIAA1267, MSL1V1, KDVS	612452	17q21.31	KANSL1
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Kowarski syndrome, 262650 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Krabbe disease, 245200 (3)	GALC	606890	14q31.3	GALC
Krabbe disease, atypical, 611722 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Kufor-Rakeb syndrome, 606693 (3)	ATP13A2, PARK9, KRPPD, SPG78	610513	1p36.13	ATP13A2
Kyphoscoliosis 1 (2)	KYPSC1	610170	5p13	KYPSC1
L-2-hydroxyglutaric aciduria, 236792 (3)	L2HGDH, C14orf160, L2HGA	609584	14q21.3	L2HGDH
L-ferritin deficiency, dominant and recessive, 615604 (3)	FTL, NBIA3, LFTD	134790	19q13.33	FTL
LADD syndrome, 149730 (3)	FGF10	602115	5p12	FGF10
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
LADD syndrome, 149730 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
LCHAD deficiency, 609016 (3)	HADHA, MTPA	600890	2p23.3	HADHA
LDL cholesterol level QTL2, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	LDLR
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
LEOPARD syndrome 2, 611554 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	RAF1
LEOPARD syndrome 3, 613707 (3)	BRAF, NS7	164757	7q34	BRAF
LIG4 syndrome, 606593 (3)	LIG4, LIG4S	601837	13q33.3	LIG4
Lactase deficiency, congenital, 223000 (3)	LCT, LAC, LPH	603202	2q21.3	LCT
Lactase persistence/nonpersistence, 223100 (3)	MCM6	601806	2q21.3	MCM6
Lacticacidemia due to PDX1 deficiency, 245349 (3)	PDHX, PDX1, E3BP, PDHXD	608769	11p13	PDHX
Laing distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Lamb-Shaffer syndrome, 616803 (3)	SOX5, LAMSHF	604975	12p12.1	SOX5
Langer mesomelic dysplasia, 249700 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SHOX
Langer mesomelic dysplasia, 249700 (3)	SHOXY	400020	Yp11.2	SHOXY
Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia, 617182 (3)	GNB5, GB5, IDDCA, LADCI	604447	15q21.2	GNB5
Laron dwarfism, 262500 (3)	GHR, GHIP	600946	5p13-p12	GHR
Larsen syndrome, 150250 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Larsen-like syndrome (2)	LRSL	608545	6p25	LRSL
Laryngoonychocutaneous syndrome, 245660 (3)	LAMA3, LOCS	600805	18q11.2	LAMA3
Lateral meningocele syndrome, 130720 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	NOTCH3
Lathosterolosis, 607330 (3)	SC5DL, ERG3	602286	11q23.3-q24.1	SC5DL
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Leber congenital amaurosis 1, 204000 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1	600179	17p13.1	GUCY2D
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Leber congenital amaurosis 11, 613837 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	IMPDH1
Leber congenital amaurosis 12, 610612 (3)	RD3, LCA12, C1orf36	180040	1q32.3	RD3
Leber congenital amaurosis 13, 612712 (3)	RDH12, LCA13	608830	14q24.1	RDH12
Leber congenital amaurosis 14, 613341 (3)	LRAT, LCA14	604863	4q32.1	LRAT
Leber congenital amaurosis 15, 613843 (3)	TULP1, RP14, LCA15	602280	6p21.31	TULP1
Leber congenital amaurosis 16, 614186 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	KCNJ13
Leber congenital amaurosis 17, 615360 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Leber congenital amaurosis 2, 204100 (3)	RPE65, RP20, LCA2	180069	1p31.3	RPE65
Leber congenital amaurosis 3, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	SPATA7
Leber congenital amaurosis 4, 604393 (3)	AIPL1, LCA4	604392	17p13.2	AIPL1
Leber congenital amaurosis 5, 604537 (3)	LCA5, C6orf152	611408	6q14.1	LCA5
Leber congenital amaurosis 6, 613826 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	RPGRIP1
Leber congenital amaurosis 7, 613829 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CRX
Leber congenital amaurosis 8, 613835 (3)	CRB1, RP12, LCA8	604210	1q31.3	CRB1
Leber congenital amaurosis 9, 608553 (3)	NMNAT1, NMNAT, PNAT1, LCA9	608700	1p36.22	NMNAT1
Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1	DTNA
Left ventricular noncompaction 10, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	MYBPC3
Left ventricular noncompaction 2 (2)	LVNC2	609470	11p15	LVNC2
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Left ventricular noncompaction 4, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Left ventricular noncompaction 6, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Left ventricular noncompaction 7, 615092 (3)	MIB1, MIB, DIP1, KIAA1323, LVNC7	608677	18q11.2	MIB1
Left ventricular noncompaction 8, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	PRDM16
Left ventricular noncompaction 9, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	TPM1
Left-right axis malformations (3)	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.12	EBAF
Legg-Calve-Perthes disease, 150600 (3)	COL2A1	120140	12q13.11	COL2A1
Legius syndrome, 611431 (3)	SPRED1, NFLS	609291	15q14	SPRED1
Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)	COX15, CEMCOX2	603646	10q24.2	COX15
Leigh syndrome due to mitochondrial COX4 deficiency, 256000 (3)	COX10	602125	17p12	COX10
Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3)	NDUFA12	614530	12q22	NDUFA12
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	FOXRED1	613622	11q24.2	FOXRED1
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFA2	602137	5q31.3	NDUFA2
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFA9	603834	12p13.32	NDUFA9
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFAF6, C8orf38	612392	8q22.1	NDUFAF6
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFS3	603846	11p11.2	NDUFS3
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFS8	602141	11q13.2	NDUFS8
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Leigh syndrome, 256000 (3)	NDUFA10	603835	2q37.3	NDUFA10
Leigh syndrome, 256000 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	NDUFAF2
Leigh syndrome, 256000 (3)	NDUFS4, AQDQ	602694	5q11.2	NDUFS4
Leigh syndrome, 256000 (3)	NDUFS7, PSST	601825	19p13.3	NDUFS7
Leigh syndrome, 256000 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Leigh syndrome, French-Canadian type, 220111 (3)	LRPPRC, LRP130, LSFC	607544	2p21	LRPPRC
Leigh syndrome, due to COX IV deficiency, 256000 (3)	SURF1, CMT4K	185620	9q34.2	SURF1
Leiomyoma, uterine, somatic, 150699 (1)	HMGA2, HMGIC, BABL	600698	12q14.3	HMGA2
Leiomyomatosis and renal cell cancer, 150800 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	FH
Lenz-Majewski hyperostotic dwarfism, 151050 (3)	PTDSS1, PSS1, KIAA0024, LMHD	612792	8q22.1	PTDSS1
Leprechaunism, 246200 (3)	INSR, HHF5	147670	19p13.2	INSR
Leri pleonosteosis chromosome duplication syndrome (4)	DUP8q22.1, C8DUPq22.1	151200	8q22.1	DUP8q22.1
Leri-Weill dyschondrosteosis, 127300 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SHOX
Leri-Weill dyschondrosteosis, 127300 (3)	SHOXY	400020	Yp11.2	SHOXY
Lesch-Nyhan syndrome, 300322 (3)	HPRT1, HPRT	308000	Xq26.2-q26.3	HPRT1
Lethal congenital contractural syndrome 2, 607598 (3)	ERBB3, LCCS2	190151	12q13.2	ERBB3
Lethal congenital contractural syndrome 3, 611369 (3)	PIP5K1C, LCCS3	606102	19p13.3	PIP5K1C
Lethal congenital contracture syndrome 1, 253310 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	GLE1
Lethal congenital contracture syndrome 10, 617022 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NEK9
Lethal congenital contracture syndrome 11, 617194 (3)	GLDN, CRGL2, LCCS11	608603	15q21.2	GLDN
Lethal congenital contracture syndrome 4, 614915 (3)	MYBPC1, LCCS4	160794	12q23.2	MYBPC1
Lethal congenital contracture syndrome 5, 615368 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Lethal congenital contracture syndrome 7, 616286 (3)	CNTNAP1, CASPR, P190	602346	17q21.2	CNTNAP1
Lethal congenital contracture syndrome 9, 616503 (3)	ADGRG6, PR126, VIGR, LCCS9	612243	6q24.2	ADGRG6
Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)	ABL1, CHDSKM	189980	9q34.12	ABL1
Leukemia, T-cell acute lymphoblastic (2)	LMO1, RBTN1, RHOM1	186921	11p15.4	LMO1
Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	NUP214
Leukemia, T-cell acute lymphoblastoid (2)	LYL1	151440	19p13.13	LYL1
Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	TAL1, TCL5, SCL	187040	1p33	TAL1
Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	TAL2	186855	9q31.2	TAL2
Leukemia, acute T-cell (2)	LMO2, RBTNL1, RHOM2, TTG2	180385	11p13	LMO2
Leukemia, acute lymphoblastic (2)	LALL	247640	9p22-p21	LALL
Leukemia, acute lymphoblastic, 613065 (3)	NBN, NBS1	602667	8q21.3	NBN
Leukemia, acute lymphoblastic, somatic, 613065 (3)	FLT3	136351	13q12.2	FLT3
Leukemia, acute lymphoblastic, somatic, 613065 (3)	GNB1, MRD42	139380	1p36.33	GNB1
Leukemia, acute lymphocytic, somatic, 613065 (3)	BCR, CML, PHL, ALL	151410	22q11.23	BCR
Leukemia, acute myeloid, 601626 (1)	MLF1	601402	3q25.32	MLF1
Leukemia, acute myeloid, 601626 (1)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	NSD1
Leukemia, acute myeloid, 601626 (1)	SH3GL1, EEN	601768	19p13.3	SH3GL1
Leukemia, acute myeloid, 601626 (3)	AF10	602409	10p12.31	AF10
Leukemia, acute myeloid, 601626 (3)	KIT, PBT	164920	4q12	KIT
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Leukemia, acute myeloid, 601626 (3)	LPP	600700	3q27-q28	LPP
Leukemia, acute myeloid, 601626 (3)	NSD3, WHSC1L1	607083	8p11.23	NSD3
Leukemia, acute myeloid, 601626 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	RUNX1
Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3)	FLT3	136351	13q12.2	FLT3
Leukemia, acute myeloid, somatic, 601626 (3)	CEBPA, CEBP	116897	19q13.11	CEBPA
Leukemia, acute myeloid, somatic, 601626 (3)	ETV6, TEL, THC5	600618	12p13.2	ETV6
Leukemia, acute myeloid, somatic, 601626 (3)	FLT3	136351	13q12.2	FLT3
Leukemia, acute myeloid, somatic, 601626 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Leukemia, acute myeloid, somatic, 601626 (3)	NPM1	164040	5q35.1	NPM1
Leukemia, acute myeloid, somatic, 601626 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	NUP214
Leukemia, acute myeloid, somatic, 601626 (3)	PICALM, CALM, CLTH, LAP	603025	11q14.2	PICALM
Leukemia, acute myeloid, therapy-related (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	SEPT9
Leukemia, acute myeloid, with eosinophilia (1)	ABL2, ABLL, ARG	164690	1q25.2	ABL2
Leukemia, acute nonlymphocytic (2)	DEK, D6S231E	125264	6p22.3	DEK
Leukemia, acute promyelocytic, 612376 (1)	RARA	180240	17q21.2	RARA
Leukemia, acute promyelocytic, PL2F/RARA type (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	ZBTB16
Leukemia, acute promyelocytic, PML/RARA type (3)	PML, MYL	102578	15q24.1	PML
Leukemia, acute promyelocytic, somatic, 102578 (3)	STAT5B	604260	17q21.2	STAT5B
Leukemia, acute promyelocytic, somatic, 612376 (3)	NUMA1	164009	11q13.4	NUMA1
Leukemia, chronic myeloid, somatic, 608232 (3)	BCR, CML, PHL, ALL	151410	22q11.23	BCR
Leukemia, juvenile myelomonocytic, 607785 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	ARHGAP26, GRAF	605370	5q31.3	ARHGAP26
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Leukemia, myeloid/lymphoid or mixed-lineage (2)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	KMT2A
Leukemia, transient, of Down syndrome (2)	TAM, MST	159595	21q11.2	TAM
Leukemia/lymphoma, B-cell, 2 (3)	BCL2	151430	18q21.33	BCL2
Leukemia/lymphoma, B-cell, 3 (2)	BCL3	109560	19q13.32	BCL3
Leukemia/lymphoma, T-cell (2)	TCL1A, TCL1	186960	14q32.13	TCL1A
Leukemia/lymphoma, T-cell (2)	TCL1B, TML1	603769	14q32.13	TCL1B
Leukemia/lymphoma, T-cell (2)	TCL4	186860	2q34	TCL4
Leukocyte adhesion deficiency, 116920 (3)	ITGB2, CD18, LCAMB, LAD	600065	21q22.3	ITGB2
Leukocyte adhesion deficiency, type III, 612840 (3)	KIND3, URP2, MIG2B, FERMT3	607901	11q13.1	KIND3
Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	PLEKHG2, CLG, LDAMD	611893	19q13.2	PLEKHG2
Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	LMNB1, ADLD	150340	5q23.2	LMNB1
Leukodystrophy, hypomyelinating, 10, 616420 (3)	PYCR2, HLD10	616406	1q42.12	PYCR2
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	POLR1C
Leukodystrophy, hypomyelinating, 12, 616683 (3)	VPS11, HLD12	608549	11q23.3	VPS11
Leukodystrophy, hypomyelinating, 13, 616881 (3)	HIKESHI, C11orf73, HLD13	614908	11q14.2	HIKESHI
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJC2
Leukodystrophy, hypomyelinating, 3, 260600 (3)	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	603605	4q24	AIMP1
Leukodystrophy, hypomyelinating, 4, 612233 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HSPD1
Leukodystrophy, hypomyelinating, 5, 610532 (3)	FAM126A, DRCTNNB1A, HLD5	610531	7p15.3	FAM126A
Leukodystrophy, hypomyelinating, 6, 612438 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	TUBB4A
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	POLR3A, RPC1, RPC155, ADDH, HLD7	614258	10q22.3	POLR3A
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	POLR3B, RPC2, C128, HLD8	614366	12q23.3	POLR3B
Leukodystrophy, hypomyelinating, 9, 616140 (3)	RARS, HLD9	107820	5q34	RARS
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	DARS2, ASPRS. LBSL	610956	1q25.1	DARS2
Leukoencephalopathy with metaphyseal chondrodysplasia (2)	LKMCD	300660	Xq25-q27	LKMCD
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B1, EIF2BA	606686	12q24.31	EIF2B1
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B2	606454	14q24.3	EIF2B2
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B3	606273	1p34.1	EIF2B3
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B4	606687	2p23.3	EIF2B4
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	EIF2B5
Leukoencephalopathy, brain calcifications, and cysts, 614561 (3)	SNORD118, LCC	616663	17p13.1	SNORD118
Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	RNASET2, RNASE6PL	612944	6q27	RNASET2
Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	CSF1R, FMS, HDLS	164770	5q32	CSF1R
Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	AARS2
Leukotriene C4 synthase deficiency, 614037 (1)	LTC4S	246530	5q35.3	LTC4S
Levy-Shanske syndrome (4)	LVSKS	614846	15q26-qter	LVSKS
Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Lhermitte-Duclos syndrome, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Li-Fraumeni syndrome 3 (2)	LFS3	609266	1q23	LFS3
Li-Fraumeni syndrome, 151623 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Li-Fraumeni syndrome, 609265 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
Liddle syndrome, 177200 (3)	SCNN1B, BESC1	600760	16p12.2	SCNN1B
Liddle syndrome, 177200 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	SCNN1G
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	PITX1
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Linear skin defects with multiple congenital anomalies 1, 309801 (3)	HCCS, MCOPS7, LSDMCA1	300056	Xp22.2	HCCS
Linear skin defects with multiple congenital anomalies 2, 300887 (3)	COX7B, LSDMCA2	300885	Xq21.1	COX7B
Linear skin defects with multiple congenital anomalies 3, 300952 (3)	NDUFB11, LSDMCA3	300403	Xp11.3	NDUFB11
Lipase deficiency, combined, 246650 (3)	LMF1, TMEM112	611761	16p13.3	LMF1
Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	FLAD1, FADS, LSMFLAD	610595	1q21.3	FLAD1
Lipodystrophy, congenital generalized, type 1, 608594 (3)	AGPAT2, LPAAB, BSCL, BSCL1	603100	9q34.3	AGPAT2
Lipodystrophy, congenital generalized, type 2, 269700 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Lipodystrophy, congenital generalized, type 4, 613327 (3)	CAVIN1, PTRF	603198	17q21.2	CAVIN1
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Lipodystrophy, familial partial, type 3, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Lipodystrophy, familial partial, type 4, 613877 (3)	PLIN1, PLIN, FPLD4	170290	15q26.1	PLIN1
Lipodystrophy, familial partial, type 6, 615980 (3)	LIPE, LHS, FPLD6	151750	19q13.2	LIPE
Lipoid adrenal hyperplasia, 201710 (3)	STAR	600617	8p11.23	STAR
Lipoma (3)	LPP	600700	3q27-q28	LPP
Lipoma, somatic (3)	MEN1	613733	11q13.1	MEN1
Lipoprotein glomerulopathy, 611771 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Lipoprotein lipase deficiency, 238600 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LPL
Liposarcoma (1)	LPSA, D19S381E	164953	19p13.2-q13.3	LPSA
Lipoyltransferase 1 deficiency, 616299 (3)	LIPT1, LIPT1D	610284	2q11.2	LIPT1
Lissencephaly 1, 607432 (3)	PAFAH1B1, LIS1	601545	17p13.3	PAFAH1B1
Lissencephaly 2 (Norman-Roberts type), 257320 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	RELN
Lissencephaly 3, 611603 (3)	TUBA1A, TUBA3, LIS3	602529	12q13.12	TUBA1A
Lissencephaly 4 (with microcephaly), 614019 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	NDE1
Lissencephaly 5, 615191 (3)	LAMB1, LIS5	150240	7q31.1	LAMB1
Lissencephaly 6, with microcephaly, 616212 (3)	KATNB1, LIS6	602703	16q21	KATNB1
Lissencephaly 8, 617255 (3)	TMTC3, SMILE, LIS8	617218	12q21.32	TMTC3
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Lissencephaly, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	DCX
Liver failure, transient infantile, 613070 (3)	TRMU, MTO2	610230	22q13.31	TRMU
Loeys-Dietz syndrome 1, 609192 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	TGFBR1
Loeys-Dietz syndrome 2, 610168 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	TGFBR2
Loeys-Dietz syndrome 3, 613795 (3)	SMAD3, MADH3, LDS3	603109	15q22.33	SMAD3
Loeys-Dietz syndrome 4, 614816 (3)	TGFB2, LDS4	190220	1q41	TGFB2
Loeys-Dietz syndrome 5, 615582 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	TGFB3
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Long QT syndrome 12, 612955 (3)	SNTA1, SNT1, TACIP1, LQT12	601017	20q11.21	SNTA1
Long QT syndrome 13, 613485 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	KCNJ5
Long QT syndrome 14, 616247 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	CALM1
Long QT syndrome 15, 616249 (3)	CALM2, LQT15	114182	2p21	CALM2
Long QT syndrome 2, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	KCNH2
Long QT syndrome 4, 600919 (3)	ANK2, LQT4	106410	4q25-q26	ANK2
Long QT syndrome 5, 613695 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	KCNE1
Long QT syndrome 6, 613693 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	KCNE2
Long QT syndrome 9, 611818 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Long QT syndrome-10, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	SCN4B
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Lopes-Maciel-Rodan syndrome, 617435 (3)	HTT, HD, IT15, LOMARS	613004	4p16.3	HTT
Lowe syndrome, 309000 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	OCRL
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	MED12
Lung cancer, 211980 (1)	DLEC1, DLC1	604050	3p22.2	DLEC1
Lung cancer, 211980 (2)	RASSF1	605082	3p21.31	RASSF1
Lung cancer, 211980 (3)	PPP2R1B	603113	11q23.1	PPP2R1B
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Lung cancer, somatic, 211980 (3)	MAP3K8, COT, EST, TPL2	191195	10p11.23	MAP3K8
Lung cancer, somatic, 211980 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	SLC22A1L
Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3)	NSMCE3, NDNL2, MAGEG1, LICS	608243	15q13.1	NSMCE3
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	SETD2
Luteinizing hormone resistance, female, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Lymphangioleiomyomatosis, 606690 (3)	TSC1, LAM	605284	9q34.13	TSC1
Lymphangioleiomyomatosis, somatic, 606690 (3)	TSC2, LAM	191092	16p13.3	TSC2
Lymphedema, hereditary, IA, 153100 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	FLT4
Lymphedema, hereditary, IB (2)	LMPH1B	611944	6q16.2-q22.1	LMPH1B
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJC2
Lymphedema, hereditary, ID, 615907 (3)	VEGFC, VRP, LMPH1D	601528	4q34.3	VEGFC
Lymphedema, hereditary, III, 616843 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	PIEZO1
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	FOXC2
Lymphedema-distichiasis syndrome, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	FOXC2
Lymphocytic leukemia, acute T-cell (3)	RAP1GDS1	179502	4q23	RAP1GDS1
Lymphoma, B-cell (2)	BCL6	109565	3q27.3	BCL6
Lymphoma, B-cell non-Hodgkin, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATM
Lymphoma, MALT, somatic, 137245 (3)	BCL10, IMD37	603517	1p22.3	BCL10
Lymphoma, mantle cell, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATM
Lymphoma, non-Hodgkin, 605027 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	PRF1
Lymphoma, non-Hodgkin, somatic, 605027 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	CASP10
Lymphoma, non-Hodgkin, somatic, 605027 (3)	RAD54B	604289	8q22.1	RAD54B
Lymphoma, non-Hodgkin, somatic, 605027 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	RAD54L
Lymphoma, somatic (3)	MAD1L1, TXBP181	602686	7p22.3	MAD1L1
Lymphoproliferative syndrome 1, 613011 (3)	ITK, EMT, LPFS1	186973	5q33.3	ITK
Lymphoproliferative syndrome 2, 615122 (3)	CD27, TNFRSF7, S152. LPFS2	186711	12p13.31	CD27
Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	SH2D1A, LYP, IMD5, XLP, XLPD1	300490	Xq25	SH2D1A
Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	XIAP, BIRC4, API3, XLP2	300079	Xq25	XIAP
Lysinuric protein intolerance, 222700 (3)	SLC7A7, LPI	603593	14q11.2	SLC7A7
Lysyl hydroxylase 3 deficiency, 612394 (3)	PLOD3, LH3	603066	7q22.1	PLOD3
MASA syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
MASP2 deficiency, 613791 (3)	MASP2	605102	1p36.22	MASP2
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
MEDNIK syndrome, 609313 (3)	AP1S1, CLAPS1, AP19, MEDNIK	603531	7q22.1	AP1S1
MEHMO syndrome (2)	MEHMO	300148	Xp22.13-p21.1	MEHMO
MEND syndrome, 300960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	EBP
MHC class II deficiency, complementation group B, 209920 (3)	RFXANK	603200	19p13.11	RFXANK
MIRAGE syndrome, 617053 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	SAMD9
MODY, type I, 125850 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	HNF4A
MODY, type II, 125851 (3)	GCK, HHF3	138079	7p13	GCK
MODY, type III, 600496 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
MODY, type IV, 606392 (3)	PDX1, IPF1, MODY4, PAGEN1	600733	13q12.2	PDX1
Machado-Joseph disease, 109150 (3)	ATXN3, MJD, SCA3	607047	14q32.12	ATXN3
Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	RIN2, MACS	610222	20p11.23	RIN2
Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3)	HERC1, MDFPMR	605109	15q22.31	HERC1
Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)	RNF135, MMFD	611358	17q11.2	RNF135
Macrocephaly/autism syndrome, 605309 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	TBC1D7, PIG51, TBC7, MGCPH	612655	6p24.1	TBC1D7
Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	RPS14, EMTB	130620	5q33.1	RPS14
Macroglobulinemia, Waldenstrom, somatic, 153600 (3)	MYD88, MYD88D	602170	3p22.2	MYD88
Macrostomia (2)	MACST	613545	1p34-p32	MACST
Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)	TUBB1	612901	20q13.32	TUBB1
Macular corneal dystrophy, 217800 (3)	CHST6, MCDC1	605294	16q23.1	CHST6
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Macular degeneration, age-related, 10 (2)	ARMD10	611488	9q32-q33	ARMD10
Macular degeneration, age-related, 3, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Macular degeneration, early-onset, 616118 (3)	FBN2, CCA, EOMD	612570	5q23.3	FBN2
Macular degeneration, juvenile, 248200 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	CNGB3
Macular dystrophy with central cone involvement, 616170 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	MFSD8
Macular dystrophy, North Carolina type, 136550 (3)	DHS6S1, MCDR1	616842	6q16.2	DHS6S1
Macular dystrophy, butterfly-shaped pigmentary, 2 (2)	MDBS2	608970	5q21.3-q33.2	MDBS2
Macular dystrophy, dominant cystoid (2)	MDDC	153880	7p21-p15	MDDC
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Macular dystrophy, patterned, 2, 608970 (3)	CTNNA1, MDPT2	116805	5q31.2	CTNNA1
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Macular dystrophy, retinal, 3 (2)	MCDR3	608850	5p15.33-p13.1	MCDR3
Macular dystrophy, vitelliform, 2, 153700 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Macular dystrophy, vitelliform, 4, 616151 (3)	IMPG1, IPM150, VMD4	602870	6q14.1	IMPG1
Macular dystrophy, vitelliform, 5, 616152 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	IMPG2
Majeed syndrome, 609628 (3)	LPIN2	605519	18p11.31	LPIN2
Major affective disorder 4 (2)	MAFD4, BPAD	611247	16p12	MAFD4
Major depressive disorder 1, 608516 (2)	MDD1	608520	12q22-q23.2	MDD1
Major depressive disorder 2, 608516 (2)	MDD2	608691	15q25.3-q26.2	MDD2
Malignant fibrous histiocytoma (2)	MFHAS1, MASL1	605352	8p23.1	MFHAS1
Malignant melanoma, somatic, 155600 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Malonyl-CoA decarboxylase deficiency, 248360 (3)	MLYCD, MCD	606761	16q23.3	MLYCD
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Mammary-digital-nail syndrome (2)	MDNS	613689	22q12.3-q13.1	MDNS
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	POLD1
Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	ZMPSTE24
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Mandibulofacial dysostosis with alopecia, 616367 (3)	EDNRA, MFDA	131243	4q31.22-q31.23	EDNRA
Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	EFTUD2, KIAA0031, MFDGA	603892	17q21.31	EFTUD2
Manitoba oculotrichoanal syndrome, 248450 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	FREM1
Mannosidosis, alpha-, types I and II, 248500 (3)	MAN2B1, MANB	609458	19p13.13	MAN2B1
Mannosidosis, beta, 248510 (3)	MANBA, MANB1	609489	4q24	MANBA
Maple syrup urine disease, type II, 248600 (3)	DBT, BCATE2	248610	1p21.2	DBT
Maple syrup urine disease, type Ia, 248600 (3)	BCKDHA, MSUD1	608348	19q13.2	BCKDHA
Maple syrup urine disease, type Ib, 248600 (3)	BCKDHB, E1B	248611	6q14.1	BCKDHB
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Marinesco-Sjogren syndrome, 248800 (3)	SIL1, BAP, MSS	608005	5q31.2	SIL1
Marshall syndrome, 154780 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
Marshall-Smith syndrome, 602535 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	NFIX
Martsolf syndrome, 212720 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	RAB3GAP2
Mast cell disease, 154800 (3)	KIT, PBT	164920	4q12	KIT
Mast syndrome, 248900 (3)	ACP33, MAST, SPG21	608181	15q22.31	ACP33
Maturity-onset diabetes of the young 6, 606394 (3)	NEUROD1, NIDDM	601724	2q31.3	NEUROD1
Maturity-onset diabetes of the young, type 10, 613370 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Maturity-onset diabetes of the young, type 11, 613375 (3)	BLK, MODY11	191305	8p23.1	BLK
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Maturity-onset diabetes of the young, type IX, 612225 (3)	PAX4, MODY9, KPD	167413	7q32.1	PAX4
Maturity-onset diabetes of the young, type VII, 610508 (3)	KLF11, TIEG2, FKLF1, FKLF, MODY7	603301	2p25.1	KLF11
Maturity-onset diabetes of the young, type VIII, 609812 (3)	CEL, BSSL, CELL, MODY8	114840	9q34.13	CEL
May-Hegglin anomaly, 155100 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
McArdle disease, 232600 (3)	PYGM	608455	11q13.1	PYGM
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
McKusick-Kaufman syndrome, 236700 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	MKKS
McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	XK, MCLDS	314850	Xp21.1	XK
Meacham syndrome, 608978 (3)	WT1, NPHS4	607102	11p13	WT1
Mean platelet volume QTL4 (2)	MPVQTL4	614644	6p21.3-p21.2	MPVQTL4
Mean platelet volume QTL5 (2)	MPVQTL5	614645	6q23.3	MPVQTL5
Mean platelet volume QTL6 (2)	MPVQTL6	614646	7q22.3	MPVQTL6
Meckel syndrome 1, 249000 (3)	MKS1, MKS, BBS13, JBTS28	609883	17q22	MKS1
Meckel syndrome 11, 615397 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	TMEM231
Meckel syndrome 13, 617562 (3)	TMEM107, MKS13, JBTS29	616183	17p13.1	TMEM107
Meckel syndrome 2, 603194 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	TMEM216
Meckel syndrome 3, 607361 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Meckel syndrome 5, 611561 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	RPGRIP1L
Meckel syndrome 6, 612284 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	CC2D2A
Meckel syndrome 7, 267010 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPHP3
Meconium ileus, 614665 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	GUCY2C
Medullary cystic kidney disease 1, 174000 (3)	MUC1, PUM, MCKD1	158340	1q22	MUC1
Medullary cystic kidney disease 2, 603860 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	UMOD
Medullary thyroid carcinoma, 155240 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Medullary thyroid carcinoma, familial, 155240 (3)	NTRK1, TRKA, MTC	191315	1q23.1	NTRK1
Medulloblastoma, desmoplastic, 155255 (3)	SUFU, SUFUXL, SUFUH, JBTS32	607035	10q24.32	SUFU
Medulloblastoma, somatic, 155255 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
Medulloblastoma, somatic, 155255 (3)	PTCH2	603673	1p34.1	PTCH2
Meesmann corneal dystrophy, 122100 (3)	KRT12	601687	17q21.2	KRT12
Meesmann corneal dystrophy, 122100 (3)	KRT3	148043	12q13.13	KRT3
Meester-Loeys syndrome, 300989 (3)	BGN, SEMDX, MRLS	301870	Xq28	BGN
Megakaryoblastic leukemia, acute (2)	RBM15, SPEN, OTT	606077	1p13.3	RBM15
Megakaryoblastic leukemia, acute (3)	MKL1, AMKL, MAL	606078	22q13.1-q13.2	MKL1
Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	HEPACAM
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	HEPACAM
Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	MLC1, LVM, VL	605908	22q13.33	MLC1
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	PIK3R2, MPPH1	603157	19p13.11	PIK3R2
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	AKT3, PKBG, MPPH2	611223	1q43-q44	AKT3
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	CCND2, MPPH3	123833	12p13.32	CCND2
Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	DHFR	126060	5q14.1	DHFR
Megaloblastic anemia-1, Finnish type, 261100 (3)	CUBN, IFCR, MGA1	602997	10p13	CUBN
Megaloblastic anemia-1, Norwegian type, 261100 (3)	AMN	605799	14q32.32	AMN
Megalocornea 1, X-linked 309300 (3)	CHRDL1, VOPT, MGC1	300350	Xq23	CHRDL1
Meier-Gorlin syndrome 1, 224690 (3)	ORC1, ORC1L	601902	1p32.3	ORC1
Meier-Gorlin syndrome 2, 613800 (3)	ORC4, ORC4L	603056	2q23.1	ORC4
Meier-Gorlin syndrome 3, 613803 (3)	ORC6, ORC6L	607213	16q11.2	ORC6
Meier-Gorlin syndrome 4, 613804 (3)	CDT1	605525	16q24.3	CDT1
Meier-Gorlin syndrome 6, 616835 (3)	GMNN, MGORS6	602842	6p22.3	GMNN
Meier-Gorlin syndrome 7, 617063 (3)	CDC45L, CDC45L2, MGORS7	603465	22q11.21	CDC45L
Melanocytic nevus syndrome, congenital, somatic, 137550 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
Melanoma, malignant, somatic (3)	BRAF, NS7	164757	7q34	BRAF
Melanoma, malignant, somatic (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Meleda disease, 248300 (3)	SLURP1, MDM	606119	8q24.3	SLURP1
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Meningioma, 607174 (3)	MN1, MGCR	156100	22q12.1	MN1
Meningioma, NF2-related, somatic, 607174 (3)	NF2	607379	22q12.2	NF2
Meningioma, SIS-related, 607174 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	PDGFB
Meningioma, radiation-induced (2)	MNRI	606190	1p11	MNRI
Menkes disease, 309400 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	ATP7A
Mental retardation 105, 300984 (3)	USP27X, USP22L, MRX105	300975	Xp11.23	USP27X
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	MED13L
Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CASK
Mental retardation syndrome, X-linked, Armfield type (2)	MRXSA	300261	Xq28	MRXSA
Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	PHF8, ZNF422, KIAA1111, MRXSSD	300560	Xp11.22	PHF8
Mental retardation with language impairment and with or without autistic features, 613670 (3)	FOXP1, QRF1	605515	3p13	FOXP1
Mental retardation, FRA12A type, 136630 (3)	DIP2B, KIAA1463	611379	12q13.12	DIP2B
Mental retardation, X-linked 1/78, 309530 (3)	IQSEC2, KIAA0522, MRX1, MRX78	300522	Xp11.22	IQSEC2
Mental retardation, X-linked 102, 300958 (3)	DDX3X, DDX3, DBX, MRX102	300160	Xp11.4	DDX3X
Mental retardation, X-linked 103, 300982 (3)	KLHL15, KIAA1677	300980	Xp22.11	KLHL15
Mental retardation, X-linked 104, 300983 (3)	FRMPD4, PRESO, KIAA0316, MRX104	300838	Xp22.2	FRMPD4
Mental retardation, X-linked 106, 300997 (3)	OGT, MRX106	300255	Xq13.1	OGT
Mental retardation, X-linked 12/35, 300957 (3)	THOC2, THO2, MRX12, MRX35	300395	Xq25	THOC2
Mental retardation, X-linked 14 (2)	MRX14	300062	Xp11.3-q13.3	MRX14
Mental retardation, X-linked 19, 300844 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	RPS6KA3
Mental retardation, X-linked 2 (2)	MRX2	300428	Xp22.3	MRX2
Mental retardation, X-linked 20 (2)	MRX20	300047	Xp11-q21	MRX20
Mental retardation, X-linked 21/34, 300143 (3)	IL1RAPL1, IL1R8, MRX21, MRX34	300206	Xp21.3-p21.2	IL1RAPL1
Mental retardation, X-linked 23 (2)	MRX23	300046	Xq23-q24	MRX23
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	HCFC1, HCF1, MRX3	300019	Xq28	HCFC1
Mental retardation, X-linked 30/47, 300558 (3)	PAK3, MRX30, MRX47	300142	Xq23	PAK3
Mental retardation, X-linked 41, 300849 (3)	GDI1, RABGD1A, MRX41, MRX48	300104	Xq28	GDI1
Mental retardation, X-linked 42 (2)	MRX42	300372	Xq26	MRX42
Mental retardation, X-linked 46, 300436 (3)	ARHGEF6, MRX46, COOL2	300267	Xq26.3	ARHGEF6
Mental retardation, X-linked 49/15, 300114 (3)	CLCN4, MRX49, MRX15	302910	Xp22.2	CLCN4
Mental retardation, X-linked 50 (2)	MRX50	300115	Xp11.3-p11.21	MRX50
Mental retardation, X-linked 52 (2)	MRX52	300504	Xp11.21-q22.3	MRX52
Mental retardation, X-linked 53 (2)	MRX53	300324	Xq22.2-q26	MRX53
Mental retardation, X-linked 58, 300210 (3)	TSPAN7, TM4SF2, MXS1, A15, MRX58	300096	Xp11.4	TSPAN7
Mental retardation, X-linked 61, 300978 (3)	RNF12, RLIM, MRX61	300379	Xq13.2	RNF12
Mental retardation, X-linked 63, 300387 (3)	ACSL4, FACL4, ACS4, MRX63	300157	Xq23	ACSL4
Mental retardation, X-linked 72, 300271 (3)	RAB39B, MRX72, WSMN	300774	Xq28	RAB39B
Mental retardation, X-linked 73 (2)	MRX73	300355	Xp22.2	MRX73
Mental retardation, X-linked 77 (2)	MRX77	300454	Xq12-q21.3	MRX77
Mental retardation, X-linked 81 (2)	MRX81	300433	Xp11.2-q12	MRX81
Mental retardation, X-linked 82 (2)	MRX82	300518	Xq24-q25	MRX82
Mental retardation, X-linked 84 (2)	MRX84	300505	Xp11.3-q22.3	MRX84
Mental retardation, X-linked 88 (2)	MRX88	300852	Xq24	MRX88
Mental retardation, X-linked 89 (2)	MRX89	300848	Xp11.3	MRX89
Mental retardation, X-linked 9/44, 309549 (3)	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	FTSJ1
Mental retardation, X-linked 90, 300850 (3)	DLG3, NEDLG, SAP102, MRX90	300189	Xq13.1	DLG3
Mental retardation, X-linked 92 (2)	MRX92	300851	Xp11.3	MRX92
Mental retardation, X-linked 93, 300659 (3)	BRWD3, MRX93	300553	Xq21.1	BRWD3
Mental retardation, X-linked 94, 300699 (3)	GRIA3, GLUR3, MRX94	305915	Xq25	GRIA3
Mental retardation, X-linked 95 (2)	MRX95	300716	Chr.X	MRX95
Mental retardation, X-linked 96, 300802 (3)	SYP, MRXSYP	313475	Xp11.23	SYP
Mental retardation, X-linked 97, 300803 (3)	ZNF711, ZNF6, CMPX1, MRX97	314990	Xq21.1	ZNF711
Mental retardation, X-linked 98, 300912 (3)	NEXMIF, KIAA2022, MRX98	300524	Xq13.3	NEXMIF
Mental retardation, X-linked 99, 300919 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	USP9X
Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	USP9X
Mental retardation, X-linked syndromic 16, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	FGD1
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	AP1S2
Mental retardation, X-linked syndromic 7 (2)	MRXS7	300218	Xp11.3-q22	MRXS7
Mental retardation, X-linked syndromic, Abidi type (2)	MRXSAB	300262	Xq13.2	MRXSAB
Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	SLC9A6, NHE6	300231	Xq26.3	SLC9A6
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	UBE2A, RAD6A, MRXSN, MRXS30	312180	Xq24	UBE2A
Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	ZDHHC9, DHHC9, MRXSZ	300646	Xq26.1	ZDHHC9
Mental retardation, X-linked syndromic, Turner type, 300706 (3)	HUWE1, UREB1, KIAA0312, LASU1	300697	Xp11.22	HUWE1
Mental retardation, X-linked, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	NLGN4
Mental retardation, X-linked, FRAXE type, 309548 (3)	AFF2, FMR2, FRAXE, MRX2	300806	Xq28	AFF2
Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	SMS, SRS, MRSR	300105	Xp22.11	SMS
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
Mental retardation, X-linked, syndromic 14, 300676 (3)	UPF3B, RENT3B, MRXS14	300298	Xq24	UPF3B
Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	300304	Xq24	CUL4B
Mental retardation, X-linked, syndromic 17 (2)	MRXS17	300858	Xp21.1-p11.23	MRXS17
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	TAF1
Mental retardation, X-linked, syndromic 34, 300967 (3)	NONO, NRB54, MRXS34	300084	Xq13.1	NONO
Mental retardation, X-linked, syndromic 9 (2)	MRXS9	300709	Xq12-q21.31	MRXS9
Mental retardation, X-linked, syndromic, 35, 300998 (3)	RPL10, DXS648, QM, AUTSX5, MRXS35	312173	Xq28	RPL10
Mental retardation, X-linked, syndromic, Bain type, 300986 (3)	HNRNPH2, NRPH2, MRXSB	300610	Xq22.1	HNRNPH2
Mental retardation, X-linked, syndromic, Borck type, 300987 (3)	EIF2S3, EIF2G, MRXSBRK	300161	Xp22.11	EIF2S3
Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)	MRXSCS	300861	Xq21.33-q23	MRXSCS
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	KDM5C
Mental retardation, X-linked, syndromic, Hedera type, 300423 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	ATP6AP2
Mental retardation, X-linked, syndromic, Houge type, 301008 (3)	CNKSR2, CNK2, KIAA0902, MRXSHG	300724	Xp22.12	CNKSR2
Mental retardation, X-linked, syndromic, Martin-Probst type (2)	MRXSMP	300519	Chr.X	MRXSMP
Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	OPHN1, MRX60	300127	Xq12	OPHN1
Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)	SOX3, MRGH	313430	Xq27.1	SOX3
Mental retardation, X-linked, with short stature (2)	MRSS	300360	Xq24	MRSS
Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	SOBP, JXC1, MRAMS	613667	6q21	SOBP
Mental retardation, autosomal dominant 1, 156200 (3)	MBD5, KIAA1461, MRD1	611472	2q23.1	MBD5
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DYNC1H1
Mental retardation, autosomal dominant 18, 615074 (3)	GATAD2B, KIAA1150, p68, MRD18	614998	1q21.3	GATAD2B
Mental retardation, autosomal dominant 19, 615075 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
Mental retardation, autosomal dominant 2 (4)	MRD2	614113	9p24	MRD2
Mental retardation, autosomal dominant 21, 615502 (3)	CTCF, MRD21	604167	16q22.1	CTCF
Mental retardation, autosomal dominant 22, 612337 (3)	ZBTB18, ZNF238, RP58, MRD22	608433	1q44	ZBTB18
Mental retardation, autosomal dominant 23, 615761 (3)	SETD5, KIAA1757	615743	3p25.3	SETD5
Mental retardation, autosomal dominant 24, 615828 (3)	DEAF1, SPN, ZMYND5, MRD24	602635	11p15.5	DEAF1
Mental retardation, autosomal dominant 26, 615834 (3)	KIAA0442, MRD26	607270	7q11.22	KIAA0442
Mental retardation, autosomal dominant 27, 615866 (3)	SOX11, MRD27	600898	2p25.2	SOX11
Mental retardation, autosomal dominant 29, 616078 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	SETBP1
Mental retardation, autosomal dominant 3, 612580 (3)	CDH15, CDH14, CDH3, MRD3	114019	16q24.3	CDH15
Mental retardation, autosomal dominant 30, 616083 (3)	ZMYND11, BS69, BRAM1, MRD30	608668	10p15.3	ZMYND11
Mental retardation, autosomal dominant 31, 616158 (3)	PURA, PUR1, MRD31	600473	5q31.3	PURA
Mental retardation, autosomal dominant 32, 616268 (3)	KAT6A, MYST3, MOZ, ZNF220, MRD32	601408	8p11.21	KAT6A
Mental retardation, autosomal dominant 33, 616311 (3)	DPP6, VF2, MRD33	126141	7q36.2	DPP6
Mental retardation, autosomal dominant 34, 616351 (3)	COL4A3BP, GPBP, CERT, MRD34	604677	5q13.3	COL4A3BP
Mental retardation, autosomal dominant 35, 616355 (3)	PPP2R5D, MRD35	601646	6p21.1	PPP2R5D
Mental retardation, autosomal dominant 36, 616362 (3)	PPP2R1A, MRD36	605983	19q13.41	PPP2R1A
Mental retardation, autosomal dominant 38, 616393 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	EEF1A2
Mental retardation, autosomal dominant 39, 616521 (3)	MYT1L, KIAA1106, MRD39	613084	2p25.3	MYT1L
Mental retardation, autosomal dominant 4, 612581 (3)	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	607761	11q24.2	KIRREL3
Mental retardation, autosomal dominant 40, 616579 (3)	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	616327	13q34	CHAMP1
Mental retardation, autosomal dominant 41 , 616944 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	TBL1XR1
Mental retardation, autosomal dominant 42, 616973 (3)	GNB1, MRD42	139380	1p36.33	GNB1
Mental retardation, autosomal dominant 43, 616977 (3)	HIVEP2, MRD43	143054	6q24.2	HIVEP2
Mental retardation, autosomal dominant 44, 617061 (3)	TRIO, MRD44	601893	5p15.2	TRIO
Mental retardation, autosomal dominant 45, 617600 (3)	CIC, KIAA0306, MRD45	612082	19q13.2	CIC
Mental retardation, autosomal dominant 46, 617601 (3)	KCNQ5, MRD46	607357	6q13	KCNQ5
Mental retardation, autosomal dominant 47, 617635 (3)	STAG1, MRD47	604358	3q22.3	STAG1
Mental retardation, autosomal dominant 48, 617751 (3)	RAC1, MRD48	602048	7p22.1	RAC1
Mental retardation, autosomal dominant 49, 617752 (3)	TRIP12, MRD49	604506	2q36.3	TRIP12
Mental retardation, autosomal dominant 5, 612621 (3)	SYNGAP1, MRD5	603384	6p21.32	SYNGAP1
Mental retardation, autosomal dominant 50, 617787 (3)	NAA15, NARG1, NATH, MRD50	608000	4q31.1	NAA15
Mental retardation, autosomal dominant 51, 617788 (3)	KMT5B, SUV420H1, CGI85, MRD51	610881	11q13.2	KMT5B
Mental retardation, autosomal dominant 52, 617796 (3)	ASH1L, KIAA1420, ASH1, MRD52	607999	1q22	ASH1L
Mental retardation, autosomal dominant 53, 617798 (3)	CAMK2A, KIAA0968, CAMKA, MRD53	114078	5q32	CAMK2A
Mental retardation, autosomal dominant 54, 617799 (3)	CAMK2B, MRD54	607707	7p13	CAMK2B
Mental retardation, autosomal dominant 6, 613970 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	GRIN2B
Mental retardation, autosomal dominant 7, 614104 (3)	DYRK1A, MNBH, MNB, MRD7	600855	21q22.13	DYRK1A
Mental retardation, autosomal dominant 8, 614254 (3)	GRIN1, NMDAR1, MRD8	138249	9q34.3	GRIN1
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	KIF1A
Mental retardation, autosomal recessive 1, 249500 (3)	PRSS12, BSSP3, MRT1	606709	4q26	PRSS12
Mental retardation, autosomal recessive 10/20 (2)	MRT10, MRT20	611096	16p12.2-q12.1	MRT10
Mental retardation, autosomal recessive 12, 611090 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	ST3GAL3
Mental retardation, autosomal recessive 13, 613192 (3)	TRAPPC9, NIBP, KIAA1882, MRT13	611966	8q24.3	TRAPPC9
Mental retardation, autosomal recessive 14, 614020 (3)	TECR, GPSN2, TER, SC2, MRT14	610057	19p13.12	TECR
Mental retardation, autosomal recessive 15, 614202 (3)	MAN1B1, MRT15	604346	9q34.3	MAN1B1
Mental retardation, autosomal recessive 16 (2)	MRT16	614208	9p23-p13.3	MRT16
Mental retardation, autosomal recessive 18, 614249 (3)	MED23, MRT18	605042	6q23.2	MED23
Mental retardation, autosomal recessive 19 (2)	MRT19	614343	18p11.3	MRT19
Mental retardation, autosomal recessive 2, 607417 (3)	CRBN, MRT2	609262	3p26.2	CRBN
Mental retardation, autosomal recessive 23 (2)	MRT23	614344	11p13-q14.1	MRT23
Mental retardation, autosomal recessive 24 (2)	MRT24	614345	6p12.2-q12	MRT24
Mental retardation, autosomal recessive 25 (2)	MRT25	614346	12q13.11-q15	MRT25
Mental retardation, autosomal recessive 27, 614340 (3)	LINS1, WINS1, FLJ10583, MRT27	610350	15q26.3	LINS1
Mental retardation, autosomal recessive 28 (2)	MRT28	614347	6q26-q27	MRT28
Mental retardation, autosomal recessive 29 (2)	MRT29	614333	4q27-q28.2	MRT29
Mental retardation, autosomal recessive 3, 608443 (3)	CC2D1A, MRT3	610055	19p13.12	CC2D1A
Mental retardation, autosomal recessive 30 (2)	MRT30	614342	6q12-q15	MRT30
Mental retardation, autosomal recessive 31 (2)	MRT31	614329	4q12-q13.1	MRT31
Mental retardation, autosomal recessive 33 (2)	MRT33	614341	17p13.2-p13.1	MRT33
Mental retardation, autosomal recessive 34, with variant lissencephaly, 614499 (3)	CRADD, RAIDD, MRT34	603454	12q22	CRADD
Mental retardation, autosomal recessive 35 (2)	MRT35	615162	17q21.31-q22	MRT35
Mental retardation, autosomal recessive 36, 615286 (3)	ADAT3, TAD3, MRT36	615302	19p13.3	ADAT3
Mental retardation, autosomal recessive 38, 615516 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	HERC2
Mental retardation, autosomal recessive 39, 615541 (3)	TTI2, C8orf41, MRT39	614426	8p12	TTI2
Mental retardation, autosomal recessive 40, 615599 (3)	TAF2, TAF2B, TAFII150, CIF150, MRT40	604912	8q24.12	TAF2
Mental retardation, autosomal recessive 41, 615637 (3)	KPTN, 2E4, MRT41	615620	19q13.32	KPTN
Mental retardation, autosomal recessive 42, 615802 (3)	PGAP1, MRT42	611655	2q33.1	PGAP1
Mental retardation, autosomal recessive 44, 615942 (3)	METTL23, C17orf95, MRT44	615262	17q25.1	METTL23
Mental retardation, autosomal recessive 46, 616116 (3)	NDST1, HSST, MRT46	600853	5q33.1	NDST1
Mental retardation, autosomal recessive 47, 616193 (3)	FMN2, MRT47	606373	1q43	FMN2
Mental retardation, autosomal recessive 48, 616269 (3)	SLC6A17, NTT4, MRT48	610299	1p13.3	SLC6A17
Mental retardation, autosomal recessive 49, 616281 (3)	GPT2, ALT2, MRT49	138210	16q11.2	GPT2
Mental retardation, autosomal recessive 5, 611091 (3)	NSUN2, TRM4, SAKI, MISU, MRT5	610916	5p15.31	NSUN2
Mental retardation, autosomal recessive 51, 616739 (3)	HNMT, MRT51	605238	2q22.1	HNMT
Mental retardation, autosomal recessive 53, 616917 (3)	PIGG, GPI7, MRT53	616918	4p16.3	PIGG
Mental retardation, autosomal recessive 54, 617028 (3)	TNIK, KIAA0551, MRT54	610005	3q26.2-q26.3	TNIK
Mental retardation, autosomal recessive 56, 617125 (3)	ZC3H14, SUT2, MRT56	613279	14q31.3	ZC3H14
Mental retardation, autosomal recessive 57, 617188 (3)	MBOAT7, BB1, LENG4, MRT57	606048	19q13.42	MBOAT7
Mental retardation, autosomal recessive 58, 617270 (3)	ELP2, STATIP1, MRT58	616054	18q12.2	ELP2
Mental retardation, autosomal recessive 59, 617323 (3)	IMPA1, MRT59	602064	8q21.13	IMPA1
Mental retardation, autosomal recessive 60, 617432 (3)	TAF13, TAF2K, MRT60	600774	1p13.3	TAF13
Mental retardation, autosomal recessive 61, 617773 (3)	RUSC2, KIAA0375, IPORIN, MRT61	611053	9p13.3	RUSC2
Mental retardation, autosomal recessive 7, 611093 (3)	TUSC3, M33, D8S1992, MRT7, MRT22	601385	8p22	TUSC3
Mental retardation, autosomal recessive, 11 (2)	MRT11	611097	19q13.2-q13.3	MRT11
Mental retardation, autosomal recessive, 4 (2)	MRT4	611107	1p21.1-p13.3	MRT4
Mental retardation, autosomal recessive, 6, 611092 (3)	GRIK2, GLUR6, MRT6	138244	6q16.3	GRIK2
Mental retardation, autosomal recessive, 9/26 (2)	MRT9, MRT26	611095	14q11.2-q12	MRT9
Mental retardation, severe, with spasticity and tapetoretinal degeneration (2)	MRST	602685	15q24	MRST
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	MEF2C
Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	INPP5E
Mental retardation, with or without nystagmus, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CASK
Mental retardation,X-linked 45 (2)	MRX45	300498	Xp11.3-p11.21	MRX45
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	ATRX
Mental retardation-skeletal dysplasia (2)	MRSD, CHRS	309620	Xq28	MRSD
Mephenytoin poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Merkel cell carcinoma, somatic (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Mesomelia-synostoses syndrome (4)	DEL8q13, C8DELq13	600383	8q13	DEL8q13
Mesomelic dysplasia, Kantaputra type (2)	MMDK, MDK	156232	2q24-q32	MMDK
Mesothelioma, somatic, 156240 (3)	WT1, NPHS4	607102	11p13	WT1
Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	TANGO2, C22orf25, MECRCN	616830	22q11.21	TANGO2
Metacarpal 4-5 fusion, 309630 (3)	FGF16, MF4	300827	Xq21.1	FGF16
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Metachromatic leukodystrophy, 250100 (3)	ARSA	607574	22q13.33	ARSA
Metaphyseal anadysplasia 1, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MMP13
Metaphyseal anadysplasia 2, 613073 (3)	MMP9, CLG4B, MANDP2	120361	20q13.12	MMP9
Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	COL10A1	120110	6q22.1	COL10A1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Metaphyseal dysplasia without hypotrichosis, 250460 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRP
Metaphyseal dysplasia, Spahr type, 250400 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MMP13
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Methemoglobinemia, type I, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	CYB5R3
Methemoglobinemia, type II, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	CYB5R3
Methemoglobinemias, alpha- (3)	HBA1, HBH	141800	16p13.3	HBA1
Methemoglobinemias, beta- (3)	HBB	141900	11p15.4	HBB
Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	MAT1A
Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	ALDH6A1, MMSDH	603178	14q24.3	ALDH6A1
Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	MMACHC	609831	1p34.1	MMACHC
Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	C2orf25
Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	LMBRD1, LMBD1, NESI, MAHCF	612625	6q13	LMBRD1
Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	603214	14q24.3	ABCD4
Methylmalonic aciduria, cblD type, variant 2, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	C2orf25
Methylmalonic aciduria, mut(0) type, 251000 (3)	MUT, MCM	609058	6p12.3	MUT
Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3)	CD320, 8D6, 8D6A, TCBLR	606475	19p13.2	CD320
Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	MMAA	607481	4q31.21	MMAA
Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	MMAB	607568	12q24.11	MMAB
Methylmalonyl-CoA epimerase deficiency, 251120 (3)	MCEE	608419	2p13.3	MCEE
Mevalonic aciduria, 610377 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVK
Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	RNU4ATAC
Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	PCNT, PCNT2, KEN, SCKL4, MOPD2	605925	21q22.3	PCNT
Microcephaly 1, primary, autosomal recessive, 251200 (3)	MCPH1	607117	8p23.1	MCPH1
Microcephaly 15, primary, autosomal recessive, 616486 (3)	MFSD2A, MCPH15	614397	1p34.2	MFSD2A
Microcephaly 17, primary, autosomal recessive, 617090 (3)	CIT, STK21, CRIK, MCPH17	605629	12q24.23	CIT
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	WDR62, C19orf14, MCPH2	613583	19q13.12	WDR62
Microcephaly 3, primary, autosomal recessive, 604804 (3)	CDK5RAP2, KIAA1633, MCPH3	608201	9q33.2	CDK5RAP2
Microcephaly 4, primary, autosomal recessive, 604321 (3)	KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4	609173	15q15.1	KNL1
Microcephaly 5, primary, autosomal recessive, 608716 (3)	ASPM, MCPH5	605481	1q31.3	ASPM
Microcephaly 6, primary, autosomal recessive, 608393 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	CENPJ
Microcephaly 7, primary, autosomal recessive, 612703 (3)	STIL, SIL, MCPH7	181590	1p33	STIL
Microcephaly 8, primary, autosomal recessive, 614673 (3)	CEP135, KIAA0635, MCPH8	611423	4q12	CEP135
Microcephaly 9, primary, autosomal recessive, 614852 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	CEP152
Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	TUBGCP6, GCP6, KIAA1669, MCCRP1	610053	22q13.33	TUBGCP6
Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	PLK4, STK18, SAK, MCCRP2	605031	4q28.1	PLK4
Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	TUBGCP4, GCP4, MCCRP3	609610	15q15.3	TUBGCP4
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	KIF11, KNSL1, MCLMR	148760	10q23.33	KIF11
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	SLC25A19
Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	MSMO1, SC4MOL, ERG25, MCCPD	607545	4q32.3	MSMO1
Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	IER3IP1, MEDS	609382	18q21.1	IER3IP1
Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	MED17, CRSP6, CRSP77, TRAP80, DRIP80	603810	11q21	MED17
Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	QARS, GLNRS, MSCCA	603727	3p21.31	QARS
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, AOA4	605610	19q13.33	PNKP
Microcephaly, seizures, spasticity, and brain calcification, 605622 (3)	PCDH12, VECAD2, PCDH12	605622	5q31.3	PCDH12
Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	TRMT10A, RG9MTD2, MSSGM1	616013	4q23	TRMT10A
Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	PPP1R15B, CREP, MSSGM2	613257	1q32.1	PPP1R15B
Microcephaly, short stature, and limb abnormalities, 617604 (3)	DONSON, C21orf60, MISSLA, MIMIS	611428	21q22.11	DONSON
Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	RTTN, MSSP	610436	18q22.2	RTTN
Microcephaly-capillary malformation syndrome, 614261 (3)	STAMBP, AMSH, MICCAP	606247	2p13.1	STAMBP
Microcephaly-micromelia syndrome, 251230 (3)	DONSON, C21orf60, MISSLA, MIMIS	611428	21q22.11	DONSON
Microcoria, congenital (4)	MCOR, C13DELq32, DEL13q32	156600	13q32	MCOR
Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	ADAMTS18, MMCAT	607512	16q23.1	ADAMTS18
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Microphthalmia with cataract 1 (2)	MCOPCT1	156850	16p13.3	MCOPCT1
Microphthalmia with coloboma 1 (2)	MCOPCB1	300345	Chr.X	MCOPCB1
Microphthalmia with coloboma 2 (2)	MCOPCB2	605738	15q12-q15	MCOPCB2
Microphthalmia with coloboma 3, 610092 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	CHX10
Microphthalmia with coloboma 5, 611638 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Microphthalmia with coloboma 6, 613703 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	GDF3
Microphthalmia with coloboma 6, digenic, 613703 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Microphthalmia with limb anomalies, 206920 (3)	SMOC1, OAS	608488	14q24.2	SMOC1
Microphthalmia, isolated 1 (2)	MCOP1	251600	14q32	MCOP1
Microphthalmia, isolated 2, 610093 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	CHX10
Microphthalmia, isolated 3, 611038 (3)	RAX, RX, MCOP3	601881	18q21.32	RAX
Microphthalmia, isolated 4, 613094 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Microphthalmia, isolated 5, 611040 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	MFRP
Microphthalmia, isolated 6, 613517 (3)	PRSS56, MCOP6	613858	2q37.1	PRSS56
Microphthalmia, isolated 7, 613704 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	GDF3
Microphthalmia, isolated 8, 615113 (3)	ALDH1A3, ALDH6, MCOP8	600463	15q26.3	ALDH1A3
Microphthalmia, isolated, with coloboma 10, 616428 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	RBP4
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
Microphthalmia, isolated, with coloboma 8, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	STRA6
Microphthalmia, isolated, with coloboma 9, 615145 (3)	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	610083	4q34.3-q35.1	TENM3
Microphthalmia, syndromic 12, 615524 (3)	RARB, HAP, MCOPS12	180220	3p24.2	RARB
Microphthalmia, syndromic 2, 300166 (3)	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	300485	Xp11.4	BCOR
Microphthalmia, syndromic 3, 206900 (3)	SOX2, MCOPS3	184429	3q26.33	SOX2
Microphthalmia, syndromic 5, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	OTX2
Microphthalmia, syndromic 6, 607932 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP4
Microphthalmia, syndromic 8 (2)	MCOPS8, MMEP	601349	6q21	MCOPS8
Microphthalmia, syndromic 9, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	STRA6
Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3)	MAB21L2, MCSKS14	604357	4q31.3	MAB21L2
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP2
Microtia with nasolacrimal duct imperforation and eye coloboma (1)	MNDEC	611863	4p16-p15	MNDEC
Microvillus inclusion disease, 251850 (3)	MYO5B, KIAA1119	606540	18q21.1	MYO5B
Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3)	AMMECR1, MFHIEN	300195	Xq23	AMMECR1
Migraine, familial basilar, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	ATP1A2
Migraine, familial hemiplegic, 1, 141500 (3)	CACNA1A, CACNL1A4, SCA6, EIEE42	601011	19p13.13	CACNA1A
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	CACNA1A, CACNL1A4, SCA6, EIEE42	601011	19p13.13	CACNA1A
Migraine, familial hemiplegic, 2, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	ATP1A2
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Miles-Carpenter syndrome (2)	MCS, MRXS4	309605	Xq13-q22	MCS
Miller syndrome, 263750 (3)	DHODH, URA1, POADS	126064	16q22.2	DHODH
Miller-Dieker lissencephaly syndrome (4)	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	247200	17p13.3	MDLS
Minicore myopathy with external ophthalmoplegia, 255320 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3)	DCC, MRMV1, HGPPS2	120470	18q21.2	DCC
Mirror movements 2, 614508 (3)	RAD51A, RECA, MRMV2, FANCR	179617	15q15.1	RAD51A
Mismatch repair cancer syndrome, 276300 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	MLH1
Mismatch repair cancer syndrome, 276300 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	MSH2
Mismatch repair cancer syndrome, 276300 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	MSH6
Mismatch repair cancer syndrome, 276300 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	PMS2
Mitchell-Riley syndrome, 615710 (3)	RFX6, RFXDC1, MTCHRS	612659	6q22.1	RFX6
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	TYMP
Mitochondrial DNA depletion syndrome 11, 615084 (3)	MGME1, C20orf72, MTDPS11	615076	20p11.23	MGME1
Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	103220	4q35.1	SLC25A4
Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	103220	4q35.1	SLC25A4
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	FBXL4, FBL4, MTDPS13	605654	6q16.1-q16.2	FBXL4
Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)	TK2, MTDPS2, PEOB3	188250	16q21	TK2
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	DGUOK, DGK, MTDPS3, PEOB4, NCPH	601465	2p13.1	DGUOK
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	SUCLA2, MTDPS5	603921	13q14.2	SUCLA2
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	MPV17, MTDPS6	137960	2p23.3	MPV17
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	TWNK
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	RRM2B
Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	RRM2B
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	SUCLG1, SUCLA1, MTDPS9	611224	2p11.2	SUCLG1
Mitochondrial complex 1 deficiency, 252010 (3)	NDUFAF5, C20orf7	612360	20p12.1	NDUFAF5
Mitochondrial complex I deficiency due to ACAD9 deficiency, 611126 (3)	ACAD9	611103	3q21.3	ACAD9
Mitochondrial complex I deficiency, 252010 (3)	FOXRED1	613622	11q24.2	FOXRED1
Mitochondrial complex I deficiency, 252010 (3)	NDUFA1, MWFE	300078	Xq24	NDUFA1
Mitochondrial complex I deficiency, 252010 (3)	NDUFA11	612638	19p13.3	NDUFA11
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF1, CIA30, CGI65	606934	15q15.1	NDUFAF1
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	NDUFAF2
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF3	612911	3p21.31	NDUFAF3
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF4, HRPAP20, C6orf66	611776	6q16.1	NDUFAF4
Mitochondrial complex I deficiency, 252010 (3)	NDUFB3	603839	2q33.1	NDUFB3
Mitochondrial complex I deficiency, 252010 (3)	NDUFS1	157655	2q33.3	NDUFS1
Mitochondrial complex I deficiency, 252010 (3)	NDUFS2	602985	1q23.3	NDUFS2
Mitochondrial complex I deficiency, 252010 (3)	NDUFS3	603846	11p11.2	NDUFS3
Mitochondrial complex I deficiency, 252010 (3)	NDUFS4, AQDQ	602694	5q11.2	NDUFS4
Mitochondrial complex I deficiency, 252010 (3)	NDUFS6	603848	5p15.33	NDUFS6
Mitochondrial complex I deficiency, 252010 (3)	NDUFV1, UQOR1	161015	11q13.2	NDUFV1
Mitochondrial complex I deficiency, 252010 (3)	NDUFV2	600532	18p11.22	NDUFV2
Mitochondrial complex I deficiency, 252010 (3)	NUBPL, IND1	613621	14q12	NUBPL
Mitochondrial complex I deficiency, 252010 (3)	TIMMDC1, C3orf1	615534	3q13.33	TIMMDC1
Mitochondrial complex I deficiency, 252010 (3)	TMEM126B	615533	11q14.1	TMEM126B
Mitochondrial complex II deficiency, 252011 (3)	SDHAF1	612848	19q13.12	SDHAF1
Mitochondrial complex II deficiency, 252011 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	TTC19, MC3DN2	613814	17p12	TTC19
Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	UQCRB, UQBP, QPC, MC3DN3	191330	8q22.1	UQCRB
Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	UQCRQ, QPC, MC3DN4	612080	5q31.1	UQCRQ
Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	UQCRC2, MC3DN5	191329	16p12.2	UQCRC2
Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	CYC1, MC3DN6	123980	8q24.3	CYC1
Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	LYRM7, MZM1L, MC3DN8	615831	5q23.3-q31.1	LYRM7
Mitochondrial complex IV deficiency, 220110 (3)	APOPT1, APOP	616003	14q32.33	APOPT1
Mitochondrial complex IV deficiency, 220110 (3)	COX10	602125	17p12	COX10
Mitochondrial complex IV deficiency, 220110 (3)	COX20, FAM36A	614698	1q44	COX20
Mitochondrial complex IV deficiency, 220110 (3)	COX6B1	124089	19q13.12	COX6B1
Mitochondrial complex IV deficiency, 220110 (3)	PET100, C19orf79	614770	19p13.2	PET100
Mitochondrial complex IV deficiency, 220110 (3)	SCO1, SCOD1	603644	17p13.1	SCO1
Mitochondrial complex IV deficiency, 220110 (3)	TACO1, CCDC44	612958	17q23.3	TACO1
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	TMEM70, MC5DN2	612418	8q21.11	TMEM70
Mitochondrial phosphate carrier deficiency, 610773 (3)	SLC25A3, PHC	600370	12q23.1	SLC25A3
Mitochondrial pyruvate carrier deficiency, 614741 (3)	BRP44L, MPC1, MPYCD	614738	6q27	BRP44L
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	ECHS1, SCEH, ECHS1D	602292	10q26.3	ECHS1
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	DCHS1
Mitral valve prolapse, myxomatous 1 (2)	MMVP1, MVP, PMV	157700	16p12.1-p11.2	MMVP1
Mitral valve prolapse, myxomatous 3 (2)	MMVP3	610840	13q31.3-q32.1	MMVP3
Miyoshi muscular dystrophy 1, 254130 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	DYSF
Miyoshi muscular dystrophy 2 (2)	MMD2	613318	8q22.3	MMD2
Miyoshi muscular dystrophy 3, 613319 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	ANO5
Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22.1	TIMM8A
Molybdenum cofactor deficiency A, 252150 (3)	MOCS1, MOCODA	603707	6p21.2	MOCS1
Molybdenum cofactor deficiency B, 252160 (3)	MOCS2, MPTS, MOCODB	603708	5q11.2	MOCS2
Molybdenum cofactor deficiency C, 615501 (3)	GPHN, GPH, KIAA1385, GEPH, MOCODC	603930	14q23.3-q24.1	GPHN
Monilethrix, 158000 (3)	KRT81, KRTHB1, HB1	602153	12q13.13	KRT81
Monilethrix, 158000 (3)	KRT83, KRTHB3, HB3, MNLIX, EKVP5	602765	12q13.13	KRT83
Monilethrix, 158000 (3)	KRT86, KRTHB6, HB6	601928	12q13.13	KRT86
Monocarboxylate transporter 1 deficiency, 616095 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	SLC16A1
Mononeuropathy of the median nerve, mild, 613353 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	SH3TC2
Morbid obesity and spermatogenic failure, 615703 (3)	CEP19, C3orf34, MOSPGF	615586	3q29	CEP19
Mosaic variegated aneuploidy syndrome 1, 257300 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUB1B
Mosaic variegated aneuploidy syndrome 2, 614114 (3)	CEP57, PIG8, TSP57, KIAA0092, MVA2	607951	11q21	CEP57
Mosaic variegated aneuploidy syndrome 3, 617598 (3)	TRIP13, 16E1BP, MVA3	604507	5p15.33	TRIP13
Mowat-Wilson syndrome, 235730 (3)	ZEB2, ZFHX1B, SMADIP1, SIP1	605802	2q22.3	ZEB2
Moyamoya 6 with achalasia, 615750 (3)	GUCY1A3, GUC1A3, GUCSA3, MYMY6	139396	4q32.1	GUCY1A3
Moyamoya disease (2)	MYMY1, MYMY	252350	3p26-p24.2	MYMY1
Moyamoya disease 3 (2)	MYMY3	608796	8q23	MYMY3
Moyamoya disease 4 (4)	MYMY4, CXDELq38	300845	Xq28	MYMY4
Moyamoya disease 5, 614042 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTA2
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34	606416	1q44	NLRP3
Mucoepidermoid salivary gland carcinoma (3)	CRTC1, MECT1, KIAA0616, FLJ14027	607536	19p13.11	CRTC1
Mucoepidermoid salivary gland carcinoma (3)	MAML2, MAM3	607537	11q21	MAML2
Mucolipidosis II alpha/beta, 252500 (3)	GNPTAB, GNPTA	607840	12q23.2	GNPTAB
Mucolipidosis III alpha/beta, 252600 (3)	GNPTAB, GNPTA	607840	12q23.2	GNPTAB
Mucolipidosis III gamma, 252605 (3)	GNPTAG	607838	16p13.3	GNPTAG
Mucolipidosis IV, 252650 (3)	MCOLN1, ML4	605248	19p13.2	MCOLN1
Mucopolysaccharidosis II, 309900 (3)	IDS, MPS2, SIDS	300823	Xq28	IDS
Mucopolysaccharidosis IVA, 253000 (3)	GALNS, MPS4A	612222	16q24.3	GALNS
Mucopolysaccharidosis Ih, 607014 (3)	IDUA, IDA	252800	4p16.3	IDUA
Mucopolysaccharidosis Ih/s, 607015 (3)	IDUA, IDA	252800	4p16.3	IDUA
Mucopolysaccharidosis Is, 607016 (3)	IDUA, IDA	252800	4p16.3	IDUA
Mucopolysaccharidosis VII, 253220 (3)	GUSB, MPS7	611499	7q11.21	GUSB
Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	SGSH, MPS3A, SFMD	605270	17q25.3	SGSH
Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	NAGLU
Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	HGSNAT
Mucopolysaccharidosis type IIID, 252940 (3)	GNS, G6S	607664	12q14.3	GNS
Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	ARSB, MPS6	611542	5q14.1	ARSB
Mucopolysaccharidosis-plus syndrome, 617303 (3)	VPS33A, MPSPS	610034	12q24.31	VPS33A
Muenke syndrome, 602849 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Muir-Torre syndrome, 158320 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	MLH1
Muir-Torre syndrome, 158320 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	MSH2
Mulchandani-Bhoj-Conlin syndrome, 617352 (3)	MBCS	617352	20q11-q13	MBCS
Mulibrey nanism, 253250 (3)	TRIM37, MUL, KIAA0898	605073	17q22	TRIM37
Mullerian aplasia and hyperandrogenism, 158330 (3)	WNT4, SERKAL	603490	1p36.12	WNT4
Multicentric carpotarsal osteolysis syndrome, 166300 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	MAFB
Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	MMP2, CLG4A, MONA	120360	16q12.2	MMP2
Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3)	CEP55, MARCH	610000	10q23.33	CEP55
Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	PIGN, MCAHS1	606097	18q21.33	PIGN
Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	PIGA
Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	PIGT
Multiple endocrine neoplasia 1, 131100 (3)	MEN1	613733	11q13.1	MEN1
Multiple endocrine neoplasia IIA, 171400 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Multiple endocrine neoplasia IIB, 162300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Multiple endocrine neoplasia, type IV, 610755 (3)	CDKN1B, KIP1, CDKN4, MEN4	600778	12p13.1	CDKN1B
Multiple fibroadenomas of the breast, 615554 (3)	PRLR, MFAB, HPRL	176761	5p13.2	PRLR
Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	B3GAT3, GLCATI, JDSCD	606374	11q12.3	B3GAT3
Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	NFU1, HIRIP, MMDS1	608100	2p13.3	NFU1
Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	BOLA3, MMDS2	613183	2p13.1	BOLA3
Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	ISCA2, MMDS4	615317	14q24.3	ISCA2
Multiple mitochondrial dysfunctions syndrome 5, 617613 (3)	ISCA1, HBLD2, HISCA, MMDS5	611006	9q21.33	ISCA1
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CHRNA1
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNG, ACHRG	100730	2q37.1	CHRNG
Multiple sulfatase deficiency, 272200 (3)	SUMF1, FGE	607939	3p26.1	SUMF1
Multiple synostoses syndrome 1, 186500 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Multiple synostoses syndrome 3, 612961 (3)	FGF9, SYNS3	600921	13q12.11	FGF9
Multisystemic smooth muscle dysfunction syndrome, 613834 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTA2
Mungan syndrome (2)	MGS	611376	8q23-q24	MGS
Muscle glycogenosis, 300559 (3)	PHKA1	311870	Xq13.1	PHKA1
Muscle hypertrophy, 614160 (3)	GDF8, MSTN, MSLHP	601788	2q32.2	GDF8
Muscle strength quantitative trait locus 1 (2)	MUSTQTL1	612083	14q24.3	MUSTQTL1
Muscular dystrophy with rimmed vacuoles (2)	MDRV	601846	19p13.3	MDRV
Muscular dystrophy, congenital merosin-deficient, 607855 (3)	LAMA2, LAMM	156225	6q22.33	LAMA2
Muscular dystrophy, congenital, 1B (2)	MDC1B	604801	1q42	MDC1B
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	ITGA7	600536	12q13.2	ITGA7
Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)	LAMA2, LAMM	156225	6q22.33	LAMA2
Muscular dystrophy, congenital, megaconial type, 602541 (3)	CHKB, CHKL, CKEKB, EKB, MDCMC	612395	22q13.33	CHKB
Muscular dystrophy, congenital, merosin-positive (2)	MDCMP	609456	4p16.3	MDCMP
Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3)	INPP5K, SKIP, MDCCAID	607875	17p13.3	INPP5K
Muscular dystrophy, limb-girdle, type 1A, 159000 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MYOT
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	DNAJB6, MRJ, DJ4, LGMD1E	611332	7q36.3	DNAJB6
Muscular dystrophy, limb-girdle, type 1F, 608423 (3)	TNPO3, TRNSR, LGMD1F	610032	7q32.1	TNPO3
Muscular dystrophy, limb-girdle, type 1G, 609115 (3)	HNRNPDL, HNRPDL, JKTBP, LGMD1G	607137	4q21.22	HNRNPDL
Muscular dystrophy, limb-girdle, type 1H (2)	LGMD1H	613530	3p25.1-p23	LGMD1H
Muscular dystrophy, limb-girdle, type 2A, 253600 (3)	CAPN3, CANP3	114240	15q15.1	CAPN3
Muscular dystrophy, limb-girdle, type 2B, 253601 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	DYSF
Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	SGCG, LGMD2C, DMDA1, SCG3	608896	13q12.12	SGCG
Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q21.33	SGCA
Muscular dystrophy, limb-girdle, type 2E, 604286 (3)	SGCB, LGMD2E	600900	4q12	SGCB
Muscular dystrophy, limb-girdle, type 2F, 601287 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	SGCD
Muscular dystrophy, limb-girdle, type 2G, 601954 (3)	TCAP, LGMD2G, CMH25	604488	17q12	TCAP
Muscular dystrophy, limb-girdle, type 2H, 254110 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	TRIM32
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY	188840	2q31.2	TTN
Muscular dystrophy, limb-girdle, type 2L, 611307 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	ANO5
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Muscular dystrophy, limb-girdle, type 2S, 615356 (3)	TRAPPC11, C4orf41, LGMD2S	614138	4q35.1	TRAPPC11
Muscular dystrophy, limb-girdle, type 2W, 616827 (3)	LIMS2, PINCH2, LGMD2W	607908	2q14.3	LIMS2
Muscular dystrophy, limb-girdle, type IC, 607801 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Muscular dystrophy, rigid spine, 1, 602771 (3)	SELENON, SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	SELENON
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	POMT1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	TMEM5, MDDGA10	605862	12q14.2	TMEM5
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	POMK
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	B3GNT1, IGNT, IGAT, MDDGA13	605517	11q13.2	B3GNT1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	GMPPB
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	POMT2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76	606822	1p34.1	POMGNT1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	FKRP
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	LARGE
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	ISPD
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	DAG1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	B3GALNT2, MGC39558, MDDGA11	610194	1q42.3	B3GALNT2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	614828	3p22.1	POMGNT2
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	POMT1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	GMPPB
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	POMT2
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76	606822	1p34.1	POMGNT1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	LARGE
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	FKRP
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	POMT1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	GMPPB
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	POMT2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76	606822	1p34.1	POMGNT1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	FKRP
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	ISPD
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	DAG1
Myasthenia gravis with thymus hyperplasia (2)	MYAS1	607085	6p21.3	MYAS1
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	GFPT1
Myasthenic syndrome, congenital, 10, 254300 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	DOK7
Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	RAPSN
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DPAGT1
Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	ALG2
Myasthenic syndrome, congenital, 16, 614198 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Myasthenic syndrome, congenital, 19, 616720 (3)	COL13A1, CMS19	120350	10q22.1	COL13A1
Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CHRNA1
Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CHRNA1
Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3)	SLC5A7, CHT1, HMN7A, CMS20	608761	2q12.3	SLC5A7
Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3)	SLC18A3, VACHT, CMS21	600336	10q11.23	SLC18A3
Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CHRNB1
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CHRNE
Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CHRNE
Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CHRNE
Myasthenic syndrome, congenital, 5, 603034 (3)	COLQ, EAD, CMS5	603033	3p25.1	COLQ
Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	CHAT, CMS6	118490	10q11.23	CHAT
Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	SYT2, CMS7, MYSPC	600104	1q32.1	SYT2
Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	AGRN, CMS8	103320	1p36.33	AGRN
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3)	MUSK, CMS9, FADS	601296	9q31.3	MUSK
Myelodysplasia and leukemia syndrome with monosomy 7 (4)	MLSM7, DEL7q, C7DELq	252270	7q	MLSM7
Myelodysplasia syndrome-1 (3)	MDS1	600049	3q26	MDS1
Myelodysplastic syndrome (3)	ACSL6, FACL6, ACS2	604443	5q31.1	ACSL6
Myelodysplastic syndrome, preleukemic (3)	IRF1, MAR	147575	5q31.1	IRF1
Myelodysplastic syndrome, somatic, 614286 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	ASXL1
Myelodysplastic syndrome, somatic, 614286 (3)	SF3B1, SF3B155, SAP155, MDS	605590	2q33.1	SF3B1
Myelodysplastic syndrome, somatic, 614286 (3)	TET2, KIAA1546, MDS	612839	4q24	TET2
Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPL
Myelofibrosis, somatic, 254450 (3)	CALR, SSA	109091	19p13.13	CALR
Myelofibrosis, somatic, 254450 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Myelofibrosis, somatic, 254450 (3)	SH2B3, LNK	605093	12q24.12	SH2B3
Myelogenous leukemia, acute (3)	ACSL6, FACL6, ACS2	604443	5q31.1	ACSL6
Myelogenous leukemia, acute (3)	IRF1, MAR	147575	5q31.1	IRF1
Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	CBFB, PEBP2B	121360	16q22.1	CBFB
Myelokathexis, isolated (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	CXCR4
Myeloperoxidase deficiency, 254600 (3)	MPO	606989	17q22	MPO
Myeloproliferative disorder (2)	FGFR1OP, FOP	605392	6q27	FGFR1OP
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, JIP, MYHRS	600993	18q21.2	SMAD4
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Myoclonic epilepsy, juvenile, 4 (2)	EJM4	611364	5q12-q14	EJM4
Myoclonic-atonic epilepsy, 616421 (3)	SLC6A1, GABATR, MAE	137165	3p25.3	SLC6A1
Myoclonus, familial cortical, 614937 (3)	NOL3, NOP, MYC, ARC, FCM	605235	16q22.1	NOL3
Myoclonus, intractable, neonatal, 617235 (3)	KIF5A, NKHC, SPG10, NEIMY	602821	12q13.3	KIF5A
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	LPIN1	605518	2p25.1	LPIN1
Myokymia, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	KCNQ2
Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	AMPD1, MMDD	102770	1p13.2	AMPD1
Myopathy with extrapyramidal signs, 615673 (3)	MICU1, CBARA1, MPXPS	605084	10q22.1	MICU1
Myopathy with lactic acidosis, hereditary, 255125 (3)	ISCU, HML	611911	12q23.3	ISCU
Myopathy, X-linked, with excessive autophagy, 310440 (3)	VMA21, XMEA	300913	Xq28	VMA21
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	300163	Xq26.3	FHL1
Myopathy, actin, congenital, with cores, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	MEGF10
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	MEGF10
Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	SELENON, SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	SELENON
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	TPM3
Myopathy, congenital, with fiber-type disproportion, X-linked (2)	CFTDX	300580	Xq13.1-q22.1	CFTDX
Myopathy, distal 3 (2)	MPD3	610099	8p22-q11	MPD3
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Myopathy, distal, 5, 617030 (3)	ADSL1, MPD5	612498	14q32.33	ADSL1
Myopathy, distal, Tateyama type, 614321 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Myopathy, distal, with anterior tibial onset, 606768 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	DYSF
Myopathy, distal, with rimmed vacuoles, 617158 (3)	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	601530	5q35.3	SQSTM1
Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	PUS1, MLASA1	608109	12q24.33	PUS1
Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	YARS2, TYRRS, MLASA2	610957	12p11.21	YARS2
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	GFER, ERV1, ALR	600924	16p13.3	GFER
Myopathy, mitochondrial, and ataxia, 617675 (3)	MSTO1, MMYAT	617619	1q22	MSTO1
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Myopathy, myofibrillar, 3, 609200 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MYOT
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Myopathy, myofibrillar, 6, 612954 (3)	BAG3, MFM6	603883	10q26.11	BAG3
Myopathy, myofibrillar, 7, 617114 (3)	KY, MFM7	605739	3q22.2	KY
Myopathy, myofibrillar, 8, 617258 (3)	PYROXD1, MFM8	617220	12p12.1	PYROXD1
Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY	188840	2q31.2	TTN
Myopathy, spheroid body, 182920 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MYOT
Myopathy, tubular aggregate, 1 160565 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STIM1
Myopathy, tubular aggregate, 2, 615883 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	ORAI1
Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	CASQ1, VMCQA	114250	1q23.2	CASQ1
Myopia 10 (2)	MYP10	609259	8p23	MYP10
Myopia 11 (2)	MYP11	609994	4q22-q27	MYP11
Myopia 12 (2)	MYP12	609995	2q37.1	MYP12
Myopia 13 (2)	MYP13	300613	Xq23-q27.2	MYP13
Myopia 14 (2)	MYP14	610320	1p36	MYP14
Myopia 15 (2)	MYP15	612717	10q21.1	MYP15
Myopia 16 (2)	MYP16	612554	5p15.33-p15.2	MYP16
Myopia 17 (2)	MYP17, MYP4	608367	7p15	MYP17
Myopia 18 (2)	MYP18	255500	14q22.1-q24.2	MYP18
Myopia 19 (2)	MYP19	613969	5p15.1-p13.3	MYP19
Myopia 20, autosomal dominant (2)	MYP20	614166	13q12.12	MYP20
Myopia 21, autosomal dominant, 614167 (3)	ZNF644, MYP21	614159	1p22.2	ZNF644
Myopia 22, autosomal dominant, 615420 (3)	CCDC111, MYP22	615421	4q35.1	CCDC111
Myopia 23, autosomal recessive, 615431 (3)	LRPAP1, A2MRAP, MYP23	104225	4p16.3	LRPAP1
Myopia 24, autosomal dominant, 615946 (3)	SLC39A5, MYP24	608730	12q13.3	SLC39A5
Myopia 25, autosomal dominant, 617238 (3)	P4HA2, MYP25	600608	5q31.1	P4HA2
Myopia 26, X-linked, female-limited, 301010 (3)	ARR3, MYP26	301770	Xq13.1	ARR3
Myopia 5 (2)	MYP5	608474	17q21-q22	MYP5
Myopia 6, 608908 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	SCO2
Myopia 7 (2)	MYP7	609256	11p13	MYP7
Myopia 8 (2)	MYP8	609257	3q26	MYP8
Myopia 9 (2)	MYP9	609258	4q12	MYP9
Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	P3H2, LEPREL1, MCVD	610341	3q28	P3H2
Myopia-1 (2)	MYP1	310460	Xq28	MYP1
Myopia-2 (2)	MYP2	160700	18p11.31	MYP2
Myopia-3 (2)	MYP3	603221	12q21-q23	MYP3
Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Myotonia congenita, dominant, 160800 (3)	CLCN1	118425	7q34	CLCN1
Myotonia congenita, recessive, 255700 (3)	CLCN1	118425	7q34	CLCN1
Myotonia levior, recessive (3)	CLCN1	118425	7q34	CLCN1
Myotonic dystrophy 1, 160900 (3)	DMPK, DM, DMK	605377	19q13.32	DMPK
Myotonic dystrophy 2, 602668 (3)	ZNF9, CNBP1, DM2, PROMM	116955	3q21.3	ZNF9
Myotubular myopathy, X-linked, 310400 (3)	MTM1, MTMX	300415	Xq28	MTM1
Myxoid liposarcoma, 613488 (1)	DDIT3, GADD153, CHOP10	126337	12q13.3	DDIT3
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
N-acetylglutamate synthase deficiency, 237310 (3)	NAGS	608300	17q21.31	NAGS
NOR polyagglutination syndrome, 111400 (3)	A4GALT, P1PK	607922	22q13.2	A4GALT
Nablus mask-like facial syndrome (4)	NMLFS, DEL8q22.1, C8DELq22.1	608156	8q22.1	NMLFS
Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3)	KRT14	148066	17q21.2	KRT14
Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)	FZD6, NDNC10	603409	8q22.3	FZD6
Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	PLCD1, NDNC3	602142	3p22.2	PLCD1
Nail disorder, nonsyndromic congenital, 7 (2)	NDNC7	605779	17p13	NDNC7
Nail disorder, nonsyndromic congenital, 9 (2)	NDNC9	614149	17q25.1-q25.3	NDNC9
Nail-patella syndrome, 161200 (3)	LMX1B, NPS1	602575	9q33.3	LMX1B
Nance-Horan syndrome, 302350 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	NHS
Nanophthalmos 2, 609549 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	MFRP
Nanophthalmos 3 (2)	NNO3	611897	2q11-q14	NNO3
Nanophthalmos 4, 615972 (3)	TMEM98, NNO4	615949	17q11.2	TMEM98
Nanophthalmos-1 (2)	NNO1	600165	11p	NNO1
Narcolepsy 2 (2)	NRCLP2	605841	4p13-q21	NRCLP2
Narcolepsy 3 (2)	NRCLP3	609039	21q11.2	NRCLP3
Narcolepsy 6 (2)	NRCLP6	614223	19p13.2	NRCLP6
Nasopharyngeal carcinoma, 607107 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Nasu-Hakola disease, 221770 (3)	TREM2	605086	6p21.1	TREM2
Nasu-Hakola disease, 221770 (3)	TYROBP, PLOSL, DAP12	604142	19q13.12	TYROBP
Native American myopathy, 255995 (3)	STAC3, NAM	615521	12q13.3	STAC3
Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)	MCM4, NKGCD, NKCD	602638	8q11.21	MCM4
Naxos disease, 601214 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	JUP
Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	TPM3
Nemaline myopathy 10, 616165 (3)	LMOD3, NEM10	616112	3p14.1	LMOD3
Nemaline myopathy 11, autosomal recessive, 617336 (3)	MYPN, CMD1DD, CMH22, RCM4, NEM11	608517	10q21.3	MYPN
Nemaline myopathy 2, autosomal recessive, 256030 (3)	NEB, NEM2	161650	2q23.3	NEB
Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
Nemaline myopathy 5, Amish type, 605355 (3)	TNNT1, ANM, NEM5	191041	19q13.42	TNNT1
Nemaline myopathy 6, autosomal dominant, 609273 (3)	KBTBD13, NEM6	613727	15q22.31	KBTBD13
Nemaline myopathy 7, autosomal recessive, 610687 (3)	CFL2, NEM7	601443	14q13.1	CFL2
Nemaline myopathy 8, autosomal recessive, 615348 (3)	KLHL40, SYRP, KBTBD5, NEM8	615340	3p22.1	KLHL40
Nemaline myopathy 9, 615731 (3)	KLHL41, KBTBD10, SARCOSIN, NEM9	607701	2q31.1	KLHL41
Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	AVPR2
Nephrolithiasis, type I, 310468 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC34A1
Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	SLC9A3R1, EBP50, NHERF1, NPHLOP2	604990	17q25.1	SLC9A3R1
Nephronophthisis 1, juvenile, 256100 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPHP1
Nephronophthisis 11, 613550 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
Nephronophthisis 12, 613820 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	TTC21B
Nephronophthisis 13, 614377 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	ZNF423
Nephronophthisis 15, 614845 (3)	CEP164, KIAA1052	614848	11q23.3	CEP164
Nephronophthisis 16, 615382 (3)	ANKS6, PKDR1, NPHP16	615370	9q22.33	ANKS6
Nephronophthisis 18, 615862 (3)	CEP83, CCDC41, NPHP18	615847	12q22	CEP83
Nephronophthisis 19, 616217 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	605755	6p22.3	DCDC2
Nephronophthisis 2, infantile, 602088 (3)	INVS, INV, NPHP2, NPH2	243305	9q31.1	INVS
Nephronophthisis 20, 617271 (3)	MAPKBP1, JNKBP1, NPHP20	616786	15q15.1	MAPKBP1
Nephronophthisis 3, 604387 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPHP3
Nephronophthisis 4, 606966 (3)	NPHP4, SLSN4	607215	1p36.31	NPHP4
Nephronophthisis 7, 611498 (3)	GLIS2, NPHP7	608539	16p13.3	GLIS2
Nephronophthisis-like nephropathy 1, 613159 (3)	XPNPEP3, APP3, NPHPL1	613553	22q13.2	XPNPEP3
Nephropathy due to CFHR5 deficiency, 614809 (3)	CFHR5, CFHL5, FHR5, CFHR5D	608593	1q31.3	CFHR5
Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	CD151
Nephropathy, progressive, with deafness (2)	NEDE	609469	11q24	NEDE
Nephropathy-hypertension (2)	RFH1, AORF	161900	1q21	RFH1
Nephrotic syndrome 14, 617575 (3)	SGPL1, SPL, NPHS14	603729	10q22.1	SGPL1
Nephrotic syndrome 15, 617609 (3)	MAGI2, AIP1, KIAA0705	606382	7q21.11	MAGI2
Nephrotic syndrome 16, 617783 (3)	KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16	614610	19p13.2	KANK2
Nephrotic syndrome, type 1, 256300 (3)	NPHS1, NPHN	602716	19q13.12	NPHS1
Nephrotic syndrome, type 10, 615861 (3)	EMP2, NPHS10	602334	16p13.13	EMP2
Nephrotic syndrome, type 11, 616730 (3)	NUP107, NUP84, NPHS11	607617	12q15	NUP107
Nephrotic syndrome, type 12, 616892 (3)	NUP93, NIC96, KIAA0095, NPHS12	614351	16q13	NUP93
Nephrotic syndrome, type 2, 600995 (3)	PDCN, NPHS2, SRN1	604766	1q25.2	PDCN
Nephrotic syndrome, type 3, 610725 (3)	PLCE1, KIAA1516, NPHS3	608414	10q23.33	PLCE1
Nephrotic syndrome, type 4, 256370 (3)	WT1, NPHS4	607102	11p13	WT1
Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	LAMB2
Nephrotic syndrome, type 6, 614196 (3)	PTPRO, GLEPP1, NPHS6	600579	12p12.3	PTPRO
Nephrotic syndrome, type 7, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	DGKE
Nephrotic syndrome, type 8, 615244 (3)	ARHGDIA, GDIA1, NPHS8	601925	17q25.3	ARHGDIA
Nephrotic syndrome, type 9, 615573 (3)	COQ8B, ADCK4, NPHS9	615567	19q13.2	COQ8B
Nestor-Guillermo progeria syndrome, 614008 (3)	BANF1, BAF, NGPS	603811	11q13.1	BANF1
Netherton syndrome, 256500 (3)	SPINK5, LEKTI	605010	5q32	SPINK5
Neu-Laxova syndrome 1, 256520 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	PHGDH
Neu-Laxova syndrome 2, 616038 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSAT1
Neural tube defects, 182940 (3)	FUZ, NTD	610622	19q13.33	FUZ
Neural tube defects, 182940 (3)	VANGL2, LTAP	600533	1q23.2	VANGL2
Neuroblastoma with Hirschsprung disease, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PMX2B
Neuroblastoma, 256700 (3)	NME1, NM23	156490	17q21.33	NME1
Neurocutaneous melanosis, somatic, 249400 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	FOLR1	136430	11q13.4	FOLR1
Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3)	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	601530	5q35.3	SQSTM1
Neurodegeneration with brain iron accumulation 1, 234200 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	PANK2
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PLA2G6
Neurodegeneration with brain iron accumulation 3, 606159 (3)	FTL, NBIA3, LFTD	134790	19q13.33	FTL
Neurodegeneration with brain iron accumulation 4, 614298 (3)	C19orf12, NBIA4, SPG43	614297	19q12	C19orf12
Neurodegeneration with brain iron accumulation 5, 300894 (3)	WDR45, WIPI4, NBIA5	300526	Xp11.23	WDR45
Neurodegeneration with brain iron accumulation 6, 615643 (3)	COASY, NBIA6	609855	17q21.2	COASY
Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3)	UBTF, UBF, CONDBA	600673	17q21.31	UBTF
Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3)	RAB11B, NDAGSCW	604198	19p13.2	RAB11B
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3)	BPTF, FALZ, FAC1, NURF301, NEDDFL	601819	17q24.2	BPTF
Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3)	NACC1, BTBD14B, NECFM	610672	19p13.13	NACC1
Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3)	HECW2, NEDL2, KIAA1301, NDHSAL	617245	2q32.3	HECW2
Neurodevelopmental disorder with involuntary movements, 617493 (3)	GNAO1, EIEE17, NEDIM	139311	16q13	GNAO1
Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3)	PRUNE1, DRES17, NMIHBA	617413	1q21.3	PRUNE1
Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3)	VARS, VARS1, G7A, VARS2, NDMSCA	192150	6p21.33	VARS
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3)	RERE, NEDBEH	605226	1p36.23	RERE
Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3)	PLAA, PLAP, NDMSBA	603873	9p21.2	PLAA
Neurodevelopmental disorder with severe motor impairment and absent language, 617804 (3)	DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL	616423	3p21.31	DHX30
Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3)	WARS2, NEMMLAS	604733	1p12	WARS2
Neuroepithelioma, 612219 (3)	EWSR1, EWS	133450	22q12.2	EWSR1
Neurofibromatosis, familial spinal, 162210 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Neurofibromatosis, type 1, 162200 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Neurofibromatosis, type 2, 101000 (3)	NF2	607379	22q12.2	NF2
Neurofibromatosis-Noonan syndrome, 601321 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Neurofibrosarcoma (3)	MXI1	600020	10q25.2	MXI1
Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	HINT1, PRKCNH1, NMAN	601314	5q23.3	HINT1
Neuronopathy, distal hereditary motor, type I (2)	DHMN1	182960	7q34-q36	DHMN1
Neuronopathy, distal hereditary motor, type IID, 615575 (3)	FBXO38, FBX38, MOKA, HMN2D	608533	5q32	FBXO38
Neuronopathy, distal hereditary motor, type IX, 617721 (3)	WARS, HMN9	191050	14q32.2	WARS
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	IGHMBP2
Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)	SLC5A7, CHT1, HMN7A, CMS20	608761	2q12.3	SLC5A7
Neuropathy, congenital hypomyelinating, 1, 605253 (3)	EGR2, KROX20	129010	10q21.3	EGR2
Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	HSPB8
Neuropathy, distal hereditary motor, type IIB, 608634 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HSPB1
Neuropathy, distal hereditary motor, type VA, 600794 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Neuropathy, distal hereditary motor, type VA, 600794 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	GARS
Neuropathy, distal hereditary motor, type VIIB, 607641 (3)	DCTN1, HMN7B	601143	2p13.1	DCTN1
Neuropathy, hereditary motor and sensory, Russe type, 605285 (3)	HK1, HKD, HMSNR, RP79	142600	10q22.1	HK1
Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	SLC25A46, HMSN6B	610826	5q22.1	SLC25A46
Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.31	SPTLC1
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	SPTLC2
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	WNK1
Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	FAM134B, HSAN2B	613114	5p15.1	FAM134B
Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	NGF, NGFB, HSAN5	162030	1p13.2	NGF
Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	SCN11A
Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	PRDM12, HSAN8	616458	9q34.12	PRDM12
Neuropathy, hereditary sensory, type IB (2)	HSN1B	608088	3p24-p22	HSN1B
Neuropathy, hereditary sensory, type ID, 613708 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	ATL1
Neuropathy, hereditary sensory, type IE, 614116 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	DNMT1
Neuropathy, hereditary sensory, type IF, 615632 (3)	ATL3, HSN1F	609369	11q13.1	ATL3
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	KIF1A
Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	CCT5, KIAA0098, CCTE	610150	5p15.2	CCT5
Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Neuropathy, paraneoplastic sensory (1)	ELAVL4, HUD, PNEM	168360	1p33-p32	ELAVL4
Neuropathy, recurrent, with pressure palsies, 162500 (3)	PMP22, CMT1A, CMT1E, DSS, CIDP	601097	17p12	PMP22
Neutral lipid storage disease with myopathy, 610717 (3)	PNPLA2, TTS2, ATGL	609059	11p15.5	PNPLA2
Neutropenia, alloimmune neonatal (3)	FCGR3B	610665	1q23.3	FCGR3B
Neutropenia, cyclic, 162800 (3)	ELANE, ELA2, SCN1	130130	19p13.3	ELANE
Neutropenia, neonatal alloimmune (1)	LAG5	151450	Chr.4	LAG5
Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	ELANE, ELA2, SCN1	130130	19p13.3	ELANE
Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	HAX1, SCN3	605998	1q21.3	HAX1
Neutropenia, severe congenital 4, autosomal recessive, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	G6PC3
Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	VPS45A, VPS45, SCN5	610035	1q21.2	VPS45A
Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	JAGN1, SCN6	616012	3p25.3	JAGN1
Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	CSF3R, GCSFR, SCN7	138971	1p34.3	CSF3R
Neutropenia, severe congenital, X-linked, 300299 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Neutrophil immunodeficiency syndrome, 608203 (3)	RAC2	602049	22q13.1	RAC2
Nevus comedonicus, somatic, 617025 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NEK9
Nevus, epidermal, somatic, 162900 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Newfoundland rod-cone dystrophy, 607476 (3)	RLBP1	180090	15q26.1	RLBP1
Nicolaides-Baraitser syndrome, 601358 (3)	SMARCA2, SNF2L2, NCBRS	600014	9p24.3	SMARCA2
Niemann-Pick disease, type A, 257200 (3)	SMPD1, NPD	607608	11p15.4	SMPD1
Niemann-Pick disease, type B, 607616 (3)	SMPD1, NPD	607608	11p15.4	SMPD1
Niemann-Pick disease, type C1, 257220 (3)	NPC1, NPC	607623	18q11.2	NPC1
Niemann-Pick disease, type D, 257220 (3)	NPC1, NPC	607623	18q11.2	NPC1
Niemann-pick disease, type C2, 607625 (3)	NPC2, HE1	601015	14q24.3	NPC2
Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	NYX, CSNB1A, NBM1	300278	Xp11.4	NYX
Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	GRM6, MGLUR6, CSNB1B	604096	5q35.3	GRM6
Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	TRPM1, MLSN1, CSNB1C	603576	15q13.3	TRPM1
Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	SLC24A1, NCKX1, CSNB1D	603617	15q22.31	SLC24A1
Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	GPR179, GPR158L, GPR158L1, CSNB1E	614515	17q12	GPR179
Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	LRIT3, FIGLER4, CSNB1F	615004	4q25	LRIT3
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CACNA1F
Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RHO
Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	PDE6B
Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	GNAT1
Night blindness, congenital stationary, type 1H, 617024 (3)	GNB3, CSNB1H	139130	12p13.31	GNB3
Nijmegen breakage syndrome, 251260 (3)	NBN, NBS1	602667	8q21.3	NBN
Nijmegen breakage syndrome-like disorder, 613078 (3)	RAD50, NBSLD	604040	5q31.1	RAD50
Nonaka myopathy, 605820 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	GNE
Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
Nonsmall cell lung cancer, somatic (3)	BRAF, NS7	164757	7q34	BRAF
Nonsmall cell lung cancer, somatic, 211980 (3)	IRF1, MAR	147575	5q31.1	IRF1
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
Noonan syndrome 10, 616564 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	LZTR1
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Noonan syndrome 4, 610733 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	SOS1
Noonan syndrome 5, 611553 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	RAF1
Noonan syndrome 6, 613224 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Noonan syndrome 7, 613706 (3)	BRAF, NS7	164757	7q34	BRAF
Noonan syndrome 8, 615355 (3)	RIT1, RIT, ROC1, NS8	609591	1q22	RIT1
Noonan syndrome 9, 616559 (3)	SOS2, NS9	601247	14q21.3	SOS2
Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3)	PPP1CB, NSLH2	600590	2p23.2	PPP1CB
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3)	CBL, CBL2, NSLL	165360	11q23.3	CBL
Noonan-like syndrome with loose anagen hair, 607721 (3)	SHOC2, SIAA0862, SOC2, SUR8	602775	10q25.2	SHOC2
Norrie disease, 310600 (3)	NDP, ND, EVR2	300658	Xp11.3	NDP
North American Indian childhood cirrhosis (2)	NAIC	604901	16q22	NAIC
Norum disease, 245900 (3)	LCAT	606967	16q22.1	LCAT
Nystagmus 1, congenital, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	FRMD7
Nystagmus 2, congenital, autosomal dominant (2)	NYS2, NYSA	164100	6p12	NYS2
Nystagmus 3, congenital, autosomal dominant (2)	NYS3	608345	7p11.2	NYS3
Nystagmus 4, congenital, autosomal dominant (2)	NYS4	193003	13q31-q33	NYS4
Nystagmus 5, congenital, X-linked (2)	NYS5	300589	Xp11.4	NYS5
Nystagmus 6, congenital, X-linked, 300814 (3)	GPR143, OA1, NYS6	300808	Xp22.2	GPR143
Nystagmus 7, congenital, autosomal dominant (2)	NYS7	614826	1q31.3-q32.1	NYS7
Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	FRMD7
OKT4 epitope deficiency, 613949 (3)	CD4	186940	12p13.31	CD4
Obesity with impaired prohormone processing, 600955 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PCSK1
Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3)	POMC	176830	2p23.3	POMC
Obesity, autosomal dominant, 601665 (3)	MC4R	155541	18q21.32	MC4R
Obesity, hyperphagia, and developmental delay (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	AKR1C2
Obesity, hyperphagia, and developmental delay, 613886 (3)	NTRK2, TRKB, OBHD	600456	9q21.33	NTRK2
Obesity, mild, early-onset, 601665 (3)	NR0B2, SHP	604630	1p36.11	NR0B2
Obesity, morbid, due to leptin deficiency, 614962 (3)	LEP, OB, LEPD	164160	7q32.1	LEP
Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	LEPR, OBR, LEPRD	601007	1p31.3	LEPR
Obesity, severe, 601665 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Obesity, severe, 601665 (3)	SIM1	603128	6q16.3	SIM1
Occipital horn syndrome, 304150 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	ATP7A
Occult macular dystrophy, 613587 (3)	RP1L1	608581	8p23.1	RP1L1
Ocular albinism with sensorineural deafness (2)	OASD	300650	Xp22.3	OASD
Ocular albinism, type I, Nettleship-Falls type, 300500 (3)	GPR143, OA1, NYS6	300808	Xp22.2	GPR143
Oculoauricular syndrome, 612109 (3)	HMX1, H6	142992	4p16.1	HMX1
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Oculomotor apraxia, congenital, Cogan-type (2)	COMA	257550	2q13	COMA
Oculopharyngeal muscular dystrophy, 164300 (3)	PABPN1, PABP2, PAB2	602279	14q11.2	PABPN1
Odontohypophosphatasia, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Odontoonychodermal dysplasia, 257980 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	WNT10A
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	NAA10
Oguchi disease-1, 258100 (3)	SAG, RP47	181031	2q37.1	SAG
Oguchi disease-2, 613411 (3)	GRK1, RHOK, RK	180381	13q34	GRK1
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	MED12
Okur-Chung neurodevelopmental syndrome, 617062 (3)	CSNK2A1, CK2A1, OCNDS	115440	20p13	CSNK2A1
Oligodontia-colorectal cancer syndrome, 608615 (3)	AXIN2, ODCRCS	604025	17q24.1	AXIN2
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
Olmsted syndrome, 614594 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	TRPV3
Omenn syndrome, 603554 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	DCLRE1C
Omenn syndrome, 603554 (3)	RAG1	179615	11p12	RAG1
Omenn syndrome, 603554 (3)	RAG2	179616	11p12	RAG2
Omeprazole poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Omodysplasia 1, 258315 (3)	GPC6, OMIMD1	604404	13q31.3-q32.1	GPC6
Omphalocele due to duplication of 1p31.3 (4)	OPHLC, C1DUPp31.3, DUP1p31.3	164750	1p31.3	OPHLC
Oocyte maturation defect 1, 615774 (3)	ZP1, OOMD1	195000	11q12.2	ZP1
Oocyte maturation defect 2, 616780 (3)	TUBB8, OOMD2	616768	10p15.3	TUBB8
Oocyte maturation defect 3, 617712 (3)	ZP3, ZP3A, ZP3B, OOMD3	182889	7q11.23	ZP3
Oocyte maturation defect 4, 617743 (3)	PATL2, PAT1A, OOMD4	614661	15q21.1	PATL2
Opitz GBBB syndrome, type I, 300000 (3)	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22.2	MID1
Opitz GBBB syndrome, type II, 145410 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	SPECC1L
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	MED12
Opsismodysplasia, 258480 (3)	INPPL1, OPSMD	600829	11q13.4	INPPL1
Optic atrophy 1, 165500 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	RTN4IP1, NIMP, OPA10	610502	6q21	RTN4IP1
Optic atrophy 2, X-linked (2)	OPA2	311050	Xp11.4-p11.21	OPA2
Optic atrophy 3 with cataract, 165300 (3)	OPA3, MGA3	606580	19q13.32	OPA3
Optic atrophy 4 (2)	OPA4	605293	18q12.2-q12.3	OPA4
Optic atrophy 5, 610708 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5	603850	12p11.21	DNM1L
Optic atrophy 6 (2)	OPA6	258500	8q21-q22	OPA6
Optic atrophy 7, 612989 (3)	TMEM126A, OPA7	612988	11q14.1	TMEM126A
Optic atrophy 8 (2)	OPA8	616648	16q21-q22	OPA8
Optic atrophy plus syndrome, 125250 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	SIX6, ODRMD	606326	14q23.1	SIX6
Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	SOX2, MCOPS3	184429	3q26.33	SOX2
Optic nerve hypoplasia, 165550 (3)	PAX6, AN2, MGDA, FVH1, ASGD5	607108	11p13	PAX6
Ornithine transcarbamylase deficiency, 311250 (3)	OTC	300461	Xp11.4	OTC
Orofacial cleft 10, 613705 (3)	SUMO1, UBL1, SMT3, OFC10	601912	2q33.1	SUMO1
Orofacial cleft 11, 600625 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP4
Orofacial cleft 12 (2)	OFC12	612858	8q24.3	OFC12
Orofacial cleft 13 (2)	OFC13	613857	1p33	OFC13
Orofacial cleft 14 (2)	OFC14	615892	1p31	OFC14
Orofacial cleft 4 (2)	OFC4	608371	4q21-q31	OFC4
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	MSX1
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	NECTIN1
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Orofacial cleft 9 (2)	OFC9	610361	13q33.1-q34	OFC9
Orofacial cleft-1 (2)	OFC1, CL	119530	6p24.3	OFC1
Orofacial cleft-2 (2)	OFC2	602966	2p13	OFC2
Orofacial cleft-3 (2)	OFC3	600757	19q13	OFC3
Orofaciodigital syndrome I, 311200 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
Orofaciodigital syndrome IV, 258860 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	TCTN3
Orofaciodigital syndrome V, 174300 (3)	DDX59, OFD5	615464	1q32.1	DDX59
Orofaciodigital syndrome VI, 277170 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	C5orf42
Orofaciodigital syndrome XVI, 617563 (3)	TMEM107, MKS13, JBTS29	616183	17p13.1	TMEM107
Orolaryngeal cancer, multiple, (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
Orotic aciduria, 258900 (3)	UMPS, OPRT	613891	3q21.2	UMPS
Orthostatic hypotensive disorder of Streeten (2)	OHDS	143850	18q	OHDS
Orthostatic intolerance, 604715 (3)	SLC6A2, NAT1, NET1	163970	16q12.2	SLC6A2
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
Osteoarthritis with mild chondrodysplasia, 604864 (3)	COL2A1	120140	12q13.11	COL2A1
Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	TAPT1, CMVFR, OCLSBG	612758	4p15.32	TAPT1
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type II, 166210 (3)	COL1A2, EDSCV, EDSARTH2	120160	7q21.3	COL1A2
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A2, EDSCV, EDSARTH2	120160	7q21.3	COL1A2
Osteogenesis imperfecta, type IX, 259440 (3)	PPIB, CYPB, OI9	123841	15q22.31	PPIB
Osteogenesis imperfecta, type V, 610967 (3)	IFITM5, OI5	614757	11p15.5	IFITM5
Osteogenesis imperfecta, type VI, 613982 (3)	SERPINF1, PEDF, OI6	172860	17p13.3	SERPINF1
Osteogenesis imperfecta, type VII, 610682 (3)	CRTAP, CASP, OI7	605497	3p22.3	CRTAP
Osteogenesis imperfecta, type VIII, 610915 (3)	P3H1, LEPRE1, GROS1, OI8	610339	1p34.2	P3H1
Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	SERPINH1
Osteogenesis imperfecta, type XI, 610968 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	FKBP10
Osteogenesis imperfecta, type XIII, 614856 (3)	BMP1, OI13	112264	8p21.3	BMP1
Osteogenesis imperfecta, type XIV, 615066 (3)	TMEM38B, TRICB, OI14	611236	9q31.2	TMEM38B
Osteogenesis imperfecta, type XV, 615220 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	WNT1
Osteogenesis imperfecta, type XVI (4)	OI16, C16DELp11.2, DEL16p11.2	616229	11p11.2	OI16
Osteogenesis imperfecta, type XVII, 616507 (3)	SPARC, ON, OI17	182120	5q33.1	SPARC
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	TNFRSF11A
Osteomalacia, tumor-induced (1)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	FGF23
Osteopathia striata with cranial sclerosis, 300373 (3)	AMER1, FAM123B, WTX, OSCS	300647	Xq11.2	AMER1
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Osteopetrosis, autosomal dominant 2, 166600 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	CLCN7
Osteopetrosis, autosomal recessive 1, 259700 (3)	TCIRG1, TIRC7, OC116, OPTB1	604592	11q13.2	TCIRG1
Osteopetrosis, autosomal recessive 2, 259710 (3)	TNFSF11, OPGL, TRANCE, OPTB2	602642	13q14.11	TNFSF11
Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	CA2	611492	8q21.2	CA2
Osteopetrosis, autosomal recessive 4, 611490 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	CLCN7
Osteopetrosis, autosomal recessive 5, 259720 (3)	OSTM1, GL, OPTB5	607649	6q21	OSTM1
Osteopetrosis, autosomal recessive 6, 611497 (3)	PLEKHM1, AP162, KIAA0356, OPTB6	611466	17q21.31	PLEKHM1
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	TNFRSF11A
Osteopetrosis, autosomal recessive 8, 615085 (3)	SNX10, OPTB8	614780	7p15.2	SNX10
Osteopoikilosis with or without melorheostosis, 166700 (3)	LEMD3, MAN1	607844	12q14.3	LEMD3
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Osteosarcoma, 259500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Osteosarcoma, somatic, 259500 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
Osteosarcoma, somatic, 259500 (3)	RB1	614041	13q14.2	RB1
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Otodental dysplasia chromosome deletion syndrome (4)	OTDD, DEL11q13, C11DELq13	166750	11q13	OTDD
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Otosclerosis 1 (2)	OTSC1, OTS	166800	15q26.1-qter	OTSC1
Otosclerosis 10 (2)	OTSC10	615589	1q41-q44	OTSC10
Otosclerosis 2 (2)	OTSC2	605727	7q34-q36	OTSC2
Otosclerosis 3 (2)	OTSC3	608244	6p22.3-p21.3	OTSC3
Otosclerosis 5 (2)	OTSC5	608787	3q22-q24	OTSC5
Otosclerosis 7 (2)	OTSC7	611572	6q13-q16.1	OTSC7
Otosclerosis 8 (2)	OTSC8	612096	9p13.1-q21.11	OTSC8
Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3)	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	120290	6p21.32	COL11A2
Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3)	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB	120290	6p21.32	COL11A2
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Ovarian cancer, somatic, (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Ovarian cancer, somatic, 167000 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Ovarian cancer, somatic, 167000 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Ovarian carcinoma (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	SEPT9
Ovarian carcinoma (3)	RRAS2, TC21	600098	11p15.2	RRAS2
Ovarian carcinoma, somatic, 167000 (3)	CDH1, UVO, LCAM, ECAD, BCDS1	192090	16q22.1	CDH1
Ovarian dysgenesis 1, 233300 (3)	FSHR, ODG1	136435	2p16.3	FSHR
Ovarian dysgenesis 2, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	BMP15
Ovarian dysgenesis 3, 614324 (3)	PSMC3IP, TBPIP, GT198, HOP2, ODG3	608665	17q21.2	PSMC3IP
Ovarian dysgenesis 4, 616185 (3)	MCM9, MCMDC1, ODG4	610098	6q22.31	MCM9
Ovarian dysgenesis 5, 617690 (3)	SOHLH1, NOHLH, TEB2, ODG5	610224	9q34.3	SOHLH1
Ovarian hyperstimulation syndrome, 608115 (3)	FSHR, ODG1	136435	2p16.3	FSHR
Ovarian response to FSH stimulation, 276400 (3)	FSHR, ODG1	136435	2p16.3	FSHR
Ovarioleukodystrophy, 603896 (3)	EIF2B2	606454	14q24.3	EIF2B2
Ovarioleukodystrophy, 603896 (3)	EIF2B4	606687	2p23.3	EIF2B4
Ovarioleukodystrophy, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	EIF2B5
Overhydrated hereditary stomatocytosis, 185000 (3)	RHAG, RH50A, OHST	180297	6p12.3	RHAG
PCWH syndrome, 609136 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	SOX10
PEHO syndrome, 260565 (3)	ZNHIT3, TRIP3, PEHO	604500	17q12	ZNHIT3
PEPCK deficiency, mitochondrial, 261650 (1)	PCK2, PEPCK2	614095	14q11-q12	PCK2
PTEN hamartoma tumor syndrome (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Pachyonychia congenita 1, 167200 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	KRT16
Pachyonychia congenita 2, 167210 (3)	KRT17, PC2, PCHC1	148069	17q21.2	KRT17
Pachyonychia congenita 3, 615726 (3)	KRT6A, PC3	148041	12q13.13	KRT6A
Pachyonychia congenita 4, 615728 (3)	KRT6B, PC4	148042	12q13.13	KRT6B
Paget disease of bone 3, 167250 (3)	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV	601530	5q35.3	SQSTM1
Paget disease of bone 4 (2)	PDB4	606263	5q31	PDB4
Paget disease of bone 5, juvenile-onset, 239000 (3)	TNFRSF11B, OPG, OCIF, PDB5	602643	8q24.12	TNFRSF11B
Paget disease of bone 6, 616833 (3)	ZNF687, KIAA1441, PDB6	610568	1q21.3	ZNF687
Pallister-Hall syndrome, 146510 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Pallister-Killian syndrome (4)	PKS	601803	12p	PKS
Palmoplantar carcinoma, multiple self-healing (2)	MSPC	616964	17p13.3-p12	MSPC
Palmoplantar carcinoma, multiple self-healing, 615255 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK	606636	17p13.2	NLRP1
Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	RSPO1, FLJ40906	609595	1p34.3	RSPO1
Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3)	RSPO1, FLJ40906	609595	1p34.3	RSPO1
Palmoplantar keratoderma and woolly hair, 616099 (3)	KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16	614610	19p13.2	KANK2
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Palmoplantar keratoderma, Bothnian type, 600231 (3)	AQP5, PPKB	600442	12q13.12	AQP5
Palmoplantar keratoderma, Nagashima type, 615598 (3)	SERPINB7, MEGSIN, PPKN	603357	18q21.33	SERPINB7
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT9, EPPK	607606	17q21.2	KRT9
Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	KRT6C, PPKNEFD	612315	12q13.13	KRT6C
Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	KRT16
Panbronchiolitis, diffuse (2)	PBLT	604809	6p21.3	PBLT
Pancreatic agenesis 1, 260370 (3)	PDX1, IPF1, MODY4, PAGEN1	600733	13q12.2	PDX1
Pancreatic agenesis 2, 615935 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PTF1A
Pancreatic agenesis and congenital heart defects, 600001 (3)	GATA6, AVSD5, ASD9, PACHD	601656	18q11.2	GATA6
Pancreatic and cerebellar agenesis, 609069 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PTF1A
Pancreatic cancer, 260350 (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Pancreatic cancer, 260350 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Pancreatic cancer, somatic (3)	ACVR1B, ACVRLK4, ALK4	601300	12q13.13	ACVR1B
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, JIP, MYHRS	600993	18q21.2	SMAD4
Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
Pancreatic carcinoma, somatic (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RBBP8
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Pancreatitis, hereditary, 167800 (3)	PRSS1, TRY1	276000	7q34	PRSS1
Pancreatitis, hereditary, 167800 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	SPINK1
Panhypopituitarism, X-linked, 312000 (3)	SOX3, MRGH	313430	Xq27.1	SOX3
Panic disorder 2 (2)	PAND2	607853	9q31	PAND2
Panic disorder 3 (2)	PAND3	609985	4q31-q34	PAND3
Panic disorder syndrome 1 (2)	PAND1	167870	13q22-q32	PAND1
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CTSC
Papillorenal syndrome, 120330 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	PAX2
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHC, PGL3	602413	1q23.3	SDHC
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Paragangliomas 1, with or without deafness, 168000 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Paragangliomas 2, 601650 (3)	SDHAF2, SDH5, PGL2	613019	11q12.2	SDHAF2
Paragangliomas 3, 605373 (3)	SDHC, PGL3	602413	1q23.3	SDHC
Paragangliomas 4, 115310 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Paragangliomas 5, 614165 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Paramyotonia congenita, 168300 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Parasomnia, sleepwalking type (2)	PSMNSW	613938	20q12-q13.12	PSMNSW
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Parathyroid adenoma with cystic changes, 145001 (3)	CDC73, HRPT2, C1orf28	607393	1q31.2	CDC73
Parathyroid adenoma, somatic (3)	MEN1	613733	11q13.1	MEN1
Parathyroid carcinoma, 608266 (3)	CDC73, HRPT2, C1orf28	607393	1q31.2	CDC73
Parietal foramina 1, 168500 (3)	MSX2, CRS2, HOX8	123101	5q35.2	MSX2
Parietal foramina 2, 609597 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	ALX4
Parietal foramina 3 (2)	PFM3	609566	4q21-q23	PFM3
Parietal foramina with cleidocranial dysplasia, 168550 (3)	MSX2, CRS2, HOX8	123101	5q35.2	MSX2
Parkes Weber syndrome, 608355 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	RASA1
Parkinson disease 1, 168601 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	SNCA
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PLA2G6
Parkinson disease 15, autosomal recessive, 260300 (3)	FBXO7, FBX7, FBX, PKPS, PARK15	605648	22q12.3	FBXO7
Parkinson disease 19a, juvenile-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	DNAJC6
Parkinson disease 19b, early-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	DNAJC6
Parkinson disease 20, early-onset, 615530 (3)	SYNJ1, PARK20, EIEE53	604297	21q22.11	SYNJ1
Parkinson disease 21 (2)	PARK21	616361	3q22	PARK21
Parkinson disease 22, autosomal dominant, 616710 (3)	CHCHD2, PARK22	616244	7p11.2	CHCHD2
Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	VPS13C, KIAA1421, PARK23	608879	15q22.2	VPS13C
Parkinson disease 4, 605543 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	SNCA
Parkinson disease 6, early onset, 605909 (3)	PINK1, PARK6	608309	1p36.12	PINK1
Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	DJ1, PARK7	602533	1p36.23	DJ1
Parkinson disease, juvenile, type 2, 600116 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
Parkinsonism-dystonia, infantile, 613135 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	SLC6A3
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	PIGA
Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD1, FPD1, PDC, DYT8	609023	2q35	MR1
Paroxysmal nonkinesigenic dyskinesia 2 (2)	PNKD2	611147	2q31	PNKD2
Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3)	KCNMA1, SLO, PNKD3, CADEDS	600150	10q22.3	KCNMA1
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Patella aplasia or hypoplasia (2)	PTLAH, FPAH	168860	17q21-q22	PTLAH
Patent ductus arteriosus 2, 617035 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	TFAP2B
Patent ductus arteriosus 3, 617039 (3)	PRDM6, PRISM, PDA3	616982	5q23.2	PRDM6
Peeling skin syndrome 1, 270300 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	CDSN
Peeling skin syndrome 2, 609796 (3)	TGM5, TGX, PSS2	603805	15q15.2	TGM5
Peeling skin syndrome 4, 607936 (3)	CSTA, STFA, STF1, AREI, PSS4	184600	3q21.1	CSTA
Peeling skin syndrome 5, 617115 (3)	SERPINB8, PI8, CAP2, PSS5	601697	18q22.1	SERPINB8
Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	CAST, PLACK	114090	5q15	CAST
Pelger-Huet anomaly, 169400 (3)	LBR, PHA	600024	1q42.12	LBR
Pelizaeus-Merzbacher disease, 312080 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	PLP1
Pendred syndrome, 274600 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	SLC26A4
Periodic fever, familial, 142680 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFRSF1A
Periodic fever, menstrual cycle dependent, 614674 (3)	HTR1A, ADRB2RL1, PFMCD	109760	5q12.3	HTR1A
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CTSC
Periodontitis, aggressive, 2 (2)	PDON2	608526	1q25	PDON2
Peripheral arterial occlusive disease 1 (2)	PAOD1	606787	1p31	PAOD1
Periventricular heterotopia with microcephaly, 608097 (3)	ARFGEF2, BIG2, PVNH2	605371	20q13.13	ARFGEF2
Periventricular nodular heterotopia 3 (2)	PVNH3	608098	5p15.1	PVNH3
Periventricular nodular heterotopia 5 (4)	PVNH5	612881	5q14.3-q15	PVNH5
Periventricular nodular heterotopia 7, 617201 (3)	NEDD4L, KIAA0439, RSP5, PVNH7	606384	18q21.31	NEDD4L
Perlman syndrome, 267000 (3)	DIS3L2, PRLMNS	614184	2q37.1	DIS3L2
Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	ACOX1, ACOX, SCOX	609751	17q25.1	ACOX1
Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	FAR1, MLSTD2, PFCRD	616107	11p15.3	FAR1
Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3)	PEX3, PBD10A, PBD10B	603164	6q24.2	PEX3
Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PEX13
Peroxisome biogenesis disorder 11B, 614885 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PEX13
Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	PEX19, PXF, HK33, D1S2223E, PBD12A	600279	1q23.2	PEX19
Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	PEX14, PBD13A	601791	1p36.22	PEX14
Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PEX1
Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PEX1
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PEX5
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PEX5
Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3)	PEX12, PBD3A	601758	17q12	PEX12
Peroxisome biogenesis disorder 3B, 266510 (3)	PEX12, PBD3A	601758	17q12	PEX12
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PEX6
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PEX6
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PEX2
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PEX2
Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PEX10
Peroxisome biogenesis disorder 6B, 614871 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PEX10
Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PEX26
Peroxisome biogenesis disorder 7B, 614873 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PEX26
Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PEX16
Peroxisome biogenesis disorder 8B, 614877 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PEX16
Peroxisome biogenesis disorder 9B, 614879 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	PEX7
Perrault syndrome 1, 233400 (3)	HSD17B4, PRLTS1	601860	5q23.1	HSD17B4
Perrault syndrome 3, 614129 (3)	CLPP, PRLTS3, DFNB81	601119	19p13.3	CLPP
Perrault syndrome 4, 615300 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	LARS2
Perrault syndrome 5, 616138 (3)	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	TWNK
Perrault syndrome 6, 617565 (3)	ERAL1, ERAL1A, ERAL1B, PRLTS6	607435	17q11.2	ERAL1
Perry syndrome, 168605 (3)	DCTN1, HMN7B	601143	2p13.1	DCTN1
Persistent Mullerian duct syndrome, type I, 261550 (3)	AMH, MIF	600957	19p13.3	AMH
Persistent Mullerian duct syndrome, type II, 261550 (3)	AMHR2, AMHR	600956	12q13.13	AMHR2
Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	ATOH7, PHPVAR, NCRNA	609875	10q21.3	ATOH7
Persistent truncus arteriosus, 217095 (3)	GATA6, AVSD5, ASD9, PACHD	601656	18q11.2	GATA6
Persistent truncus arteriosus, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	NKX2-6
Peters-plus syndrome, 261540 (3)	B3GLCT, B3GALTL, B3GTL	610308	13q12.3	B3GLCT
Peutz-Jeghers syndrome, 175200 (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	SHANK3
Phenylketonuria, 261600 (3)	PAH, PKU1	612349	12q23.2	PAH
Pheochromocytoma, 171300 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	KIF1B
Pheochromocytoma, 171300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Pheochromocytoma, 171300 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Pheochromocytoma, 171300 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Pheochromocytoma, 171300 (3)	VHL	608537	3p25.3	VHL
Phobia, specific (2)	PHOBS	608251	Chr.14	PHOBS
Phosphoglycerate dehydrogenase deficiency, 601815 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	PHGDH
Phosphoglycerate kinase 1 deficiency, 300653 (3)	PGK1, PGKA	311800	Xq21.1	PGK1
Phospholipase A2, group IV A, deficiency of (3)	PLA2G4A, PLA2G4	600522	1q31.1	PLA2G4A
Phospholipid phosphatase 6, 611666 (3)	PLPP6, PPAPDC2	611666	9p24.1	PLPP6
Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	PHKB	172490	16q12.1	PHKB
Phosphoserine phosphatase deficiency, 614023 (3)	PSPH, PSP, PSPHD	172480	7p11.2	PSPH
Photoparoxysmal response 1 (2)	PPR1	132100	6p21.1	PPR1
Photoparoxysmal response 2 (2)	PPR2	609572	13q31.3	PPR2
Photoparoxysmal response 3 (2)	PPR3	609573	7q32	PPR3
Pick disease, 172700 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Pick disease, 172700 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Piebaldism, 172800 (3)	KIT, PBT	164920	4q12	KIT
Piebaldism, 172800 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	SNAI2
Pierpont syndrome, 602342 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	TBL1XR1
Pierre Robin syndrome (2)	PRBNS	261800	17q24.3-q25.1	PRBNS
Pierson syndrome, 609049 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	LAMB2
Pigment dispersion syndrome (2)	GPDS1, PDS1	600510	7q35-q36	GPDS1
Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3)	POLA1	312040	Xp22.1-p21.3	POLA1
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	604961	2q31.2	PDE11A
Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	PDE8B
Pigmented nodular adrenocortical disease, primary, 4 (4)	PPNAD4	615830	19p13	PPNAD4
Pigmented paravenous chorioretinal atrophy, 172870 (3)	CRB1, RP12, LCA8	604210	1q31.3	CRB1
Pilarowski-Bjornsson syndrome, 617682 (3)	CHD1, PILBOS	602118	5q15-q21	CHD1
Pilomatricoma, somatic, 132600 (3)	CTNNB1, MRD19, EVR7	116806	3p22.1	CTNNB1
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CNTNAP2
Pitt-Hopkins syndrome, 610954 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	TCF4
Pitt-Hopkins-like syndrome 2, 614325 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	NRXN1
Pituitary ACTH-secreting adenoma (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GNAI2
Pituitary adenoma 1, multiple types, 102200 (3)	AIP, XAP2, ARA9, PITA1	605555	11q13.2	AIP
Pituitary adenoma 2, GH-secreting, 300943 (3)	GPR101, PAGH2, PITA2	300393	Xq26.3	GPR101
Pituitary adenoma 3, multiple types, somatic, 617686 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3)	USP8, HUMORF8, PITA4	603158	15q21.2	USP8
Pituitary adenoma predisposition, 102000 (3)	AIP, XAP2, ARA9, PITA1	605555	11q13.2	AIP
Pituitary hormone deficiency, combined, 1, 613038 (3)	POU1F1, PIT1, CPHD1	173110	3p11.2	POU1F1
Pituitary hormone deficiency, combined, 2, 262600 (3)	PROP1, CPHD2	601538	5q35.3	PROP1
Pituitary hormone deficiency, combined, 3, 221750 (3)	LHX3, CPHD3	600577	9q34.3	LHX3
Pituitary hormone deficiency, combined, 4, 262700 (3)	LHX4, CPHD4	602146	1q25.2	LHX4
Pituitary hormone deficiency, combined, 5, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	HESX1
Pituitary hormone deficiency, combined, 6, 613986 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	OTX2
Pituitary tumor, invasive (3)	PRKCA, PKCA	176960	17q24.2	PRKCA
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	CARD14
Plasma fibronectin deficiency, 614101 (1)	FN1, FN, LETS, FNZ, GFND2, SMDCF	135600	2q35	FN1
Plasma triglyceride level QTL, low, 615881 (3)	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	605910	19p13.2	ANGPTL4
Plasminogen activator inhibitor-1 deficiency, 613329 (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	PAI1
Plasminogen deficiency, type I, 217090 (3)	PLG	173350	6q26	PLG
Platelet PLC beta-2 deficiency (1)	PLCB2	604114	15q15.1	PLCB2
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, 617718 (3)	ARPC1B, ARC41, PLTEID	604223	7q22.1	ARPC1B
Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	RUNX1
Platelet glycoprotein IV deficiency, 608404 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
Platelet-activating factor acetylhydrolase deficiency, 614278 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PLA2G7
Platyspondylic skeletal dysplasia, Torrance type, 151210 (3)	COL2A1	120140	12q13.11	COL2A1
Pleuropulmonary blastoma, 601200 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	DICER1
Pneumothorax, primary spontaneous, 173600 (3)	FLCN, BHD	607273	17p11.2	FLCN
Poikiloderma with neutropenia, 604173 (3)	USB1, C16orf57, PN	613276	16q21	USB1
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	FAM111B, POIKTMP	615584	11q12.1	FAM111B
Polyarteritis nodosa, childhood-onset, 615688 (3)	CECR1, PAN, SNEDS	607575	22q11.1	CECR1
Polycystic kidney disease 1, 173900 (3)	PKD1	601313	16p13.3	PKD1
Polycystic kidney disease 2, 613095 (3)	PKD2	173910	4q22.1	PKD2
Polycystic kidney disease 3, 600666 (3)	GANAB, PKD3	104160	11q12.3	GANAB
Polycystic kidney disease 4, with or without hepatic disease, 263200 (3)	FCYT, PKHD1, ARPKD, PKD4	606702	6p12.3-p12.2	FCYT
Polycystic kidney disease 5, 617610 (3)	DZIP1L, DZIP2, PKD5	617570	3q22.3	DZIP1L
Polycystic kidney disease, infantile severe, with tuberous sclerosis (4)	PKDTS	600273	16p13.3	PKDTS
Polycystic liver disease 1, 174050 (3)	PRKCSH, G19P1, PCLD1	177060	19p13.2	PRKCSH
Polycystic liver disease 2, 617004 (3)	SEC63, PCLD2	608648	6q21	SEC63
Polycystic ovary syndrome 1 (2)	PCOS1, PCO1, PCO	184700	19p13.2	PCOS1
Polycythemia vera, somatic, 263300 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Polydactyly, postaxial, type A3 (2)	PAPA3	607324	19p13.2-p13.1	PAPA3
Polydactyly, postaxial, type A4 (2)	PAPA4	608562	7q22	PAPA4
Polydactyly, postaxial, type A5 (2)	PAPA5	263450	13q13.3-q21	PAPA5
Polydactyly, postaxial, types A1 and B, 174200 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Polydactyly, preaxial, type IV, 174700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Polyglucosan body disease, adult form, 263570 (3)	GBE1, GSD4, APBD	607839	3p12.2	GBE1
Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	RBCK1, HOIL1, PGBM1, PBMEI	610924	20p13	RBCK1
Polyglucosan body myopathy 2, 616199 (3)	GYG1, GSD15	603942	3q24	GYG1
Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	STRADA, STRAD, LYK5	608626	17q23.3	STRADA
Polymicrogyria, bilateral frontoparietal, 606854 (3)	ADGRG1, GPR56, TM7XN1, BFPP, BPPR	604110	16q21	ADGRG1
Polymicrogyria, bilateral perisylvian (2)	BPP, PMGX, CBPS	300388	Xq27.2-q28	BPP
Polymicrogyria, bilateral perisylvian, 615752 (3)	ADGRG1, GPR56, TM7XN1, BFPP, BPPR	604110	16q21	ADGRG1
Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	PI4KA, PIK4CA, PMGYCHA	600286	22q11.21	PI4KA
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	ABHD12, PHARC	613599	20p11.21	ABHD12
Polyposis syndrome, hereditary mixed, 2, 610069 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	BMPR1A
Polyposis syndrome, mixed hereditary 1 (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	HMPS1
Polyposis, juvenile intestinal, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	BMPR1A
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, JIP, MYHRS	600993	18q21.2	SMAD4
Pontocerebellar hypoplasia type 1A, 607596 (3)	VRK1, PCH1A	602168	14q32.2	VRK1
Pontocerebellar hypoplasia type 2A, 277470 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	TSEN54
Pontocerebellar hypoplasia type 2B, 612389 (3)	TSEN2, SEN2, PCH2B	608753	3p25.2	TSEN2
Pontocerebellar hypoplasia type 2D, 613811 (3)	SEPSECS, SLA, LP, PCH2D	613009	4p15.2	SEPSECS
Pontocerebellar hypoplasia type 4, 225753 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	TSEN54
Pontocerebellar hypoplasia, type 10, 615803 (3)	CLP1, HEAB, PCH10	608757	11q12.1	CLP1
Pontocerebellar hypoplasia, type 11, 617695 (3)	TBC1D23, PCH11	617687	3q12.1-q12.2	TBC1D23
Pontocerebellar hypoplasia, type 1B, 614678 (3)	EXOSC3, RRP40, PCH1B	606489	9p13.2	EXOSC3
Pontocerebellar hypoplasia, type 1C, 616081 (3)	EXOSC8, OIP2, RRP43, PCH1C	606019	13q13.3	EXOSC8
Pontocerebellar hypoplasia, type 2E, 615851 (3)	VPS53, HCCS1, PCH2E	615850	17p13.3	VPS53
Pontocerebellar hypoplasia, type 2F, 617026 (3)	TSEN15, SEN15, C1orf19, PCH2F	608756	1q25.3	TSEN15
Pontocerebellar hypoplasia, type 6, 611523 (3)	RARS2, RARSL, PCH6	611524	6q15	RARS2
Pontocerebellar hypoplasia, type 7, 614969 (3)	TOE1, PCH7	613931	1p34.1	TOE1
Pontocerebellar hypoplasia, type 8, 614961 (3)	CHMP1A, PCOLN3, PRSM1, PCH8	164010	16q24.3	CHMP1A
Pontocerebellar hypoplasia, type 9, 615809 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	AMPD2
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	IRF6
Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3)	RIPK4, NKRD3, DIK, PPS2	605706	21q22.3	RIPK4
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Porencephaly 2, 614483 (3)	COL4A2, POREN2, ICH	120090	13q34	COL4A2
Poretti-Boltshauser syndrome, 615960 (3)	LAMA1, PTBHS	150320	18p11.31	LAMA1
Porokeratosis 1, multiple types, 175800 (3)	PMVK, PMK, POROK1	607622	1q21.3	PMVK
Porokeratosis 2, palmar, plantar, and disseminated (2)	POROK2, PPPD1	175850	12q24.1-q24.2	POROK2
Porokeratosis 3, multiple types, 175900 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVK
Porokeratosis 4, disseminated superficial actinic (2)	POROK4, DSAP2	607728	15q25.1-q26.1	POROK4
Porokeratosis 5, disseminated superficial actinic (2)	POROK5, DSAP3	612293	1p31.3-p31.1	POROK5
Porokeratosis 6, multiple types (2)	POROK6, DSAP4	612353	18p11.3	POROK6
Porokeratosis 7, multiple types, 614714 (3)	MVD, MPD, POROK7	603236	16q24.2	MVD
Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	SLC17A9, C20orf59, POROK8	612107	20q13.33	SLC17A9
Porokeratosis 9, multiple types, 616631 (3)	FDPS, FPS, POROK9	134629	1q22	FDPS
Porphyria cutanea tarda, 176100 (3)	UROD	613521	1p34.1	UROD
Porphyria variegata, 176200 (3)	PPOX	600923	1q23.3	PPOX
Porphyria, acute hepatic, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	ALAD
Porphyria, acute intermittent, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	HMBS
Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	HMBS
Porphyria, congenital erythropoietic, 263700 (3)	UROS	606938	10q26.2	UROS
Porphyria, hepatoerythropoietic, 176100 (3)	UROD	613521	1p34.1	UROD
Portal hypertension, noncirrhotic, 617068 (3)	DGUOK, DGK, MTDPS3, PEOB4, NCPH	601465	2p13.1	DGUOK
Postaxial polydactyly, type A2 (2)	PAPA2	602085	13q21-q32	PAPA2
Potocki-Lupski syndrome (4)	PTLS	610883	17p11.2	PTLS
Potocki-Shaffer syndrome (4)	PSS	601224	11p11.2	PSS
Prader-Willi syndrome, 176270 (3)	NDN	602117	15q11.2	NDN
Prader-Willi syndrome, 176270 (3)	SNRPN	182279	15q11.2	SNRPN
Preauricular tag, isolated, autosomal dominant, 1 (2)	PAURT1	610420	14q11.2-q12	PAURT1
Precocious puberty, central, 2, 615346 (3)	MKRN3, ZFP127, ZNF127, CPPB2	603856	15q11.2	MKRN3
Precocious puberty, male, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Preeclampsia/eclampsia 1 (2)	PEE1, PREG1	189800	2p13	PEE1
Preeclampsia/eclampsia 2 (2)	PEE2	609402	2p25	PEE2
Preeclampsia/eclampsia 3 (2)	PEE3	609403	9p13	PEE3
Preeclampsia/eclampsia 4, 609404 (3)	STOX1, PEE4	609397	10q22.1	STOX1
Preeclampsia/eclampsia 5, 614595 (3)	CORIN, CRN, TMPRSS10, ATC2, PEE5	605236	4p12	CORIN
Pregnancy loss, recurrent, 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SYCP3
Preimplantation embryonic lethality 2, 617234 (3)	PADI6, PREMBL2	610363	1p36.13	PADI6
Preimplantation embryonic lethality, 616814 (3)	TLE6, GRG6, PREMBL	612399	19p13.3	TLE6
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Premature ovarian failure 1, 311360 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FMR1
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
Premature ovarian failure 3, 608996 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	FOXL2
Premature ovarian failure 4, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	BMP15
Premature ovarian failure 5, 611548 (3)	NOBOX, POF5	610934	7q35	NOBOX
Premature ovarian failure 6, 612310 (3)	FIGLA, POF6	608697	2p13.3	FIGLA
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	184757	9q33.3	NR5A1
Premature ovarian failure 8, 615723 (3)	STAG3, POF8	608489	7q22.1	STAG3
Premature ovarian failure 9, 615724 (3)	HFM1, MER3, POF9	615684	1p22.2	HFM1
Prieto syndrome (2)	PRS, MRXS2	309610	Xp11-q21	PRS
Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CACNA1D
Primary lateral sclerosis, adult, 1 (2)	PLSA1, PLSA	611637	4p16	PLSA1
Primary lateral sclerosis, juvenile, 606353 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALS2
Primrose syndrome, 259050 (3)	ZBTB20, ZNF288, DPZF, PRIMS	606025	3q13.31	ZBTB20
Prion disease with protracted course, 606688 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2	103220	4q35.1	SLC25A4
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	TWNK
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	POLG2, POLGB, PEOA4	604983	17q23.3	POLG2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	RRM2B
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	DNA2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	RNASEH1, PEOB2	604123	2p25.3	RNASEH1
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3)	DGUOK, DGK, MTDPS3, PEOB4, NCPH	601465	2p13.1	DGUOK
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Progressive familial heart block, type IB, 604559 (3)	TRPM4, PFHB1B	606936	19q13.33	TRPM4
Progressive familial heart block, type II (2)	PFHB2	140400	1q32	PFHB2
Proguanil poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Prolidase deficiency, 170100 (3)	PEPD	613230	19q13.11	PEPD
Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3)	FLVCR2, C14orf58, CCT, PVHH, EPV	610865	14q24.3	FLVCR2
Properdin deficiency, X-linked, 312060 (3)	PFC, PFD	300383	Xp11.23	PFC
Propionicacidemia, 606054 (3)	PCCA	232000	13q32.3	PCCA
Propionicacidemia, 606054 (3)	PCCB	232050	3q22.3	PCCB
Prostate adenocarcinoma (2)	ST12, PAC1	601188	10pter-q11	ST12
Prostate cancer 1, 601518 (3)	RNASEL, RNS4, PRCA1, HPC1	180435	1q25.3	RNASEL
Prostate cancer, hereditary, 176807 (3)	MSR1, SCARA1, SRA	153622	8p22	MSR1
Prostate cancer, somatic, 176807 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	KLF6
Prostate cancer, somatic, 176807 (3)	MAD1L1, TXBP181	602686	7p22.3	MAD1L1
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Proteus syndrome, somatic, 176920 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1	301300	Xp11.21	ALAS2
Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)	FECH, FCE	612386	18q21.31	FECH
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Proximal myopathy and ophthalmoplegia, 605637 (3)	MYH2, MYPOP	160740	17p13.1	MYH2
Pseudo-TORCH syndrome 1, 251290 (3)	OCLN, BLCPMG, PTORCH1	602876	5q13.2	OCLN
Pseudo-TORCH syndrome 2, 617397 (3)	USP18, UBP43, ISG43, PTORCH2	607057	22q11.21	USP18
Pseudoachondroplasia, 177170 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	COMP
Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	HSD17B3, EDH17B3	605573	9q22.32	HSD17B3
Pseudohyperkalemia, familial, 2, due to red cell leak (2)	PSHK2	609153	2q35-q36	PSHK2
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)	NR3C2, MLR, MCR	600983	4q31.23	NR3C2
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1A, BESC2	600228	12p13.31	SCNN1A
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1B, BESC1	600760	16p12.2	SCNN1B
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	SCNN1G
Pseudohypoaldosteronism, type IIA (2)	PHA2A, PHA2	145260	1q31-q42	PHA2A
Pseudohypoaldosteronism, type IIB, 614491 (3)	WNK4, PRKWNK4, PHA2B	601844	17q21.2	WNK4
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	WNK1
Pseudohypoaldosteronism, type IID, 614495 (3)	KLHL3, PHA2D	605775	5q31.2	KLHL3
Pseudohypoaldosteronism, type IIE, 614496 (3)	CUL3, PHA2E	603136	2q36.2	CUL3
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
Pseudohypoparathyroidism, type IB, 603233 (3)	GNASAS1, GNASAS, SANG, NESPAS	610540	20q13.32	GNASAS1
Pseudohypoparathyroidism, type IB, 603233 (3)	STX16, SYN16	603666	20q13.32	STX16
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3	139320	20q13.32	GNAS
Pseudovaginal perineoscrotal hypospadias, 264600 (3)	SRD5A2	607306	2p23.1	SRD5A2
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABCC6
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABCC6
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	GGCX, VKCFD1	137167	2p11.2	GGCX
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	IL36RN
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	CARD14
Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	SNIP1, PMRED	608241	1p34.3	SNIP1
Ptosis, hereditary congenital 2 (2)	PTOS2, PTOSX	300245	Xq24-q27.1	PTOS2
Ptosis, hereditary congenital, 1 (2)	PTOS1	178300	1p34.1-p32	PTOS1
Pulmonary alveolar microlithiasis, 265100 (3)	SLC34A2	604217	4p15.2	SLC34A2
Pulmonary disease, chronic obstructive, severe early-onset (2)	COPD	606963	2q	COPD
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	RTEL1
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	PARN
Pulmonary fibrosis, idiopathic, 178500 (3)	SFTPA2, SPA2, COLEC5	178642	10q22.3	SFTPA2
Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	BMPR2
Pulmonary hypertension, primary, 2, 615342 (3)	MADH9, SMAD9, MADH6, PPH2	603295	13q13.3	MADH9
Pulmonary hypertension, primary, 3, 615343 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CAV1
Pulmonary hypertension, primary, 4, 615344 (3)	KCNK3, TASK, PPH4	603220	2p23.3	KCNK3
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	BMPR2
Pulmonary venoocclusive disease 1, 265450 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	BMPR2
Pulmonary venoocclusive disease 2, 234810 (3)	EIF2AK4, GCN2, KIAA1338, PVOD2	609280	15q15.1	EIF2AK4
Purpura, posttransfusion (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Pycnodysostosis, 265800 (3)	CTSK	601105	1q21.3	CTSK
Pyle disease, 265900 (3)	SFRP4, FRPHE, PYL	606570	7p14.1	SFRP4
Pyloric stenosis, infantile hypertrophic 1 (2)	IHPS1, IHPS	179010	12q	IHPS1
Pyloric stenosis, infantile hypertrophic, 2 (2)	IHPS2	610260	16p13-p12	IHPS2
Pyloric stenosis, infantile hypertrophic, 3 (2)	IHPS3	612017	11q14-q22	IHPS3
Pyloric stenosis, infantile hypertrophic, 4 (2)	IHPS4	300711	Xq23	IHPS4
Pyloric stenosis, infantile hypertrophic, 5 (2)	IHPS5	612525	16q24.3	IHPS5
Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3)	MYD88, MYD88D	602170	3p22.2	MYD88
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	PSTPIP1, PSTPIP, CD2BP1, PAPAS	606347	15q24.3	PSTPIP1
Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	PNPO	603287	17q21.32	PNPO
Pyropoikilocytosis, 266140 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPTA1
Pyruvate carboxylase deficiency, 266150 (3)	PC	608786	11q13.2	PC
Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	PDHA1, PHE1A, PDHAD	300502	Xp22.12	PDHA1
Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	PDHB, PDHBD	179060	3p14.3	PDHB
Pyruvate dehydrogenase E2 deficiency, 245348 (3)	DLAT, PDCE2	608770	11q23.1	DLAT
Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	PDP1, PPM2C, PDPC	605993	8q22.1	PDP1
Pyruvate kinase deficiency, 266200 (3)	PKLR, PK1	609712	1q22	PKLR
Quebec platelet disorder, 601709 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	PLAU
Question mark ears, isolated, 612798 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	EDN1
RAPADILINO syndrome, 266280 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQL4
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
RIDDLE syndrome, 611943 (3)	RNF168	612688	3q29	RNF168
Rabson-Mendenhall syndrome, 262190 (3)	INSR, HHF5	147670	19p13.2	INSR
Radial ray deficiency (2)	RRDX	300378	Xq24-q25	RRDX
Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)	RSCIS	605463	14q11.2	RSCIS
Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	HOXA11, HOX1I, RUSAT1	142958	7p15.2	HOXA11
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	MECOM, EVI1, RUSAT2	165215	3q26.2	MECOM
Rahman syndrome, 617537 (3)	HIST1H1E, H1F4, RMNS	142220	6p22.2	HIST1H1E
Raine syndrome, 259775 (3)	FAM20C, DMP4	611061	7p22.3	FAM20C
Rajab syndrome (2)	RJBS	613658	2q36.2	RJBS
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Recombination rate QTL 1, 612042 (3)	RNF212, ZHP3	612041	4p16.3	RNF212
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	300163	Xq26.3	FHL1
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	300163	Xq26.3	FHL1
Refsum disease, 266500 (3)	PHYH, PAHX	602026	10p13	PHYH
Renal carcinoma, chromophobe, somatic, 144700 (3)	FLCN, BHD	607273	17p11.2	FLCN
Renal cell carcinoma, 144700 (1)	DIRC2, RCC4	602773	3q21.1	DIRC2
Renal cell carcinoma, 144700 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
Renal cell carcinoma, 144700 (3)	RNF139, TRC8, RCA1	603046	8q24.13	RNF139
Renal cell carcinoma, clear cell, somatic, 144700 (3)	OGG1	601982	3p25.3	OGG1
Renal cell carcinoma, papillary, 1, 300854 (3)	TFE3, RCCX1	314310	Xp11.23	TFE3
Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
Renal cell carcinoma, papillary, 605074 (3)	PRCC, RCCP1	179755	1q23.1	PRCC
Renal cell carcinoma, somatic, 144700 (3)	VHL	608537	3p25.3	VHL
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF1B
Renal glucosuria, 233100 (3)	SLC5A2, SGLT2	182381	16p11.2	SLC5A2
Renal hypodysplasia/aplasia 1, 191830 (3)	ITGA8, RHDA1	604063	10p13	ITGA8
Renal hypodysplasia/aplasia 3, 617805 (3)	GREB1L, C18orf6, KIAA1772, RHDA3	617782	18q11.1-q11.2	GREB1L
Renal tubular acidosis with deafness, 267300 (3)	ATP6B1, VPP3	192132	2p13.3	ATP6B1
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q34	ATP6V0A4
Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	SLC4A4, NBC1, KNBC	603345	4q13.3	SLC4A4
Renal tubular dysgenesis, 267430 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
Renal tubular dysgenesis, 267430 (3)	AGT, SERPINA8	106150	1q42.2	AGT
Renal tubular dysgenesis, 267430 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AGTR1
Renal tubular dysgenesis, 267430 (3)	REN, HNFJ2	179820	1q32.1	REN
Renal-hepatic-pancreatic dysplasia 1, 208540 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPHP3
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	PQBP1
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Restrictive dermopathy, lethal, 275210 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	ZMPSTE24
Reticular dysgenesis, 267500 (3)	AK2	103020	1p35.1	AK2
Reticulate acropigmentation of Kitamura, 615537 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	ADAM10
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	IGFBP7, MAC25, RAMSVPS	602867	4q12	IGFBP7
Retinal cone dystrophy 3, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	PDE6H
Retinal cone dystrophy 3B, 610356 (3)	KCNV2, KV11.1, RCD3B	607604	9p24.2	KCNV2
Retinal cone dystrophy 4, 610478 (3)	CACNA2D4, RCD4	608171	12p13.33	CACNA2D4
Retinal degeneration, autosomal recessive, clumped pigment type (3)	NRL, D14S46E, RP27	162080	14q11-q12	NRL
Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	C1QTNF5, CTRP5, LORD	608752	11q23.3	C1QTNF5
Retinal dystrophy with macular staphyloma, 617547 (3)	C21orf2, SMDAX, RDMS	603191	21q22.3	C21orf2
Retinal dystrophy with or without extraocular anomalies, 617175 (3)	RCBTB1, CLLD7, GLP, RDEOA	607867	13q14.2	RCBTB1
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Retinal dystrophy, early-onset severe, 613341 (3)	LRAT, LCA14	604863	4q32.1	LRAT
Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	OTX2
Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	RBP4
Retinitis pigmentosa 1, 180100 (3)	RP1, ORP1	603937	8q11.2-q12.1	RP1
Retinitis pigmentosa 10, 180105 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	IMPDH1
Retinitis pigmentosa 11, 600138 (3)	PRPF31, PRP31, RP11	606419	19q13.42	PRPF31
Retinitis pigmentosa 13, 600059 (3)	PRPF8, PRPC8, RP13	607300	17p13.3	PRPF8
Retinitis pigmentosa 14, 600132 (3)	TULP1, RP14, LCA15	602280	6p21.31	TULP1
Retinitis pigmentosa 17, 600852 (3)	CA4, RP17	114760	17q23.1	CA4
Retinitis pigmentosa 18, 601414 (3)	PRPF3, HPRP3, RP18	607301	1q21.2	PRPF3
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Retinitis pigmentosa 2, 312600 (3)	RP2	300757	Xp11.3	RP2
Retinitis pigmentosa 20, 613794 (3)	RPE65, RP20, LCA2	180069	1p31.3	RPE65
Retinitis pigmentosa 22 (2)	RP22	602594	16p12.3-p12.1	RP22
Retinitis pigmentosa 24 (2)	RP24	300155	Xq26-q27	RP24
Retinitis pigmentosa 25, 602772 (3)	EYS, RP25	612424	6q12	EYS
Retinitis pigmentosa 26, 608380 (3)	CERKL, RP26	608381	2q31.3	CERKL
Retinitis pigmentosa 27, 613750 (3)	NRL, D14S46E, RP27	162080	14q11-q12	NRL
Retinitis pigmentosa 28, 606068 (3)	FAM161A, RP28	613596	2p15	FAM161A
Retinitis pigmentosa 29 (2)	RP29	612165	4q32-q34	RP29
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Retinitis pigmentosa 30, 607921 (3)	FSCN2, RFSN, RP30	607643	17q25.3	FSCN2
Retinitis pigmentosa 31, 609923 (3)	TOPORS, P53BP3, LUN, RP31	609507	9p21.1	TOPORS
Retinitis pigmentosa 32 (2)	RP32	609913	1p21.3-p13.3	RP32
Retinitis pigmentosa 33, 610359 (3)	SNRNP200, ASCC3L1, KIAA0788, RP33	601664	2q11.2	SNRNP200
Retinitis pigmentosa 34 (2)	RP34	300605	Xq28	RP34
Retinitis pigmentosa 35, 610282 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	SEMA4A
Retinitis pigmentosa 36, 610599 (3)	PRCD, RP36	610598	17q25.1	PRCD
Retinitis pigmentosa 37, 611131 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	NR2E3
Retinitis pigmentosa 38, 613862 (3)	MERTK, RP38	604705	2q13	MERTK
Retinitis pigmentosa 39, 613809 (3)	USH2A, RP39	608400	1q41	USH2A
Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RHO
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Retinitis pigmentosa 42, 612943 (3)	KLHL7, RP42, CISS3	611119	7p15.3	KLHL7
Retinitis pigmentosa 43, 613810 (3)	PDE6A, PDEA, RP43	180071	5q32	PDE6A
Retinitis pigmentosa 44, 613769 (3)	RGR, RP44	600342	10q23.1	RGR
Retinitis pigmentosa 45, 613767 (3)	CNGB1, CNCG3L, CNCG2, RP45	600724	16q21	CNGB1
Retinitis pigmentosa 46, 612572 (3)	IDH3B, RP46	604526	20p13	IDH3B
Retinitis pigmentosa 47, 613758 (3)	SAG, RP47	181031	2q37.1	SAG
Retinitis pigmentosa 48, 613827 (3)	GUCA1B, GCAP2, GUCA2, RP48	602275	6p21.1	GUCA1B
Retinitis pigmentosa 49, 613756 (3)	CNGA1, CNCG1, RP49	123825	4p12	CNGA1
Retinitis pigmentosa 54, 613428 (3)	C2orf71	613425	2p23.2	C2orf71
Retinitis pigmentosa 56, 613581 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	IMPG2
Retinitis pigmentosa 57, 613582 (3)	PDE6G, PDEG, RP57	180073	17q25.3	PDE6G
Retinitis pigmentosa 59, 613861 (3)	DHDDS, HDS, RP59	608172	1p36.11	DHDDS
Retinitis pigmentosa 60, 613983 (3)	PRPF6, PRP6, ANT1, TOM, C20orf14	613979	20q13.33	PRPF6
Retinitis pigmentosa 61, 614180 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	CLRN1
Retinitis pigmentosa 62, 614181 (3)	MAK, RP62	154235	6p24.2	MAK
Retinitis pigmentosa 63 (2)	RP63	614494	6q23	RP63
Retinitis pigmentosa 64, 614500 (3)	C8orf37, CORD16, RP64, BBS21	614477	8q22.1	C8orf37
Retinitis pigmentosa 65, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	CDHR1
Retinitis pigmentosa 68, 615725 (3)	SLC7A14, KIAA1613, RP68	615720	3q26.2	SLC7A14
Retinitis pigmentosa 69, 615780 (3)	KIZ, KIZUNA, C20orf19, RP69	615757	20p11.23	KIZ
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Retinitis pigmentosa 7, digenic, 608133 (3)	ROM1, ROSP1, RP7	180721	11q12.3	ROM1
Retinitis pigmentosa 70, 615922 (3)	PRPF4, PRP4, HPRP4, RP70	607795	9q32	PRPF4
Retinitis pigmentosa 71, 616394 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	IFT172
Retinitis pigmentosa 72, 616469 (3)	ZNF408, EVR6, RP72	616454	11p11.2	ZNF408
Retinitis pigmentosa 73, 616544 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	HGSNAT
Retinitis pigmentosa 74, 616562 (3)	BBS2, RP74	606151	16q13	BBS2
Retinitis pigmentosa 75, 617023 (3)	AGBL5, CCP5, RP75	615900	2p23.3	AGBL5
Retinitis pigmentosa 76, 617123 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76	606822	1p34.1	POMGNT1
Retinitis pigmentosa 77, 617304 (3)	REEP6, DP1L1, TB2L1, C19orf32, RP77	609346	19p13.3	REEP6
Retinitis pigmentosa 78, 617433 (3)	ARHGEF18, KIAA0521, RP78	616432	19p13.2	ARHGEF18
Retinitis pigmentosa 79, 617460 (3)	HK1, HKD, HMSNR, RP79	142600	10q22.1	HK1
Retinitis pigmentosa 80, 617781 (3)	IFT140, KIAA0590, SRTD9, MZSDS, RP80	614620	16p13.3	IFT140
Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	TRNT1
Retinitis pigmentosa with or without situs inversus, 615434 (3)	ARL2BP, BART	615407	16q13	ARL2BP
Retinitis pigmentosa with or without skeletal anomalies, 250410 (3)	CWC27, SDCCAG10, RPSKA	617170	5q12.3	CWC27
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Retinitis pigmentosa, Y-linked (2)	RPY	400004	Chr.Y	RPY
Retinitis pigmentosa, concentric, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Retinitis pigmentosa, juvenile, 604393 (3)	AIPL1, LCA4	604392	17p13.2	AIPL1
Retinitis pigmentosa, juvenile, 613341 (3)	LRAT, LCA14	604863	4q32.1	LRAT
Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	SPATA7
Retinitis pigmentosa-12, autosomal recessive, 600105 (3)	CRB1, RP12, LCA8	604210	1q31.3	CRB1
Retinitis pigmentosa-40, 613801 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	PDE6B
Retinitis pigmentosa-50, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Retinitis punctata albescens, 136880 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RHO
Retinitis punctata albescens, 136880 (3)	RLBP1	180090	15q26.1	RLBP1
Retinoblastoma, 180200 (3)	RB1	614041	13q14.2	RB1
Retinoblastoma, trilateral, 180200 (3)	RB1	614041	13q14.2	RB1
Retinopathy of prematurity, 133780 (3)	FZD4, EVR1	604579	11q14.2	FZD4
Retinoschisis, 312700 (3)	RS1, XLRS1	300839	Xp22.13	RS1
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	FOXG1
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
Revesz syndrome, 268130 (3)	TINF2, TIN2, DKCA3	604319	14q12	TINF2
Rh-mod syndrome (3)	RHAG, RH50A, OHST	180297	6p12.3	RHAG
Rh-null disease, amorph type (3)	RHCE	111700	1p36.11	RHCE
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
Rhabdomyolysis, cerivastatin-induced (3)	CYP2C8	601129	10q23.33	CYP2C8
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX7, RMS2	167410	1p36.13	PAX7
Rhabdomyosarcoma, alveolar, 268220 (3)	FOXO1A, FKHR	136533	13q14.11	FOXO1A
Rhabdomyosarcoma, embryonal, 2, 180295 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	DICER1
Rhabdomyosarcoma, somatic, 268210 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	SLC22A1L
Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	PEX7
Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	GNPAT, DHAPAT, RCDP2	602744	1q42.2	GNPAT
Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	AGPS, ADHAPS, RCDP3	603051	2q31.2	AGPS
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PEX5
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	SLC52A1
Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)	CYP2R1	608713	11p15.2	CYP2R1
Rickets, vitamin D-resistant, type IIA, 277440 (3)	VDR	601769	12q13.11	VDR
Rieger syndrome, type 2 (2)	RIEG2, RGS2	601499	13q14	RIEG2
Right atrial isomerism, 208530 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	BRAT1, BAAT1, C7orf27, RMFSL	614506	7p22.3	BRAT1
Ring chromosome 14 syndrome (4)	RC14S	616606	Chr.14	RC14S
Ring dermoid of cornea, 180550 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4	601542	4q25	PITX2
Rippling muscle disease, 606072 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Rippling muscle disease-1 (2)	RMD1	600332	1q41	RMD1
Ritscher-Schinzel syndrome 1, 220210 (3)	WSHC5, KIAA0196, SPG8, RTSC1	610657	8q24.13	WSHC5
Ritscher-Schinzel syndrome 2, 300963 (3)	CCDC22, RTSC2	300859	Xp11.23	CCDC22
Roberts syndrome, 268300 (3)	ESCO2	609353	8p21.1	ESCO2
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	DDX48
Robinow syndrome, autosomal dominant 1, 180700 (3)	WNT5A	164975	3p14.3	WNT5A
Robinow syndrome, autosomal dominant 2, 616331 (3)	DVL1, DRS2	601365	1p36.33	DVL1
Robinow syndrome, autosomal dominant 3, 616894 (3)	DVL3, DRS3	601368	3q27.1	DVL3
Robinow syndrome, autosomal recessive, 268310 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	ROR2
Robinow-Sorauf syndrome, 180750 (3)	TWIST1, ACS3, SCS, CRS1, SWCOS	601622	7p21.1	TWIST1
Roifman syndrome, 616651 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	RNU4ATAC
Rothmund-Thomson syndrome, 268400 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQL4
Roussy-Levy syndrome, 180800 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Roussy-Levy syndrome, 180800 (3)	PMP22, CMT1A, CMT1E, DSS, CIDP	601097	17p12	PMP22
Rubinstein-Taybi syndrome 1, 180849 (3)	CREBBP, CBP, RSTS1	600140	16p13.3	CREBBP
Rubinstein-Taybi syndrome 2, 613684 (3)	EP300, RSTS2	602700	22q13.2	EP300
Ruijs-Aalfs syndrome, 616200 (3)	SPRTN, DVC1, C1orf124, RJALS	616086	1q42.2	SPRTN
SADDAN, 616482 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
SARS infection, protection against (2)	CLEC4M, CD209L, LSIGN, DCSIGNR	605872	19p13.2	CLEC4M
SBBYSS syndrome, 603736 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	KAT6B
SC phocomelia syndrome, 269000 (3)	ESCO2	609353	8p21.1	ESCO2
SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	JAK3, JAKL	600173	19p13.11	JAK3
SED congenita, 183900 (3)	COL2A1	120140	12q13.11	COL2A1
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
SESAME syndrome, 612780 (3)	KCNJ10, SESAME	602208	1q23.2	KCNJ10
SHORT syndrome, 269880 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	PIK3R1
SMED Strudwick type, 184250 (3)	COL2A1	120140	12q13.11	COL2A1
STAR syndrome, 300707 (3)	FAM58A, STAR	300708	Xq28	FAM58A
STING-associated vasculopathy, infantile-onset, 615934 (3)	TMEM173, STING, MPYS, SAVI	612374	5q31.2	TMEM173
Saccharopinuria, 268700 (1)	AASS	605113	7q31.32	AASS
Sacral agenesis with vertebral anomalies, 615709 (3)	T, TFT, SAVA	601397	6q27	T
Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3)	TWIST1, ACS3, SCS, CRS1, SWCOS	601622	7p21.1	TWIST1
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Salih myopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY	188840	2q31.2	TTN
Salla disease, 604369 (3)	SLC17A5, SIASD, SLD	604322	6q13	SLC17A5
Salt and pepper developmental regression syndrome, 609056 (3)	SIAT9, ST3GALV, SPDRS	604402	2p11.2	SIAT9
Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	HEXB	606873	5q13.3	HEXB
Sarcoma, synovial (1)	SS18, SSXT, SYT	600192	18q11.2	SS18
Scalp-ear-nipple syndrome, 181270 (3)	KCTD1, SENS	613420	18q11.2	KCTD1
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU	300163	Xq26.3	FHL1
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
Schaaf-Yang syndrome, 615547 (3)	MAGEL2, NDNL1, SHFYNG	605283	15q11.2	MAGEL2
Schimke immunoosseous dysplasia, 242900 (3)	SMARCAL1, HARP, SIOD	606622	2q35	SMARCAL1
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	HRAS	190020	11p15.5	HRAS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Schindler disease, type I, 609241 (3)	NAGA	104170	22q13.2	NAGA
Schindler disease, type III, 609241 (3)	NAGA	104170	22q13.2	NAGA
Schinzel-Giedion midface retraction syndrome, 269150 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	SETBP1
Schizencephaly, 269160 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Schizencephaly, 269160 (3)	EMX2	600035	10q26.11	EMX2
Schizencephaly, 269160 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Schizencephaly, 269160 (3)	SIX3, HPE2	603714	2p21	SIX3
Schizophrenia 16 (4)	SCZD16, C16DUPq36.3, DUP7q36.3	613959	7q36.3	SCZD16
Schizophrenia, 181500 (2)	DISC2	606271	1q42.2	DISC2
Schneckenbecken dysplasia, 269250 (3)	SLC35D1, UGTREL7, KIAA0260, SHNKND	610804	1p31.3	SLC35D1
Schopf-Schulz-Passarge syndrome, 224750 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	WNT10A
Schuurs-Hoeijmakers syndrome, 615009 (3)	PACS1, SHMS, MRD17	607492	11q13.1-q13.2	PACS1
Schwannomatosis, 162091 (3)	NF2	607379	22q12.2	NF2
Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	HSPG2
Sclerosing cholangitis, neonatal, 617394 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC	605755	6p22.3	DCDC2
Sclerosteosis 1, 269500 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST
Sclerosteosis 2, 614305 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	LRP4
Scoliosis, idiopathic 1 (2)	IS1, AIS	181800	19p13.3	IS1
Scoliosis, idiopathic 2 (2)	IS2, AIS2	607354	17p11.2	IS2
Scott syndrome, 262890 (3)	ANO6, TMEM16F, SCTS, BDPLT7	608663	12q12	ANO6
Scurvy (3)	GULOP, GULO	240400	8p21.1	GULOP
Sea-blue histiocyte disease, 269600 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Sebaceous tumors, somatic (3)	LEF1	153245	4q25	LEF1
Sebastian syndrome, 605249 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	ZNF750, FLJ13841	610226	17q25.3	ZNF750
Seckel syndrome 1, 210600 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	ATR
Seckel syndrome 10, 617253 (3)	NSMCE2, NSE2, MMS21	617246	8q24.13	NSMCE2
Seckel syndrome 2, 606744 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RBBP8
Seckel syndrome 5, 613823 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	CEP152
Seckel syndrome 9, 616777 (3)	TRAIP, TRIP, RNF206, SCKL9	605958	3p21.31	TRAIP
Segawa syndrome, recessive, 605407 (3)	TH, TYH	191290	11p15.5	TH
Seizures, benign familial infantile, 1 (2)	BFIS1, BFIC1	601764	19q	BFIS1
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PRRT2
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	SCN2A
Seizures, benign familial infantile, 4 (2)	BFIS4, BFIC4	612627	1p36.12-p35.1	BFIS4
Seizures, benign familial infantile, 5, 617080 (3)	SCN8A, CIAT, EIEE13, BFIS5	600702	12q13.13	SCN8A
Seizures, benign neonatal, 1, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	KCNQ2
Seizures, benign neonatal, type 2, 121201 (3)	KCNQ3, EBN2, BFNC2	602232	8q24.22	KCNQ3
Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	DIAPH1
Sengers syndrome, 212350 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	AGK
Senior-Loken syndrome 3 (2)	SLSN3	606995	3q22	SLSN3
Senior-Loken syndrome 4, 606996 (3)	NPHP4, SLSN4	607215	1p36.31	NPHP4
Senior-Loken syndrome 5, 609254 (3)	IQCB1, NPHP5, KIAA0036	609237	3q13.33	IQCB1
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Senior-Loken syndrome 7, 613615 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	SDCCAG8
Senior-Loken syndrome 8, 616307 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
Senior-Loken syndrome 9, 616629 (3)	TRAF3IP1, MIPT3, SLSN9	607380	2q37.3	TRAF3IP1
Senior-Loken syndrome-1, 266900 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPHP1
Sensorineural deafness with mild renal dysfunction, 602522 (3)	BSND	606412	1p32.3	BSND
Septooptic dysplasia, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	HESX1
Sessile serrated polyposis cancer syndrome, 617108 (3)	RNF43, RNF124, SSPCS	612482	17q22	RNF43
Severe combined immunodeficiency due to ADA deficiency, 102700 (3)	ADA	608958	20q13.12	ADA
Severe combined immunodeficiency due to IL2 deficiency (1)	IL2	147680	4q27	IL2
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	NHEJ1, XLF	611290	2q35	NHEJ1
Severe combined immunodeficiency, Athabascan type, 602450 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	DCLRE1C
Severe combined immunodeficiency, B cell-negative, 601457 (3)	RAG1	179615	11p12	RAG1
Severe combined immunodeficiency, B cell-negative, 601457 (3)	RAG2	179616	11p12	RAG2
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	PTPRC
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	IL7R, IL7RA, CD127	146661	5p13.2	IL7R
Severe combined immunodeficiency, X-linked, 300400 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	IL2RG
Shaheen syndrome, 615328 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	COG6
Shashi-Pena syndrome, 617190 (3)	ASXL2, KIAA1685, SHAPNS	612991	2p23.3	ASXL2
Short QT syndrome 1, 609620 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	KCNH2
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KCNJ2
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD	155760	15q26.1	ACAN
Short stature with microcephaly and distinctive facies, 615789 (3)	CRIPT, SSMDF	604594	2p21	CRIPT
Short stature with nonspecific skeletal abnormalities, 616255 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	NPR2
Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	GSC, SAMS	138890	14q32.13	GSC
Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3)	PRMT7, KIAA1933, SBIDDS	610087	16q22.1	PRMT7
Short stature, developmental delay, and congenital heart defects, 617044 (3)	TKT, SDDHD	606781	3p21.1	TKT
Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3)	EXOSC2, RRP4, SHRF	602238	9q34.12	EXOSC2
Short stature, idiopathic familial, 300582 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SHOX
Short stature, idiopathic familial, 300582 (3)	SHOXY	400020	Yp11.2	SHOXY
Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	XRCC4, SSMED	194363	5q14.2	XRCC4
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	POC1A, PIX2, SOFT	614783	3p21.2	POC1A
Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	NBAS
Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, 617164 (3)	ARCN1, SRMMD	600820	11q23.3	ARCN1
Short-rib thoracic dysplasia 1 with or without polydactyly (2)	SRTD1, ATD1	208500	15q13	SRTD1
Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	IFT172
Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	WDR34, SRTD11	613363	9q34.11	WDR34
Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3)	CEP120, CCDC100, SRTD13, JBTS31	613446	5q23.2	CEP120
Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	KIAA0586
Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3)	DYNC2LI1, D2LIC, LIC3, SRTD15	617083	2p21	DYNC2LI1
Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3)	IFT52	617094	20q13.12	IFT52
Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3)	TCTEX1D2, SRTD17	617353	3q29	TCTEX1D2
Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	IFT80, KIAA1374, WDR56, SRTD2, ATD2	611177	3q25.33	IFT80
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	DYNC2H1
Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	TTC21B
Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3)	NEK1, SRTD6, SRPS2A	604588	4q33	NEK1
Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	WDR35
Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	WDR60, SRTD8, SRPS6	615462	7q36.3	WDR60
Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	IFT140, KIAA0590, SRTD9, MZSDS, RP80	614620	16p13.3	IFT140
Shprintzen-Goldberg syndrome, 182212 (3)	SKI, SGS	164780	1p36.33-p36.32	SKI
Shwachman-Diamond syndrome, 260400 (3)	SBDS, SDS	607444	7q11.21	SBDS
Sialic acid storage disorder, infantile, 269920 (3)	SLC17A5, SIASD, SLD	604322	6q13	SLC17A5
Sialidosis, type I, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	NEU1
Sialidosis, type II, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	NEU1
Sialuria, 269921 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	GNE
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Sick sinus syndrome 2, 163800 (3)	HCN4, SSS2	605206	15q24.1	HCN4
Sickle cell anemia, 603903 (3)	HBB	141900	11p15.4	HBB
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	TRNT1
Sifrim-Hitz-Weiss syndrome, 617159 (3)	CHD4, SIHIWES	603277	12p13.31	CHD4
Silver spastic paraplegia syndrome, 270685 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Silver-Russell syndrome (4)	SRS, RSS	180860	7p11.2	SRS
Silver-Russell syndrome, 180860 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	H19
Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	GPC3
Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
Single median maxillary central incisor, 147250 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Singleton-Merten syndrome 1, 182250 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	IFIH1
Singleton-Merten syndrome 2, 616298 (3)	DDX58, RIGI, SGMRT2	609631	9p21.1	DDX58
Sinoatrial node dysfunction and deafness, 614896 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CACNA1D
Sitosterolemia, 210250 (3)	ABCG5	605459	2p21	ABCG5
Sitosterolemia, 210250 (3)	ABCG8, GBD4	605460	2p21	ABCG8
Sjogren-Larsson syndrome, 270200 (3)	ALDH3A2, ALDH10, SLS, FALDH	609523	17p11.2	ALDH3A2
Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	ZBTB16
Skin fragility-woolly hair syndrome, 607655 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Skraban-Deardorff syndrome, 617616 (3)	WDR26, SKDEAS	617424	1q42.11-q42.12	WDR26
Small cell cancer of the lung, somatic, 182280 (3)	RB1	614041	13q14.2	RB1
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Small-cell cancer of lung (2)	SCLC1	182280	3p23-p21	SCLC1
Smith-Kingsmore syndrome, 616638 (3)	MTOR, FRAP1, SKS	601231	1p36.22	MTOR
Smith-Lemli-Opitz syndrome, 270400 (3)	DHCR7, SLOS	602858	11q13.4	DHCR7
Smith-Magenis syndrome, 182290 (3)	RAI1, SMCR, SMS	607642	17p11.2	RAI1
Smith-McCort dysplasia 2, 615222 (3)	RAB33B, SMC2	605950	4q31.1	RAB33B
Smith-McCort dysplasia, 607326 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	DYM
Snowflake vitreoretinal degeneration, 193230 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	KCNJ13
Somatostatin analog, resistance to (3)	SSTR5	182455	16p13.3	SSTR5
Sorsby fundus dystrophy, 136900 (3)	TIMP3, SFD	188826	22q12.3	TIMP3
Sotos syndrome 1, 117550 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	NSD1
Sotos syndrome 2, 614753 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	NFIX
Spastic ataxia 1, autosomal dominant, 108600 (3)	VAMP1, SYB1, SPAX1	185880	12p13.31	VAMP1
Spastic ataxia 2, autosomal recessive, 611302 (3)	KIF1C, LTXS1, KIAA0706, SPAX2	603060	17p13.2	KIF1C
Spastic ataxia 3, autosomal recessive, 611390 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	MARS2
Spastic ataxia 5, autosomal recessive, 614487 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	AFG3L2
Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3)	NKX6-2, NKX6B, NKX6.2, SPAX8	605955	10q26.3	NKX6-2
Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	SACS, ARSACS	604490	13q12.12	SACS
Spastic paralysis, infantile onset ascending, 607225 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALS2
Spastic paraplegia 10, autosomal dominant, 604187 (3)	KIF5A, NKHC, SPG10, NEIMY	602821	12q13.3	KIF5A
Spastic paraplegia 11, autosomal recessive, 604360 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	SPG11
Spastic paraplegia 12, autosomal dominant, 604805 (3)	RTN2, NSPL1, SPG12	603183	19q13.32	RTN2
Spastic paraplegia 13, autosomal dominant, 605280 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HSPD1
Spastic paraplegia 14, autosomal recessive (2)	SPG14	605229	3q27-q28	SPG14
Spastic paraplegia 15, autosomal recessive, 270700 (3)	ZFYVE26, KIAA0321, SPG15	612012	14q24.1	ZFYVE26
Spastic paraplegia 16, X-linked, complicated (2)	SPG16	300266	Xq11.2	SPG16
Spastic paraplegia 18, autosomal recessive, 611225 (3)	ERLIN2, SPFH2, C8orf2, SPG18	611605	8p11.23	ERLIN2
Spastic paraplegia 19, autosomal dominant (2)	SPG19	607152	9q	SPG19
Spastic paraplegia 2, X-linked, 312920 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	PLP1
Spastic paraplegia 23, 270750 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23	612666	1q32.1	DSTYK
Spastic paraplegia 24, autosomal recessive (2)	SPG24	607584	13q14	SPG24
Spastic paraplegia 25, autosomal recessive (2)	SPG25	608220	6q23-q24.1	SPG25
Spastic paraplegia 26, autosomal recessive, 609195 (3)	B4GALNT1, GALGT, GALNACT, SPG26	601873	12q13.3	B4GALNT1
Spastic paraplegia 27, autosomal recessive (2)	SPG27	609041	10q22.1-q24.1	SPG27
Spastic paraplegia 28, autosomal recessive, 609340 (3)	DDHD1, PAPLA1, KIAA1705, SPG28	614603	14q22.1	DDHD1
Spastic paraplegia 29, autosomal dominant (2)	SPG29	609727	1p31.1-p21.1	SPG29
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	KIF1A
Spastic paraplegia 31, autosomal dominant, 610250 (3)	REEP1, C2orf23, SPG31, HMN5B	609139	2p11.2	REEP1
Spastic paraplegia 32, autosomal recessive (2)	SPG32	611252	14q12-q21	SPG32
Spastic paraplegia 33, autosomal dominant, 610244 (3)	ZFYVE27, SPG33	610243	10q24.2	ZFYVE27
Spastic paraplegia 34, X-linked (2)	SPG34	300750	Xq24-q25	SPG34
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	FA2H
Spastic paraplegia 36, autosomal dominant (2)	SPG36	613096	12q23-q24	SPG36
Spastic paraplegia 37, autosomal dominant (2)	SPG37	611945	8p21.1-q13.3	SPG37
Spastic paraplegia 38, autosomal dominant (2)	SPG38	612335	4p16-p15	SPG38
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
Spastic paraplegia 3A, autosomal dominant, 182600 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	ATL1
Spastic paraplegia 4, autosomal dominant, 182601 (3)	SPAST, SPG4	604277	2p22.3	SPAST
Spastic paraplegia 42, autosomal dominant, 612539 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	SLC33A1
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJC2
Spastic paraplegia 45, autosomal recessive, 613162 (3)	NT5C2, NT5B, PNT5, SPG45	600417	10q24.32-q24.33	NT5C2
Spastic paraplegia 46, autosomal recessive, 614409 (3)	GBA2, KIAA1605, SPG46	609471	9p13.3	GBA2
Spastic paraplegia 47, autosomal recessive, 614066 (3)	AP4B1, SPG47, CPSQ5	607245	1p13.2	AP4B1
Spastic paraplegia 48, autosomal recessive, 613647 (3)	AP5Z1, KIAA0415, SPG48	613653	7p22.1	AP5Z1
Spastic paraplegia 49, autosomal recessive, 615031 (3)	TECPR2, KIAA0329, SPG49	615000	14q32.31	TECPR2
Spastic paraplegia 50, autosomal recessive, 612936 (3)	AP4M1, SPG50, CPSQ3	602296	7q22.1	AP4M1
Spastic paraplegia 51, autosomal recessive, 613744 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	AP4E1
Spastic paraplegia 52, autosomal recessive, 614067 (3)	AP4S1, CPSQ6, SPG52	607243	14q12	AP4S1
Spastic paraplegia 53, autosomal recessive, 614898 (3)	VPS37A, HCRP1, SPG53	609927	8p22	VPS37A
Spastic paraplegia 54, autosomal recessive, 615033 (3)	DDHD2, KIAA0725, SPG54	615003	8p11.23	DDHD2
Spastic paraplegia 55, autosomal recessive, 615035 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	C12orf65
Spastic paraplegia 56, autosomal recessive, 615030 (3)	CYP2U1, SPG56	610670	4q25	CYP2U1
Spastic paraplegia 5A, autosomal recessive, 270800 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	CYP7B1
Spastic paraplegia 6, autosomal dominant, 600363 (3)	NIPA1, SPG6	608145	15q11.2	NIPA1
Spastic paraplegia 62, 615681 (3)	ERLIN1, SPG62	611604	10q24.31	ERLIN1
Spastic paraplegia 64, autosomal recessive, 615683 (3)	ENTPD1, CD39, SPG64	601752	10q24.1	ENTPD1
Spastic paraplegia 7, autosomal recessive, 607259 (3)	PGN, SPG7, CMAR, CAR	602783	16q24.3	PGN
Spastic paraplegia 75, autosomal recessive, 616680 (3)	MAG, GMA, SPG75	159460	19q13.12	MAG
Spastic paraplegia 76, autosomal recessive, 616907 (3)	CAPN1, SPG76	114220	11q13.1	CAPN1
Spastic paraplegia 78, autosomal recessive, 617225 (3)	ATP13A2, PARK9, KRPPD, SPG78	610513	1p36.13	ATP13A2
Spastic paraplegia 79, autosomal recessive, 615491 (3)	UCHL1, PARK5, SPG79, NDGOA	191342	4p13	UCHL1
Spastic paraplegia 8, autosomal dominant, 603563 (3)	WSHC5, KIAA0196, SPG8, RTSC1	610657	8q24.13	WSHC5
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	HACE1, KIAA1320, SPPRS	610876	6q16.3	HACE1
Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3)	KIDINS220, ARMS, SINO	615759	2p25.1	KIDINS220
Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	KLC2, SPOAN	611729	11q13.2	KLC2
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	SLC1A4, SATT, ASCT1, SPATCCM	600229	2p14	SLC1A4
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	GLRX5
Specific granule deficiency 2, 617475 (3)	SMARCD2, BAF60B, SGD2	601736	17q23.3	SMARCD2
Specific granule deficiency, 245480 (3)	CEBPE, CRP1	600749	14q11.2	CEBPE
Specific language impairment QTL, 1 (2)	SLI1	606711	16q	SLI1
Specific language impairment QTL, 2 (2)	SLI2	606712	19q	SLI2
Specific language impairment QTL, 3 (2)	SLI3	607134	13q21	SLI3
Speech-language disorder-1, 602081 (3)	FOXP2, SPCH1, TNRC10, CAGH44	605317	7q31.1	FOXP2
Spermatocytic seminoma, somatic, 273300 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Spermatogenic failure 10, 614822 (3)	SEPT12, SPGF10	611562	16p13.3	SEPT12
Spermatogenic failure 11, 615081 (3)	KLHL10, SPGF11	608778	17q21.2	KLHL10
Spermatogenic failure 12, 615413 (3)	NANOS1, NOS1, SPGF12	608226	10q26.11	NANOS1
Spermatogenic failure 16, 617187 (3)	SUN5, TSARG4, SPAG4L, SPGF16	613942	20q11.21	SUN5
Spermatogenic failure 18, 617576 (3)	DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37	603332	3p21.1	DNAH1
Spermatogenic failure 19, 617592 (3)	CFAP43, WDR96, C10orf79, SPGF19	617558	10q25.1	CFAP43
Spermatogenic failure 2 (2)	SPGF2, ASG	108420	Chr.1	SPGF2
Spermatogenic failure 3, 606766 (3)	SLC26A8, TAT1, SPGF3	608480	6p21.31	SLC26A8
Spermatogenic failure 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SYCP3
Spermatogenic failure 5, 243060 (3)	AURKC, STK13, AIE2, SPGF5	603495	19q13.43	AURKC
Spermatogenic failure 7, 612997 (3)	CATSPER1, CATSPER, SPGF7	606389	11q13.1	CATSPER1
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4	184757	9q33.3	NR5A1
Spermatogenic failure 9, 613958 (3)	DPY19L2, SPGF9	613893	12q14.2	DPY19L2
Spermatogenic failure, X-linked, 2, 309120 (3)	TEX11, SPGFX2	300311	Xq13.1	TEX11
Spermatogenic failure, Y-linked, 1 (4)	DELYq11, CYDELq11, SPGFY1	400042	Yq11	DELYq11
Spermatogenic failure, Y-linked, 2, 415000 (3)	USP9Y, DFFRY, SPGFY2	400005	Yq11.221	USP9Y
Spherocytosis, type 1, 182900 (3)	ANK1, SPH1	612641	8p11.21	ANK1
Spherocytosis, type 2, 616649 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPTB
Spherocytosis, type 3, 270970 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPTA1
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Spherocytosis, type 5, 612690 (3)	EPB42, SPH5	177070	15q15.2	EPB42
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	TRIP4
Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	ASAH1, AC, SMAPME	613468	8p22	ASAH1
Spinal muscular atrophy, Jokela type, 615048 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	CHCHD10
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	UBA1
Spinal muscular atrophy, chronic distal, autosomal recessive (2)	SMAR	607088	11q13	SMAR
Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	ATP7A
Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	PLEKHG5
Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	DNAJB2, HSJ1, HSPF3, DSMA5	604139	2q35	DNAJB2
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	VAPB, VAPC, ALS8	605704	20q13.32	VAPB
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DYNC1H1
Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3)	BICD2, KIAA0699, SMALED2	609797	9q22.31	BICD2
Spinal muscular atrophy-1, 253300 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-2, 253550 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-3, 253400 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-4, 271150 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinocerebellar ataxia 1, 164400 (3)	ATXN1, ATX1, SCA1	601556	6p22.3	ATXN1
Spinocerebellar ataxia 10, 603516 (3)	ATXN10, SCA10	611150	22q13.31	ATXN10
Spinocerebellar ataxia 11, 604432 (3)	TTBK2, SCA11	611695	15q15.2	TTBK2
Spinocerebellar ataxia 12, 604326 (3)	PPP2R2B	604325	5q32	PPP2R2B
Spinocerebellar ataxia 13, 605259 (3)	KCNC3, SCA13	176264	19q13.33	KCNC3
Spinocerebellar ataxia 14, 605361 (3)	PRKCG, PKCC, PKCG, SCA14	176980	19q13.42	PRKCG
Spinocerebellar ataxia 15, 606658 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	ITPR1
Spinocerebellar ataxia 17, 607136 (3)	TBP, SCA17, HDL4	600075	6q27	TBP
Spinocerebellar ataxia 18 (2)	SCA18, SMNA	607458	7q22-q32	SCA18
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3
Spinocerebellar ataxia 2, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATXN2
Spinocerebellar ataxia 20 (4)	SCA20, DUP11q12, C11DUPq12	608687	11q12	SCA20
Spinocerebellar ataxia 21, 607454 (3)	TMEM240, C1orf70, SCA21	616101	1p36.33	TMEM240
Spinocerebellar ataxia 23, 610245 (3)	PDYN, SCA23	131340	20p13	PDYN
Spinocerebellar ataxia 25 (2)	SCA25	608703	2p21-p13	SCA25
Spinocerebellar ataxia 27, 609307 (3)	FGF14, FHF4, SCA27	601515	13q33.1	FGF14
Spinocerebellar ataxia 28, 610246 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	AFG3L2
Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	ITPR1
Spinocerebellar ataxia 31, 117210 (3)	BEAN, SCA31	612051	16q21	BEAN
Spinocerebellar ataxia 32 (2)	SCA32	613909	7q32-q33	SCA32
Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ELOVL4
Spinocerebellar ataxia 35, 613908 (3)	TGM6, TG6, TGY, SCA35	613900	20p13	TGM6
Spinocerebellar ataxia 36, 614153 (3)	NOP56, SCA36	614154	20p13	NOP56
Spinocerebellar ataxia 37, 615945 (3)	DAB1, SCA37	603448	1p32.2	DAB1
Spinocerebellar ataxia 38, 615957 (3)	ELOVL5, HELO1, SCA38	611805	6p12.1	ELOVL5
Spinocerebellar ataxia 4 (2)	SCA4	600223	16q22.1	SCA4
Spinocerebellar ataxia 42, 616795 (3)	CACNA1G, SCA42	604065	17q21.33	CACNA1G
Spinocerebellar ataxia 44, 617691 (3)	GRM1, MGLUR1, GRM1A, SCAR13, SCA44	604473	6q24.3	GRM1
Spinocerebellar ataxia 45, 617769 (3)	FAT2, MEGF1, SCA45	604269	5q33.1	FAT2
Spinocerebellar ataxia 5, 600224 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SPTBN2
Spinocerebellar ataxia 6, 183086 (3)	CACNA1A, CACNL1A4, SCA6, EIEE42	601011	19p13.13	CACNA1A
Spinocerebellar ataxia 7, 164500 (3)	ATXN7, SCA7, OPCA3	607640	3p14.1	ATXN7
Spinocerebellar ataxia 8, 608768 (3)	ATXN8	613289	13q21	ATXN8
Spinocerebellar ataxia 8, 608768 (3)	ATXN8OS, SCA8, KLHL1AS	603680	13q21.33	ATXN8OS
Spinocerebellar ataxia, X-linked 5 (2)	SCAX5	300703	Xq25-q27.1	SCAX5
Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	SETX
Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	ANO10, TMEM16K, SCAR10	613726	3p22.1-p21.3	ANO10
Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	SYT14, SCAR11	610949	1q32.2	SYT14
Spinocerebellar ataxia, autosomal recessive 12, 614322 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	WWOX
Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	GRM1, MGLUR1, GRM1A, SCAR13, SCA44	604473	6q24.3	GRM1
Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SPTBN2
Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	STUB1, CHIP, SCAR16	607207	16p13.3	STUB1
Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	CWF19L1, C19L1, SCAR17	616120	10q24.31	CWF19L1
Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	GRID2, SCAR18	602368	4q22.1-q22.2	GRID2
Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	PMPCA, KIAA0123, SCAR2	613036	9q34.3	PMPCA
Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	SNX14, SCAR20	616105	6q14.3	SNX14
Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	SCYL1, NTKL, SCAR21	607982	11q13.1	SCYL1
Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	TDP2, TTRAP	605764	6p22.3	TDP2
Spinocerebellar ataxia, autosomal recessive 3 (2)	SCAR3, SCABD	271250	6p23-p21	SCAR3
Spinocerebellar ataxia, autosomal recessive 4 (2)	SCAR4, SCASI	607317	1p36	SCAR4
Spinocerebellar ataxia, autosomal recessive 6 (2)	SCAR6, CLA3	608029	20q11-q13	SCAR6
Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	TPP1
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	SYNE1
Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)	TDP1	607198	14q32.11	TDP1
Split hand/foot malformation 1 (4)	SHFM1, SHFD1, SHSF1	183600	7q21.2-q21.3	SHFM1
Split hand/foot malformation 2 (2)	SHFM2, SHFD2	313350	Xq26	SHFM2
Split-foot malformation with mesoaxial polydactyly, 616890 (3)	ZAK, MLTK, MRK, SFMMP, CNM6	609479	2q31.1	ZAK
Split-hand/foot malformation 3, gene duplication syndrome (4)	SHFM3, SHSF3, DUP10q24, C10DUPq24	246560	10q24	SHFM3
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Split-hand/foot malformation 5 (2)	SHFM5	606708	2q31	SHFM5
Split-hand/foot malformation 6, 225300 (3)	WNT10B, SHFM6, STHAG8	601906	12q13.12	WNT10B
Split-hand/foot malformation with long bone deficiency 1 (2)	SHFL1, SHFLD	119100	1q42.2-q43	SHFL1
Split-hand/foot malformation with long bone deficiency 2 (2)	SHFLD2	610685	6q14.1	SHFLD2
Split-hand/foot malformation with long bone deficiency 3 (4)	SHFLD3, DUP17p13.3, C17DUPp13.3	612576	17p13.3-p13.1	SHFLD3
Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	NKX3-2, BAPX1, SMMD	602183	4p15.33	NKX3-2
Spondylocarpotarsal synostosis syndrome, 272460 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)	SLC39A13, ZIP13, SCDEDS	608735	11p11.2	SLC39A13
Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	DLL3, SCDO1	602768	19q13.2	DLL3
Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	MESP2, SCDO2	605195	15q26.1	MESP2
Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	HES7, SCDO4	608059	17p13.1	HES7
Spondylocostal dysostosis 5, 122600 (3)	TBX6, SCDO5	602427	16p11.2	TBX6
Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	ACP5, SPENCDI	171640	19p13.2	ACP5
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3)	B3GALT6, SEMDJL1, EDSSPD2	615291	1p36.33	B3GALT6
Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	KIF22, KNSL4, KID, OBP, SEMDJL2	603213	16p11.2	KIF22
Spondyloepimetaphyseal dysplasia, 608728 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	MATN3
Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3)	NANS, SAS, SEMDCG	605202	9q22.33	NANS
Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3)	RSPRY1, KIAA1972, SEMDFA	616585	16q13	RSPRY1
Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MMP13
Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3)	BGN, SEMDX, MRLS	301870	Xq28	BGN
Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	WISP3
Spondyloepiphyseal dysplasia tarda, 313400 (3)	TRAPPC2, SEDL, SEDT	300202	Xp22.2	TRAPPC2
Spondyloepiphyseal dysplasia tarda, autosomal dominant (2)	SPDT	184100	12q13	SPDT
Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	CHST3, C6ST, C6ST1, HSD	603799	10q22.1	CHST3
Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3)	COL2A1	120140	12q13.11	COL2A1
Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	DDR2, NTRKR3, TKT	191311	1q23.3	DDR2
Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	PCYT1A, CTPCT, PCYT1, SMDCRD	123695	3q29	PCYT1A
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	PAM16, MAGMAS, SMDMDM	614336	16p13.3	PAM16
Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	GPX4, SMDS	138322	19p13.3	GPX4
Spondylometaphyseal dysplasia, axial, 602271 (3)	C21orf2, SMDAX, RDMS	603191	21q22.3	C21orf2
Spondylometaphyseal dysplasia, corner fracture type, 184255 (3)	FN1, FN, LETS, FNZ, GFND2, SMDCF	135600	2q35	FN1
Spondyloocular syndrome, 605822 (3)	XYLT2, XT2, SOS	608125	17q21.33	XYLT2
Spondyloperipheral dysplasia, 271700 (3)	COL2A1	120140	12q13.11	COL2A1
Squamous cell carcinoma, burn scar-related, somatic (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	FAS
Squamous cell carcinoma, head and neck, 275355 (3)	TNFRSF10B, DR5, TRAILR2	603612	8p21.3	TNFRSF10B
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	ING1	601566	13q34	ING1
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Stankiewicz-Isidor syndrome, 617516 (3)	PSMD12, P55, STISS	604450	17q24.2	PSMD12
Stapes ankylosis with broad thumb and toes, 184460 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ELOVL4
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Steatocystoma multiplex, 184500 (3)	KRT17, PC2, PCHC1	148069	17q21.2	KRT17
Stickler sydrome, type I, nonsyndromic ocular, 609508 (3)	COL2A1	120140	12q13.11	COL2A1
Stickler syndrome, type I, 108300 (3)	COL2A1	120140	12q13.11	COL2A1
Stickler syndrome, type II, 604841 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
Stickler syndrome, type IV, 614134 (3)	COL9A1, EDM6, STL4	120210	6q13	COL9A1
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	SHROOM4, KIAA1202, SDSX	300579	Xp11.22	SHROOM4
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
Stormorken syndrome, 185070 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STIM1
Striatal degeneration, autosomal dominant, 609161 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	PDE8B
Striatal degeneration, autosomal dominant, 616922 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	PDE10A
Striatonigral degeneration, childhood-onset, 617054 (3)	VAC14, TAX1BP2, TRX, SNDC	604632	16q22.1-q22.2	VAC14
Striatonigral degeneration, infantile, 271930 (3)	NUP62, SNDI, IBSN	605815	19q13.33	NUP62
Stromme syndrome, 243605 (3)	CENPF, CILD31, STROMS	600236	1q41	CENPF
Structural heart defects and renal anomalies syndrome, 617478 (3)	TMEM260, C14orf101, SHDRA	617449	14q22.3	TMEM260
Sturge-Weber syndrome, somatic, mosaic, 185300 (3)	GNAQ, SWS, CMC1	600998	9q21.2	GNAQ
Stuttering, familial persistent, 1, 184450 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	AP4E1
Stuttering, familial persistent, 2 (2)	STUT2	609261	12q24.1	STUT2
Stuttering, familial persistent, 3 (2)	STUT3	614655	3q13.2-q13.33	STUT3
Stuttering, familial persistent, 4 (2)	STUT4	614668	16q12.1-q23.1	STUT4
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	LIFR, STWS, SWS, SJS2	151443	5p13.1	LIFR
Subcortical laminal heterotopia, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	DCX
Subcortical laminar heterotopia, 607432 (3)	PAFAH1B1, LIS1	601545	17p13.3	PAFAH1B1
Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	ALDH5A1, SSADH	610045	6p22.3	ALDH5A1
Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	OXCT1, OXCT, SCOT	601424	5p13.1	OXCT1
Sucrase-isomaltase deficiency, congenital, 222900 (3)	SI	609845	3q26.1	SI
Sudden cardiac failure, infantile, 617222 (3)	PPA2, SCFI, SCFAI	609988	4q24	PPA2
Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	TSPYL1, TSPYL, SIDDT	604714	6q22.1	TSPYL1
Sulfite oxidase deficiency, 272300 (3)	SUOX	606887	12q13.2	SUOX
Supernumerary der(22)t(8-22) syndrome (4)	DER22t8-22	613700	22q11.2	DER22t8-22
Supranuclear palsy, progressive atypical, 260540 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Supranuclear palsy, progressive, 2 (2)	PSNP2	609454	1q31.1	PSNP2
Supranuclear palsy, progressive, 3 (2)	PSNP3	610898	11p12-p11	PSNP3
Supranuclear palsy, progressive, 601104 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Supravalvar aortic stenosis, 185500 (3)	ELN, SVAS, ADCL1	130160	7q11.23	ELN
Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	SFTPB, SFTB3, SMDP1	178640	2p11.2	SFTPB
Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	SFTPC, SFTP2, SMDP2	178620	8p21.3	SFTPC
Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	ABCA3, ABC3, SMDP3	601615	16p13.3	ABCA3
Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	CSF2RA, SMDP4	306250	Xp22.33	CSF2RA
Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	CSF2RB, SMDP5	138981	22q12.3	CSF2RB
Sveinsson chorioretinal atrophy, 108985 (3)	TEAD1, TCF13, REF1	189967	11p15.3	TEAD1
Sweat chloride elevation without CF (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
Sweeney-Cox syndrome, 617746 (3)	TWIST1, ACS3, SCS, CRS1, SWCOS	601622	7p21.1	TWIST1
Symmetric circumferential skin creases, congenital, 1, 156610 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	TUBB
Symmetric circumferential skin creases, congenital, 2, 616734 (3)	MAPRE2, EB2, RP1, CSCSC2	605789	18q12.1-q12.2	MAPRE2
Symphalangism, proximal, 1A, 185800 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Syncope, familial vasovagal (2)	VVS	609289	15q26	VVS
Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	BHLHA9
Syndactyly, type 1, with or without craniosynostosis (4)	DUP2q35, C2DUPq35, SDTY1, SD1	185900	2q34-q36	DUP2q35
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3	121014	6q22.31	GJA1
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Syndactyly, type V, 186300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Synesthesia (2)	SYNSTH	612759	2q24.1	SYNSTH
Synpolydactyly 1, 186000 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Synpolydactyly 3 (2)	SPD3	610234	14q11.2-q12	SPD3
Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4)	FBLN1	135820	22q13.31	FBLN1
Systemic lupus erythematosus 16, 614420 (3)	DNASE1L3, SLEB16	602244	3p14.3	DNASE1L3
T-cell acute lymphoblastic leukemia, somatic, 613065 (3)	BAX	600040	19q13.33	BAX
T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	FOXN1, WHN	600838	17q11.2	FOXN1
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	STK4, MST1, KRS2, TIIAC	604965	20q13.12	STK4
T-cell prolymphocytic leukemia, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATM
TARP syndrome, 311900 (3)	RBM10, DXS8237E, KIAA0122, TARPS	300080	Xp11.3	RBM10
Takenouchi-Kosaki syndrome, 616737 (3)	CDC42, TKS	116952	1p36.12	CDC42
Tangier disease, 205400 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABCA1
Tarsal-carpal coalition syndrome, 186570 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Tatton-Brown-Rahman syndrome, 615879 (3)	DNMT3A, TBRS	602769	2p23.3	DNMT3A
Tay-Sachs disease, 272800 (3)	HEXA, TSD	606869	15q23	HEXA
Telangiectasia, hereditary benign (2)	HBT	187260	5q14	HBT
Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	ENG, END, HHT1, ORW	131195	9q34.11	ENG
Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	ACVRL1, ACVRLK1, ALK1, HHT2	601284	12q13.13	ACVRL1
Telangiectasia, hereditary hemorrhagic, type 3 (2)	HHT3, ORW3	601101	5q31.3-q32	HHT3
Telangiectasia, hereditary hemorrhagic, type 4 (2)	HHT4	610655	7p14	HHT4
Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	GDF2, BMP9, HHT5	605120	10q11.22	GDF2
Temple syndrome (4)	TEMPS	616222	14q32	TEMPS
Temple-Baraitser syndrome, 611816 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	KCNH1
Temtamy preaxial brachydactyly syndrome, 605282 (3)	CHSY1, KIAA0990, TPBS	608183	15q26.3	CHSY1
Temtamy syndrome, 218340 (3)	C12orf57, C10, TEMTYS	615140	12p13.31	C12orf57
Tenorio syndrome, 616260 (3)	RNF125, TRAC1, TNORS	610432	18q12.1	RNF125
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Testicular germ cell tumor (2)	TGCT1	300228	Xq27	TGCT1
Testicular tumor, somatic, 273300 (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Tetralogy of Fallot, 187500 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Tetralogy of Fallot, 187500 (3)	GATA6, AVSD5, ASD9, PACHD	601656	18q11.2	GATA6
Tetralogy of Fallot, 187500 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Tetralogy of Fallot, 187500 (3)	JAG1, AGS1, AHD	601920	20p12.2	JAG1
Tetralogy of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
Tetralogy of Fallot, 187500 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	ZFPM2
Tetrasomy 18p (4)	TET18P	614290	18p	TET18P
Thalassemia due to Hb Lepore (3)	HBD	142000	11p15.4	HBD
Thalassemia, Hispanic gamma-delta-beta, 613985 (3)	LCRB	152424	11p15.4	LCRB
Thalassemia, alpha-, 604131 (3)	HBA2, HBH	141850	16p13.3	HBA2
Thalassemia, delta- (3)	HBD	142000	11p15.4	HBD
Thalassemia-beta, dominant inclusion-body, 603902 (3)	HBB	141900	11p15.4	HBB
Thalassemias, alpha-, 604131 (3)	HBA1, HBH	141800	16p13.3	HBA1
Thalassemias, beta-, 613985 (3)	HBB	141900	11p15.4	HBB
Thanatophoric dysplasia, type I, 187600 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Thanatophoric dysplasia, type II, 187601 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Thauvin-Robinet-Faivre syndrome, 617107 (3)	FIBP, TROFAS	608296	11q13.1	FIBP
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	SLC19A3, THMD2, BBGD	606152	2q36.3	SLC19A3
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	SLC25A19
Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	TPK1, THMD5	606370	7q35	TPK1
Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	SLC19A2, THTR1, TRMA, THMD1	603941	1q24.2	SLC19A2
Thoracoabdominal syndrome (2)	THAS, TAS	313850	Xq25-q26.1	THAS
Thrombocythemia 1, 187950 (3)	THPO, MGDF, MPLLG, TPO, THCYT1	600044	3q27.1	THPO
Thrombocythemia 2, 601977 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPL
Thrombocythemia 3, 614521 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Thrombocythemia, X-linked (2)	THCYTX	300331	Chr.X	THCYTX
Thrombocythemia, somatic, 187950 (3)	CALR, SSA	109091	19p13.13	CALR
Thrombocythemia, somatic, 187950 (3)	SH2B3, LNK	605093	12q24.12	SH2B3
Thrombocytopenia 2, 188000 (3)	ANKRD26, KIAA1074, THC2	610855	10p12.1	ANKRD26
Thrombocytopenia 3, 273900 (3)	FYB, SLAP130, ADAP, THC3	602731	5p13.1	FYB
Thrombocytopenia 4, 612004 (3)	CYCS, CYC, THC4	123970	7p15.3	CYCS
Thrombocytopenia 5, 616216 (3)	ETV6, TEL, THC5	600618	12p13.2	ETV6
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Thrombocytopenia, X-linked, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Thrombocytopenia, X-linked, intermittent, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPL
Thrombocytopenia, neonatal alloimmune (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	ITGA2B
Thrombocytopenia-absent radius syndrome, 274000 (3)	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	605313	1q21.1	RBM8A
Thrombocytopenic purpura, autoimmune, 188030 (1)	FCGR2C, CD32C	612169	1q23.3	FCGR2C
Thrombophilia due to HRG deficiency, 613116 (3)	HRG, THPH11	142640	3q27.3	HRG
Thrombophilia due to activated protein C resistance, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
Thrombophilia due to antithrombin III deficiency, 613118 (3)	SERPINC1, AT3, AT3D, THPH7	107300	1q25.1	SERPINC1
Thrombophilia due to elevated HRG, 613116 (1)	HRG, THPH11	142640	3q27.3	HRG
Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	HCF2, HC2, SERPIND1, THPH10	142360	22q11.21	HCF2
Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	PROC
Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	PROC
Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)	PROS1, THPH5, THPH6	176880	3q11.1	PROS1
Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	PROS1, THPH5, THPH6	176880	3q11.1	PROS1
Thrombophilia due to thrombin defect, 188050 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
Thrombophilia due to thrombomodulin defect, 614486 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THBD
Thrombophilia, X-linked, due to factor IX defect, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)	PLAT, TPA	173370	8p11.21	PLAT
Thrombosis, hyperhomocysteinemic, 236200 (3)	CBS	613381	21q22.3	CBS
Thrombotic thrombocytopenic purpura, familial, 274150 (3)	ADAMTS13, VWFCP, TTP	604134	9q34.2	ADAMTS13
Thyroid adenoma, hyperfunctioning, somatic (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Thyroid carcinoma with thyrotoxicosis (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Thyroid carcinoma, follicular, 188470 (3)	MINPP1, HIPER1	605391	10q23.2	MINPP1
Thyroid carcinoma, follicular, somatic, 188470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)	TCO	603386	19p13.2	TCO
Thyroid carcinoma, papillary, with papillary renal neoplasia (2)	PTCPRN, PRN1	605642	1q21	PTCPRN
Thyroid dyshormonogenesis 1, 274400 (3)	SLC5A5, NIS, TDH1	601843	19p13.11	SLC5A5
Thyroid dyshormonogenesis 2A, 274500 (3)	TPO, TPX, TDH2A	606765	2p25.3	TPO
Thyroid dyshormonogenesis 3, 274700 (3)	TG, AITD3, TDH3	188450	8q24.22	TG
Thyroid dyshormonogenesis 4, 274800 (3)	IYD, DEHAL1, TDH4	612025	6q25.1	IYD
Thyroid dyshormonogenesis 5, 274900 (3)	DUOXA2, TDH5	612772	15q21.1	DUOXA2
Thyroid dyshormonogenesis 6, 607200 (3)	DUOX2, THOX2, TDH6	606759	15q21.1	DUOX2
Thyroid hormone metabolism, abnormal, 609698 (3)	SECISBP2, SBP2	607693	9q22.2	SECISBP2
Thyroid hormone resistance, 188570 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THRB
Thyroid hormone resistance, autosomal recessive, 274300 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THRB
Thyroid hormone resistance, selective pituitary, 145650 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THRB
Thyrotropin-releasing hormone deficiency, 275120 (1)	TRH	613879	3q22.1	TRH
Thyrotropin-releasing hormone resistance, generalized (3)	TRHR	188545	8q23.1	TRHR
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, SALMY	188840	2q31.2	TTN
Tietz albinism-deafness syndrome, 103500 (3)	MITF, WS2A, CMM8, COMMAD	156845	3p13	MITF
Timothy syndrome, 601005 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CACNA1C
Tn polyagglutination syndrome, somatic, 300622 (3)	C1GALT1C1, COSMC, C1GALT2, TNPS	300611	Xq24	C1GALT1C1
Toenail dystrophy, isolated, 607523 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Tolbutamide poor metabolizer (3)	CYP2C9	601130	10q23.33	CYP2C9
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	MSX1
Tooth agenesis, selective, 2 (2)	STHAG2, HYD2	602639	16q12.1	STHAG2
Tooth agenesis, selective, 3, 604625 (3)	PAX9, STHAG3	167416	14q13.3	PAX9
Tooth agenesis, selective, 4, 150400 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	WNT10A
Tooth agenesis, selective, 5 (2)	STHAG5	610926	10q11.2-q21	STHAG5
Tooth agenesis, selective, 7, 616724 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	LRP6
Tooth agenesis, selective, 8, 617073 (3)	WNT10B, SHFM6, STHAG8	601906	12q13.12	WNT10B
Tooth agenesis, selective, 9, 617275 (3)	GREM2, PRDC, STHAG9	608832	1q43	GREM2
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, HED1, STHAGX1	300451	Xq13.1	EDA
Total anomalous pulmonary venous return (2)	TAPVR1	106700	4q12	TAPVR1
Tourette syndrome (2)	GTS	137580	11q23	GTS
Tourette syndrome, 137580 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	SLITRK1
Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	SALL1
Townes-Brocks syndrome 1, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	SALL1
Traboulsi syndrome, 601552 (3)	ASPH, HAAH, FDLAB	600582	8q12.3	ASPH
Transaldolase deficiency, 606003 (3)	TALDO1	602063	11p15.5	TALDO1
Transcobalamin II deficiency, 275350 (3)	TCN2, TC2	613441	22q12.2	TCN2
Transient bullous of the newborn, 131705 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Transient erythroblastopenia of childhood (2)	TEC	227050	19q13.2	TEC
Transposition of great arteries, dextro-looped 3, 613854 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	MED13L
Treacher Collins syndrome 1, 154500 (3)	TCOF1, MFD1, TCS1	606847	5q32-q33	TCOF1
Treacher Collins syndrome 2, 613717 (3)	POLR1D, RPA16, RPAC2, TCS2	613715	13q12.2	POLR1D
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	POLR1C
Trehalase deficiency, 612119 (1)	TREH	275360	11q23.3	TREH
Trichilemmal cyst 1 (2)	TRICY1	609649	3p24-p21.2	TRICY1
Trichodontoosseous syndrome, 190320 (3)	DLX3, TDO, AI4	600525	17q21.33	DLX3
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CYLD
Trichoepithelioma, multiple familial, 2 (2)	MFT2, TEM	612099	9p21	MFT2
Trichohepatoenteric syndrome 1, 222470 (3)	TTC37, KIAA0372	614589	5q15	TTC37
Trichohepatoenteric syndrome 2, 614602 (3)	SKIV2L, SKI2, SKI2W, THES2	600478	6p21.33	SKIV2L
Trichomegaly, 190330 (3)	FGF5, TCMGLY	165190	4q21.21	FGF5
Trichorhinophalangeal syndrome, type I, 190350 (3)	TRPS1	604386	8q23.3	TRPS1
Trichorhinophalangeal syndrome, type II (4)	TRPS2, LGCR, LGS	150230	8q24.11-q24.13	TRPS2
Trichorhinophalangeal syndrome, type III, 190351 (3)	TRPS1	604386	8q23.3	TRPS1
Trichothiodystrophy 1, photosensitive, 601675 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	ERCC2
Trichothiodystrophy 2, photosensitive, 616390 (3)	ERCC3, XPB, TTD2	133510	2q14.3	ERCC3
Trichothiodystrophy 3, photosensitive, 616395 (3)	GTF2H5, TTD3, TFB5, C6orf175, TTDA	608780	6q25.3	GTF2H5
Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	609188	7p14.1	MPLKIP
Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	GTF2E2, TTD6	189964	8p12	GTF2E2
Trifunctional protein deficiency, 609015 (3)	HADHA, MTPA	600890	2p23.3	HADHA
Trifunctional protein deficiency, 609015 (3)	HADHB	143450	2p23.3	HADHB
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Trigonocephaly 2, 614485 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	FREM1
Trimethylaminuria, 602079 (3)	FMO3, TMAU	136132	1q24.3	FMO3
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Trismus-pseudocamptodactyly syndrome, 158300 (3)	MYH8, DA7	160741	17p13.1	MYH8
Tropical calcific pancreatitis, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	SPINK1
Troyer syndrome, 275900 (3)	SPG20	607111	13q13.3	SPG20
Trypsinogen deficiency, 614044 (1)	PRSS1, TRY1	276000	7q34	PRSS1
Tuberous sclerosis-1, 191100 (3)	TSC1, LAM	605284	9q34.13	TSC1
Tuberous sclerosis-2, 613254 (3)	TSC2, LAM	191092	16p13.3	TSC2
Tukel syndrome (2)	TUKLS	609428	21q22	TUKLS
Tumor predisposition syndrome, 614327 (3)	BAP1, TPDS	603089	3p21.1	BAP1
Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	SAMD9
Tumoral calcinosis, hyperphosphatemic, 211900 (3)	KL, KLOTHO	604824	13q13.1	KL
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	FGF23
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	GALNT3, HHS, HFTC	601756	2q24.3	GALNT3
Turner syndrome-associated neurocognitive phenotype (2)	VSPA	313000	Xp22.33	VSPA
Tylosis with esophageal cancer, 148500 (3)	RHBDF2, IRHOM2, TOC	614404	17q25.1	RHBDF2
Tyrosinemia, type I, 276700 (3)	FAH	613871	15q25.1	FAH
Tyrosinemia, type II, 276600 (3)	TAT	613018	16q22.2	TAT
Tyrosinemia, type III, 276710 (3)	HPD	609695	12q24.31	HPD
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
UV-sensitive syndrome 2, 614621 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	ERCC8
UV-sensitive syndrome 3, 614640 (3)	UVSSA, KIAA1530, UVSS3	614632	4p16.3	UVSSA
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	COL6A1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	COL6A2
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	COL6A3
Ulna and fibula, absence of, with severe limb deficiency, 276820 (3)	WNT7A	601570	3p25.1	WNT7A
Ulnar-mammary syndrome, 181450 (3)	TBX3	601621	12q24.21	TBX3
Uncombable hair syndrome, 191480 (3)	PADI3, UHS1	606755	1p36.13	PADI3
Urbach-Wiethe disease, 247100 (3)	ECM1, URBWD	602201	1q21.2	ECM1
Urofacial syndrome 1, 236730 (3)	HPSE2, HPA2, UFS1	613469	10q24.2	HPSE2
Urofacial syndrome 2, 615112 (3)	LRIG2, LIG2, KIAA0806, UFS2	608869	1p13.2	LRIG2
Usher syndrome type 3B, 614504 (3)	HARS, USH3B, CMT2W	142810	5q31.3	HARS
Usher syndrome, type 1B, 276900 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	MYO7A
Usher syndrome, type 1C, 276904 (3)	USH1C, DFNB18A	605242	11p15.1	USH1C
Usher syndrome, type 1D, 601067 (3)	CDH23, USH1D, DFNB12, PITA5	605516	10q22.1	CDH23
Usher syndrome, type 1D/F digenic, 601067 (3)	CDH23, USH1D, DFNB12, PITA5	605516	10q22.1	CDH23
Usher syndrome, type 1D/F digenic, 601067 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	PCDH15
Usher syndrome, type 1E (2)	USH1E	602097	21q21	USH1E
Usher syndrome, type 1F, 602083 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	PCDH15
Usher syndrome, type 1G, 606943 (3)	SANS, USH1G	607696	17q25.1	SANS
Usher syndrome, type 1H (2)	USH1H	612632	15q22-q23	USH1H
Usher syndrome, type 2A, 276901 (3)	USH2A, RP39	608400	1q41	USH2A
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	ADGRV1
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	ADGRV1
Usher syndrome, type 2D, 611383 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	WHRN
Usher syndrome, type 3A, 276902 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	CLRN1
Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3)	PDZD7	612971	10q24.31	PDZD7
Usher syndrome, type IJ, 614869 (3)	CIB2, KIP2	605564	15q25.1	CIB2
Usher syndrome, type IK (2)	USH1K	614990	10p11.21-q21.1	USH1K
VACTERL association, X-linked, 314390 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	ZIC3
VATER association with macrocephaly and ventriculomegaly, 276950 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
VLCAD deficiency, 201475 (3)	ACADVL, VLCAD	609575	17p13.1	ACADVL
Van Buchem disease, 239100 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	DCHS1
Van Maldergem syndrome 2, 615546 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	FAT4
Van den Ende-Gupta syndrome, 600920 (3)	SCARF2, SREC2, VDEGS	613619	22q11.21	SCARF2
Van der Woude syndrome 2, 606713 (3)	GRHL3, SOM, TFCP2L4, VWS2	608317	1p36.11	GRHL3
Vas deferens, congenital bilateral aplasia of, X-linked, 300985 (3)	ADGRG2, GPR64, HE6, CBAVDX	300572	Xp22.13	ADGRG2
Vascular malformation, primary intraosseous, 606893 (3)	ELMO2, CED12, VMPI	606421	20q13.12	ELMO2
Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
Venous malformations, multiple cutaneous and mucosal, 600195 (3)	TEK, TIE2, VMCM, GLC3E	600221	9p21.2	TEK
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Ventricular septal defect 1, 614429 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Ventricular septal defect 2, 614431 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	CITED2
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	RYR2
Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	CASQ2	114251	1p13.1	CASQ2
Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)	CPVT3	614021	7p22-p14	CPVT3
Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3)	TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3	617242	4q13.1	TECRL
Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	CALM1
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	TRDN, TDN, CPVT5	603283	6q22.31	TRDN
Ventricular tachycardia, idiopathic, 192605 (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GNAI2
Ventriculomegaly with cystic kidney disease, 219730 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	CRB2
Verheij syndrome, 615583 (3)	PUF60, FIR, SIAHBP1, VRJS	604819	8q24.3	PUF60
Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3)	HAAO, VCRL1	604521	2p21	HAAO
Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)	KYNU, KYNUU, VCRL2	605197	2q22.2	KYNU
Vertical talus, congenital, 192950 (3)	HOXD10, HOX4D	142984	2q31.1	HOXD10
Vertigo, benign recurrent, 2 (2)	BRV2	613106	22q12	BRV2
Vesicoureteral reflux (2)	VUR	193000	1p13	VUR
Vesicoureteral reflux 2, 610878 (3)	ROBO2, SAX3, KIAA1568	602431	3p12.3	ROBO2
Vesicoureteral reflux 3, 613674 (3)	SOX17, VUR3	610928	8q11.23	SOX17
Vesicoureteral reflux 4 (2)	VUR4	614317	5q14.2	VUR4
Vesicoureteral reflux 5 (2)	VUR5	614318	13q33.2	VUR5
Vesicoureteral reflux 6 (2)	VUR6	614319	18q12.3	VUR6
Vesicoureteral reflux 7 (2)	VUR7	615390	12p11-q13	VUR7
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL, VUR8	600985	6p21.33-p21.32	TNXB
Vestibulopathy, familial (2)	BPPV	193007	6q	BPPV
Vibratory urticaria, 125630 (3)	ADGRE2, EMR2, VBU	606100	19p13.12	ADGRE2
Vici syndrome, 242840 (3)	EPG5, KIAA1632, HEEW1, VICIS	615068	18q12.3-q21.1	EPG5
Visceral myopathy, 155310 (3)	ACTG2, ACTA3, VSCM	102545	2p13.1	ACTG2
Vitamin D-dependent rickets, type I, 264700 (3)	CYP27B1, VDD1, PDDR	609506	12q14.1	CYP27B1
Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3)	GGCX, VKCFD1	137167	2p11.2	GGCX
Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKORC1
Vitreoretinochoroidopathy, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Vitreoretinopathy with phalangeal epiphyseal dysplasia (3)	COL2A1	120140	12q13.11	COL2A1
Vitreoretinopathy, neovascular inflammatory, 193235 (3)	CAPN5, HTRA3, VRNI	602537	11q13.5	CAPN5
Vohwinkel syndrome with ichthyosis, 604117 (3)	LOR	152445	1q21.3	LOR
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
WAGRO syndrome (4)	WAGRO, DEL11p14p12	612469	11p13-p12	WAGRO
WHIM syndrome, 193670 (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	CXCR4
Waardenburg syndrome, type 1, 193500 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Waardenburg syndrome, type 2A, 193510 (3)	MITF, WS2A, CMM8, COMMAD	156845	3p13	MITF
Waardenburg syndrome, type 2B (2)	WS2B	600193	1p21-p13.3	WS2B
Waardenburg syndrome, type 2C (2)	WS2C	606662	8p23	WS2C
Waardenburg syndrome, type 2D, 608890 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	SNAI2
Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	SOX10
Waardenburg syndrome, type 3, 148820 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Waardenburg syndrome, type 4A, 277580 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	EDNRB
Waardenburg syndrome, type 4B, 613265 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	EDN3
Waardenburg syndrome, type 4C, 613266 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	SOX10
Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
Waardenburg syndrome/ocular albinism, digenic, 103470 (3)	MITF, WS2A, CMM8, COMMAD	156845	3p13	MITF
Wagner syndrome 1, 143200 (3)	VCAN, CSPG2, WGN, WGN1, ERVR	118661	5q14.2-q14.3	VCAN
Warburg micro syndrome 1, 600118 (3)	RAB3GAP1, WARBM1, P130	602536	2q21.3	RAB3GAP1
Warburg micro syndrome 2, 614225 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	RAB3GAP2
Warburg micro syndrome 3, 614222 (3)	RAB18, WARBM3	602207	10p12.1	RAB18
Warburg micro syndrome 4, 615663 (3)	TBC1D20, C20orf140, WARBM4	611663	20p13	TBC1D20
Warfarin resistance, 122700 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKORC1
Warfarin sensitivity, 122700 (3)	CYP2C9	601130	10q23.33	CYP2C9
Warsaw breakage syndrome, 613398 (3)	DDX11, CHLR1, KRG2	601150	12p11.21	DDX11
Watson syndrome, 193520 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Weaver syndrome, 277590 (3)	EZH2, EZH1, WVS	601573	7q36.1	EZH2
Wegener granulomatosis (2)	WG	608710	6p21.3	WG
Wegener-like granulomatosis (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	TAP2
Weill-Marchesani syndrome 1, recessive, 277600 (3)	ADAMTS10, WMS1	608990	19p13.2	ADAMTS10
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Weill-Marchesani-like syndrome, 613195 (3)	ADAMTS17	607511	15q26.3	ADAMTS17
Welander distal myopathy, 604454 (3)	TIA1, WDM	603518	2p13.3	TIA1
Werner syndrome, 277700 (3)	RECQL2, RECQ3, WRN	604611	8p12	RECQL2
Weyers acrofacial dysostosis, 193530 (3)	EVC2, LBN, WAD	607261	4p16.2	EVC2
White sponge nevus 1, 193900 (3)	KRT4, CYK4, WSN1	123940	12q13.13	KRT4
White sponge nevus 2, 615785 (3)	KRT13, WSN2	148065	17q21.2	KRT13
White-Sutton syndrome, 616364 (3)	POGZ, KIAA0461, MRD37, WHSUS	614787	1q21.3	POGZ
Wieacker-Wolff syndrome, 314580 (3)	ZC4H2, KIAA1166, WRWF	300897	Xq11.2	ZC4H2
Wiedemann-Steiner syndrome, 605130 (3)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	KMT2A
Williams-Beuren syndrome (4)	WBS, WMS, WS, DEL7q11, C7DELq11	194050	7q11.23	WBS
Wilms tumor 2, 194071 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	H19
Wilms tumor, 194070 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	DEL11p13, C11DELp13, WAGR	194072	11p13	DEL11p13
Wilms tumor, somatic, 194070 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	GPC3
Wilms tumor, type 1, 194070 (3)	WT1, NPHS4	607102	11p13	WT1
Wilms tumor, type 3 (2)	WT3	194090	16q	WT3
Wilms tumor, type 4 (2)	WT4	601363	17q12-q21	WT4
Wilson disease, 277900 (3)	ATP7B, WND	606882	13q14.3	ATP7B
Wilson-Turner syndrome, 309585 (3)	LAS1L, WTS	300964	Xq12	LAS1L
Wiskott-Aldrich syndrome, 301000 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Witteveen-Kolk syndrome, 613406 (3)	SIN3A, WITKOS	607776	15q24.2	SIN3A
Wolcott-Rallison syndrome, 226980 (3)	EIF2AK3, PEK, PERK, WRS	604032	2p11.2	EIF2AK3
Wolf-Hirschhorn syndrome (4)	WHS	194190	4p16.3	WHS
Wolff-Parkinson-White syndrome, 194200 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	PRKAG2
Wolfram syndrome 1, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
Wolfram syndrome 2, 604928 (3)	CISD2, WFS2, ZCD2, ERIS	611507	4q24	CISD2
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
Wolman disease, 278000 (3)	LIPA, CESD	613497	10q23.31	LIPA
Woodhouse-Sakati syndrome, 241080 (3)	DCAF17, C20orf37	612515	2q31.1	DCAF17
Woods-Black-Norbury syndrome (2)	INDX	300076	Xq26-qter	INDX
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT74
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	LPAR6
Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	LIPH
Woolly hair, autosomal recessive 3, 616760 (3)	KRT25, K25, KRT24IRS1, ARWH3	616646	17q21.2	KRT25
Wrinkly skin syndrome, 278250 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	ATP6V0A2
X inactivation, familial skewed, 2 (2)	SXI2	300179	Xq25-q26	SXI2
X-inactivation, familial skewed, 300087 (3)	XIC, XCE, XIST, SXI1	314670	Xq13.2	XIC
Xanthinuria, type I, 278300 (3)	XDH, XAN1	607633	2p23.1	XDH
Xanthinuria, type II, 603592 (3)	MOCOS, MCS, XAN2	613274	18q12.2	MOCOS
Xeroderma pigmentosum, group A, 278700 (3)	XPA, XPAC	611153	9q22.33	XPA
Xeroderma pigmentosum, group B, 610651 (3)	ERCC3, XPB, TTD2	133510	2q14.3	ERCC3
Xeroderma pigmentosum, group C, 278720 (3)	XPC, XPCC	613208	3p25.1	XPC
Xeroderma pigmentosum, group D, 278730 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	ERCC2
Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	DDB2	600811	11p11.2	DDB2
Xeroderma pigmentosum, group F, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
Xeroderma pigmentosum, group G, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	ERCC5
Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	ERCC5
Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
Xeroderma pigmentosum, variant type, 278750 (3)	POLH, XPV	603968	6p21.1	POLH
Xia-Gibbs syndrome, 615829 (3)	AHDC1, MRD25	615790	1p36.1-p35.3	AHDC1
Xp11.22 microduplication syndrome (4)	DUPXp11.22, MRX17, MRX31	300705	Xp11.22	DUPXp11.22
Xq25 duplication syndrome (4)	DUPXq25	300979	Xq25	DUPXq25
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	TELO2
Yuan-Harel-Lupski syndrome (4)	YUHAL	616652	17p12-p11.2	YUHAL
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
ZTTK syndrome, 617140 (3)	SON, TOKIMS	182465	21q22.11	SON
Zimmermann-Laband syndrome 1, 135500 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	KCNH1
Zimmermann-Laband syndrome 2, 616455 (3)	ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ATP6V1B2
Zinc deficiency, transient neonatal, 608118 (3)	SLC30A2, ZNT2, TNZD	609617	1p36.11	SLC30A2
Zygodactyly 1 (2)	ZD1	609815	3p21.31	ZD1
[?Birbeck granule deficiency], 613393 (3)	CD207, LANGERIN, CLEC4K	604862	2p13.3	CD207
[?Homosexuality, male] (2)	HMS1, GAY1	306995	Xq28	HMS1
[?Hyperproglucagonemia] (1)	GCG	138030	2q24.2	GCG
[?Hypertryptophanemia], 600627 (3)	TDO2, TPH2, TRPO, HYPTRP	191070	4q32.1	TDO2
[?Phosphohydroxylysinuria], 615011 (3)	PHYKPL, AGXT2L2, PHLU	614683	5q35.3	PHYKPL
[AMP deaminase deficiency, erythrocytic], 612874 (3)	AMPD3	102772	11p15.4	AMPD3
[Acetylation, slow], 243400 (3)	NAT2, AAC2	612182	8p22	NAT2
[Alpha-actinin-3 deficiency], 617749 (3)	ACTN3, ACTN3D	102574	11q13.2	ACTN3
[Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
[Angiotensin I-converting enzyme, benign serum increase] (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
[Anhaptoglobinemia], 614081 (3)	HP	140100	16q22.2	HP
[Aquaporin-1 deficiency] (3)	AQP1, CHIP28, CO	107776	7p14.3	AQP1
[Axillary odor, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	ABCC11
[Beta-aminoisobutyric acid, urinary excretion of], 210100 (3)	AGXT2, AGT2, BAIBA	612471	5p13.2	AGXT2
[Beta-glycopyranoside tasting] (3)	TAS2R16, T2R16	604867	7q31.32	TAS2R16
[Bilirubin, serum level of, QTL1], 601816 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
[Birth weight QTL 1] (2)	FGQTL2, BWQTL1	613219	7p15-p13	FGQTL2
[Birth weight QTL 2] (2)	BWQTL2	613459	3q25.3	BWQTL2
[Birth weight QTL 3] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	FGQTL6
[Birth weight QTL4] (2)	BWQTL4	615192	6p22.3	BWQTL4
[Blood group Cromer], 613793 (3)	CD55, DAF, CROM, CHAPLE	125240	1q32.2	CD55
[Blood group GIL], 607457 (3)	AQP3	600170	9p13.3	AQP3
[Blood group, ABO system], 616093 (3)	ABO	110300	9q34.2	ABO
[Blood group, Auberger system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	LU
[Blood group, Colton], 110450 (3)	AQP1, CHIP28, CO	107776	7p14.3	AQP1
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Dombrock], 616060 (3)	ART4, DO, DOK1	110600	12p12.3	ART4
[Blood group, Duffy system], 110700 (3)	ACKR1, DARC, FY, GPD, WBCQ1	613665	1q23.2	ACKR1
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Gerbich], 616089 (3)	GYPC, GE, GPC	110750	2q14.3	GYPC
[Blood group, Ii], 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	GCNT2
[Blood group, Indian system], 609027 (3)	CD44, MDU2, MDU3, MIC4, IN	107269	11p13	CD44
[Blood group, John-Milton-Hagen system], 614745 (3)	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	607961	15q24.1	SEMA7A
[Blood group, Kell], 110900 (3)	KEL	613883	7q34	KEL
[Blood group, Kidd], 111000 (3)	SLC14A1, JK, UTE, UT1	613868	18q12.3	SLC14A1
[Blood group, Knops system], 607486 (3)	CR1, C3BR	120620	1q32.2	CR1
[Blood group, Landsteiner-Wiener], 111250 (3)	ICAM4, CD242, LW	614088	19p13.2	ICAM4
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
[Blood group, Lewis] (3)	FUT3, LE	111100	19p13.3	FUT3
[Blood group, Lutheran null], 247420 (3)	LU, AU, BCAM	612773	19q13.32	LU
[Blood group, Lutheran system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	LU
[Blood group, MN] (3)	GYPA, MN, GPA	111300	4q31.21	GYPA
[Blood group, OK], 111380 (3)	BSG	109480	19p13.3	BSG
[Blood group, P1PK system, P(k) phenotype], 111400 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	B3GALT3
[Blood group, P1Pk system, P(2) phenotype], 111400 (3)	A4GALT, P1PK	607922	22q13.2	A4GALT
[Blood group, P1Pk system, p phenotype], 111400 (3)	A4GALT, P1PK	607922	22q13.2	A4GALT
[Blood group, Radin], 111620 (3)	ERMAP, SC, RD	609017	1p34.2	ERMAP
[Blood group, Raph], 179620 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	CD151
[Blood group, Rhesus], 111690 (3)	RHCE	111700	1p36.11	RHCE
[Blood group, Rodgers], 614374 (3)	C4A, C4S, C4AD	120810	6p21.33	C4A
[Blood group, Scianna system], 111750 (3)	ERMAP, SC, RD	609017	1p34.2	ERMAP
[Blood group, Ss] (3)	GYPB, SS, MNS	111740	4q31.21	GYPB
[Blood group, Stoltzfus system] (2)	SF	111800	4q28-q31	SF
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Vel system], 615264 (3)	SMIM1, VEL	615242	1p36.32	SMIM1
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, XG system] (3)	XG	314700	Xpter-p22.32	XG
[Blood group, Yt system], 112100 (3)	ACHE, YT	100740	7q22.1	ACHE
[Blood group, globoside system], 615021 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	B3GALT3
[Blood pressure regulation QTL], 145500 (2)	ATP1B1	182330	1q24.2	ATP1B1
[Blood pressure regulation QTL], 145500 (2)	RGS5	603276	1q23.3	RGS5
[Blood pressure regulation QTL], 145500 (2)	SELE, ELAM1	131210	1q24.2	SELE
[Body mass index QTL 15] (2)	BMIQ15	612967	17q23.2-q25.1	BMIQ15
[Body mass index QTL13] (2)	BMIQ13	612459	2q14.1	BMIQ13
[Body mass index QTL16] (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	BMIQ16
[Body mass index QTL1] (2)	BMIQ1	606641	7q32.3	BMIQ1
[Body mass index QTL2] (2)	BMIQ2	606643	13q14	BMIQ2
[Body mass index QTL3] (2)	BMIQ3	607446	6q23-q25	BMIQ3
[Body mass index QTL5] (2)	BMIQ5	608558	16p13	BMIQ5
[Body mass index QTL6] (2)	BMIQ6	608559	20pter-p11.2	BMIQ6
[Bombay phenotype] (3)	FUT2, SE, B12QTL1	182100	19q13.33	FUT2
[Bombay phenotype], 616754 (3)	FUT1, H, HH	211100	19q13.33	FUT1
[Bone mineral density QTL 10] (2)	BMND10	612113	8q24	BMND10
[Bone mineral density QTL 11] (2)	BMND11	612114	6q25	BMND11
[Bone mineral density QTL 13] (2)	BMND13	612727	16q23	BMND13
[Bone mineral density QTL 14] (2)	BMND14	612728	1p33-p32	BMND14
[Bone mineral density QTL 15], 613418 (3)	MIR2861, MIRN2861, BMND15	613405	9q34.11	MIR2861
[Bone mineral density QTL 2] (2)	BMND2	605833	1q21-q23	BMND2
[Bone mineral density QTL 3] (2)	BMND3	606928	1p36	BMND3
[Bone mineral density QTL 4] (2)	BMND4	300536	Xq27	BMND4
[Bone mineral density QTL 5] (2)	BMND5	609354	11q23	BMND5
[Bone mineral density QTL 6] (2)	BMND6	609876	21q22.13-qter	BMND6
[Bone mineral density QTL 9] (2)	BMND9	612110	13q14	BMND9
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
[Bone size quantitative trait locus 3] (2)	BSZQTL3	610649	8q24	BSZQTL3
[C-reactive protein QTL] (2)	CPROTQ	611920	10q23-q24	CPROTQ
[C3HEX, ability to smell], 615082 (3)	OR2J3, C3HEXS	615016	6p22.1	OR2J3
[Chitotriosidase deficiency], 614122 (3)	CHIT, CHITD	600031	1q32.1	CHIT
[Cholesterol level QTL 1] (2)	CLQTL1, CLF	604595	13q	CLQTL1
[Cholesterol level QTL 2] (2)	CLQTL2	610760	2p24-p22	CLQTL2
[Cinnamon odor, pleasantness of] (2)	CINN	611109	4q32.3	CINN
[Colostrum secretion, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	ABCC11
[Creatine kinase, brain type, ectopic expression of] (2)	CKBE	123270	14q32	CKBE
[Dopamine-beta-hydroxylase activity levels, plasma] (3)	DBH	609312	9q34.2	DBH
[Dysalbuminemic hyperthyroxinemia], 615999 (3)	ALB, ANALBA, FDAH	103600	4q13.3	ALB
[Dystransthyretinemic hyperthyroxinemia], 145680 (3)	TTR, PALB	176300	18q12.1	TTR
[Earwax, wet/dry], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	ABCC11
[Eculizumab, poor response to], 615749 (3)	C5, C5D, ECLZB	120900	9q33.2	C5
[Eosinophil peroxidase deficiency], 261500 (3)	EPX, EPXD	131399	17q22	EPX
[Erythrocytosis, familial, 1], 133100 (3)	EPOR	133171	19p13.2	EPOR
[Ezetimibe, nonresponse to] (3)	NPC1L1	608010	7p13	NPC1L1
[Fasting insulin level quantitative trait locus 1] (2)	FIQTL1	606035	6q22-q24	FIQTL1
[Fasting plasma glucose level QTL 1] (2)	FGQTL1	612108	2q24-q32	FGQTL1
[Fasting plasma glucose level QTL 2] (2)	FGQTL2, BWQTL1	613219	7p15-p13	FGQTL2
[Fasting plasma glucose level QTL 3] (2)	FGQTL3	613233	11q21-q22	FGQTL3
[Fasting plasma glucose level QTL 4] (2)	FGQTL4	613462	7p21.2	FGQTL4
[Fasting plasma glucose level QTL 5], 613463 (3)	GCKR, GKRP, FGQTL5	600842	2p23.3	GCKR
[Fasting plasma glucose level QTL 6] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	FGQTL6
[Fetal hemoglobin QTL5] (2)	HBFQTL5	142335	2p16.1	HBFQTL5
[Fleck retina, familial benign], 228980 (3)	PLA2G5, FRFB	601192	1p36.13	PLA2G5
[Fructosuria], 229800 (3)	KHK	614058	2p23.3	KHK
[Gamma-glutamyltransferase, familial high serum] (2)	GGT2	137181	22q11.21	GGT2
[Gilbert syndrome], 143500 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
[Glycerol quantitative trait locus], 614411 (3)	AQP7, GLYCQTL	602974	9p13.3	AQP7
[Glyoxalase II deficiency], 614033 (1)	HAGH, GLO2	138760	16p13.3	HAGH
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDAR
[Handedness] (2)	HSR	139900	2p12-q22	HSR
[Hematocrit/hemoglobin quantitative trait locus 1] (2)	HCHGQ1	609319	6q23	HCHGQ1
[Hematocrit/hemoglobin quantitative trait locus 2] (2)	HCHGQ2	609320	9q	HCHGQ2
[Hematocrit/hemoglobin quantitative trait locus 3] (2)	HCHGQ3	613284	22q12-q13	HCHGQ3
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	EGLN1
[Hereditary persistence of alpha-fetoprotein], 615970 (3)	AFP, HPAFP, AFPD	104150	4q13.3	AFP
[Hereditary persistence of fetal hemoglobin], 613566 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	KLF1
[Hex A pseudodeficiency], 272800 (3)	HEXA, TSD	606869	15q23	HEXA
[High density lipoprotein cholesterol level QTL 10], 143470 (3)	CETP, HDLCQ10	118470	16q13	CETP
[High density lipoprotein cholesterol level QTL 11] (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LPL
[High density lipoprotein cholesterol level QTL 12], 612797 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPC
[High density lipoprotein cholesterol level QTL 1] (2)	HDLCQ1	606613	9p	HDLCQ1
[High density lipoprotein cholesterol level QTL 2] (2)	HDLCQ2	607053	8q23	HDLCQ2
[High density lipoprotein cholesterol level QTL 4] (2)	HDLCQ4	610239	4q32.3	HDLCQ4
[High density lipoprotein cholesterol level QTL 5] (2)	HDLCQ5	610761	3q24-q26	HDLCQ5
[High density lipoprotein cholesterol level QTL 8] (3)	VNN1, HDLCQ8	603570	6q23.2	VNN1
[High density lipoprotein cholesterol level QTL 9] (3)	PLTP, HDLCQ9	172425	20q13.12	PLTP
[High density lipoprotein cholesterol level QTL6], 610762 (3)	SCARB1, CD36L1, CLA1, HDLQTL6	601040	12q24.31	SCARB1
[High molecular weight kininogen deficiency], 228960 (3)	KNG1, KNG	612358	3q27.3	KNG1
[Histidinemia], 235800 (3)	HAL, HSTD	609457	12q23.1	HAL
[Hyperphenylalaninemia, non-PKU mild], 261600 (3)	PAH, PKU1	612349	12q23.2	PAH
[Hyperproreninemia] (3)	REN, HNFJ2	179820	1q32.1	REN
[Hypoceruloplasminemia, hereditary], 604290 (3)	CP	117700	3q24-q25	CP
[Hypohaptoglobinemia], 614081 (3)	HP	140100	16q22.2	HP
[IMPDH2 enzyme activity, variation in] (3)	IMPDH2, IMPD2	146691	3p21.31	IMPDH2
[IgE, elevated level of], 147050 (3)	IL21R	605383	16p12.1	IL21R
[IgG receptor I, phagocytic, familial deficiency of] (3)	FCGR1A, IGFR1, CD64	146760	1q21.2	FCGR1A
[Inosine triphosphatase deficiency], 613850 (3)	ITPA, EIEE35	147520	20p13	ITPA
[Interleukin 6, serum level of, QTL], 614752 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6R
[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6R
[Junior blood group system], 614490 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	ABCG2
[Kallikrein, decreased urinary activity of], 615953 (3)	KLK1, KLKR	147910	19q13.33	KLK1
[Kininogen deficiency], 228960 (3)	KNG1, KNG	612358	3q27.3	KNG1
[LPA deficiency, congenital] (3)	LPA	152200	6q25-q26	LPA
[Lactate dehydrogenase-B deficiency], 614128 (3)	LDHB, LDHBD	150100	12p12.1	LDHB
[Lean body mass QTL 1] (2)	LBMQTL1	612729	8q23	LBMQTL1
[Leptin serum levels QTL1] (2)	LEPQTL1, LSL	601694	2p21	LEPQTL1
[Longevity 1] (2)	LGV1	152430	4q25	LGV1
[Longevity 2] (2)	LGV2	606460	6q21	LGV2
[Low density lipoprotein cholesterol level QTL 3] (3)	HMGCR, LDLCQ3	142910	5q13.3	HMGCR
[Low density lipoprotein cholesterol level QTL6], 613589 (3)	SORT1, NT3, LDLCQ6	602458	1p13.3	SORT1
[Macrothrombocytopenia] (1)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Maleylacetoacetate isomerase deficiency], 617596 (3)	GSTZ1, MAAI, MAAID	603758	14q24.3	GSTZ1
[Mean platelet volume QTL1] (2)	MPVQTL1	612573	12q24.31	MPVQTL1
[Mean platelet volume QTL2] (2)	MPVQTL2	612574	3p21-p13	MPVQTL2
[Mean platelet volume QTL3] (2)	MPVQTL3	612575	17q11.2	MPVQTL3
[Memory, enhanced, QTL], 615602 (3)	WWC1, KIBRA, KIAA0869, MEMRYQTL	610533	5q34	WWC1
[Musical aptitude QTL 1] (2)	MUSQTL1	612343	4q22	MUSQTL1
[Novelty seeking personality], 601696 (1)	DRD4	126452	11p15.5	DRD4
[Obesity, resistance to] (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
[Pentosuria], 260800 (3)	DCXR, P34H, PNTSU	608347	17q25.3	DCXR
[Phenylthiocarbamide tasting], 171200 (3)	TAS2R38, T2R61, PTC	607751	7q34	TAS2R38
[Placental lactogen deficiency] (1)	CSH1, CSA, PL	150200	17q23.3	CSH1
[Plasma glucose, 2-hour, QTL 1] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	FGQTL6
[Plasma glucose, 2-hour, QTL 2] (2)	GIPR, PGQTL2	137241	19q13.32	GIPR
[Polyunsaturated fatty acids plasma level QTL1] (2)	PURAQTL1	612795	11q12-q13.1	PURAQTL1
[Premature chromatid separation trait], 176430 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUB1B
[Protein Z deficiency], 614024 (3)	PROZ, PZ	176895	13q34	PROZ
[QT interval, variation in] (2)	QTV	610141	1q23.3	QTV
[Respiratory rhythmicity in sleep] (2)	RRIS	609116	10q26	RRIS
[Resting heart rate], 607276 (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	ADRB1
[Rh-negative blood type] (3)	RHD	111680	1p36.11	RHD
[Sarcosinemia], 268900 (3)	SARDH, SARD, SAR	604455	9q34.2	SARDH
[Sedoheptulokinase deficiency], 617213 (3)	SHPK, CARKL	605060	17p13.2	SHPK
[Sex hormone-binding globulin circulating level QTL 1] (2)	SXGQTL1	613498	17p13	SXGQTL1
[Short sleeper], 612975 (3)	BHLHE41, BHLHB3, DEC2, SHARP1	606200	12p12.1	BHLHE41
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	HERC2
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	HERC2
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	TPCN2, TPC2, SHEP10	612163	11q13.3	TPCN2
[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	SLC24A5
[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SLC24A4
[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SLC24A4
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	KITLG
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	ASIP
[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	ASIP
[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	TYRP1
[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	IRF4, LSIRF, SHEP8	601900	6p25.3	IRF4
[Social cognition] (2)	CGF1	300082	Xq	CGF1
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
[Sprinting performance], 617749 (3)	ACTN3, ACTN3D	102574	11q13.2	ACTN3
[Statins, attenuated cholesterol lowering by] (3)	HMGCR, LDLCQ3	142910	5q13.3	HMGCR
[Superoxide dismutase, elevated extracellular] (3)	SOD3	185490	4p15.2	SOD3
[Telomere length, mean leukocyte] (2)	TELM	609113	14q23.2	TELM
[Thyroid-stimulating hormone level QTL 1] (2)	TSHQTL1	612306	5q13	TSHQTL1
[Thyroxine-binding globulin QTL], 300932 (3)	TBG, TBGQTL	314200	Xq22.3	TBG
[Transferrin serum level QTL2], 614193 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
[Tuberculin skin test reactivity QTL] (2)	TST2	613637	5p15	TST2
[Tuberculin skin test reactivity, absence of] (2)	TST1	613636	11p14	TST1
[Urate oxidase deficiency] (1)	UOX	191540	1p22	UOX
[Uric acid concentration, serum, QTL1], 138900 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	ABCG2
[Uric acid concentration, serum, QTL4], 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	SLC17A3
[Uric acid concentration, serum, QTL5] (2)	UAQTL5	614746	19q13	UAQTL5
[Uric acid concentration, serum, QTL6] (2)	UAQTL6	614747	1q21.1	UAQTL6
[Visuospatial/perceptual abilities] (2)	VSPA	313000	Xp22.33	VSPA
[White blood cell count QTL], 611862 (3)	ACKR1, DARC, FY, GPD, WBCQ1	613665	1q23.2	ACKR1
imperfecta, type III, 259420 (3)	COL1A2, EDSCV, EDSARTH2	120160	7q21.3	COL1A2
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	IRF6
von Hippel-Lindau syndrome, 193300 (3)	VHL	608537	3p25.3	VHL
von Willebrand disease, platelet-type, 177820 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
von Willebrand disease, type 1, 193400 (3)	VWF, F8VWF	613160	12p13.31	VWF
von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)	VWF, F8VWF	613160	12p13.31	VWF
von Willibrand disease, type 3, 277480 (3)	VWF, F8VWF	613160	12p13.31	VWF
{46XY sex reversal 8, modifier of}, 614279 (3)	AKR1C4, CHDR, CDR, HAKRA, DD4	600451	10p15.1	AKR1C4
{?Allergy and asthma susceptibility} (2)	IGES	147061	5q31.1	IGES
{?Amyloidosis, secondary, susceptibility to} (1)	APCS, SAP	104770	1q23.2	APCS
{?Autism susceptibility 16}, 613410 (3)	SLC9A9, AUTS16	608396	3q24	SLC9A9
{?Breast cancer susceptibility}, 114480 (1)	NQO2, NMOR2	160998	6p25.2	NQO2
{?Hearing loss, cisplatin-induced, susceptibility to} (2)	CIHL	613290	6p22.3	CIHL
{?Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	ANTXR1
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	TRAF3
{?Herpes simplex encephalitis, susceptibility to, 7}, 616532 (3)	IRF3, IIAE7	603734	19q13.33	IRF3
{?Hypertension, essential} (1)	ACSM3, SAH	145505	16p12.3	ACSM3
{?IgA nephropathy, susceptibility to, 3}, 616818 (3)	SPRY2, IGAN3	602466	13q31.1	SPRY2
{?Macular degeneration, age-related}, 603075 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
{?Major affective disorder 2} (2)	MAFD2, MDX	309200	Xq28	MAFD2
{?Membranous nephropathy, susceptibility to} (2)	MBNP	614692	6p21.3	MBNP
{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	MRAP2, C6orf117, BMIQ18	615410	6q14.2	MRAP2
{?Obesity, susceptibility to}, 601665 (3)	CARTPT, CART	602606	5q13.2	CARTPT
{?Parkinson disease 5, susceptibility to}, 613643 (3)	UCHL1, PARK5, SPG79, NDGOA	191342	4p13	UCHL1
{?SLE susceptibility} (1)	CR1, C3BR	120620	1q32.2	CR1
{?Schizophrenia susceptibility 18}, 615232 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	SLC1A1
{?Schizophrenia, susceptibility to}, 603013 (1)	NRG1, HGL, HRGA, ARIA	142445	8p12	NRG1
{?Schizophrenia}, 181500 (2)	SCZD2	603342	11q14-q21	SCZD2
{?Thyroid cancer, nonmedullary, 5}, 616535 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	HABP2
{AIDS, delayed/rapid progression to}, 609423 (3)	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.42	KIR3DL1
{AIDS, rapid progression to}, 609423 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{AIDS, resistance to}, 609423 (3)	CXCL12, SDF1	600835	10q11.21	CXCL12
{AIDS, slow progression to}, 609423 (3)	CXCR1, IL8RA	146929	2q35	CXCR1
{AIDS, slow progression to}, 609423 (3)	IL4R, IL4RA	147781	16p12.1	IL4R
{Abacavir hypersensitivity, susceptibility to} (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Accelerated tumor formation, susceptibility to}, 614401 (3)	MDM2, ACTFS	164785	12q15	MDM2
{Adiponectin, serum level of, QTL2} (2)	ADIPQTL2, CAQ5	606770	5p15.2-p14	ADIPQTL2
{Adiponectin, serum level of, QTL3} (2)	ADIPQTL3, CAQ14	606771	14p11.2-q13	ADIPQTL3
{Adiponectin, serum level of, QTL4} (2)	ADIPQTL4	612629	11q23-q24	ADIPQTL4
{Adiponectin, serum level of, QTL5] (2)	ADIPQTL5	613836	16q23.3	ADIPQTL5
{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	ADH1B, ADH2	103720	4q23	ADH1B
{Age-related hearing impairment 1} (2)	ARHI1	612448	8q24.13-q24.22	ARHI1
{Age-related hearing impairment 2} (2)	ARHI2	612976	3p26.1-p25.1	ARHI2
{Albinism, oculocutaneous, type II, modifier of}, 203200 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
{Alcohol dependence, protection against}, 103780 (3)	ADH1B, ADH2	103720	4q23	ADH1B
{Alcohol dependence, protection against}, 103780 (3)	ADH1C, ADH3	103730	4q23	ADH1C
{Alcohol dependence, susceptibility to}, 103780 (3)	GABRA2	137140	4p12	GABRA2
{Alcohol dependence, susceptibility to}, 103780 (3)	HTR2A	182135	13q14.2	HTR2A
{Alcohol dependence, susceptibility to}, 103780 (3)	TAS2R16, T2R16	604867	7q31.32	TAS2R16
{Alkaline phosphatase, plasma level of, QTL 2} (2)	ALPQTL2	612367	1p36	ALPQTL2
{Alkaline phosphatase, plasma level of, QTL1} (2)	ALPQTL1	171720	9q34.13	ALPQTL1
{Alkaline phosphatase, plasma level of, QTL3} (2)	ALPQTL3	612368	6p22	ALPQTL3
{Alkaline phosphatase, plasma level of, QTL4} (2)	ALPQTL4	612369	10q21	ALPQTL4
{Allergic rhinitis, susceptibility to}, 607154 (3)	IL13, ALRH, BHR1	147683	5q31.1	IL13
{Alzheimer disease 12} (2)	AD12	611073	8p12-q22	AD12
{Alzheimer disease 16} (2)	AD16	300756	Xq21.3	AD16
{Alzheimer disease 18, susceptibility to}, 615590 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	ADAM10
{Alzheimer disease 9, susceptibility to}, 608907 (3)	ABCA7, ABCX, AD9	605414	19p13.3	ABCA7
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	NOS3	163729	7q36.1	NOS3
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	PLAU
{Alzheimer disease, susceptibility to}, 104300 (3)	A2M , A2MD	103950	12p13.31	A2M 
{Alzheimer disease, susceptibility to}, 104300 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Alzheimer disease, susceptibility to}, 104300 (3)	MPO	606989	17q22	MPO
{Alzheimer disease-13} (2)	AD13	611152	1q21	AD13
{Alzheimer disease-14} (2)	AD14	611154	1q25	AD14
{Alzheimer disease-15} (2)	AD15	611155	3q22-q24	AD15
{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATXN2
{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	DCTN1, HMN7B	601143	2p13.1	DCTN1
{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	PRPH	170710	12q13.12	PRPH
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	TRPM7, LTRPC7, CHAK, ALSPDC	605692	15q21.2	TRPM7
{Aneurysm, familial abdominal 3} (2)	AAA3	611891	9p21	AAA3
{Aneurysm, intracranial berry, 10} (2)	ANIB10	612587	8q12.1	ANIB10
{Aneurysm, intracranial berry, 6} (2)	ANIB6	611892	9p21	ANIB6
{Aneurysm, intracranial berry, 9} (2)	ANIB9	612586	2q33.1	ANIB9
{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)	XPNPEP2, AEACEI	300145	Xq26.1	XPNPEP2
{Anorexia nervosa, susceptibility to, 1} (2)	ANON1	606788	1p	ANON1
{Anorexia nervosa, susceptibility to}, 606788 (3)	HTR2A	182135	13q14.2	HTR2A
{Anorexia nervosa, susceptibility to}, 610269 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Antisocial behavior}, 300615 (3)	MAOA, BRNRS	309850	Xp11.3	MAOA
{Anxiety-related personality traits}, 607834 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	SLC6A4
{Aortic aneurysm, familial thoracic 11, susceptibility to}, 617349 (3)	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11	601094	1p33	FOXE3
{Aplastic anemia, susceptibility to}, 609135 (3)	SBDS, SDS	607444	7q11.21	SBDS
{Aplastic anemia}, 609135 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Aplastic anemia}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TERC
{Asperger syndrome susceptibility 1} (2)	ASPG1	608638	3q25-q27	ASPG1
{Asperger syndrome susceptibility 2} (2)	ASPG2	608631	17p13	ASPG2
{Asperger syndrome susceptibility 3} (2)	ASPG3	608781	1q21-q22	ASPG3
{Asperger syndrome susceptibility 4} (2)	ASPG4	609954	3p24-p21	ASPG4
{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	NLGN3
{Asperger syndrome susceptibility, X-linked 2}, 300497 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	NLGN4
{Aspergillosis, susceptibility to}, 614079 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CLEC7A
{Asthma susceptibility 5}, 611064 (3)	IRAK3, IRAKM, ASRT5	604459	12q14.3	IRAK3
{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	PTGER2	176804	14q22.1	PTGER2
{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	TBX21, TBET	604895	17q21.32	TBX21
{Asthma, diminished response to antileukotriene treatment in}, 600807 (3)	ALOX5	152390	10q11.21	ALOX5
{Asthma, nocturnal, susceptibility to}, 600807 (3)	ADRB2	109690	5q32	ADRB2
{Asthma, protection against}, 600807 (3)	MUC7	158375	4q13.3	MUC7
{Asthma, susceptibility to, 1}, 607277 (3)	PTGDR, AS1, ASRT1	604687	14q22.1	PTGDR
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	NPSR1
{Asthma, susceptibility to}, 600807 (2)	HLA-G	142871	6p22.1	HLA-G
{Asthma, susceptibility to}, 600807 (3)	CCL11, SCYA11	601156	17q12	CCL11
{Asthma, susceptibility to}, 600807 (3)	HNMT, MRT51	605238	2q22.1	HNMT
{Asthma, susceptibility to}, 600807 (3)	IL13, ALRH, BHR1	147683	5q31.1	IL13
{Asthma, susceptibility to}, 600807 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PLA2G7
{Asthma, susceptibility to}, 600807 (3)	SCGB3A2, UGRP1	606531	5q32	SCGB3A2
{Asthma, susceptibility to}, 600807 (3)	TNF, TNFA	191160	6p21.33	TNF
{Asthma-related traits, susceptibility to, 3} (2)	ASRT3	609958	2p16	ASRT3
{Asthma-related traits, susceptibility to, 4} (2)	ASRT4	610906	1p31	ASRT4
{Asthma-related traits, susceptibility to, 6} (2)	ASRT6	611403	17q21	ASRT6
{Asthma-related traits, susceptibility to, 7}, 611960 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	CHI3L1
{Asthma-related traits, susceptibility to, 8} (2)	ASRT8	613207	9q33	ASRT8
{Atherosclerosis, susceptibility to} (2)	ATHS, ALP	108725	19p13.3-p13.2	ATHS
{Atherosclerosis, susceptibility to} (3)	ALOX5	152390	10q11.21	ALOX5
{Atherosclerosis, susceptibility to} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Atopy, susceptibility to}, 147050 (3)	IL4R, IL4RA	147781	16p12.1	IL4R
{Atopy, susceptibility to}, 147050 (3)	MS4A2, FCER1B	147138	11q12.1	MS4A2
{Atopy, susceptibility to}, 147050 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PLA2G7
{Atrial fibrillation, familial, 5} (2)	ATFB5	611494	4q25	ATFB5
{Atrioventricular septal defect, susceptibility to, 1} (2)	AVSD1, AVCD	606215	1p31-p21	AVSD1
{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3)	CRELD1, AVSD2	607170	3p25.3	CRELD1
{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)	ADHD5	612311	2q21.1	ADHD5
{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)	ADHD6	612312	13q12.11	ADHD6
{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	TPH2
{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD5
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD1	608903	16p13	ADHD1
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD2	608904	17p11	ADHD2
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD3	608905	6q12	ADHD3
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD4	608906	5p13	ADHD4
{Attention deficit-hyperactivity disorder}, 143465 (3)	DRD4	126452	11p15.5	DRD4
{Autism susceptibility 11} (2)	AUTS11	610836	1q41-q42	AUTS11
{Autism susceptibility 12} (2)	AUTS12	610838	21p13-q11	AUTS12
{Autism susceptibility 13} (2)	AUTS13	610908	12q14.2	AUTS13
{Autism susceptibility 14A} (2)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	DEL16p11.2
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CNTNAP2
{Autism susceptibility 17}, 613436 (3)	SHANK2, CORTBP1, AUTS17	603290	11q13.3-q13.4	SHANK2
{Autism susceptibility 1} (2)	AUTS1	209850	7q22	AUTS1
{Autism susceptibility 3} (2)	AUTS3	608049	13q14.2-q14.1	AUTS3
{Autism susceptibility 4} (2)	AUTS4	608636	15q11	AUTS4
{Autism susceptibility 5} (2)	AUTS5	606053	2q	AUTS5
{Autism susceptibility 6} (2)	AUTS6	609378	17q11	AUTS6
{Autism susceptibility 7} (2)	AUTS7	610676	17q21	AUTS7
{Autism susceptibility 8} (2)	AUTS8	607373	3q25-q27	AUTS8
{Autism susceptibility, X-linked 1}, 300425 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	NLGN3
{Autism susceptibility, X-linked 2}, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	NLGN4
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13	300005	Xq28	MECP2
{Autism, susceptibility to, 10} (2)	AUTS10	611016	7q36	AUTS10
{Autism, susceptibility to, 14B} (2)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	DUP16p11.2
{Autism, susceptibility to, 18}, 615032 (3)	CHD8, DUPLIN, KIAA1564, AUTS18	610528	14q11.2	CHD8
{Autism, susceptibility to, 19}, 615091 (3)	EIF4E, EIF4EL1, AUTS19	133440	4q23	EIF4E
{Autism, susceptibility to, 9} (2)	AUTS9	611015	7q31	AUTS9
{Autism, susceptibility to, X-linked 4}, 300830 (3)	PTCHD1, AUTSX4	300828	Xp22.11	PTCHD1
{Autism, susceptibility to, X-linked 5}, 300847 (3)	RPL10, DXS648, QM, AUTSX5, MRXS35	312173	Xq28	RPL10
{Autism, susceptibility to, X-linked 6}, 300872 (3)	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	300777	Xq28	TMLHE
{Autoimmune disease, susceptibility to, 1}, 607836 (3)	FOXD3, AIS1, VAMAS2	611539	1p31.3	FOXD3
{Autoimmune disease, susceptibility to, 2} (2)	AIS2, VAMAS3	608391	Chr.7	AIS2
{Autoimmune disease, susceptibility to, 3} (2)	AIS3, VAMAS4	608392	Chr.8	AIS3
{Autoimmune disease, susceptibility to, 4} (2)	AIS4, VAMAS5	609400	4q13-q21	AIS4
{Autoimmune disease, susceptibility to, 5} (2)	CELIAC6, AIS5	611598	4q27	CELIAC6
{Autoimmune disease, susceptibility to, 6}, 613551 (3)	SIAE, AIS6	610079	11q24.2	SIAE
{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3)	COPA, AILJK	601924	1q23.2	COPA
{Autoimmune lymphoproliferative syndrome}, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	FAS
{Autoimmune thyroid disease, susceptibility to, 1} (2)	AITD1	608173	6p11	AITD1
{Autoimmune thyroid disease, susceptibility to, 2} (2)	AITD2	608174	5q31-q33	AITD2
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	TG, AITD3, TDH3	188450	8q24.22	TG
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	ZFAT1, ZNF406, AITD3	610931	8q24.22	ZFAT1
{Autoimmune thyroid disease, susceptibility to, 4} (2)	AITD4	608176	10q	AITD4
{Bacteremia, protection against}, 614382 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Bacteremia, susceptibility to}, 614383 (3)	CISH, BACTS2	602441	3p21.2	CISH
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	ARL6, BBS3, RP55	608845	3q11.2	ARL6
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	CCDC28B, MGC1203	610162	1p35.2	CCDC28B
{Bardet-Biedl syndrome 14, modifier of}, 615991 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
{Basal cell carcinoma 7}, 614740 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
{Basal cell carcinoma, susceptibility to, 1} (2)	BCC1	605462	1p36	BCC1
{Basal cell carcinoma, susceptibility to, 2} (2)	BCC2	613058	1q42	BCC2
{Basal cell carcinoma, susceptibility to, 3} (2)	BCC3	613059	5p15.33	BCC3
{Basal cell carcinoma, susceptibility to, 4} (2)	BCC4	613061	12q13	BCC4
{Basal cell carcinoma, susceptibility to, 5} (2)	BCC5	613062	9p21	BCC5
{Basal cell carcinoma, susceptibility to, 6} (2)	BCC6	613063	7q32	BCC6
{Benzene toxicity, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NQO1
{Beryllium disease, chronic, susceptibility to} (3)	HLA-DPB1	142858	6p21.32	HLA-DPB1
{Biliary cirrhosis, primary, 2} (2)	PBC2	613007	6p21.3	PBC2
{Biliary cirrhosis, primary, 3} (2)	PBC3	613008	1p31.2	PBC3
{Bladder cancer, somatic}, 109800 (3)	HRAS	190020	11p15.5	HRAS
{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	TBXA2R, BDPLT13	188070	19p13.3	TBXA2R
{Blepharospasm, primary benign}, 606798 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD5
{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	UGT2B17, BMND12	601903	4q13.2	UGT2B17
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1	120150	17q21.33	COL1A1
{Bone mineral density, low, susceptibility to}, 615311 (3)	LGR4, GPR48, BNMD17	606666	11p14.1	LGR4
{Bone size QTL} (2)	BSZQTL	609656	17q23	BSZQTL
{Bone size QTL} (2)	BSZQTL2	609657	5q	BSZQTL2
{Breast and colorectal cancer, susceptibility to} (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
{Breast cancer, invasive ductal}, 114480 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	RAD54L
{Breast cancer, lobular}, 114480 (3)	CDH1, UVO, LCAM, ECAD, BCDS1	192090	16q22.1	CDH1
{Breast cancer, male, susceptibility to}, 114480 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Breast cancer, poor survival after chemotherapy for} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NQO1
{Breast cancer, protection against}, 114480 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
{Breast cancer, susceptibility to}, 114480 (3)	ATM, ATA, AT1	607585	11q22.3	ATM
{Breast cancer, susceptibility to}, 114480 (3)	BARD1	601593	2q35	BARD1
{Breast cancer, susceptibility to}, 114480 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
{Breast cancer, susceptibility to}, 114480 (3)	HMMR	600936	5q34	HMMR
{Breast cancer, susceptibility to}, 114480 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PALB2
{Breast cancer, susceptibility to}, 114480 (3)	PHB	176705	17q21.33	PHB
{Breast cancer, susceptibility to}, 114480 (3)	RAD51A, RECA, MRMV2, FANCR	179617	15q15.1	RAD51A
{Breast cancer, susceptibility to}, 114480 (3)	XRCC3, CMM6	600675	14q32.33	XRCC3
{Breast cancer}, 114480 (1)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Breast-ovarian cancer, familial, 1}, 604370 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	BRCA1
{Breast-ovarian cancer, familial, 2}, 612555 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	RAD51C
{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	RAD51D, RAD51L3, BROVCA4	602954	17q12	RAD51D
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
{Budd-Chiari syndrome, somatic}, 600880 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
{Budd-Chiari syndrome}, 600880 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Bulimia nervosa, age of onset of weight loss in}, 607499 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Bulimia nervosa, susceptibility to} (2)	BULN	607499	10p	BULN
{Buruli ulcer, susceptibility to}, 610446 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	NRAMP1
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
{Cancer progression/metastasis} (3)	FGFR4	134935	5q35.2	FGFR4
{Cardiac conduction defect, susceptibility to}, 115080 (3)	AKAP10	604694	17p11.2	AKAP10
{Cataract 28, age-related cortical, susceptibility to} (2)	CTRCT28, ARCC1	609026	6p12-q12	CTRCT28
{Celiac disease, susceptibility to, 10} (2)	CELIAC10	612008	3q25-q26	CELIAC10
{Celiac disease, susceptibility to, 11} (2)	CELIAC11	612009	3q28	CELIAC11
{Celiac disease, susceptibility to, 12} (2)	CELIAC12	612010	6q25.3	CELIAC12
{Celiac disease, susceptibility to, 13} (2)	CELIAC13	612011	12q24	CELIAC13
{Celiac disease, susceptibility to, 2} (2)	CELIAC2	609754	5q31-q33	CELIAC2
{Celiac disease, susceptibility to, 3}, 609755 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Celiac disease, susceptibility to, 4}, 609753 (3)	MYO9B, MYR5, CELIAC4	602129	19p13.11	MYO9B
{Celiac disease, susceptibility to, 5} (2)	CELIAC5, GSES	607202	15q11-q13	CELIAC5
{Celiac disease, susceptibility to, 6} (2)	CELIAC6, AIS5	611598	4q27	CELIAC6
{Celiac disease, susceptibility to, 7} (2)	CELIAC7	612005	1q31	CELIAC7
{Celiac disease, susceptibility to, 8} (2)	CELIAC8	612006	2q11-q12	CELIAC8
{Celiac disease, susceptibility to, 9} (2)	CELIAC9	612007	3p21	CELIAC9
{Celiac disease, susceptibility to}, 212750 (3)	HLA-DQA1, CELIAC1	146880	6p21.32	HLA-DQA1
{Celiac disease, susceptibility to}, 212750 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	HLA-DQB1
{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	MTMR14, C3orf29, HJUMPY	611089	3p25.3	MTMR14
{Cerebral infarction, susceptibility to}, 601367 (3)	PRKCH, PKCL, PRKCL	605437	14q23.1	PRKCH
{Chordoma, susceptibility to} (4)	CHDM	215400	6q27	CHDM
{Chronic infections, due to MBL deficiency}, 614372 (3)	MBL2, MBL, MBP1, MBL2D, MBPD	154545	10q21.1	MBL2
{Chronic mountain sickness, susceptibility to} (2)	CMTS	616182	12q13	CMTS
{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	KRT18	148070	12q13.13	KRT18
{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	KRT8	148060	12q13.13	KRT8
{Codeine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	CYP2D6
{Colchicine resistance}, 120080 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	ABCB1
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	AURKA
{Colonic adenoma recurrence, reduced risk of}, 114500 (3)	ODC1	165640	2p25.1	ODC1
{Colorectal cancer, susceptibility to, 10}, 612591 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	POLD1
{Colorectal cancer, susceptibility to, 11} (2)	CRCS11	612592	20p12.3	CRCS11
{Colorectal cancer, susceptibility to, 12}, 615083 (3)	POLE1, CRCS12, FILS	174762	12q24.33	POLE1
{Colorectal cancer, susceptibility to, 1}, 608812 (3)	GALNT12, CRCS1	610290	9q22.33	GALNT12
{Colorectal cancer, susceptibility to, 2} (2)	CRCS2	611469	8q24	CRCS2
{Colorectal cancer, susceptibility to, 3}, 612229 (3)	SMAD7, MADH7, CRCS3	602932	18q21.1	SMAD7
{Colorectal cancer, susceptibility to, 4} (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	HMPS1
{Colorectal cancer, susceptibility to, 5} (2)	CRCS5	612230	10p14	CRCS5
{Colorectal cancer, susceptibility to, 6} (2)	CRCS6	612231	8q23	CRCS6
{Colorectal cancer, susceptibility to, 7} (2)	CRCS7	612232	11q23	CRCS7
{Colorectal cancer, susceptibility to, 8} (2)	CRCS8	612589	14q22.2	CRCS8
{Colorectal cancer, susceptibility to, 9} (2)	CRCS9	612590	16q22.1	CRCS9
{Colorectal cancer, susceptibility to}, 114500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	CCND1
{Colorectal cancer, susceptibility to}, 114500 (3)	TLR2, TIL4	603028	4q31.3	TLR2
{Colorectal cancer}, 114500 (3)	PLA2G2A, PLA2B, PLA2L, MOM1	172411	1p36.13	PLA2G2A
{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23	612666	1q32.1	DSTYK
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRA2C, ADRA2L2	104250	4p16.3	ADRA2C
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	ADRB1
{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABCA1
{Coronary artery disease, autosomal dominant, 1}, 608320 (3)	MEF2A, ADCAD1	600660	15q26.3	MEF2A
{Coronary artery disease, autosomal dominant, 2}, 610947 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	LRP6
{Coronary artery disease, modifier of} (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{Coronary artery disease, resistance to}, 607339 (3)	CX3CR1, GPR13, V28	601470	3p22.2	CX3CR1
{Coronary artery disease, severe, susceptibility to}, 617347 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
{Coronary artery disease, susceptibility to} (1)	LPA	152200	6q25-q26	LPA
{Coronary artery disease, susceptibility to} (3)	IRS1	147545	2q36.3	IRS1
{Coronary artery disease, susceptibility to} (3)	KL, KLOTHO	604824	13q13.1	KL
{Coronary artery disease, susceptibility to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Coronary artery disease, susceptibility to} (3)	PON2	602447	7q21.3	PON2
{Coronary artery spasm 1, susceptibility to} (3)	NOS3	163729	7q36.1	NOS3
{Coronary artery spasm 2, susceptibility to (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Coronary heart disease, susceptibility to, 2} (2)	CHDS2	608316	2q21.1-q22	CHDS2
{Coronary heart disease, susceptibility to, 3} (2)	CHDS3	300464	Xq23-q26	CHDS3
{Coronary heart disease, susceptibility to, 4} (2)	CHDS4	608318	14q32	CHDS4
{Coronary heart disease, susceptibility to, 5}, 608901 (3)	KALRN, HAPIP, DUO, CHDS5	604605	3q21.1-q21.2	KALRN
{Coronary heart disease, susceptibility to, 6}, 614466 (3)	MMP3, STMY1, CHDS6	185250	11q22.2	MMP3
{Coronary heart disease, susceptibility to, 7}, 610938 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
{Coronary heart disease, susceptibility to, 8} (2)	CHDS8	611139	9p21	CHDS8
{Coronary heart disease, susceptibility to, 9} (2)	CHDS9	612030	8p22	CHDS9
{Coronary heart disease, susceptibility to} (2)	CHDS1	607339	16pter-p13	CHDS1
{Craniosynostosis 5, susceptibility to}, 615529 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	ALX4
{Craniosynostosis 7, susceptibility to}, 617439 (3)	SMAD6, MADH6, AOVD2	602931	15q22.31	SMAD6
{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	HLA-DQB1
{Crohn disease-associated growth failure}, 266600 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Cystic fibrosis lung disease, modifier of}, 219700 (3)	TGFB1, DPD1, CED	190180	19q13.2	TGFB1
{Deafness, autosomal recessive 12, modifier of}, 601386 (3)	ATP2B2, PMCA2	108733	3p25.3	ATP2B2
{Deafness, mitochondrial, modifier of}, 580000 (3)	TRMU, MTO2	610230	22q13.31	TRMU
{Deafness, nonsyndromic, modifier 1} (2)	DFNM1	605429	1q24	DFNM1
{Debrisoquine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	CYP2D6
{Deep venous thrombosis, protection against}, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
{Delayed sleep phase disorder, susceptibility to}, 614163 (3)	CRY1, PHLL1, DSPD	601933	12q23.3	CRY1
{Delayed sleep phase syndrome, susceptibility to} (2)	DSPS	614163	17q25	DSPS
{Dementia, vascular, susceptibility to} (3)	TNF, TNFA	191160	6p21.33	TNF
{Dengue fever, protection against}, 614371 (3)	CD209, CDSIGN	604672	19p13.2	CD209
{Dermatitis, atopic, susceptibility to, 1} (2)	ATOD1	603165	3q21	ATOD1
{Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	FLG, ATOD2	135940	1q21.3	FLG
{Dermatitis, atopic, susceptibility to, 3} (2)	ATOD3	605804	20p	ATOD3
{Dermatitis, atopic, susceptibility to, 4} (2)	ATOD4	605805	17q25.3	ATOD4
{Dermatitis, atopic, susceptibility to, 5} (2)	ATOD5	605844	13q12-q14	ATOD5
{Dermatitis, atopic, susceptibility to, 6} (2)	ATOD6	605845	5q31-q33	ATOD6
{Dermatitis, atopic, susceptibility to, 7} (2)	ATOD7	613064	11q13.5	ATOD7
{Dermatitis, atopic, susceptibility to, 8} (2)	ATOD8	613518	4q22.1	ATOD8
{Dermatitis, atopic, susceptibility to, 9} (2)	ATOD9	613519	3p24	ATOD9
{Diabetes mellitus, insulin-dependent, 11} (2)	IDDM11	601208	14q24.3-q31	IDDM11
{Diabetes mellitus, insulin-dependent, 12}, 601388 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Diabetes mellitus, insulin-dependent, 13} (2)	IDDM13	601318	2q34	IDDM13
{Diabetes mellitus, insulin-dependent, 15} (2)	IDDM15	601666	6q21	IDDM15
{Diabetes mellitus, insulin-dependent, 17} (2)	IDDM17	603266	10q25	IDDM17
{Diabetes mellitus, insulin-dependent, 18} (2)	IDDM18	605598	5q31.1-q33.1	IDDM18
{Diabetes mellitus, insulin-dependent, 19} (2)	IDDM19	610155	2q24.3	IDDM19
{Diabetes mellitus, insulin-dependent, 21} (2)	IDDM21	612521	6q25	IDDM21
{Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{Diabetes mellitus, insulin-dependent, 23} (2)	IDDM23	612622	4q27	IDDM23
{Diabetes mellitus, insulin-dependent, 24} (2)	IDDM24	613006	10q23.31	IDDM24
{Diabetes mellitus, insulin-dependent, 3} (2)	IDDM3	600318	15q26	IDDM3
{Diabetes mellitus, insulin-dependent, 4} (2)	IDDM4	600319	11q13	IDDM4
{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	SUMO4, IDDM5	608829	6q25.1	SUMO4
{Diabetes mellitus, insulin-dependent, 6} (2)	IDDM6	601941	18q21	IDDM6
{Diabetes mellitus, insulin-dependent, 7} (2)	IDDM7	600321	2q31	IDDM7
{Diabetes mellitus, insulin-dependent, 8} (2)	IDDM8	600883	6q25-q27	IDDM8
{Diabetes mellitus, insulin-dependent, X-linked} (2)	IDDMX	300136	Xp11	IDDMX
{Diabetes mellitus, insulin-dependent-1} (2)	IDDM1	222100	6p21.3	IDDM1
{Diabetes mellitus, insulin-dependent}, 222100 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	PAX4, MODY9, KPD	167413	7q32.1	PAX4
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	CAPN10, NIDDM1	605286	2q37.3	CAPN10
{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	TBC1D4, AS160, KIAA0603, NIDDM5	612465	13q22.2	TBC1D4
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	CDKAL1	611259	6p22.3	CDKAL1
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	HMGA1, HMGIY	600701	6p21.31	HMGA1
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	IGF2BP2, IMP2	608289	3q27.2	IGF2BP2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	RETN
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	SLC30A8, ZNT8	611145	8q24.11	SLC30A8
{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	NIDDM3	603694	20q12-q13.1	NIDDM3
{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	NIDDM4	608036	5q34-q35.2	NIDDM4
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	GCGR	138033	17q25.3	GCGR
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	HNF4A
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	IRS1	147545	2q36.3	IRS1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	IRS2	600797	13q34	IRS2
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPC
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	MAPK8IP1, IB1	604641	11p11.2	MAPK8IP1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	NEUROD1, NIDDM	601724	2q31.3	NEUROD1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	SLC2A2, GLUT2	138160	3q26.2	SLC2A2
{Diabetes mellitus, transient neonatal}, 601410 (1)	PLAGL1, ZAC, LOT1	603044	6q24.2	PLAGL1
{Diabetes mellitus, type 1, susceptibility to}, 222100 (3)	OAS1, OIAS	164350	12q24.13	OAS1
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	MTNR1B	600804	11q14.3	MTNR1B
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	TCF7L2, TCF4	602228	10q25.2-q25.3	TCF7L2
{Diabetes mellitus, type I, susceptibility to}, 222100 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	FOXP3
{Diabetes mellitus, type II, susceptibility to}, 125853 (3)	PDX1, IPF1, MODY4, PAGEN1	600733	13q12.2	PDX1
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IL2RA
{Diabetes, susceptibility to}, 222100, 125853 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Diabetes, type 1, susceptibility to}, 222100 (2)	ITPR3	147267	6p21.31	ITPR3
{Diabetes, type 1, susceptibility to}, 222100 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN22
{Diabetes, type 2, susceptibility to}, 125853 (3)	GPD2	138430	2q24.1	GPD2
{Diabetes, type 2}, 125853 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
{Diphtheria, susceptibility to} (1)	HBEGF, DTR, DTSF, HEGFL	126150	5q31.3	HBEGF
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
{Drug addiction, susceptibility to}, 606581 (3)	FAAH	602935	1p33	FAAH
{Drug-induced liver injury due to flucloxacillin} (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Dyslexia, susceptibility to, 1}, 127700 (3)	DNAAF4, DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DNAAF4
{Dyslexia, susceptibility to, 2} (2)	DYX2	600202	6p22-p21	DYX2
{Dyslexia, susceptibility to, 3} (2)	DYX3	604254	2p16-p15	DYX3
{Dyslexia, susceptibility to, 5} (2)	DYX5	606896	3p12-q13	DYX5
{Dyslexia, susceptibility to, 6} (2)	DYX6, DYXQTL18	606616	18p11.2	DYX6
{Dyslexia, susceptibility to, 8} (2)	DYX8	608995	1p36-p34	DYX8
{Dyslexia, susceptibility to, 9} (2)	DYX9	300509	Xq27.3	DYX9
{Dystonia-1, modifier of} (3)	DYT1, TOR1A	605204	9q34.11	DYT1
{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	CYP2B6
{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	RANBP2, NUP358, ANE1, IIAE3	601181	2q13	RANBP2
{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
{End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	APOL1, FSGS4	603743	22q12.3	APOL1
{Endometrial cancer, susceptibility to}, 608089 (3)	MLH3, HNPCC7	604395	14q24.3	MLH3
{Endometriosis, susceptibility to, 1} (2)	ENDO1	131200	10q26	ENDO1
{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	MMP1, CLG	120353	11q22.2	MMP1
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GABRG2
{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	GABRA1
{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3)	GABRB3, ECA5, EIEE43	137192	15q12	GABRB3
{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	CACNA1H
{Epilepsy, familial temporal lobe, 7}, 616436 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	RELN
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GABRD
{Epilepsy, idiopathic generalized, 10}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GABRD
{Epilepsy, idiopathic generalized, susceptibility to 4} (2)	EIG4	609750	10q25-q26	EIG4
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	SLC12A5
{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)	EIG1	600669	8q24	EIG1
{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)	EIG2	606972	14q23	EIG2
{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)	EIG3	608762	9q32-q33	EIG3
{Epilepsy, idiopathic generalized, susceptibility to, 5} (2)	EIG5	611934	10p11.22	EIG5
{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	CACNA1H
{Epilepsy, idiopathic generalized, susceptibility to, 7} (2)	EIG7, EJM2	604827	15q14	EIG7
{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	CACNB4
{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EFHC1
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	GABRA1
{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	CACNB4
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
{Epilepsy, juvenile myoclonic, susceptibility to, 9} (2)	EJM9	614280	2q33-q36	EJM9
{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GABRD
{Esophageal cancer, alcohol-related, susceptibility to} (3)	ALDH2	100650	12q24.12	ALDH2
{Esophagitis, eosinophilic, 1} (2)	EOE1, EE	610247	7q11.2	EOE1
{Esophagitis, eosinophilic, 2} (2)	EOE2	613412	5q22	EOE2
{Essential tremor, hereditary, 1}, 190300 (3)	DRD3, ETM1, FET1	126451	3q13.31	DRD3
{Exfoliation syndrome, susceptibility to}, 177650 (3)	LOXL1, LOXL	153456	15q24.1	LOXL1
{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)	NAFLD1	613282	22q13	NAFLD1
{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)	NAFLD2	613387	11q23	NAFLD2
{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	SPINK1
{Follicular lymphoma, susceptibility to, 1} (2)	FL1	613024	6p21.33	FL1
{Gallbladder disease 4}, 611465 (3)	ABCG8, GBD4	605460	2p21	ABCG8
{Gastric cancer risk after H. pylori infection}, 137215 (3)	IL1B	147720	2q14.1	IL1B
{Gastric cancer risk after H. pylori infection}, 137215 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	IL1RN
{Gene expression, variation in, QTL} (2)	GEVQ1	608875	14q32	GEVQ1
{Gene expression, variation in, QTL} (2)	GEVQ2	608878	20q13	GEVQ2
{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3)	HDC	142704	15q21.2	HDC
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	OPTN
{Glioblastoma 3}, 613029 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Glioma susceptibility 1}, 137800 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
{Glioma susceptibility 2}, 613028 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
{Glioma susceptibility 4} (2)	GLM4	607248	15q23-q26.3	GLM4
{Glioma susceptibility 5} (2)	GLM5	613030	9p21.3	GLM5
{Glioma susceptibility 6} (2)	GLM6	613031	20q13.33	GLM6
{Glioma susceptibility 7} (2)	GLM7	613032	8q24.21	GLM7
{Glioma susceptibility 8} (2)	GLM8	613033	5p15.33	GLM8
{Glioma susceptibility 9}, 616568 (3)	POT1, CMM10, GLM9	606478	7q31.33	POT1
{Glioma, susceptibility to, somatic}, 137800 (3)	IDH1	147700	2q34	IDH1
{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3)	APOL1, FSGS4	603743	22q12.3	APOL1
{Glucocorticoid therapy, response to}, 614400 (3)	GLCCI1, TSSN1, GCTR	614283	7p21.3	GLCCI1
{Gout susceptibility 4}, 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	SLC17A3
{Graft-versus-host disease, protection against}, 614395 (3)	IL10, CSIF, GVHDS	124092	1q32.1	IL10
{Graves disease, susceptibility to, 1} (2)	GRD1	275000	14q31	GRD1
{Graves disease, susceptibility to, 2} (2)	GRD2	603388	20q13.11	GRD2
{Graves disease, susceptibility to, X-linked} (2)	GRDX, GD3	300351	Xp11	GRDX
{H. pylori infection, susceptibility to}, 600263 (1)	PTPRZ1, PTP18	176891	7q31.32	PTPRZ1
{H. pylori infection, susceptibility to}, 600263 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{HDL response to hormone replacement, augmented} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{HFE hemochromatosis, modifier of}, 235200 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BMP2
{HIV infection, resistance to}, 609423 (2)	CCL3, SCYA3, MIP1A	182283	17q12	CCL3
{HIV infection, susceptibility/resistance to} (3)	CCR2, CMKBR2	601267	3p21.31	CCR2
{HIV infection, susceptibility/resistance to} (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{HIV type 1, susceptibility to}, 609423 (3)	CD209, CDSIGN	604672	19p13.2	CD209
{HIV-1 disease, delayed progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	CCL5
{HIV-1 disease, rapid progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	CCL5
{HIV-1 viremia, susceptibility to}, 609423 (3)	HLA-C, PSORS1	142840	6p21.33	HLA-C
{HIV-1, resistance to}, 609423 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{HIV-1, susceptibility to}, 609423 (3)	IL10, CSIF, GVHDS	124092	1q32.1	IL10
{HIV/AIDS, susceptibility to}, 609423 (3)	CCL3L1, SCYA3L1, LD78	601395	17q11.2	CCL3L1
{HIV1 infection, resistance to}, 609423 (3)	TLR3, IIAE2	603029	4q35.1	TLR3
{HIV1, resistance to}, 609423 (3)	CCL11, SCYA11	601156	17q12	CCL11
{Hangover, susceptibility to}, 610251 (3)	ALDH2	100650	12q24.12	ALDH2
{Hashimoto thyroiditis}, 140300 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	KDR	191306	4q12	KDR
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	MCP, CD46, AHUS2	120920	1q32.2	MCP
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	CFI
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFB
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3)	C3, ARMD9, AHUS5	120700	19p13.3	C3
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THBD
{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	DGKE
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	CFHR1
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	CFHR3
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A2, POREN2, ICH	120090	13q34	COL4A2
{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2)	SM2	604201	6q22-q23	SM2
{Hepatitis B virus infection, susceptibility to}, 610424 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{Hepatitis B virus, susceptibility to}, 610424 (3)	CRFB4, IBD25	123889	21q22.11	CRFB4
{Hepatitis B virus, susceptibility to}, 610424 (3)	IFNAR2, IMD45	602376	21q22.11	IFNAR2
{Hepatitis C virus infection, response to therapy of}, 609532 (3)	IFNL3, IL28B	607402	19q13.2	IFNL3
{Hepatitis C virus, resistance to}, 609532 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{Hepatitis C virus, response to therapy of}, 609532 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Hepatitis C virus, susceptibility to}, 609532 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	PTPRC
{Herpes simplex encephalitic, susceptibility to, 6}, 614850 (3)	TICAM1, TRIF, IIAE6	607601	19p13.3	TICAM1
{Herpes simplex encephalitis, susceptibility to, 1}, 610551 (3)	UNC93B1, IIAE1	608204	11q13.2	UNC93B1
{Herpes simplex encephalitis, susceptibility to, 2} 613002 (3)	TLR3, IIAE2	603029	4q35.1	TLR3
{High density lipoprotein cholesterol level QTL 7} (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	EDN1
{High density lipoprotein cholesterol, low serum, 3} (2)	HDLC3	607687	16q24.1	HDLC3
{Hirschsprung disease, susceptibility to, 1}, 142623 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
{Hirschsprung disease, susceptibility to, 2}, 600155 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	EDNRB
{Hirschsprung disease, susceptibility to, 3}, 613711 (3)	GDNF, HSCR3	600837	5p13.2	GDNF
{Hirschsprung disease, susceptibility to, 4}, 613712 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	EDN3
{Hirschsprung disease, susceptibility to, 5} (2)	HSCR5	600156	9q31	HSCR5
{Hirschsprung disease, susceptibility to, 6} (2)	HSCR6	606874	3p21	HSCR6
{Hirschsprung disease, susceptibility to, 7} (2)	HSCR7	606875	19q12	HSCR7
{Hirschsprung disease, susceptibility to, 8} (2)	HSCR8	608462	16q23	HSCR8
{Hirschsprung disease, susceptibility to, 9} (2)	HSCR9	611644	4q31.3-q32.3	HSCR9
{Hodgkin disease susceptibility, pseudoautosomal} (2)	HDPA	300221	Xpter-p22.32	HDPA
{Hodgkin lymphoma, susceptibility to}, 236000 (3)	KLHDC8B, CHL	613169	3p21.31	KLHDC8B
{Human herpesvirus 8, susceptibility to} (2)	HHV8S	614836	3p22	HHV8S
{Hydrops fetalis, nonimmune, and/or atrial septal defect}, 617300 (3)	EPHB4, HTK, MYK1, HFASD	600011	7q22.1	EPHB4
{Hyperapobetalipoproteinemia, susceptibility to} (3)	PPARA, PPAR	170998	22q13.31	PPARA
{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	ADCY10, SAC, HCA2	605205	1q24.2	ADCY10
{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)	EPHX2	132811	8p21.2-p21.1	EPHX2
{Hypercholesterolemia, familial, modifier of}, 143890 (3)	APOA2	107670	1q23.3	APOA2
{Hypercholesterolemia, familial, modifier of}, 143890 (3)	GHR, GHIP	600946	5p13-p12	GHR
{Hypercholesterolemia, susceptibility to}, 143890 (3)	GSBS	604088	7p14.3	GSBS
{Hypercholesterolemia, susceptibility to}, 143890 (3)	ITIH4, PK120, ITIHL1	600564	3p21.1	ITIH4
{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	USF1, HYPLIP1	191523	1q23.3	USF1
{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)	HLA-A	142800	6p22.1	HLA-A
{Hypertension, diastolic, resistance to}, 608622 (3)	KCNMB1	603951	5q35.1	KCNMB1
{Hypertension, essential, salt-sensitive}, 145500 (3)	ADD1	102680	4p16.3	ADD1
{Hypertension, essential, susceptibility to, 1}, 145500 (2)	HYT1	603918	17q	HYT1
{Hypertension, essential, susceptibility to, 2}, 145500 (2)	HYT2	604329	15q	HYT2
{Hypertension, essential, susceptibility to, 3}, 145500 (2)	HYT3	607329	2p25-p24	HYT3
{Hypertension, essential, susceptibility to, 4}, 145500 (2)	HYT4	608742	12p12.2-p12.1	HYT4
{Hypertension, essential, susceptibility to, 5}, 145500 (2)	HYT5	610261	20q11-q13	HYT5
{Hypertension, essential, susceptibility to, 6}, 145500 (2)	HYT6	610262	5p13-q12	HYT6
{Hypertension, essential, susceptibility to, 7} (2)	HYT7	610948	3p14.1-q12.3	HYT7
{Hypertension, essential, susceptibility to, 8} (2)	HYT8	611014	18q21.2	HYT8
{Hypertension, essential, susceptibility to}, 145500 (3)	AGT, SERPINA8	106150	1q42.2	AGT
{Hypertension, essential, susceptibility to}, 145500 (3)	ECE1	600423	1p36.12	ECE1
{Hypertension, essential, susceptibility to}, 145500 (3)	GNB3, CSNB1H	139130	12p13.31	GNB3
{Hypertension, essential}, 145500 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AGTR1
{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	RETN
{Hypertension, pregnancy-induced}, 189800 (3)	NOS3	163729	7q36.1	NOS3
{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	CYP3A5, P450PCN3	605325	7q22.1	CYP3A5
{Hypertension, susceptibility to}, 145500 (2)	NOS2A, NOS2	163730	17q11.2	NOS2A
{Hypertension, susceptibility to}, 145500 (3)	NOS3	163729	7q36.1	NOS3
{Hypertriglyceridemia, susceptibility to}, 145750 (3)	APOA5	606368	11q23.3	APOA5
{Hypertriglyceridemia, susceptibility to}, 145750 (3)	LIPI, LPDL, PRED5	609252	21q11.2	LIPI
{Hypertrypsinemia, neonatal} (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	HS6ST1, HS6ST, HH15	604846	2q14.3	HS6ST1
{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	SEMA3A, SEMAD, COLL1, HH16	603961	7q21.11	SEMA3A
{Hypospadias 4, X-linked, susceptibility to} (2)	HYSP4	300856	Xp11.22	HYSP4
{Hypothalamic hamartomas, somatic}, 241800 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
{IgA nephropathy, susceptibility to, 1} (2)	IGAN1	161950	6q22-q23	IGAN1
{IgA nephropathy, susceptibility to, 2} (2)	IGAN2	613944	2q36	IGAN2
{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)	ATG16L1, APG16L, IBD10	610767	2q37.1	ATG16L1
{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IRGM
{Inflammatory bowel disease 1, Crohn disease}, 266600 (3)	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	605956	16q12.1	NOD2
{Inflammatory bowel disease 11} (2)	IBD11	191390	7q22	IBD11
{Inflammatory bowel disease 12} (2)	IBD12	612241	3p21.3	IBD12
{Inflammatory bowel disease 13}, 612244 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	ABCB1
{Inflammatory bowel disease 14}, 612245 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	IRF5
{Inflammatory bowel disease 15} (2)	IBD15	612255	10q21	IBD15
{Inflammatory bowel disease 16} (2)	IBD16	612259	9q32	IBD16
{Inflammatory bowel disease 17, protection against}, 612261 (3)	IL23R, IBD17	607562	1p31.3	IL23R
{Inflammatory bowel disease 18} (2)	IBD18	612262	5p13.1	IBD18
{Inflammatory bowel disease 20} (2)	IBD20	612288	10q23-q24	IBD20
{Inflammatory bowel disease 21} (2)	IBD21	612354	18p11	IBD21
{Inflammatory bowel disease 22} (2)	IBD22	612380	17q21.2	IBD22
{Inflammatory bowel disease 23} (2)	IBD23	612381	1q32.1	IBD23
{Inflammatory bowel disease 24} (2)	IBD24	612566	20q13	IBD24
{Inflammatory bowel disease 26} (2)	IBD26	612639	12q15	IBD26
{Inflammatory bowel disease 27} (2)	IBD27	612796	13q13.3	IBD27
{Inflammatory bowel disease 2} (2)	IBD2	601458	12p13.2-q24.1	IBD2
{Inflammatory bowel disease 3} (2)	IBD3	604519	6p21.3	IBD3
{Inflammatory bowel disease 4} (2)	IBD4	606675	14q11-q12	IBD4
{Inflammatory bowel disease 5} (2)	IBD5	606348	5q31	IBD5
{Inflammatory bowel disease 6} (2)	IBD6	606674	19p13	IBD6
{Inflammatory bowel disease 7} (2)	IBD7	605225	1p36	IBD7
{Inflammatory bowel disease 8} (2)	IBD8	606668	16p	IBD8
{Inflammatory bowel disease 9} (2)	IBD9	608448	3p26	IBD9
{Influenza, severe, susceptibility to}, 614680 (3)	IFITM3	605579	11p15.5	IFITM3
{Insulin resistance, susceptibility to}, 125853 (3)	PTPN1, PTP1B	176885	20q13.13	PTPN1
{Intelligence QTL1} (2)	INTLQ1	603783	4p16-q34	INTLQ1
{Intelligence QTL3} (2)	INTLQ2	610295	2q24.1-q31.1	INTLQ2
{Intelligence QTL3} (2)	INTLQ3	610294	6p25.3-p22.3	INTLQ3
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A3, EDM3, IDD	120270	20q13.33	COL9A3
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Ischemic stroke, susceptibility to}, 601367 (3)	NOS3	163729	7q36.1	NOS3
{Kala-azar, susceptibility to, 1} (2)	KAZA1	608207	22q12	KAZA1
{Kala-azar, susceptibility to, 2} (2)	KAZA2	611381	1p22	KAZA2
{Kala-azar, susceptibility to, 3} (2)	KAZA3	611382	6q27	KAZA3
{Kaposi sarcoma, susceptibility to}, 148000 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Kawasaki disease, susceptibility to}, 611775 (3)	ITPKC	606476	19q13.2	ITPKC
{Kuru, susceptibility to}, 245300 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
{Lead poisoning, susceptibility to}, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	ALAD
{Leanness, inherited} (3)	AGRP, ART, AGRT	602311	16q22.1	AGRP
{Leber optic atrophy, susceptibility to} (2)	LOAS	308905	Xp11	LOAS
{Legionnaire disease, susceptibility to}, 608556 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Leprosy, paucibacillary type, susceptibility to} (2)	LPRS	609888	10p13	LPRS
{Leprosy, protection against}, 613223 (3)	TLR1, TIL. LPRS5	601194	4p14	TLR1
{Leprosy, susceptibility to, 4}, 610988 (3)	LTA, TNFB	153440	6p21.33	LTA
{Leprosy, susceptibility to, 5}, 613223 (3)	TLR1, TIL. LPRS5	601194	4p14	TLR1
{Leprosy, susceptibility to, 6} (2)	LPRS6	613407	13q14.11	LPRS6
{Leprosy, susceptibility to}, 246300 (3)	TLR2, TIL4	603028	4q31.3	TLR2
{Leprosy, susceptibility to}, 607572 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)	ALL2	613067	7p12.2	ALL2
{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	PAX5, BSAP, ALL3	167414	9p13.2	PAX5
{Leukemia, acute lymphocytic, susceptibility to, 1} (2)	ALL1	613065	10q21	ALL1
{Leukemia, acute myeloid, susceptibility to}, 601626 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
{Leukemia, acute myeloid}, 601626 (3)	CHIC2, BTL	604332	4q12	CHIC2
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Leukemia, chronic lymphocytic susceptibility to, 4} (2)	CLLS4	612558	6p25	CLLS4
{Leukemia, chronic lymphocytic susceptibility to, 5} (2)	CLLS5	612559	11q24.1	CLLS5
{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)	CLLS1	609630	11p11	CLLS1
{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	CLLS2, D13S25, DBM	109543	13q14	CLLS2
{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)	CLLS3	612557	9q34.1	CLLS3
{Leukemia, post-chemotherapy, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NQO1
{Lewy body dementia, susceptibility to}, 127750 (3)	GBA	606463	1q22	GBA
{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	LMNB2
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
{Long QT syndrome 2, acquired, susceptibility to}, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	KCNH2
{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3)	ALG10, KCR1	603313	12p11.1	ALG10
{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	PCSK9
{Low renin hypertension, susceptibility to} (3)	CYP11B2	124080	8q24.3	CYP11B2
{Lumbar disc degeneration}, 603932 (3)	ASPN, PLAP1, OS3	608135	9q22.31	ASPN
{Lumbar disc disease, susceptibility to}, 603932 (3)	CILP	603489	15q22.31	CILP
{Lumbar disc herniation, susceptibility to}, 603932 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
{Lumbar disc herniation, susceptibility to}, 603932 (3)	THBS2	188061	6q27	THBS2
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA3, LNCR2, PAOD2	118503	15q25.1	CHRNA3
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA5, LNCR2	118505	15q25.1	CHRNA5
{Lung cancer susceptibility 3} (2)	LNCR3	612571	5p15.33	LNCR3
{Lung cancer susceptibility 4} (2)	LNCR4	612593	6p21.33	LNCR4
{Lung cancer susceptibility 5} (2)	LNCR5	614210	3q28	LNCR5
{Lung cancer susceptibility} (2)	LNCR1	608935	6q23-q25	LNCR1
{Lung cancer, protection against, in smokers} (3)	MPO	606989	17q22	MPO
{Lung cancer, protection against}, 211980 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
{Lung cancer, resistance to}, 211980 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A6
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
{Lung cancer, susceptibility to}, 211980 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	FASLG
{Lupus nephritis, susceptibility to}, 152700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	FCGR2A
{Lymphoma, follicular, somatic}, 605027 (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)	WM1	153600	6p21.3	WM1
{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)	WM2	610430	4q	WM2
{Macular degeneration, age-related, 11}, 611953 (3)	CST3, ARMD11	604312	20p11.21	CST3
{Macular degeneration, age-related, 12}, 613784 (3)	CX3CR1, GPR13, V28	601470	3p22.2	CX3CR1
{Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	CFI
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	C2, ARMD14	613927	6p21.33	C2
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFB
{Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	C9, C9D, ARMD15	120940	5p13.1	C9
{Macular degeneration, age-related, 1}, 603075 (3)	HMCN1, FBLN6, FIBL6, ARMD1	608548	1q25.3-q31.1	HMCN1
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
{Macular degeneration, age-related, 4}, 610698 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
{Macular degeneration, age-related, 7}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
{Macular degeneration, age-related, 8}, 613778 (3)	LOC387715, ARMD8	611313	10q26.13	LOC387715
{Macular degeneration, age-related, 9}, 611378 (3)	C3, ARMD9, AHUS5	120700	19p13.3	C3
{Macular degeneration, age-related, neovascular type}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	CFHR1
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	CFHR3
{Macular degeneration, age-related, susceptibility to, 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
{Major affective disorder 1} (2)	MAFD1, BPAD, MD1	125480	18p	MAFD1
{Major affective disorder 3, early onset} (2)	MAFD3, BPEO	609633	21q22.13	MAFD3
{Major affective disorder 5} (2)	MAFD5	611535	2q22-q24	MAFD5
{Major affective disorder 6} (2)	MAFD6, BPAD	611536	6q23-q24	MAFD6
{Major affective disorder-7, susceptibility to}, 612371 (3)	XBP1, XBP2	194355	22q12.1	XBP1
{Major affective disorder-8, susceptibility to} (2)	MAFD8	612357	10q21	MAFD8
{Major affective disorder-9, susceptibility to} (2)	MAFD9	612372	12p13.3	MAFD9
{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	FKBP5, FKBP51	602623	6p21.31	FKBP5
{Major depressive disorder, response to citalopram therapy in}, 608516 (3)	HTR2A	182135	13q14.2	HTR2A
{Malaria, cerebral, reduced risk of}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
{Malaria, cerebral, susceptibility to}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
{Malaria, cerebral, susceptibility to}, 611162 (3)	ICAM1	147840	19p13.2	ICAM1
{Malaria, cerebral, susceptibility to}, 611162 (3)	TNF, TNFA	191160	6p21.33	TNF
{Malaria, intensity of infection} (2)	PFBI	248310	5q31-q33	PFBI
{Malaria, mild, susceptibility to}, 609148 (3)	NCR3, 1C7, NKP30, CD337, MALS	611550	6p21.33	NCR3
{Malaria, protection against}, 611162 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Malaria, resistance to}, 611162 (3)	FCGR2B, CD32	604590	1q23.3	FCGR2B
{Malaria, resistance to}, 611162 (3)	GYPA, MN, GPA	111300	4q31.21	GYPA
{Malaria, resistance to}, 611162 (3)	GYPB, SS, MNS	111740	4q31.21	GYPB
{Malaria, resistance to}, 611162 (3)	GYPC, GE, GPC	110750	2q14.3	GYPC
{Malaria, resistance to}, 611162 (3)	HBB	141900	11p15.4	HBB
{Malaria, resistance to}, 611162 (3)	NOS2A, NOS2	163730	17q11.2	NOS2A
{Malaria, severe, resistance to}, 611162 (3)	CR1, C3BR	120620	1q32.2	CR1
{Malaria, severe, susceptibility to}, 611162 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	FCGR2A
{Malaria, susceptibility to}, 611162 (3)	CISH, BACTS2	602441	3p21.2	CISH
{Malaria, vivax, protection against}, 611162 (3)	ACKR1, DARC, FY, GPD, WBCQ1	613665	1q23.2	ACKR1
{Male germ cell tumor, somatic}, 273300, (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Malignant hyperthermia susceptibility 1}, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
{Malignant hyperthermia susceptibility 2} (2)	MHS2	154275	17q11.2-q24	MHS2
{Malignant hyperthermia susceptibility 3} (2)	MHS3	154276	7q21-q22	MHS3
{Malignant hyperthermia susceptibility 4} (2)	MHS4	600467	3q13.1	MHS4
{Malignant hyperthermia susceptibility 5}, 601887 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNA1S
{Malignant hyperthermia susceptibility 6} (2)	MHS6	601888	5p	MHS6
{Maturity-onset diabetes of the young, type 14}, 616511 (3)	APPL1, APPL, MODY14	604299	3p14.3	APPL1
{Meconium ileus in cystic fibrosis, susceptibility to} (2)	CFM1	603855	19q13.2-q13.4	CFM1
{Medulloblastoma}, 155255 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Melanoma, cutaneous malignant, 1} (2)	CMM, MLM, DNS	155600	1p36	CMM
{Melanoma, cutaneous malignant, 2}, 155601 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
{Melanoma, cutaneous malignant, 3}, 609048 (3)	CDK4, CMM3	123829	12q14.1	CDK4
{Melanoma, cutaneous malignant, 4} (2)	CMM4	608035	1p22	CMM4
{Melanoma, cutaneous malignant, 5}, 613099 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
{Melanoma, cutaneous malignant, 6}, 613972 (3)	XRCC3, CMM6	600675	14q32.33	XRCC3
{Melanoma, cutaneous malignant, 7} (2)	CMM7	612263	20q11.2	CMM7
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3)	POT1, CMM10, GLM9	606478	7q31.33	POT1
{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
{Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3)	MITF, WS2A, CMM8, COMMAD	156845	3p13	MITF
{Melanoma, uveal, susceptibility to, 1} (2)	UVM1	606660	3q24-q26	UVM1
{Melanoma, uveal, susceptibility to, 2} (2)	UVM2	606661	3p25.2-p25.1	UVM2
{Melioidosis, susceptibility to}, 615557 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Memory impairment, susceptibility to} (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Menarche, age at, QTL2} (2)	MENAQ2	612882	6q21	MENAQ2
{Menarche, age at, QTL3} (2)	MENAQ3	612883	9q31.2	MENAQ3
{Menarche, age at, QTL} (2)	MENAQ1	610873	22q13	MENAQ1
{Meningioma, familial, susceptibility to}, 607174 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	SMARCE1
{Meningioma, familial, susceptibility to}, 607174 (3)	SUFU, SUFUXL, SUFUH, JBTS32	607035	10q24.32	SUFU
{Meningioma}, 607174 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
{Menopause, natural, age at, QTL1} (2)	MENOQ1	300488	Xp21.3	MENOQ1
{Menopause, natural, age at, QTL2} (2)	MENOQ2	612884	19q13.4	MENOQ2
{Menopause, natural, age at, QTL4} (2)	MENOQ4	612886	5q35.2	MENOQ4
{Mental health wellness-1} (2)	MHW1	603663	4p	MHW1
{Mental health wellness-2} (2)	MHW2	603664	4q	MHW2
{Mesothelioma, somatic}, 156240 (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Metabolic syndrome, protection against}, 605552 (3)	MTP	157147	4q23	MTP
{Microvascular complications of diabetes 1}, 603933 (3)	VEGF, MVCD1	192240	6p21.1	VEGF
{Microvascular complications of diabetes 2}, 612623 (3)	EPO, MVCD2	133170	7q22.1	EPO
{Microvascular complications of diabetes 3}, 612624 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Microvascular complications of diabetes 4}, 612628 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	IL1RN
{Microvascular complications of diabetes 5}, 612633 (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Microvascular complications of diabetes 6}, 612634 (3)	SOD2, MNSOD, MVCD6	147460	6q25.3	SOD2
{Microvascular complications of diabetes 7}, 612635 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Migraine with aura, susceptibility to, 7} (2)	MGR7	609179	15q11.2-q12	MGR7
{Migraine with aura, susceptibility to, 9} (2)	MGR9	609670	11q24	MGR9
{Migraine with or without aura, susceptibility to, 1} (2)	MGR1, MA	157300	4q24	MGR1
{Migraine with or without aura, susceptibility to, 3} (2)	MGR3	607498	6p21.1-p12.2	MGR3
{Migraine with or without aura, susceptibility to, 5} (2)	MGR5	607508	19p13	MGR5
{Migraine with or without aura, susceptibility to, 6} (2)	MGR6, FHM3	607516	1q31	MGR6
{Migraine without aura, susceptibility to, 4} (2)	MGR4, MGOA	607501	14q21.2-q22.3	MGR4
{Migraine without aura, susceptibility to}, 157300 (3)	TNF, TNFA	191160	6p21.33	TNF
{Migraine, familial hemiplegic, 4} (2)	MGR6, FHM3	607516	1q31	MGR6
{Migraine, familial typical, susceptibility to, 2} (2)	MGR2	300125	Xq	MGR2
{Migraine, resistance to}, 157300 (3)	EDNRA, MFDA	131243	4q31.22-q31.23	EDNRA
{Migraine, susceptibility to, 8} (2)	MGR8	609570	5q21	MGR8
{Migraine, susceptibility to}, 157300 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Migraine, with or without aura, susceptibility to, 12} (2)	MGR12	611706	10q22-q23	MGR12
{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	KCNK18, TRESK, TRIK, MGR13	613655	10q25.3	KCNK18
{Moyamoya disease 2, susceptibility to}, 607151 (3)	RNF213, ALO17, KIAA1618, MYMY2	613768	17q25.3	RNF213
{Multiple myeloma, resistance to}, 254500 (3)	LIG4, LIG4S	601837	13q33.3	LIG4
{Multiple myeloma, susceptibility to}, 254500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	CCND1
{Multiple sclerosis, disease progression, modifier of}, 126200 (3)	PDCD1, SLEB2	600244	2q37.3	PDCD1
{Multiple sclerosis, susceptibility to, 1}, 126200 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	HLA-DQB1
{Multiple sclerosis, susceptibility to, 1}, 126200 (3)	HLA-DRB1, SS1	142857	6p21.32	HLA-DRB1
{Multiple sclerosis, susceptibility to, 2} (2)	MS2	612594	10p15.1	MS2
{Multiple sclerosis, susceptibility to, 3} (2)	MS3	612595	5p13.2	MS3
{Multiple sclerosis, susceptibility to, 4} (2)	MS4	612596	1p36	MS4
{Multiple sclerosis, susceptibility to, 5}, 614810 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFRSF1A
{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	TGFBR1
{Multiple system atrophy, susceptibility to}, 146500 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	COQ2
{Mycobacterium tuberculosis, protection against}, 607948 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IRGM
{Mycobacterium tuberculosis, protection against}, 607948 (3)	MC3R, BMIQ9	155540	20q13.2	MC3R
{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	NRAMP1
{Mycobacterium tuberculosis, susceptibility to, 2} (2)	MTBS2	611046	8q12-q13	MTBS2
{Mycobacterium tuberculosis, susceptibility to, 3} (2)	MTBS3	612929	20q13.31-q13.33	MTBS3
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CD209, CDSIGN	604672	19p13.2	CD209
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	SP110
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	TLR2, TIL4	603028	4q31.3	TLR2
{Mycobacterium tuberculosis, susceptibility, X-linked} (2)	MTBSX	300259	Xq	MTBSX
{Myelodysplastic syndrome, susceptibility to}, 614286 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
{Myeloproliferative neoplasms, familial, susceptibility to} (4)	DUP14q32, C14DUPq32	616604	14q32	DUP14q32
{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	DDX41, ABS, MPLPF	608170	5q35.3	DDX41
{Myocardial infarction, decreased susceptibility to}, 608446 (3)	F7	613878	13q34	F7
{Myocardial infarction, protection against}, 608446 (3)	F13A1, F13A	134570	6p25.1	F13A1
{Myocardial infarction, susceptibility to, 2} (2)	MCI2	608557	13q12	MCI2
{Myocardial infarction, susceptibility to} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Myocardial infarction, susceptibility to}, 608446 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Myocardial infarction, susceptibility to}, 608446 (3)	GCLC, GLCLC	606857	6p12.1	GCLC
{Myocardial infarction, susceptibility to}, 608446 (3)	GCLM, GLCLR	601176	1p22.1	GCLM
{Myocardial infarction, susceptibility to}, 608446 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
{Myocardial infarction, susceptibility to}, 608446 (3)	LGALS2	150571	22q13.1	LGALS2
{Myocardial infarction, susceptibility to}, 608446 (3)	LRP8, APOER2, MCI1	602600	1p32.3	LRP8
{Myocardial infarction, susceptibility to}, 608446 (3)	LTA, TNFB	153440	6p21.33	LTA
{Myocardial infarction, susceptibility to}, 608446 (3)	MIAT, C22orf35	611082	22q12.1	MIAT
{Myocardial infarction, susceptibility to}, 608446 (3)	OLR1, LOX1	602601	12p13.2	OLR1
{Myocardial infarction, susceptibility to}, 608446 (3)	PSMA6, PROS27, P27K	602855	14q13.2	PSMA6
{Myocardial infarction, susceptibility to}, 608446 (3)	TNFSF4, GP34, OX4OL	603594	1q25.1	TNFSF4
{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EFHC1
{Narcolepsy 4} (2)	NRCLP4	612417	22q13	NRCLP4
{Narcolepsy 5} (2)	NRCLP5	612851	14q11.2	NRCLP5
{Nasopharyngeal carcinoma 1} (2)	NPC1, NPCA1	607107	4p15.1-q12	NPC1
{Nasopharyngeal carcinoma, susceptibility to, 2} (2)	NPCA2	161550	6p21.3	NPCA2
{Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3)	MST1R, RON, NPCA3	600168	3p21.31	MST1R
{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	ZNF365, UAN	607818	10q21.2	ZNF365
{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	MTHFD1, MTHFC, CIMAH	172460	14q23.3	MTHFD1
{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	MTR, HMAG	156570	1q43	MTR
{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	MTRR	602568	5p15.31	MTRR
{Neural tube defects, susceptibility to}, 182940 (3)	T, TFT, SAVA	601397	6q27	T
{Neural tube defects, susceptibility to}, 182940 (3)	VANGL1, STBM2	610132	1p13.1	VANGL1
{Neural tube defects, susceptibility to}, 601634 (3)	MTHFR	607093	1p36.22	MTHFR
{Neuroblastoma, susceptibility to, 1}, 256700 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	KIF1B
{Neuroblastoma, susceptibility to, 2}, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PMX2B
{Neuroblastoma, susceptibility to, 3}, 613014 (3)	ALK, NBLST3	105590	2p23.2-p23.1	ALK
{Neuroblastoma, susceptibility to, 4} (2)	NBLST4	613015	6p22	NBLST4
{Neuroblastoma, susceptibility to, 5} (2)	NBLST5	613016	2q35	NBLST5
{Neuroblastoma, susceptibility to, 6} (2)	NBLST6	613017	1q21.1	NBLST6
{Neuroblastoma, susceptibility to, 7} (2)	NBLST7	616792	11p15	NBLST7
{Nevus sebaceous or woolly hair nevus, somatic}, 162900 (3)	HRAS	190020	11p15.5	HRAS
{Nicotine addiction, protection from}, 188890 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A6
{Nicotine addiction, susceptibility to}, 188890 (3)	CHRNA4, ENFL1	118504	20q13.33	CHRNA4
{Nicotine dependence, protection against}, 188890 (3)	GPR51, GABBR2	607340	9q22.33	GPR51
{Nicotine dependence, protection against}, 188890 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	SLC6A3
{Nicotine dependence, susceptibility to}, 188890 (3)	GPR51, GABBR2	607340	9q22.33	GPR51
{Nicotine dependence, susceptibility to}, 612052 (3)	CHRNA5, LNCR2	118505	15q25.1	CHRNA5
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
{Nonsmall cell lung cancer} (2)	TSG11	603040	11q23	TSG11
{Norwalk virus infection, resistance to} (3)	FUT2, SE, B12QTL1	182100	19q13.33	FUT2
{Obesity, association with}, 601665 (3)	SDC3, SYND3, SDCN	186357	1p35.2	SDC3
{Obesity, early-onset, susceptibility to}, 601665 (3)	POMC	176830	2p23.3	POMC
{Obesity, late-onset}, 601665 (3)	AGRP, ART, AGRT	602311	16q22.1	AGRP
{Obesity, severe, and type II diabetes}, 601665 (3)	UCP3	602044	11q13.4	UCP3
{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)	MC3R, BMIQ9	155540	20q13.2	MC3R
{Obesity, susceptibility to, BMIQ11}, 300306 (3)	SLC6A14, OBX, BMIQ11	300444	Xq23	SLC6A14
{Obesity, susceptibility to, BMIQ12}, 612362 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PCSK1
{Obesity, susceptibility to, BMIQ14}, 612460 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	FTO
{Obesity, susceptibility to, BMIQ4}, 607447 (3)	UCP2, BMIQ4	601693	11q13.4	UCP2
{Obesity, susceptibility to, BMIQ7} (2)	BMIQ7	608410	4p15-p14	BMIQ7
{Obesity, susceptibility to, BMIQ8} (2)	BMIQ8	603188	10p	BMIQ8
{Obesity, susceptibility to}, 601665 (3)	ADRB2	109690	5q32	ADRB2
{Obesity, susceptibility to}, 601665 (3)	ADRB3	109691	8p11.23	ADRB3
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
{Obesity, susceptibility to}, 601665 (3)	GHRL	605353	3p25.3	GHRL
{Obesity, susceptibility to}, 601665 (3)	UCP1	113730	4q31.1	UCP1
{Obesity, susceptibility to}, 607514 (3)	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	609044	10q23.33	FFAR4
{Obesity, variation in}, 601665 (3)	PPARGC1B, PGC1B, PERC	608886	5q32	PPARGC1B
{Obsessive-compulsive disorder, protection against}, 164230 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Obsessive-compulsive disorder, susceptibility to}, 164230 (3)	HTR2A	182135	13q14.2	HTR2A
{Obsessive-compulsive disorder}, 164230 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	SLC6A4
{Opioid dependence, susceptibility to, 1} (2)	ODS1	610064	Chr.17	ODS1
{Organophosphate poisoning, sensitivity to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	IRF6
{Osteoarthritis susceptibility 1}, 165720 (3)	FRZB, FRZB1, SRFP3, OS1	605083	2q32.1	FRZB
{Osteoarthritis susceptibility 2}, 140600 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	MATN3
{Osteoarthritis susceptibility 3}, 607850 (3)	ASPN, PLAP1, OS3	608135	9q22.31	ASPN
{Osteoarthritis susceptibility 4} (2)	OS4, GOA1	610839	2q33.3	OS4
{Osteoarthritis susceptibility 6} (2)	OS6	612401	3p24.3	OS6
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
{Osteofibrous dysplasia, susceptibility to}, 607278 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	WNT1
{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	CALCR, CRT	114131	7q21.3	CALCR
{Osteoporosis, postmenopausal}, 166710 (3)	COL1A2, EDSCV, EDSARTH2	120160	7q21.3	COL1A2
{Osteoporosis, susceptibility to}, 166710 (3)	RIL	603422	5q31.1	RIL
{Osteoporosis}, 166710 (2)	BMND7	611738	20p12.3	BMND7
{Osteoporosis}, 166710 (2)	BMND8	611739	11p12	BMND8
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
{Otitis media, susceptibility to} (2)	OMS	166760	10q26.3	OMS
{Otosclerosis 4} (2)	OTSC4	611571	16q22.1-q23.1	OTSC4
{Ovarian cancer, somatic}, 167000 (3)	OPCML	600632	11q25	OPCML
{Ovarian cancer, susceptibility to} (2)	OVCAS1	607893	3p25-p22	OVCAS1
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	TNFRSF11A
{Pancreatic cancer 2}, 613347 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	PALLD, KIAA0992, PNCA1	608092	4q32.3	PALLD
{Pancreatic cancer, susceptibility to, 3}, 613348 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PALB2
{Pancreatic cancer, susceptibility to, 4}, 614320 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	BRCA1
{Pancreatitis, chronic, protection against}, 167800 (3)	PRSS2, TRY2	601564	7q34	PRSS2
{Pancreatitis, chronic, susceptibility to}, 167800 (3)	CTRC, CLCR	601405	1p36.21	CTRC
{Pancreatitis, idiopathic}, 167800 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
{Panic disorder, susceptibility to}, 167870 (3)	COMT	116790	22q11.21	COMT
{Parkinson disease 10} (2)	PARK10, AAOPD	606852	1p32	PARK10
{Parkinson disease 11}, 607688 (3)	GIGYF2, KIAA0642, PARK11	612003	2q37.1	GIGYF2
{Parkinson disease 12} (2)	PARK12	300557	Xq21-q25	PARK12
{Parkinson disease 13}, 610297 (3)	HTRA2, OMI, PARK13, PRSS25, MGCA8	606441	2p13.1	HTRA2
{Parkinson disease 16} (2)	PARK16	613164	1q32	PARK16
{Parkinson disease 17}, 614203 (3)	VPS35, MEM3, PARK17	601501	16q11.2	VPS35
{Parkinson disease 18}, 614251 (3)	EIF4G1, EIF4G, PARK18	600495	3q27.1	EIF4G1
{Parkinson disease 3} (2)	PARK3	602404	2p13	PARK3
{Parkinson disease 8}, 607060 (3)	LRRK2, PARK8	609007	12q12	LRRK2
{Parkinson disease, age of onset, modifier}, 168600 (3)	GLUD2	300144	Xq24	GLUD2
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATXN2
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	GBA	606463	1q22	GBA
{Parkinson disease, susceptibility to}, 168600 (3)	ADH1C, ADH3	103730	4q23	ADH1C
{Parkinson disease, susceptibility to}, 168600 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
{Parkinson disease, susceptibility to}, 168600 (3)	TBP, SCA17, HDL4	600075	6q27	TBP
{Patent ductus arteriosus, susceptibility to} (2)	PDA1	607411	12q24	PDA1
{Pelvic organ prolapse, susceptibility to, 1} (2)	PVOP1	176780	1q31	PVOP1
{Pelvic organ prolapse, susceptibility to, 2} (2)	PVOP2	613088	9q21	PVOP2
{Pheochromocytoma, modifier of}, 171300 (3)	GDNF, HSCR3	600837	5p13.2	GDNF
{Pheochromocytoma, susceptibility to}, 171300 (3)	MAX	154950	14q23.3	MAX
{Pheochromocytoma, susceptibility to}, 171300 (3)	TMEM127	613403	2q11.2	TMEM127
{Pituitary adenoma 5, multiple types}, 617540 (3)	CDH23, USH1D, DFNB12, PITA5	605516	10q22.1	CDH23
{Placental abruption} (3)	NOS3	163729	7q36.1	NOS3
{Plasmodium falciparum fever episodes QTL1} (2)	PFFE1	611384	10p15	PFFE1
{Pneumococcal disease, invasive, protection against}, 610799 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Podoconiosis, susceptibility to} (2)	PDCOS	614590	6p21.3	PDCOS
{Porphyria cutanea tarda, susceptibility to}, 176100 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Porphyria variegata, susceptibility to}, 176200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Preeclampsia, susceptibility to} (3)	AGT, SERPINA8	106150	1q42.2	AGT
{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	ANXA5, ENX2, RPRGL3	131230	4q27	ANXA5
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	SERPINH1
{Prostate cancer aggressiveness QTL}, 176807 (2)	HPCQTL19	607592	19q	HPCQTL19
{Prostate cancer, familial, susceptibility to}, 176807 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
{Prostate cancer, hereditary, 10} (2)	HPC10	611100	8q24	HPC10
{Prostate cancer, hereditary, 11} (2)	HPC11	611955	17q12	HPC11
{Prostate cancer, hereditary, 12}, 611868 (3)	EHBP1, KIAA0903, HPC12	609922	2p15	EHBP1
{Prostate cancer, hereditary, 13}, 611928 (3)	MSMB, HPC13	157145	10q11.22	MSMB
{Prostate cancer, hereditary, 14} (2)	HPC14	611958	11q13	HPC14
{Prostate cancer, hereditary, 15} (2)	HPC15	611959	19q13.4	HPC15
{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3)	ELAC2, HPC2, COXPD17	605367	17p12	ELAC2
{Prostate cancer, hereditary, 5}, 176807 (2)	HPC5	609299	3p26	HPC5
{Prostate cancer, hereditary, 7} (2)	HPC7	610321	15q12	HPC7
{Prostate cancer, hereditary, 9} (2)	HPC9	610997	17q21-q22	HPC9
{Prostate cancer, hereditary, X-linked 1} (2)	HPCX1	300147	Xq27-q28	HPCX1
{Prostate cancer, hereditary, X-linked 2} (2)	HPCX2	300704	Xp11.22	HPCX2
{Prostate cancer, progression of}, 176807 (1)	HIP1	601767	7q11.23	HIP1
{Prostate cancer, somatic}, 176807 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
{Prostate cancer, susceptibility to, 3}, 176807 (2)	HPC3	608656	20q13	HPC3
{Prostate cancer, susceptibility to, 4}, 176807 (2)	HPC4	608658	7p11-q21	HPC4
{Prostate cancer, susceptibility to, somatic}, 176807 (3)	ZFHX3, ATBF1	104155	16q22.2-q22.3	ZFHX3
{Prostate cancer, susceptibility to}, 176807 (2)	CD82, SAR2, KAI1, ST6	600623	11p11.2	CD82
{Prostate cancer, susceptibility to}, 176807 (2)	HPC6	609558	22q12.3	HPC6
{Prostate cancer, susceptibility to}, 176807 (2)	PCAP	602759	1q42.2-q43	PCAP
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
{Prostate cancer, susceptibility to}, 176807 (3)	CDH1, UVO, LCAM, ECAD, BCDS1	192090	16q22.1	CDH1
{Prostate cancer, susceptibility to}, 176807 (3)	MXI1	600020	10q25.2	MXI1
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	EPHB2
{Prostate cancer}, 176807 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	KRT75, K6HF, PFB	609025	12q13.13	KRT75
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	FCGR2A
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	XYLT1
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT2, XT2, SOS	608125	17q21.33	XYLT2
{Psoriasis 15, pustular, susceptibility to}, 616106 (3)	AP1S3, PSORS15	615781	2q36.1	AP1S3
{Psoriasis susceptibility 10} (2)	PSORS10	612410	18p11.23	PSORS10
{Psoriasis susceptibility 11} (2)	PSORS11	612599	5q31.1-q33.1	PSORS11
{Psoriasis susceptibility 12} (2)	PSORS12	612950	20q13	PSORS12
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	TRAF3IP2
{Psoriasis susceptibility 1}, 177900 (3)	HLA-C, PSORS1	142840	6p21.33	HLA-C
{Psoriasis susceptibility 3} (2)	PSORS3	601454	4q	PSORS3
{Psoriasis susceptibility 4} (2)	PSORS4	603935	1q21	PSORS4
{Psoriasis susceptibility 5} (2)	PSORS5	604316	3q21	PSORS5
{Psoriasis susceptibility 6} (2)	PSORS6	605364	19p13	PSORS6
{Psoriasis susceptibility 7} (2)	PSORS7	605606	1p	PSORS7
{Psoriasis susceptibility 8} (2)	PSORS8	610707	16q	PSORS8
{Psoriasis susceptibility 9} (2)	PSORS9	607857	4q31-q34	PSORS9
{Psoriasis, protection against}, 605606 (3)	IL23R, IBD17	607562	1p31.3	IL23R
{Psoriatic arthritis, susceptibility to}, 607507 (2)	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	605956	16q12.1	NOD2
{Psoriatic arthritis, susceptibility to}, 607507 (3)	LTA, TNFB	153440	6p21.33	LTA
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	HMOX1, HMOX1D	141250	22q12.3	HMOX1
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	MUC5B	600770	11p15.5	MUC5B
{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	SFTPA1, SFTP1	178630	10q22.3	SFTPA1
{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TERC
{Pulmonary function} (2)	PLF	608852	6q21-q22	PLF
{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)	CTEPH1	612862	6p21.3	CTEPH1
{Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3)	CPS1, PHN	608307	2q34	CPS1
{Rapid progression to AIDS from HIV1 infection}, 609423 (3)	CX3CR1, GPR13, V28	601470	3p22.2	CX3CR1
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF1B
{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	BICC1, BICC, CYSRD	614295	10q21.1	BICC1
{Resistance to malaria due to G6PD deficiency}, 611162 (3)	G6PD, G6PD1	305900	Xq28	G6PD
{Restless legs syndrome 1} (2)	RLS1	102300	12q12-q21	RLS1
{Restless legs syndrome 2} (2)	RLS2	608831	14q13-q21	RLS2
{Restless legs syndrome 3} (2)	RLS3	610438	9p24-p22	RLS3
{Restless legs syndrome 4} (2)	RLS4	610439	2q33	RLS4
{Restless legs syndrome 5} (2)	RLS5	611242	20p13	RLS5
{Restless legs syndrome 6} (2)	RLS6	611185	6p21	RLS6
{Restless legs syndrome 7} (2)	RLS7	612853	2p14-p13	RLS7
{Restless legs syndrome 8} (2)	RLS8	615197	5q31	RLS8
{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3)	PDZD7	612971	10q24.31	PDZD7
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
{Rhabdoid tumor predisposition syndrome 2}, 613325 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	SMARCA4
{Rheumatoid arthritis, progression of}, 180300 (3)	IL10, CSIF, GVHDS	124092	1q32.1	IL10
{Rheumatoid arthritis, susceptibility to} (2)	RA	180300	6q23	RA
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	CD244, NAIL, NKR2B4, SLAMF4	605554	1q23.3	CD244
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	CIITA, MHC2TA, C2TA	600005	16p13.13	CIITA
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	NFKBIL1	601022	6p21.33	NFKBIL1
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PADI4, PADI5, PAD	605347	1p36.13	PADI4
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN22
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	SLC22A4, OCTN1	604190	5q31.1	SLC22A4
{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)	MIF	153620	22q11.23	MIF
{Rheumatoid arthritis, systemic juvenile}, 604302 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{SARS, progression of} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Sarcoidosis, susceptibility to, 1}, 181000 (3)	HLA-DRB1, SS1	142857	6p21.32	HLA-DRB1
{Sarcoidosis, susceptibility to, 2}, 612387 (3)	BTNL2, SS2	606000	6p21.32	BTNL2
{Sarcoidosis, susceptibility to, 3} (2)	SS3	612388	10q22.3	SS3
{Schistosoma mansoni infection, susceptibility/resistance to} (2)	SM1	181460	5q31-q33	SM1
{Schizophrenia 10} (2)	SCZD10	605419	15q15	SCZD10
{Schizophrenia 12}, 181500 (2)	SCZD12	608543	1p36.2	SCZD12
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	SHANK3
{Schizophrenia 19, susceptibility to}, 617629 (3)	RBM12, KIAA0765, SCZD19	607179	20q11.22	RBM12
{Schizophrenia 9, susceptibility to}, 604906 (3)	DISC1, SCZD9	605210	1q42.2	DISC1
{Schizophrenia, susceptibility to, 13} (2)	SCZD13	613025	15q13	SCZD13
{Schizophrenia, susceptibility to, 14} (2)	SCZD14	612361	2q32.1	SCZD14
{Schizophrenia, susceptibility to, 17}, 614332 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	NRXN1
{Schizophrenia, susceptibility to, 4}, 600850 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	PRODH
{Schizophrenia, susceptibility to}, 181500 (2)	AKT1, CWS6	164730	14q32.33	AKT1
{Schizophrenia, susceptibility to}, 181500 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	CHI3L1
{Schizophrenia, susceptibility to}, 181500 (3)	COMT	116790	22q11.21	COMT
{Schizophrenia, susceptibility to}, 181500 (3)	DRD3, ETM1, FET1	126451	3q13.31	DRD3
{Schizophrenia, susceptibility to}, 181500 (3)	HTR2A	182135	13q14.2	HTR2A
{Schizophrenia, susceptibility to}, 181500 (3)	MTHFR	607093	1p36.22	MTHFR
{Schizophrenia, susceptibility to}, 181500 (3)	RTN4R, NOGOR	605566	22q11.21	RTN4R
{Schizophrenia, susceptibility to}, 181500 (3)	SYN2	600755	3p25.2	SYN2
{Schizophrenia}, 181500 (1)	APOL2	607252	22q12.3	APOL2
{Schizophrenia}, 181500 (1)	APOL4	607254	22q12.3	APOL4
{Schizophrenia}, 181500 (2)	DAO, DAMOX	124050	12q24.11	DAO
{Schizophrenia}, 181500 (2)	DAOA, G72	607408	13q33.2	DAOA
{Schizophrenia}, 181500 (2)	SCZD1	181510	5q23-q35	SCZD1
{Schizophrenia}, 181500 (2)	SCZD11	608078	10q22.3	SCZD11
{Schizophrenia}, 181500 (2)	SCZD3	600511	6p23	SCZD3
{Schizophrenia}, 181500 (2)	SCZD5	603175	6q13-q26	SCZD5
{Schizophrenia}, 181500 (2)	SCZD6	603013	8p21	SCZD6
{Schizophrenia}, 181500 (2)	SCZD7	603176	13q32	SCZD7
{Schizophrenia}, 181500 (2)	SCZD8	603206	18p	SCZD8
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
{Schwannomatosis-2, susceptibility to}, 615670 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	LZTR1
{Scoliosis, idiopathic, susceptibility to, 4} (2)	IS4	612238	9q31.2-q34.2	IS4
{Scoliosis, idiopathic, susceptibility to, 5} (2)	IS5	612239	17q25.3	IS5
{Scoliosis, isolated, susceptibility to, 3} (2)	IS3	608765	8q12	IS3
{Seasonal affective disorder, susceptibility to}, 608516 (3)	HTR2A	182135	13q14.2	HTR2A
{Sepsis, susceptibility to} (3)	CASP12, CASP12P1	608633	11q22.3	CASP12
{Septic shock, susceptibility to} (3)	TNF, TNFA	191160	6p21.33	TNF
{Sezary syndrome, somatic}, (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
{Smoking as a quantitative trait locus 1} (2)	SQTL1	611003	10q22	SQTL1
{Smoking as a quantitative trait locus 2} (2)	SQTL2	611004	22q12	SQTL2
{Specific language impairment 4} (2)	SLI4	612514	7q35-q36	SLI4
{Specific language impairment 5}, 615432 (3)	TM4SF20, SLI5	615404	2q36.3	TM4SF20
{Speech-sound disorder} (2)	SSD	608445	3p12-q13	SSD
{Spermatogenic failure, susceptibility to} (3)	DAZL, DAZH, SPGYLA	601486	3p24.3	DAZL
{Spina bifida, susceptibility to}, 182940 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{Spinal muscular atrophy, type III, modifier of}, 253400 (3)	SMN2	601627	5q13.2	SMN2
{Spitz nevus or nevus spilus, somatic}, 137550 (3)	HRAS	190020	11p15.5	HRAS
{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Spondyloarthropathy, susceptibility to, 2} (2)	SPDA2	183840	9q31-q34	SPDA2
{Spondyloarthropathy, susceptibility to, 3} (2)	SPDA3	613238	2q36.1-q36.3	SPDA3
{Stature QTL 10} (2)	STQTL10	612221	3q23	STQTL10
{Stature QTL 11} (2)	STQTL11	612223	7q21	STQTL11
{Stature QTL 12} (2)	STQTL12	612224	4q31	STQTL12
{Stature QTL 13} (2)	STQTL13	612226	4p15.3	STQTL13
{Stature QTL 14} (2)	STQTL14	612228	20q11.22	STQTL14
{Stature QTL 15} (2)	STQTL15	612578	8q21.13	STQTL15
{Stature QTL 16} (2)	STQTL16	612579	15q22.32	STQTL16
{Stature QTL 17} (2)	STQTL17	612737	7p15	STQTL17
{Stature QTL 18} (2)	STQTL18	612892	6p22.1	STQTL18
{Stature QTL 19} (2)	STQTL19	612893	6p21.31	STQTL19
{Stature QTL 1} (2)	STQTL1	606255	6q24-q25	STQTL1
{Stature QTL 20} (2)	STQTL20	612894	13q14.3	STQTL20
{Stature QTL 21} (2)	STQTL21	613440	2q37.1	STQTL21
{Stature QTL 22} (2)	STQTL22	613547	16q24	STQTL22
{Stature QTL 23} (2)	STQTL23	613548	1p32	STQTL23
{Stature QTL 24} (2)	STQTL24	613549	2p16	STQTL24
{Stature QTL 2} (2)	STQTL2	606256	7q31.3	STQTL2
{Stature QTL 3} (2)	STQTL3	606257	12p11.2-q14	STQTL3
{Stature QTL 4} (2)	STQTL4	606258	13q32-q33	STQTL4
{Stature QTL 5} (2)	STQTL5	608982	3p26	STQTL5
{Stature QTL 6} (2)	STQTL6	300591	Xq24-q25	STQTL6
{Stature QTL 7} (2)	STQTL7	609822	1p21	STQTL7
{Stature QTL 8} (2)	STQTL8	610114	9q22	STQTL8
{Stature QTL 9} (2)	STQTL9	611547	12q14.3	STQTL9
{Stevens-Johnson syndrome, susceptibility to}, 608579 (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Strabismus, susceptibility to, 1} (2)	STBMS1	185100	7p22.1	STBMS1
{Stroke, hemorrhagic}, 614519 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Stroke, ischemic, susceptibility to}, 601367 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
{Stroke, ischemic, susceptibility to}, 601367 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Stroke, susceptibility to, 1}, 606799 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	PDE4D
{Stroke, susceptibility to}, 601367 (3)	ALOX5AP, FLAP	603700	13q12.3	ALOX5AP
{Sublingual nitroglycerin, susceptibility to poor response to} (3)	ALDH2	100650	12q24.12	ALDH2
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
{Synovitis, chronic, susceptibility to} (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Systemic lupus erythematosus susceptibility to}, 152700 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN22
{Systemic lupus erythematosus with hemolytic anemia} (2)	SLEH1	607279	11q14	SLEH1
{Systemic lupus erythematosus with nephritis, susceptibility to, 1} (2)	SLEN1	607965	10q22.3	SLEN1
{Systemic lupus erythematosus with nephritis, susceptibility to, 2} (2)	SLEN2	607966	2q34-q35	SLEN2
{Systemic lupus erythematosus with nephritis, susceptibility to, 3} (2)	SLEN3	607967	11p15.5	SLEN3
{Systemic lupus erythematosus, resistance to}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	IRF5
{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)	STAT4, SLEB11	600558	2q32.2-q32.3	STAT4
{Systemic lupus erythematosus, susceptibility to, 12} (2)	SLEB12	612254	8p23.1	SLEB12
{Systemic lupus erythematosus, susceptibility to, 13} (2)	SLEB13	612378	6q23	SLEB13
{Systemic lupus erythematosus, susceptibility to, 14} (2)	SLEB14	613145	1q21-q23	SLEB14
{Systemic lupus erythematosus, susceptibility to, 15} (2)	SLEB15	300809	Xq28	SLEB15
{Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3)	PDCD1, SLEB2	600244	2q37.3	PDCD1
{Systemic lupus erythematosus, susceptibility to, 3} (2)	SLEB3	605480	4p16-p15.2	SLEB3
{Systemic lupus erythematosus, susceptibility to, 4} (2)	SLEB4	608437	12q24	SLEB4
{Systemic lupus erythematosus, susceptibility to, 5} (2)	SLEB5	609903	13q32	SLEB5
{Systemic lupus erythematosus, susceptibility to, 7} (2)	SLEB7	610065	20p12	SLEB7
{Systemic lupus erythematosus, susceptibility to, 8} (2)	SLEB8	610066	20q13	SLEB8
{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	CR2
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	DNASE1, DNL1	125505	16p13.3	DNASE1
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	FCGR2B, CD32	604590	1q23.3	FCGR2B
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	ITGAM, CR3A, CD11B, MAC1A, SLEB6	120980	16p11.2	ITGAM
{T-cell acute lymphoblastic leukemia} (3)	MYB	189990	6q23.3	MYB
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Thiopurines, poor metabolism of, 1}, 610460 (3)	TPMT, TPMTD	187680	6p22.3	TPMT
{Thiopurines, poor metabolism of, 2}, 616903 (3)	NUDT15, MTH2, NUDT15D	615792	13q14.2	NUDT15
{Thromboembolism, susceptibility to}, 188050 (3)	MTHFR	607093	1p36.22	MTHFR
{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Thyroid cancer, nonmedullary, 1}, 188550 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2-1
{Thyroid cancer, nonmedullary, 2}, 188470 (3)	SRGAP1, KIAA1304, NMTC2	606523	12q14.2	SRGAP1
{Thyroid cancer, nonmedullary, 4}, 616534 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	FOXE1
{Thyroid carcinoma, Hurthle cell}, 607464 (3)	NDUFA13, GRIM19	609435	19p13.11	NDUFA13
{Thyroid carcinoma, follicular, somatic}, 188470 (3)	HRAS	190020	11p15.5	HRAS
{Thyroid carcinoma, nonmedullary, 3} (2)	NMTC3	606240	2q21	NMTC3
{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNA1S
{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	KCNJ18, KIR2.6, TTPP2	613236	17p11.2	KCNJ18
{Toxic epidermal necrolysis, susceptibility to}, 608579 (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Transcription of plasminogen activator inhibitor, modulator of} (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	PAI1
{Tuberculosis infection, protection against}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{Tuberculosis, protection against}, 607948 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Tuberculosis, protection against}, 607948 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Tuberculosis, susceptibility to} (2)	MTBS1	607949	2q35	MTBS1
{Tuberculosis, susceptibility to}, 607948 (3)	CISH, BACTS2	602441	3p21.2	CISH
{Tuberculosis, susceptibility to}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{UV-induced skin damage}, 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
{Unipolar depression, susceptibility to}, 608516 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	TPH2
{Uric acid concentration, serum, QTL 2}, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	SLC2A9
{Vascular disease, susceptibility to} (3)	MTHFR	607093	1p36.22	MTHFR
{Venoocclusive disease after bone marrow transplantation} (3)	CPS1, PHN	608307	2q34	CPS1
{Venous thromboembolism, susceptibility to}, 188050 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	HABP2
{Venous thrombosis, protection against}, 188050 (3)	F13A1, F13A	134570	6p25.1	F13A1
{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3)	DPP6, VF2, MRD33	126141	7q36.2	DPP6
{Viral infection, susceptibility to} (3)	OAS1, OIAS	164350	12q24.13	OAS1
{Vitamin B12 plasma level QTL1}, 612542 (3)	FUT2, SE, B12QTL1	182100	19q13.33	FUT2
{Vitamin B6 plasma level QTL 1} (2)	B6QTL1	612957	1p36.12	B6QTL1
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK	606636	17p13.2	NLRP1
{Vitiligo-associated multiple autoimmune disease susceptibility 6} (2)	VAMAS6	193200	6p21.3	VAMAS6
{Warfarin sensitivity}, 122700 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
{West nile virus, susceptibility to}, 610379 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{Wilms tumor 6, susceptibility to}, 616806 (3)	REST, NRSF, WT6, GINGF5, HGF5	600571	4q12	REST
{Wilms tumor susceptibility-5}, 601583 (3)	POU6F2, WTSL, WT5	609062	7p14.1	POU6F2
{Yao syndrome}, 617321 (3)	NOD2, CARD15, IBD1, CD, YAOS, BLAUS	605956	16q12.1	NOD2
{von Hippel-Lindau syndrome, modifier of}, 193300 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	CCND1
